id	sid	tid	token	lemma	pos
ajlm-1458	1	1	abstract	abstract	ADJ
ajlm-1458	1	2	introduction	introduction	NOUN
ajlm-1458	1	3	methods	method	NOUN
ajlm-1458	1	4	results	result	VERB
ajlm-1458	1	5	discussion	discussion	NOUN
ajlm-1458	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1458	1	7	references	reference	NOUN
ajlm-1458	1	8	about	about	ADP
ajlm-1458	1	9	the	the	DET
ajlm-1458	1	10	author(s	author(s	NOUN
ajlm-1458	1	11	)	)	PUNCT
ajlm-1458	2	1	deborah	deborah	PROPN
ajlm-1458	2	2	k.	k.	PROPN
ajlm-1458	2	3	glencross	glencross	PROPN
ajlm-1458	2	4	department	department	PROPN
ajlm-1458	2	5	of	of	ADP
ajlm-1458	2	6	molecular	molecular	ADJ
ajlm-1458	2	7	medicine	medicine	NOUN
ajlm-1458	2	8	and	and	CCONJ
ajlm-1458	2	9	haematology	haematology	NOUN
ajlm-1458	2	10	,	,	PUNCT
ajlm-1458	2	11	faculty	faculty	NOUN
ajlm-1458	2	12	of	of	ADP
ajlm-1458	2	13	health	health	NOUN
ajlm-1458	2	14	sciences	sciences	PROPN
ajlm-1458	2	15	,	,	PUNCT
ajlm-1458	2	16	university	university	NOUN
ajlm-1458	2	17	of	of	ADP
ajlm-1458	2	18	the	the	DET
ajlm-1458	2	19	witwatersrand	witwatersrand	NOUN
ajlm-1458	2	20	,	,	PUNCT
ajlm-1458	2	21	johannesburg	johannesburg	PROPN
ajlm-1458	2	22	,	,	PUNCT
ajlm-1458	2	23	south	south	PROPN
ajlm-1458	2	24	africa	africa	PROPN
ajlm-1458	2	25	department	department	PROPN
ajlm-1458	2	26	of	of	ADP
ajlm-1458	2	27	molecular	molecular	ADJ
ajlm-1458	2	28	medicine	medicine	NOUN
ajlm-1458	2	29	and	and	CCONJ
ajlm-1458	2	30	haematology	haematology	NOUN
ajlm-1458	2	31	,	,	PUNCT
ajlm-1458	2	32	charlotte	charlotte	PROPN
ajlm-1458	2	33	maxeke	maxeke	NOUN
ajlm-1458	2	34	academic	academic	ADJ
ajlm-1458	2	35	hospital	hospital	NOUN
ajlm-1458	2	36	,	,	PUNCT
ajlm-1458	2	37	national	national	PROPN
ajlm-1458	2	38	health	health	PROPN
ajlm-1458	2	39	laboratory	laboratory	PROPN
ajlm-1458	2	40	service	service	PROPN
ajlm-1458	2	41	,	,	PUNCT
ajlm-1458	2	42	johannesburg	johannesburg	PROPN
ajlm-1458	2	43	,	,	PUNCT
ajlm-1458	2	44	south	south	PROPN
ajlm-1458	2	45	africa	africa	PROPN
ajlm-1458	2	46	leanne	leanne	PROPN
ajlm-1458	2	47	swart	swart	PROPN
ajlm-1458	2	48	department	department	PROPN
ajlm-1458	2	49	of	of	ADP
ajlm-1458	2	50	molecular	molecular	ADJ
ajlm-1458	2	51	medicine	medicine	NOUN
ajlm-1458	2	52	and	and	CCONJ
ajlm-1458	2	53	haematology	haematology	NOUN
ajlm-1458	2	54	,	,	PUNCT
ajlm-1458	2	55	faculty	faculty	NOUN
ajlm-1458	2	56	of	of	ADP
ajlm-1458	2	57	health	health	NOUN
ajlm-1458	2	58	sciences	sciences	PROPN
ajlm-1458	2	59	,	,	PUNCT
ajlm-1458	2	60	university	university	NOUN
ajlm-1458	2	61	of	of	ADP
ajlm-1458	2	62	the	the	DET
ajlm-1458	2	63	witwatersrand	witwatersrand	NOUN
ajlm-1458	2	64	,	,	PUNCT
ajlm-1458	2	65	johannesburg	johannesburg	PROPN
ajlm-1458	2	66	,	,	PUNCT
ajlm-1458	2	67	south	south	PROPN
ajlm-1458	2	68	africa	africa	PROPN
ajlm-1458	2	69	department	department	PROPN
ajlm-1458	2	70	of	of	ADP
ajlm-1458	2	71	molecular	molecular	ADJ
ajlm-1458	2	72	medicine	medicine	NOUN
ajlm-1458	2	73	and	and	CCONJ
ajlm-1458	2	74	haematology	haematology	NOUN
ajlm-1458	2	75	,	,	PUNCT
ajlm-1458	2	76	charlotte	charlotte	PROPN
ajlm-1458	2	77	maxeke	maxeke	NOUN
ajlm-1458	2	78	academic	academic	ADJ
ajlm-1458	2	79	hospital	hospital	NOUN
ajlm-1458	2	80	,	,	PUNCT
ajlm-1458	2	81	national	national	PROPN
ajlm-1458	2	82	health	health	PROPN
ajlm-1458	2	83	laboratory	laboratory	PROPN
ajlm-1458	2	84	service	service	PROPN
ajlm-1458	2	85	,	,	PUNCT
ajlm-1458	2	86	johannesburg	johannesburg	PROPN
ajlm-1458	2	87	,	,	PUNCT
ajlm-1458	2	88	south	south	PROPN
ajlm-1458	2	89	africa	africa	PROPN
ajlm-1458	2	90	melanie	melanie	PROPN
ajlm-1458	2	91	pretorius	pretorius	PROPN
ajlm-1458	2	92	department	department	PROPN
ajlm-1458	2	93	of	of	ADP
ajlm-1458	2	94	molecular	molecular	ADJ
ajlm-1458	2	95	medicine	medicine	NOUN
ajlm-1458	2	96	and	and	CCONJ
ajlm-1458	2	97	haematology	haematology	NOUN
ajlm-1458	2	98	,	,	PUNCT
ajlm-1458	2	99	faculty	faculty	NOUN
ajlm-1458	2	100	of	of	ADP
ajlm-1458	2	101	health	health	NOUN
ajlm-1458	2	102	sciences	sciences	PROPN
ajlm-1458	2	103	,	,	PUNCT
ajlm-1458	2	104	university	university	NOUN
ajlm-1458	2	105	of	of	ADP
ajlm-1458	2	106	the	the	DET
ajlm-1458	2	107	witwatersrand	witwatersrand	NOUN
ajlm-1458	2	108	,	,	PUNCT
ajlm-1458	2	109	johannesburg	johannesburg	PROPN
ajlm-1458	2	110	,	,	PUNCT
ajlm-1458	2	111	south	south	PROPN
ajlm-1458	2	112	africa	africa	PROPN
ajlm-1458	2	113	department	department	PROPN
ajlm-1458	2	114	of	of	ADP
ajlm-1458	2	115	molecular	molecular	ADJ
ajlm-1458	2	116	medicine	medicine	NOUN
ajlm-1458	2	117	and	and	CCONJ
ajlm-1458	2	118	haematology	haematology	NOUN
ajlm-1458	2	119	,	,	PUNCT
ajlm-1458	2	120	charlotte	charlotte	PROPN
ajlm-1458	2	121	maxeke	maxeke	NOUN
ajlm-1458	2	122	academic	academic	ADJ
ajlm-1458	2	123	hospital	hospital	NOUN
ajlm-1458	2	124	,	,	PUNCT
ajlm-1458	2	125	national	national	PROPN
ajlm-1458	2	126	health	health	PROPN
ajlm-1458	2	127	laboratory	laboratory	PROPN
ajlm-1458	2	128	service	service	PROPN
ajlm-1458	2	129	,	,	PUNCT
ajlm-1458	2	130	johannesburg	johannesburg	PROPN
ajlm-1458	2	131	,	,	PUNCT
ajlm-1458	2	132	south	south	PROPN
ajlm-1458	2	133	africa	africa	PROPN
ajlm-1458	2	134	denise	denise	PROPN
ajlm-1458	2	135	lawrie	lawrie	PROPN
ajlm-1458	2	136	department	department	PROPN
ajlm-1458	2	137	of	of	ADP
ajlm-1458	2	138	molecular	molecular	ADJ
ajlm-1458	2	139	medicine	medicine	NOUN
ajlm-1458	2	140	and	and	CCONJ
ajlm-1458	2	141	haematology	haematology	NOUN
ajlm-1458	2	142	,	,	PUNCT
ajlm-1458	2	143	faculty	faculty	NOUN
ajlm-1458	2	144	of	of	ADP
ajlm-1458	2	145	health	health	NOUN
ajlm-1458	2	146	sciences	sciences	PROPN
ajlm-1458	2	147	,	,	PUNCT
ajlm-1458	2	148	university	university	NOUN
ajlm-1458	2	149	of	of	ADP
ajlm-1458	2	150	the	the	DET
ajlm-1458	2	151	witwatersrand	witwatersrand	NOUN
ajlm-1458	2	152	,	,	PUNCT
ajlm-1458	2	153	johannesburg	johannesburg	PROPN
ajlm-1458	2	154	,	,	PUNCT
ajlm-1458	2	155	south	south	PROPN
ajlm-1458	2	156	africa	africa	PROPN
ajlm-1458	2	157	department	department	PROPN
ajlm-1458	2	158	of	of	ADP
ajlm-1458	2	159	molecular	molecular	ADJ
ajlm-1458	2	160	medicine	medicine	NOUN
ajlm-1458	2	161	and	and	CCONJ
ajlm-1458	2	162	haematology	haematology	NOUN
ajlm-1458	2	163	,	,	PUNCT
ajlm-1458	2	164	charlotte	charlotte	PROPN
ajlm-1458	2	165	maxeke	maxeke	NOUN
ajlm-1458	2	166	academic	academic	ADJ
ajlm-1458	2	167	hospital	hospital	NOUN
ajlm-1458	2	168	,	,	PUNCT
ajlm-1458	2	169	national	national	PROPN
ajlm-1458	2	170	health	health	PROPN
ajlm-1458	2	171	laboratory	laboratory	PROPN
ajlm-1458	2	172	service	service	PROPN
ajlm-1458	2	173	,	,	PUNCT
ajlm-1458	2	174	johannesburg	johannesburg	PROPN
ajlm-1458	2	175	,	,	PUNCT
ajlm-1458	2	176	south	south	PROPN
ajlm-1458	2	177	africa	africa	PROPN
ajlm-1458	2	178	citation	citation	PROPN
ajlm-1458	2	179	glencross	glencross	PROPN
ajlm-1458	2	180	dk	dk	PROPN
ajlm-1458	2	181	,	,	PUNCT
ajlm-1458	2	182	swart	swart	PROPN
ajlm-1458	2	183	l	l	PROPN
ajlm-1458	2	184	,	,	PUNCT
ajlm-1458	2	185	pretorius	pretorius	PROPN
ajlm-1458	2	186	m	m	PROPN
ajlm-1458	2	187	,	,	PUNCT
ajlm-1458	2	188	lawrie	lawrie	PROPN
ajlm-1458	2	189	d.	d.	PROPN
ajlm-1458	2	190	evaluation	evaluation	NOUN
ajlm-1458	2	191	of	of	ADP
ajlm-1458	2	192	fixed	fix	VERB
ajlm-1458	2	193	-	-	PUNCT
ajlm-1458	2	194	panel	panel	NOUN
ajlm-1458	2	195	,	,	PUNCT
ajlm-1458	2	196	multicolour	multicolour	ADJ
ajlm-1458	2	197	clearllab	clearllab	NOUN
ajlm-1458	2	198	10c	10c	NOUN
ajlm-1458	2	199	at	at	ADP
ajlm-1458	2	200	an	an	DET
ajlm-1458	2	201	academic	academic	ADJ
ajlm-1458	2	202	flow	flow	NOUN
ajlm-1458	2	203	cytometry	cytometry	PROPN
ajlm-1458	2	204	laboratory	laboratory	NOUN
ajlm-1458	2	205	in	in	ADP
ajlm-1458	2	206	johannesburg	johannesburg	PROPN
ajlm-1458	2	207	,	,	PUNCT
ajlm-1458	2	208	south	south	PROPN
ajlm-1458	2	209	africa	africa	PROPN
ajlm-1458	2	210	.	.	PUNCT
ajlm-1458	3	1	afr	afr	PROPN
ajlm-1458	3	2	j	j	PROPN
ajlm-1458	3	3	lab	lab	PROPN
ajlm-1458	3	4	med	med	PROPN
ajlm-1458	3	5	.	.	PUNCT
ajlm-1458	4	1	2022;11(1	2022;11(1	NUM
ajlm-1458	4	2	)	)	PUNCT
ajlm-1458	4	3	,	,	PUNCT
ajlm-1458	4	4	a1458	a1458	PROPN
ajlm-1458	4	5	.	.	PUNCT
ajlm-1458	5	1	https://doi.org/10.4102/ajlm.v11i1.1458	https://doi.org/10.4102/ajlm.v11i1.1458	PROPN
ajlm-1458	5	2	original	original	ADJ
ajlm-1458	5	3	research	research	NOUN
ajlm-1458	5	4	evaluation	evaluation	NOUN
ajlm-1458	5	5	of	of	ADP
ajlm-1458	5	6	fixed	fix	VERB
ajlm-1458	5	7	-	-	PUNCT
ajlm-1458	5	8	panel	panel	NOUN
ajlm-1458	5	9	,	,	PUNCT
ajlm-1458	5	10	multicolour	multicolour	ADJ
ajlm-1458	5	11	clearllab	clearllab	NOUN
ajlm-1458	5	12	10c	10c	NOUN
ajlm-1458	5	13	at	at	ADP
ajlm-1458	5	14	an	an	DET
ajlm-1458	5	15	academic	academic	ADJ
ajlm-1458	5	16	flow	flow	NOUN
ajlm-1458	5	17	cytometry	cytometry	PROPN
ajlm-1458	5	18	laboratory	laboratory	NOUN
ajlm-1458	5	19	in	in	ADP
ajlm-1458	5	20	johannesburg	johannesburg	PROPN
ajlm-1458	5	21	,	,	PUNCT
ajlm-1458	5	22	south	south	PROPN
ajlm-1458	5	23	africa	africa	PROPN
ajlm-1458	5	24	deborah	deborah	PROPN
ajlm-1458	5	25	k.	k.	PROPN
ajlm-1458	5	26	glencross	glencross	PROPN
ajlm-1458	5	27	,	,	PUNCT
ajlm-1458	5	28	leanne	leanne	PROPN
ajlm-1458	5	29	swart	swart	PROPN
ajlm-1458	5	30	,	,	PUNCT
ajlm-1458	5	31	melanie	melanie	PROPN
ajlm-1458	5	32	pretorius	pretorius	PROPN
ajlm-1458	5	33	,	,	PUNCT
ajlm-1458	5	34	denise	denise	PROPN
ajlm-1458	5	35	lawrie	lawrie	PROPN
ajlm-1458	5	36	received	receive	VERB
ajlm-1458	5	37	:	:	PUNCT
ajlm-1458	5	38	19	19	NUM
ajlm-1458	5	39	nov	nov	PROPN
ajlm-1458	5	40	.	.	PROPN
ajlm-1458	5	41	2020	2020	NUM
ajlm-1458	5	42	;	;	PUNCT
ajlm-1458	5	43	accepted	accept	VERB
ajlm-1458	5	44	:	:	PUNCT
ajlm-1458	5	45	30	30	NUM
ajlm-1458	5	46	mar	mar	PROPN
ajlm-1458	5	47	.	.	PROPN
ajlm-1458	5	48	2022	2022	NUM
ajlm-1458	5	49	;	;	PUNCT
ajlm-1458	5	50	published	publish	VERB
ajlm-1458	5	51	:	:	PUNCT
ajlm-1458	5	52	15	15	NUM
ajlm-1458	5	53	july	july	PROPN
ajlm-1458	5	54	2022	2022	NUM
ajlm-1458	5	55	copyright	copyright	NOUN
ajlm-1458	5	56	:	:	PUNCT
ajlm-1458	5	57	©	©	PROPN
ajlm-1458	5	58	2022	2022	NUM
ajlm-1458	5	59	.	.	PUNCT
ajlm-1458	6	1	the	the	DET
ajlm-1458	6	2	author(s	author(s	PROPN
ajlm-1458	6	3	)	)	PUNCT
ajlm-1458	6	4	.	.	PUNCT
ajlm-1458	7	1	licensee	licensee	NOUN
ajlm-1458	7	2	:	:	PUNCT
ajlm-1458	7	3	aosis	aosis	NOUN
ajlm-1458	7	4	.	.	PUNCT
ajlm-1458	8	1	this	this	PRON
ajlm-1458	8	2	is	be	AUX
ajlm-1458	8	3	an	an	DET
ajlm-1458	8	4	open	open	ADJ
ajlm-1458	8	5	access	access	NOUN
ajlm-1458	8	6	article	article	NOUN
ajlm-1458	8	7	distributed	distribute	VERB
ajlm-1458	8	8	under	under	ADP
ajlm-1458	8	9	the	the	DET
ajlm-1458	8	10	terms	term	NOUN
ajlm-1458	8	11	of	of	ADP
ajlm-1458	8	12	the	the	DET
ajlm-1458	8	13	creative	creative	ADJ
ajlm-1458	8	14	commons	common	NOUN
ajlm-1458	8	15	attribution	attribution	NOUN
ajlm-1458	8	16	license	license	NOUN
ajlm-1458	8	17	,	,	PUNCT
ajlm-1458	8	18	which	which	PRON
ajlm-1458	8	19	permits	permit	VERB
ajlm-1458	8	20	unrestricted	unrestricted	ADJ
ajlm-1458	8	21	use	use	NOUN
ajlm-1458	8	22	,	,	PUNCT
ajlm-1458	8	23	distribution	distribution	NOUN
ajlm-1458	8	24	,	,	PUNCT
ajlm-1458	8	25	and	and	CCONJ
ajlm-1458	8	26	reproduction	reproduction	NOUN
ajlm-1458	8	27	in	in	ADP
ajlm-1458	8	28	any	any	DET
ajlm-1458	8	29	medium	medium	NOUN
ajlm-1458	8	30	,	,	PUNCT
ajlm-1458	8	31	provided	provide	VERB
ajlm-1458	8	32	the	the	DET
ajlm-1458	8	33	original	original	ADJ
ajlm-1458	8	34	work	work	NOUN
ajlm-1458	8	35	is	be	AUX
ajlm-1458	8	36	properly	properly	ADV
ajlm-1458	8	37	cited	cite	VERB
ajlm-1458	8	38	.	.	PUNCT
ajlm-1458	9	1	abstract	abstract	ADJ
ajlm-1458	9	2	background	background	NOUN
ajlm-1458	9	3	:	:	PUNCT
ajlm-1458	9	4	flow	flow	NOUN
ajlm-1458	9	5	cytometric	cytometric	ADJ
ajlm-1458	9	6	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	9	7	is	be	AUX
ajlm-1458	9	8	well	well	ADV
ajlm-1458	9	9	established	establish	VERB
ajlm-1458	9	10	for	for	ADP
ajlm-1458	9	11	the	the	DET
ajlm-1458	9	12	diagnosis	diagnosis	NOUN
ajlm-1458	9	13	of	of	ADP
ajlm-1458	9	14	haematological	haematological	ADJ
ajlm-1458	9	15	neoplasms	neoplasm	NOUN
ajlm-1458	9	16	.	.	PUNCT
ajlm-1458	10	1	new	new	ADJ
ajlm-1458	10	2	commercially	commercially	ADV
ajlm-1458	10	3	available	available	ADJ
ajlm-1458	10	4	systems	system	NOUN
ajlm-1458	10	5	offer	offer	VERB
ajlm-1458	10	6	fixed	fix	VERB
ajlm-1458	10	7	,	,	PUNCT
ajlm-1458	10	8	pre	pre	ADJ
ajlm-1458	10	9	-	-	ADJ
ajlm-1458	10	10	aliquoted	aliquoted	ADJ
ajlm-1458	10	11	multi	multi	ADJ
ajlm-1458	10	12	-	-	ADJ
ajlm-1458	10	13	parameter	parameter	ADJ
ajlm-1458	10	14	analysis	analysis	NOUN
ajlm-1458	10	15	to	to	PART
ajlm-1458	10	16	simplify	simplify	VERB
ajlm-1458	10	17	sample	sample	NOUN
ajlm-1458	10	18	preparation	preparation	NOUN
ajlm-1458	10	19	and	and	CCONJ
ajlm-1458	10	20	standardise	standardise	VERB
ajlm-1458	10	21	data	datum	NOUN
ajlm-1458	10	22	analysis	analysis	NOUN
ajlm-1458	10	23	.	.	PUNCT
ajlm-1458	11	1	objective	objective	NOUN
ajlm-1458	11	2	:	:	PUNCT
ajlm-1458	11	3	the	the	DET
ajlm-1458	11	4	beckman	beckman	PROPN
ajlm-1458	11	5	coulter	coulter	PROPN
ajlm-1458	11	6	(	(	PUNCT
ajlm-1458	11	7	bc	bc	PROPN
ajlm-1458	11	8	)	)	PUNCT
ajlm-1458	11	9	clearllab	clearllab	PROPN
ajlm-1458	11	10	™	™	PROPN
ajlm-1458	11	11	10c	10c	NOUN
ajlm-1458	11	12	(	(	PUNCT
ajlm-1458	11	13	4	4	NUM
ajlm-1458	11	14	-	-	PUNCT
ajlm-1458	11	15	tube	tube	NOUN
ajlm-1458	11	16	)	)	PUNCT
ajlm-1458	11	17	system	system	NOUN
ajlm-1458	11	18	was	be	AUX
ajlm-1458	11	19	evaluated	evaluate	VERB
ajlm-1458	11	20	against	against	ADP
ajlm-1458	11	21	an	an	DET
ajlm-1458	11	22	existing	exist	VERB
ajlm-1458	11	23	laboratory	laboratory	NOUN
ajlm-1458	11	24	developed	develop	VERB
ajlm-1458	11	25	test	test	NOUN
ajlm-1458	11	26	(	(	PUNCT
ajlm-1458	11	27	ldt	ldt	PROPN
ajlm-1458	11	28	)	)	PUNCT
ajlm-1458	11	29	.	.	PUNCT
ajlm-1458	12	1	methods	method	NOUN
ajlm-1458	12	2	:	:	PUNCT
ajlm-1458	12	3	peripheral	peripheral	ADJ
ajlm-1458	12	4	blood	blood	NOUN
ajlm-1458	12	5	and	and	CCONJ
ajlm-1458	12	6	bone	bone	NOUN
ajlm-1458	12	7	marrow	marrow	NOUN
ajlm-1458	12	8	aspirates	aspirate	NOUN
ajlm-1458	12	9	(	(	PUNCT
ajlm-1458	12	10	n	n	NOUN
ajlm-1458	12	11	=	=	SYM
ajlm-1458	12	12	101	101	NUM
ajlm-1458	12	13	)	)	PUNCT
ajlm-1458	12	14	,	,	PUNCT
ajlm-1458	12	15	tested	test	VERB
ajlm-1458	12	16	between	between	ADP
ajlm-1458	12	17	august	august	PROPN
ajlm-1458	12	18	2019	2019	NUM
ajlm-1458	12	19	and	and	CCONJ
ajlm-1458	12	20	november	november	PROPN
ajlm-1458	12	21	2019	2019	NUM
ajlm-1458	12	22	at	at	ADP
ajlm-1458	12	23	an	an	DET
ajlm-1458	12	24	academic	academic	ADJ
ajlm-1458	12	25	pathology	pathology	NOUN
ajlm-1458	12	26	laboratory	laboratory	NOUN
ajlm-1458	12	27	in	in	ADP
ajlm-1458	12	28	johannesburg	johannesburg	PROPN
ajlm-1458	12	29	,	,	PUNCT
ajlm-1458	12	30	south	south	PROPN
ajlm-1458	12	31	africa	africa	PROPN
ajlm-1458	12	32	,	,	PUNCT
ajlm-1458	12	33	were	be	AUX
ajlm-1458	12	34	analysed	analyse	VERB
ajlm-1458	12	35	.	.	PUNCT
ajlm-1458	13	1	following	follow	VERB
ajlm-1458	13	2	daily	daily	ADJ
ajlm-1458	13	3	instrument	instrument	NOUN
ajlm-1458	13	4	quality	quality	NOUN
ajlm-1458	13	5	control	control	NOUN
ajlm-1458	13	6	,	,	PUNCT
ajlm-1458	13	7	samples	sample	NOUN
ajlm-1458	13	8	were	be	AUX
ajlm-1458	13	9	prepared	prepare	VERB
ajlm-1458	13	10	for	for	ADP
ajlm-1458	13	11	ldt	ldt	PROPN
ajlm-1458	13	12	(	(	PUNCT
ajlm-1458	13	13	using	use	VERB
ajlm-1458	13	14	>	>	X
ajlm-1458	13	15	20	20	NUM
ajlm-1458	13	16	2–4	2–4	NUM
ajlm-1458	13	17	-	-	PUNCT
ajlm-1458	13	18	colour	colour	NOUN
ajlm-1458	13	19	in	in	ADP
ajlm-1458	13	20	-	-	PUNCT
ajlm-1458	13	21	house	house	NOUN
ajlm-1458	13	22	panels	panel	NOUN
ajlm-1458	13	23	and	and	CCONJ
ajlm-1458	13	24	an	an	DET
ajlm-1458	13	25	extensive	extensive	ADJ
ajlm-1458	13	26	liquid	liquid	ADJ
ajlm-1458	13	27	monoclonal	monoclonal	NOUN
ajlm-1458	13	28	reagent	reagent	ADJ
ajlm-1458	13	29	repertoire	repertoire	NOUN
ajlm-1458	13	30	)	)	PUNCT
ajlm-1458	13	31	or	or	CCONJ
ajlm-1458	13	32	clearllab	clearllab	NOUN
ajlm-1458	13	33	10c	10c	NOUN
ajlm-1458	13	34	,	,	PUNCT
ajlm-1458	13	35	and	and	CCONJ
ajlm-1458	13	36	respectively	respectively	ADV
ajlm-1458	13	37	analysed	analyse	VERB
ajlm-1458	13	38	using	use	VERB
ajlm-1458	13	39	in	in	ADP
ajlm-1458	13	40	-	-	PUNCT
ajlm-1458	13	41	house	house	NOUN
ajlm-1458	13	42	protocols	protocol	NOUN
ajlm-1458	13	43	on	on	ADP
ajlm-1458	13	44	a	a	DET
ajlm-1458	13	45	becton	becton	PROPN
ajlm-1458	13	46	dickinson	dickinson	PROPN
ajlm-1458	13	47	facscalibur	facscalibur	PROPN
ajlm-1458	13	48	,	,	PUNCT
ajlm-1458	13	49	or	or	CCONJ
ajlm-1458	13	50	manufacturer	manufacturer	NOUN
ajlm-1458	13	51	-	-	PUNCT
ajlm-1458	13	52	directed	direct	VERB
ajlm-1458	13	53	protocols	protocol	NOUN
ajlm-1458	13	54	on	on	ADP
ajlm-1458	13	55	a	a	DET
ajlm-1458	13	56	bc	bc	PROPN
ajlm-1458	13	57	navios	navio	NOUN
ajlm-1458	13	58	.	.	PUNCT
ajlm-1458	14	1	becton	becton	PROPN
ajlm-1458	14	2	dickinson	dickinson	PROPN
ajlm-1458	14	3	paint	paint	PROPN
ajlm-1458	14	4	-	-	PUNCT
ajlm-1458	14	5	a	a	DET
ajlm-1458	14	6	-	-	PUNCT
ajlm-1458	14	7	gate	gate	NOUN
ajlm-1458	14	8	or	or	CCONJ
ajlm-1458	14	9	bc	bc	PROPN
ajlm-1458	14	10	kaluza	kaluza	PROPN
ajlm-1458	14	11	c	c	PROPN
ajlm-1458	14	12	software	software	PROPN
ajlm-1458	14	13	facilitated	facilitate	VERB
ajlm-1458	14	14	data	datum	NOUN
ajlm-1458	14	15	interpretation	interpretation	NOUN
ajlm-1458	14	16	.	.	PUNCT
ajlm-1458	15	1	diagnostic	diagnostic	ADJ
ajlm-1458	15	2	accuracy	accuracy	NOUN
ajlm-1458	15	3	(	(	PUNCT
ajlm-1458	15	4	concordance	concordance	NOUN
ajlm-1458	15	5	)	)	PUNCT
ajlm-1458	15	6	was	be	AUX
ajlm-1458	15	7	established	establish	VERB
ajlm-1458	15	8	by	by	ADP
ajlm-1458	15	9	calculating	calculate	VERB
ajlm-1458	15	10	sensitivity	sensitivity	NOUN
ajlm-1458	15	11	and	and	CCONJ
ajlm-1458	15	12	specificity	specificity	NOUN
ajlm-1458	15	13	outcomes	outcome	NOUN
ajlm-1458	15	14	.	.	PUNCT
ajlm-1458	16	1	results	result	NOUN
ajlm-1458	16	2	:	:	PUNCT
ajlm-1458	16	3	excellent	excellent	ADJ
ajlm-1458	16	4	agreement	agreement	NOUN
ajlm-1458	16	5	(	(	PUNCT
ajlm-1458	16	6	clinical	clinical	ADJ
ajlm-1458	16	7	diagnostic	diagnostic	ADJ
ajlm-1458	16	8	concordance	concordance	NOUN
ajlm-1458	16	9	)	)	PUNCT
ajlm-1458	16	10	with	with	ADP
ajlm-1458	16	11	100	100	NUM
ajlm-1458	16	12	%	%	NOUN
ajlm-1458	16	13	specificity	specificity	NOUN
ajlm-1458	16	14	and	and	CCONJ
ajlm-1458	16	15	sensitivity	sensitivity	NOUN
ajlm-1458	16	16	was	be	AUX
ajlm-1458	16	17	established	establish	VERB
ajlm-1458	16	18	between	between	ADP
ajlm-1458	16	19	ldt	ldt	PROPN
ajlm-1458	16	20	and	and	CCONJ
ajlm-1458	16	21	clearllab	clearllab	NOUN
ajlm-1458	16	22	10c	10c	NOUN
ajlm-1458	16	23	in	in	ADP
ajlm-1458	16	24	67	67	NUM
ajlm-1458	16	25	patients	patient	NOUN
ajlm-1458	16	26	with	with	ADP
ajlm-1458	16	27	a	a	DET
ajlm-1458	16	28	haematological	haematological	ADJ
ajlm-1458	16	29	neoplasm	neoplasm	NOUN
ajlm-1458	16	30	and	and	CCONJ
ajlm-1458	16	31	34	34	NUM
ajlm-1458	16	32	participants	participant	NOUN
ajlm-1458	16	33	with	with	ADP
ajlm-1458	16	34	no	no	DET
ajlm-1458	16	35	haematological	haematological	ADJ
ajlm-1458	16	36	disease	disease	NOUN
ajlm-1458	16	37	.	.	PUNCT
ajlm-1458	17	1	similar	similar	ADJ
ajlm-1458	17	2	acceptable	acceptable	ADJ
ajlm-1458	17	3	diagnostic	diagnostic	ADJ
ajlm-1458	17	4	concordance	concordance	NOUN
ajlm-1458	17	5	(	(	PUNCT
ajlm-1458	17	6	97	97	NUM
ajlm-1458	17	7	%	%	NOUN
ajlm-1458	17	8	)	)	PUNCT
ajlm-1458	17	9	was	be	AUX
ajlm-1458	17	10	noted	note	VERB
ajlm-1458	17	11	when	when	SCONJ
ajlm-1458	17	12	comparing	compare	VERB
ajlm-1458	17	13	clearllab	clearllab	NOUN
ajlm-1458	17	14	10c	10c	NOUN
ajlm-1458	17	15	to	to	ADP
ajlm-1458	17	16	clinicopathological	clinicopathological	ADJ
ajlm-1458	17	17	outcomes	outcome	NOUN
ajlm-1458	17	18	.	.	PUNCT
ajlm-1458	18	1	additionally	additionally	ADV
ajlm-1458	18	2	,	,	PUNCT
ajlm-1458	18	3	the	the	DET
ajlm-1458	18	4	clearllab	clearllab	NOUN
ajlm-1458	18	5	10c	10c	NUM
ajlm-1458	18	6	panels	panel	NOUN
ajlm-1458	18	7	,	,	PUNCT
ajlm-1458	18	8	analysed	analyse	VERB
ajlm-1458	18	9	with	with	ADP
ajlm-1458	18	10	kaluza	kaluza	PROPN
ajlm-1458	18	11	c	c	PROPN
ajlm-1458	18	12	software	software	NOUN
ajlm-1458	18	13	,	,	PUNCT
ajlm-1458	18	14	enabled	enable	VERB
ajlm-1458	18	15	simultaneous	simultaneous	ADJ
ajlm-1458	18	16	discrimination	discrimination	NOUN
ajlm-1458	18	17	of	of	ADP
ajlm-1458	18	18	disease	disease	NOUN
ajlm-1458	18	19	and	and	CCONJ
ajlm-1458	18	20	concurrent	concurrent	ADJ
ajlm-1458	18	21	background	background	NOUN
ajlm-1458	18	22	myeloid	myeloid	NOUN
ajlm-1458	18	23	and	and	CCONJ
ajlm-1458	18	24	lymphoid	lymphoid	ADJ
ajlm-1458	18	25	haematological	haematological	ADJ
ajlm-1458	18	26	populations	population	NOUN
ajlm-1458	18	27	,	,	PUNCT
ajlm-1458	18	28	including	include	VERB
ajlm-1458	18	29	assessing	assess	VERB
ajlm-1458	18	30	stages	stage	NOUN
ajlm-1458	18	31	of	of	ADP
ajlm-1458	18	32	maturation	maturation	NOUN
ajlm-1458	18	33	or	or	CCONJ
ajlm-1458	18	34	sub	sub	NOUN
ajlm-1458	18	35	-	-	NOUN
ajlm-1458	18	36	populations	population	NOUN
ajlm-1458	18	37	.	.	PUNCT
ajlm-1458	19	1	conclusion	conclusion	NOUN
ajlm-1458	19	2	:	:	PUNCT
ajlm-1458	19	3	clearllab	clearllab	PROPN
ajlm-1458	19	4	10c	10c	NUM
ajlm-1458	19	5	panels	panel	NOUN
ajlm-1458	19	6	provide	provide	VERB
ajlm-1458	19	7	excellent	excellent	ADJ
ajlm-1458	19	8	agreement	agreement	NOUN
ajlm-1458	19	9	to	to	ADP
ajlm-1458	19	10	existing	exist	VERB
ajlm-1458	19	11	ldts	ldts	NOUN
ajlm-1458	19	12	and	and	CCONJ
ajlm-1458	19	13	may	may	AUX
ajlm-1458	19	14	reliably	reliably	ADV
ajlm-1458	19	15	be	be	AUX
ajlm-1458	19	16	used	use	VERB
ajlm-1458	19	17	for	for	ADP
ajlm-1458	19	18	immunophenotyping	immunophenotype	VERB
ajlm-1458	19	19	of	of	ADP
ajlm-1458	19	20	haematological	haematological	ADJ
ajlm-1458	19	21	neoplasms	neoplasm	NOUN
ajlm-1458	19	22	,	,	PUNCT
ajlm-1458	19	23	simplifying	simplify	VERB
ajlm-1458	19	24	and	and	CCONJ
ajlm-1458	19	25	standardising	standardise	VERB
ajlm-1458	19	26	sample	sample	NOUN
ajlm-1458	19	27	preparation	preparation	NOUN
ajlm-1458	19	28	and	and	CCONJ
ajlm-1458	19	29	data	datum	NOUN
ajlm-1458	19	30	acquisition	acquisition	NOUN
ajlm-1458	19	31	.	.	PUNCT
ajlm-1458	20	1	keywords	keyword	NOUN
ajlm-1458	20	2	:	:	PUNCT
ajlm-1458	20	3	clearllab	clearllab	PROPN
ajlm-1458	20	4	10c	10c	NOUN
ajlm-1458	20	5	;	;	PUNCT
ajlm-1458	20	6	immunophenotyping	immunophenotype	VERB
ajlm-1458	20	7	;	;	PUNCT
ajlm-1458	20	8	fixed	fix	VERB
ajlm-1458	20	9	-	-	PUNCT
ajlm-1458	20	10	panel	panel	NOUN
ajlm-1458	20	11	;	;	PUNCT
ajlm-1458	20	12	standardisation	standardisation	NOUN
ajlm-1458	20	13	;	;	PUNCT
ajlm-1458	20	14	multicolour	multicolour	NOUN
ajlm-1458	20	15	;	;	PUNCT
ajlm-1458	20	16	leukaemia	leukaemia	NOUN
ajlm-1458	20	17	;	;	PUNCT
ajlm-1458	20	18	lymphoma	lymphoma	NOUN
ajlm-1458	20	19	;	;	PUNCT
ajlm-1458	20	20	diagnostics	diagnostic	NOUN
ajlm-1458	20	21	.	.	PUNCT
ajlm-1458	21	1	introduction	introduction	NOUN
ajlm-1458	21	2	flow	flow	NOUN
ajlm-1458	21	3	cytometric	cytometric	ADJ
ajlm-1458	21	4	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	21	5	is	be	AUX
ajlm-1458	21	6	an	an	DET
ajlm-1458	21	7	established	establish	VERB
ajlm-1458	21	8	methodology	methodology	NOUN
ajlm-1458	21	9	for	for	ADP
ajlm-1458	21	10	the	the	DET
ajlm-1458	21	11	diagnosis	diagnosis	NOUN
ajlm-1458	21	12	of	of	ADP
ajlm-1458	21	13	haematological	haematological	ADJ
ajlm-1458	21	14	neoplasms1,2,3,4,5,6	neoplasms1,2,3,4,5,6	NOUN
ajlm-1458	21	15	outlined	outline	VERB
ajlm-1458	21	16	in	in	ADP
ajlm-1458	21	17	the	the	DET
ajlm-1458	21	18	world	world	NOUN
ajlm-1458	21	19	health	health	NOUN
ajlm-1458	21	20	organization	organization	NOUN
ajlm-1458	21	21	classification	classification	NOUN
ajlm-1458	21	22	of	of	ADP
ajlm-1458	21	23	haemopoietic	haemopoietic	ADJ
ajlm-1458	21	24	and	and	CCONJ
ajlm-1458	21	25	lymphoid	lymphoid	ADJ
ajlm-1458	21	26	tissues.7,8	tissues.7,8	ADP
ajlm-1458	21	27	published	publish	VERB
ajlm-1458	21	28	protocols	protocol	NOUN
ajlm-1458	21	29	for	for	ADP
ajlm-1458	21	30	sophisticated	sophisticated	ADJ
ajlm-1458	21	31	multicolour	multicolour	ADJ
ajlm-1458	21	32	flow	flow	NOUN
ajlm-1458	21	33	cytometry	cytometry	NOUN
ajlm-1458	21	34	systems	system	NOUN
ajlm-1458	21	35	have	have	AUX
ajlm-1458	21	36	markedly	markedly	ADV
ajlm-1458	21	37	expanded	expand	VERB
ajlm-1458	21	38	the	the	DET
ajlm-1458	21	39	scope	scope	NOUN
ajlm-1458	21	40	of	of	ADP
ajlm-1458	21	41	routine	routine	ADJ
ajlm-1458	21	42	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	21	43	testing	testing	NOUN
ajlm-1458	21	44	and	and	CCONJ
ajlm-1458	21	45	improved	improve	VERB
ajlm-1458	21	46	diagnostic	diagnostic	ADJ
ajlm-1458	21	47	capabilities	capability	NOUN
ajlm-1458	21	48	,	,	PUNCT
ajlm-1458	21	49	allowing	allow	VERB
ajlm-1458	21	50	for	for	ADP
ajlm-1458	21	51	simultaneous	simultaneous	ADJ
ajlm-1458	21	52	multi	multi	ADJ
ajlm-1458	21	53	-	-	ADJ
ajlm-1458	21	54	parameter	parameter	ADJ
ajlm-1458	21	55	examination	examination	NOUN
ajlm-1458	21	56	and	and	CCONJ
ajlm-1458	21	57	documentation	documentation	NOUN
ajlm-1458	21	58	of	of	ADP
ajlm-1458	21	59	specific	specific	ADJ
ajlm-1458	21	60	neoplastic	neoplastic	ADJ
ajlm-1458	21	61	disease	disease	NOUN
ajlm-1458	21	62	immunophenotypes	immunophenotype	NOUN
ajlm-1458	21	63	alongside	alongside	ADP
ajlm-1458	21	64	normal	normal	ADJ
ajlm-1458	21	65	haematological	haematological	NOUN
ajlm-1458	21	66	development.9,10,11,12,13,14	development.9,10,11,12,13,14	ADV
ajlm-1458	21	67	rare	rare	ADJ
ajlm-1458	21	68	event	event	NOUN
ajlm-1458	21	69	populations	population	NOUN
ajlm-1458	21	70	,	,	PUNCT
ajlm-1458	21	71	however	however	ADV
ajlm-1458	21	72	small	small	ADJ
ajlm-1458	21	73	,	,	PUNCT
ajlm-1458	21	74	are	be	AUX
ajlm-1458	21	75	likewise	likewise	ADV
ajlm-1458	21	76	identified	identify	VERB
ajlm-1458	21	77	to	to	PART
ajlm-1458	21	78	reveal	reveal	VERB
ajlm-1458	21	79	evidence	evidence	NOUN
ajlm-1458	21	80	of	of	ADP
ajlm-1458	21	81	minimal	minimal	ADJ
ajlm-1458	21	82	residual	residual	ADJ
ajlm-1458	21	83	disease.13,15,16	disease.13,15,16	PUNCT
ajlm-1458	21	84	in	in	ADP
ajlm-1458	21	85	addition	addition	NOUN
ajlm-1458	21	86	,	,	PUNCT
ajlm-1458	21	87	harmonised	harmonise	VERB
ajlm-1458	21	88	approaches	approach	NOUN
ajlm-1458	21	89	,	,	PUNCT
ajlm-1458	21	90	including	include	VERB
ajlm-1458	21	91	standardised	standardise	VERB
ajlm-1458	21	92	multi	multi	ADJ
ajlm-1458	21	93	-	-	ADJ
ajlm-1458	21	94	parameter	parameter	ADJ
ajlm-1458	21	95	marker	marker	NOUN
ajlm-1458	21	96	staining	staining	NOUN
ajlm-1458	21	97	,	,	PUNCT
ajlm-1458	21	98	instrument	instrument	NOUN
ajlm-1458	21	99	setup	setup	NOUN
ajlm-1458	21	100	and	and	CCONJ
ajlm-1458	21	101	data	datum	NOUN
ajlm-1458	21	102	collection	collection	NOUN
ajlm-1458	21	103	,	,	PUNCT
ajlm-1458	21	104	and	and	CCONJ
ajlm-1458	21	105	automated	automated	ADJ
ajlm-1458	21	106	gating	gating	NOUN
ajlm-1458	21	107	,	,	PUNCT
ajlm-1458	21	108	can	can	AUX
ajlm-1458	21	109	reduce	reduce	VERB
ajlm-1458	21	110	test	test	NOUN
ajlm-1458	21	111	variability	variability	NOUN
ajlm-1458	21	112	,	,	PUNCT
ajlm-1458	21	113	streamline	streamline	VERB
ajlm-1458	21	114	analysis	analysis	NOUN
ajlm-1458	21	115	for	for	ADP
ajlm-1458	21	116	immunophenotyping	immunophenotype	VERB
ajlm-1458	21	117	and	and	CCONJ
ajlm-1458	21	118	ensure	ensure	VERB
ajlm-1458	21	119	reproducible	reproducible	ADJ
ajlm-1458	21	120	outcomes	outcome	NOUN
ajlm-1458	21	121	between	between	ADP
ajlm-1458	21	122	and	and	CCONJ
ajlm-1458	21	123	within	within	ADP
ajlm-1458	21	124	centres.17,18	centres.17,18	NOUN
ajlm-1458	21	125	leading	lead	VERB
ajlm-1458	21	126	experienced	experienced	ADJ
ajlm-1458	21	127	and	and	CCONJ
ajlm-1458	21	128	knowledgeable	knowledgeable	ADJ
ajlm-1458	21	129	groups	group	NOUN
ajlm-1458	21	130	have	have	AUX
ajlm-1458	21	131	published	publish	VERB
ajlm-1458	21	132	specific	specific	ADJ
ajlm-1458	21	133	panels	panel	NOUN
ajlm-1458	21	134	and	and	CCONJ
ajlm-1458	21	135	protocols	protocol	NOUN
ajlm-1458	21	136	for	for	ADP
ajlm-1458	21	137	multi	multi	ADJ
ajlm-1458	21	138	-	-	ADJ
ajlm-1458	21	139	parametric	parametric	ADJ
ajlm-1458	21	140	flow	flow	NOUN
ajlm-1458	21	141	cytometry	cytometry	NOUN
ajlm-1458	21	142	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	21	143	method	method	NOUN
ajlm-1458	21	144	setups	setup	NOUN
ajlm-1458	21	145	,	,	PUNCT
ajlm-1458	21	146	panel	panel	NOUN
ajlm-1458	21	147	selection	selection	NOUN
ajlm-1458	21	148	and	and	CCONJ
ajlm-1458	21	149	data	datum	NOUN
ajlm-1458	21	150	analysis,9,19,20	analysis,9,19,20	NOUN
ajlm-1458	21	151	irrespective	irrespective	ADV
ajlm-1458	21	152	of	of	ADP
ajlm-1458	21	153	the	the	DET
ajlm-1458	21	154	flow	flow	NOUN
ajlm-1458	21	155	cytometer	cytometer	NOUN
ajlm-1458	21	156	used	use	VERB
ajlm-1458	21	157	.	.	PUNCT
ajlm-1458	22	1	however	however	ADV
ajlm-1458	22	2	,	,	PUNCT
ajlm-1458	22	3	multi	multi	ADJ
ajlm-1458	22	4	-	-	ADJ
ajlm-1458	22	5	parametric	parametric	ADJ
ajlm-1458	22	6	flow	flow	NOUN
ajlm-1458	22	7	cytometry	cytometry	NOUN
ajlm-1458	22	8	is	be	AUX
ajlm-1458	22	9	not	not	PART
ajlm-1458	22	10	straightforward18,19,20,21,22,23,24	straightforward18,19,20,21,22,23,24	NOUN
ajlm-1458	22	11	;	;	PUNCT
ajlm-1458	22	12	the	the	DET
ajlm-1458	22	13	setup	setup	NOUN
ajlm-1458	22	14	is	be	AUX
ajlm-1458	22	15	complex	complex	ADJ
ajlm-1458	22	16	,	,	PUNCT
ajlm-1458	22	17	requiring	require	VERB
ajlm-1458	22	18	expertise	expertise	NOUN
ajlm-1458	22	19	in	in	ADP
ajlm-1458	22	20	flow	flow	NOUN
ajlm-1458	22	21	cytometry	cytometry	PROPN
ajlm-1458	22	22	techniques.20,25	techniques.20,25	NOUN
ajlm-1458	22	23	therefore	therefore	ADV
ajlm-1458	22	24	,	,	PUNCT
ajlm-1458	22	25	many	many	ADJ
ajlm-1458	22	26	testing	testing	NOUN
ajlm-1458	22	27	facilities	facility	NOUN
ajlm-1458	22	28	opt	opt	VERB
ajlm-1458	22	29	to	to	PART
ajlm-1458	22	30	retain	retain	VERB
ajlm-1458	22	31	their	their	PRON
ajlm-1458	22	32	in	in	ADP
ajlm-1458	22	33	-	-	PUNCT
ajlm-1458	22	34	house	house	NOUN
ajlm-1458	22	35	-	-	PUNCT
ajlm-1458	22	36	developed	develop	VERB
ajlm-1458	22	37	predicate	predicate	NOUN
ajlm-1458	22	38	testing	testing	NOUN
ajlm-1458	22	39	methods	method	NOUN
ajlm-1458	22	40	to	to	PART
ajlm-1458	22	41	meet	meet	VERB
ajlm-1458	22	42	their	their	PRON
ajlm-1458	22	43	local	local	ADJ
ajlm-1458	22	44	service	service	NOUN
ajlm-1458	22	45	needs.26	needs.26	ADJ
ajlm-1458	22	46	to	to	PART
ajlm-1458	22	47	meet	meet	VERB
ajlm-1458	22	48	these	these	DET
ajlm-1458	22	49	challenges	challenge	NOUN
ajlm-1458	22	50	,	,	PUNCT
ajlm-1458	22	51	beckman	beckman	PROPN
ajlm-1458	22	52	coulter	coulter	PROPN
ajlm-1458	22	53	(	(	PUNCT
ajlm-1458	22	54	bc	bc	PROPN
ajlm-1458	22	55	)	)	PUNCT
ajlm-1458	22	56	launched	launch	VERB
ajlm-1458	22	57	a	a	DET
ajlm-1458	22	58	united	united	PROPN
ajlm-1458	22	59	states	states	PROPN
ajlm-1458	22	60	food	food	NOUN
ajlm-1458	22	61	and	and	CCONJ
ajlm-1458	22	62	drug	drug	PROPN
ajlm-1458	22	63	administration	administration	NOUN
ajlm-1458	22	64	-	-	PUNCT
ajlm-1458	22	65	approved	approve	VERB
ajlm-1458	22	66	,	,	PUNCT
ajlm-1458	22	67	standardised	standardised	ADJ
ajlm-1458	22	68	,	,	PUNCT
ajlm-1458	22	69	fixed	fix	VERB
ajlm-1458	22	70	multicolour	multicolour	ADJ
ajlm-1458	22	71	clearllab	clearllab	NOUN
ajlm-1458	22	72	reagent	reagent	ADJ
ajlm-1458	22	73	system	system	NOUN
ajlm-1458	22	74	for	for	ADP
ajlm-1458	22	75	leukaemia	leukaemia	NOUN
ajlm-1458	22	76	and	and	CCONJ
ajlm-1458	22	77	lymphoma	lymphoma	NOUN
ajlm-1458	22	78	immunophenotyping	immunophenotype	VERB
ajlm-1458	22	79	in	in	ADP
ajlm-1458	22	80	2019.27,28	2019.27,28	NUM
ajlm-1458	22	81	the	the	DET
ajlm-1458	22	82	four	four	NUM
ajlm-1458	22	83	10	10	NUM
ajlm-1458	22	84	-	-	PUNCT
ajlm-1458	22	85	colour	colour	NOUN
ajlm-1458	22	86	marker	marker	NOUN
ajlm-1458	22	87	panels	panel	NOUN
ajlm-1458	22	88	facilitate	facilitate	VERB
ajlm-1458	22	89	the	the	DET
ajlm-1458	22	90	detection	detection	NOUN
ajlm-1458	22	91	of	of	ADP
ajlm-1458	22	92	most	most	ADJ
ajlm-1458	22	93	acute	acute	NOUN
ajlm-1458	22	94	leukaemias	leukaemia	NOUN
ajlm-1458	22	95	and	and	CCONJ
ajlm-1458	22	96	lymphomas	lymphoma	NOUN
ajlm-1458	22	97	.	.	PUNCT
ajlm-1458	23	1	when	when	SCONJ
ajlm-1458	23	2	used	use	VERB
ajlm-1458	23	3	with	with	ADP
ajlm-1458	23	4	a	a	DET
ajlm-1458	23	5	bc	bc	PROPN
ajlm-1458	23	6	navios	navio	NOUN
ajlm-1458	23	7	instrument	instrument	NOUN
ajlm-1458	23	8	,	,	PUNCT
ajlm-1458	23	9	the	the	DET
ajlm-1458	23	10	system	system	NOUN
ajlm-1458	23	11	offers	offer	VERB
ajlm-1458	23	12	the	the	DET
ajlm-1458	23	13	advantages	advantage	NOUN
ajlm-1458	23	14	of	of	ADP
ajlm-1458	23	15	multi	multi	ADJ
ajlm-1458	23	16	-	-	ADJ
ajlm-1458	23	17	parametric	parametric	ADJ
ajlm-1458	23	18	analysis	analysis	NOUN
ajlm-1458	23	19	but	but	CCONJ
ajlm-1458	23	20	with	with	ADP
ajlm-1458	23	21	simplified	simplified	ADJ
ajlm-1458	23	22	pre	pre	ADJ
ajlm-1458	23	23	-	-	ADJ
ajlm-1458	23	24	prepared	prepared	ADJ
ajlm-1458	23	25	marker	marker	NOUN
ajlm-1458	23	26	panels	panel	NOUN
ajlm-1458	23	27	and	and	CCONJ
ajlm-1458	23	28	standardised	standardised	ADJ
ajlm-1458	23	29	instrument	instrument	NOUN
ajlm-1458	23	30	setup	setup	NOUN
ajlm-1458	23	31	and	and	CCONJ
ajlm-1458	23	32	quality	quality	NOUN
ajlm-1458	23	33	control.28	control.28	NOUN
ajlm-1458	23	34	this	this	DET
ajlm-1458	23	35	study	study	NOUN
ajlm-1458	23	36	aimed	aim	VERB
ajlm-1458	23	37	to	to	PART
ajlm-1458	23	38	evaluate	evaluate	VERB
ajlm-1458	23	39	the	the	DET
ajlm-1458	23	40	clearllab	clearllab	NOUN
ajlm-1458	23	41	™	™	NOUN
ajlm-1458	23	42	10c	10c	NOUN
ajlm-1458	23	43	system	system	NOUN
ajlm-1458	23	44	(	(	PUNCT
ajlm-1458	23	45	including	include	VERB
ajlm-1458	23	46	the	the	DET
ajlm-1458	23	47	b	b	NOUN
ajlm-1458	23	48	-	-	PUNCT
ajlm-1458	23	49	cell	cell	NOUN
ajlm-1458	23	50	,	,	PUNCT
ajlm-1458	23	51	t	t	NOUN
ajlm-1458	23	52	-	-	PUNCT
ajlm-1458	23	53	cell	cell	NOUN
ajlm-1458	23	54	,	,	PUNCT
ajlm-1458	23	55	m1	m1	PROPN
ajlm-1458	23	56	and	and	CCONJ
ajlm-1458	23	57	m2	m2	PROPN
ajlm-1458	23	58	diagnostic	diagnostic	ADJ
ajlm-1458	23	59	tubes)27,28	tubes)27,28	PRON
ajlm-1458	23	60	against	against	ADP
ajlm-1458	23	61	our	our	PRON
ajlm-1458	23	62	existing	exist	VERB
ajlm-1458	23	63	predicate	predicate	NOUN
ajlm-1458	23	64	method	method	NOUN
ajlm-1458	23	65	(	(	PUNCT
ajlm-1458	23	66	utilising	utilise	VERB
ajlm-1458	23	67	>	>	X
ajlm-1458	23	68	20	20	NUM
ajlm-1458	23	69	in	in	ADP
ajlm-1458	23	70	-	-	PUNCT
ajlm-1458	23	71	house	house	NOUN
ajlm-1458	23	72	,	,	PUNCT
ajlm-1458	23	73	2–4	2–4	NOUN
ajlm-1458	23	74	-	-	PUNCT
ajlm-1458	23	75	colour	colour	ADJ
ajlm-1458	23	76	fluorescence	fluorescence	NOUN
ajlm-1458	23	77	panels	panel	NOUN
ajlm-1458	23	78	and	and	CCONJ
ajlm-1458	23	79	a	a	DET
ajlm-1458	23	80	vast	vast	ADJ
ajlm-1458	23	81	liquid	liquid	ADJ
ajlm-1458	23	82	monoclonal	monoclonal	NOUN
ajlm-1458	23	83	reagent	reagent	ADJ
ajlm-1458	23	84	repertoire	repertoire	NOUN
ajlm-1458	23	85	)	)	PUNCT
ajlm-1458	23	86	in	in	ADP
ajlm-1458	23	87	our	our	PRON
ajlm-1458	23	88	busy	busy	ADJ
ajlm-1458	23	89	,	,	PUNCT
ajlm-1458	23	90	academic	academic	ADJ
ajlm-1458	23	91	flow	flow	NOUN
ajlm-1458	23	92	cytometry	cytometry	NOUN
ajlm-1458	23	93	laboratory	laboratory	NOUN
ajlm-1458	23	94	.	.	PUNCT
ajlm-1458	24	1	the	the	DET
ajlm-1458	24	2	laboratory	laboratory	NOUN
ajlm-1458	24	3	offers	offer	VERB
ajlm-1458	24	4	leukaemia	leukaemia	NOUN
ajlm-1458	24	5	and	and	CCONJ
ajlm-1458	24	6	lymphoma	lymphoma	NOUN
ajlm-1458	24	7	immunophenotyping	immunophenotype	VERB
ajlm-1458	24	8	services	service	NOUN
ajlm-1458	24	9	at	at	ADP
ajlm-1458	24	10	the	the	DET
ajlm-1458	24	11	national	national	PROPN
ajlm-1458	24	12	health	health	PROPN
ajlm-1458	24	13	laboratory	laboratory	PROPN
ajlm-1458	24	14	service	service	PROPN
ajlm-1458	24	15	,	,	PUNCT
ajlm-1458	24	16	johannesburg	johannesburg	PROPN
ajlm-1458	24	17	,	,	PUNCT
ajlm-1458	24	18	south	south	PROPN
ajlm-1458	24	19	africa	africa	PROPN
ajlm-1458	24	20	.	.	PUNCT
ajlm-1458	25	1	a	a	DET
ajlm-1458	25	2	secondary	secondary	ADJ
ajlm-1458	25	3	aim	aim	NOUN
ajlm-1458	25	4	of	of	ADP
ajlm-1458	25	5	this	this	DET
ajlm-1458	25	6	study	study	NOUN
ajlm-1458	25	7	was	be	AUX
ajlm-1458	25	8	to	to	PART
ajlm-1458	25	9	compare	compare	VERB
ajlm-1458	25	10	the	the	DET
ajlm-1458	25	11	clearllab	clearllab	NOUN
ajlm-1458	25	12	10c	10c	NOUN
ajlm-1458	25	13	system	system	NOUN
ajlm-1458	25	14	against	against	ADP
ajlm-1458	25	15	other	other	ADJ
ajlm-1458	25	16	routinely	routinely	ADV
ajlm-1458	25	17	employed	employ	VERB
ajlm-1458	25	18	clinicopathological	clinicopathological	ADJ
ajlm-1458	25	19	diagnostic	diagnostic	ADJ
ajlm-1458	25	20	methods	method	NOUN
ajlm-1458	25	21	used	use	VERB
ajlm-1458	25	22	in	in	ADP
ajlm-1458	25	23	our	our	PRON
ajlm-1458	25	24	site	site	NOUN
ajlm-1458	25	25	for	for	ADP
ajlm-1458	25	26	detecting	detect	VERB
ajlm-1458	25	27	haematological	haematological	ADJ
ajlm-1458	25	28	neoplasms	neoplasm	NOUN
ajlm-1458	25	29	,	,	PUNCT
ajlm-1458	25	30	including	include	VERB
ajlm-1458	25	31	morphological	morphological	ADJ
ajlm-1458	25	32	and/	and/	NOUN
ajlm-1458	25	33	or	or	CCONJ
ajlm-1458	25	34	histological	histological	ADJ
ajlm-1458	25	35	review	review	NOUN
ajlm-1458	25	36	.	.	PUNCT
ajlm-1458	26	1	methods	method	NOUN
ajlm-1458	26	2	ethical	ethical	ADJ
ajlm-1458	26	3	considerations	consideration	NOUN
ajlm-1458	26	4	ethics	ethic	NOUN
ajlm-1458	26	5	clearance	clearance	NOUN
ajlm-1458	26	6	for	for	ADP
ajlm-1458	26	7	this	this	DET
ajlm-1458	26	8	study	study	NOUN
ajlm-1458	26	9	was	be	AUX
ajlm-1458	26	10	obtained	obtain	VERB
ajlm-1458	26	11	from	from	ADP
ajlm-1458	26	12	the	the	DET
ajlm-1458	26	13	university	university	NOUN
ajlm-1458	26	14	of	of	ADP
ajlm-1458	26	15	the	the	DET
ajlm-1458	26	16	witwatersrand	witwatersrand	PROPN
ajlm-1458	26	17	ethics	ethics	PROPN
ajlm-1458	26	18	committee	committee	PROPN
ajlm-1458	26	19	(	(	PUNCT
ajlm-1458	26	20	hrec	hrec	PROPN
ajlm-1458	26	21	)	)	PUNCT
ajlm-1458	26	22	(	(	PUNCT
ajlm-1458	26	23	m1704129	m1704129	NUM
ajlm-1458	26	24	)	)	PUNCT
ajlm-1458	26	25	.	.	PUNCT
ajlm-1458	27	1	the	the	DET
ajlm-1458	27	2	hrec	hrec	NOUN
ajlm-1458	27	3	waived	waive	VERB
ajlm-1458	27	4	patient	patient	ADJ
ajlm-1458	27	5	consent	consent	NOUN
ajlm-1458	27	6	as	as	ADP
ajlm-1458	27	7	validation	validation	NOUN
ajlm-1458	27	8	for	for	ADP
ajlm-1458	27	9	clearllab	clearllab	NOUN
ajlm-1458	27	10	10c	10c	NOUN
ajlm-1458	27	11	testing	testing	NOUN
ajlm-1458	27	12	utilised	utilise	VERB
ajlm-1458	27	13	remnant	remnant	ADJ
ajlm-1458	27	14	samples	sample	NOUN
ajlm-1458	27	15	previously	previously	ADV
ajlm-1458	27	16	submitted	submit	VERB
ajlm-1458	27	17	for	for	ADP
ajlm-1458	27	18	routine	routine	ADJ
ajlm-1458	27	19	diagnostic	diagnostic	ADJ
ajlm-1458	27	20	testing	testing	NOUN
ajlm-1458	27	21	.	.	PUNCT
ajlm-1458	28	1	all	all	PRON
ajlm-1458	28	2	flow	flow	VERB
ajlm-1458	28	3	cytometric	cytometric	ADJ
ajlm-1458	28	4	data	datum	NOUN
ajlm-1458	28	5	analysed	analyse	VERB
ajlm-1458	28	6	were	be	AUX
ajlm-1458	28	7	de	de	ADJ
ajlm-1458	28	8	-	-	VERB
ajlm-1458	28	9	identified	identified	ADJ
ajlm-1458	28	10	;	;	PUNCT
ajlm-1458	28	11	data	datum	NOUN
ajlm-1458	28	12	were	be	AUX
ajlm-1458	28	13	therefore	therefore	ADV
ajlm-1458	28	14	effectively	effectively	ADV
ajlm-1458	28	15	anonymised	anonymise	VERB
ajlm-1458	28	16	,	,	PUNCT
ajlm-1458	28	17	and	and	CCONJ
ajlm-1458	28	18	no	no	DET
ajlm-1458	28	19	patient	patient	ADJ
ajlm-1458	28	20	identifiers	identifier	NOUN
ajlm-1458	28	21	were	be	AUX
ajlm-1458	28	22	used	use	VERB
ajlm-1458	28	23	.	.	PUNCT
ajlm-1458	29	1	study	study	NOUN
ajlm-1458	29	2	design	design	NOUN
ajlm-1458	29	3	and	and	CCONJ
ajlm-1458	29	4	site	site	NOUN
ajlm-1458	29	5	this	this	DET
ajlm-1458	29	6	prospective	prospective	ADJ
ajlm-1458	29	7	observational	observational	ADJ
ajlm-1458	29	8	cohort	cohort	NOUN
ajlm-1458	29	9	study29	study29	NOUN
ajlm-1458	29	10	was	be	AUX
ajlm-1458	29	11	performed	perform	VERB
ajlm-1458	29	12	at	at	ADP
ajlm-1458	29	13	a	a	DET
ajlm-1458	29	14	national	national	ADJ
ajlm-1458	29	15	referral	referral	NOUN
ajlm-1458	29	16	flow	flow	NOUN
ajlm-1458	29	17	cytometry	cytometry	PROPN
ajlm-1458	29	18	laboratory	laboratory	NOUN
ajlm-1458	29	19	at	at	ADP
ajlm-1458	29	20	the	the	DET
ajlm-1458	29	21	charlotte	charlotte	PROPN
ajlm-1458	29	22	maxeke	maxeke	PROPN
ajlm-1458	29	23	johannesburg	johannesburg	PROPN
ajlm-1458	29	24	academic	academic	PROPN
ajlm-1458	29	25	national	national	PROPN
ajlm-1458	29	26	health	health	PROPN
ajlm-1458	29	27	laboratory	laboratory	PROPN
ajlm-1458	29	28	service	service	NOUN
ajlm-1458	29	29	flow	flow	NOUN
ajlm-1458	29	30	cytometry	cytometry	PROPN
ajlm-1458	29	31	laboratory	laboratory	NOUN
ajlm-1458	29	32	,	,	PUNCT
ajlm-1458	29	33	johannesburg	johannesburg	PROPN
ajlm-1458	29	34	,	,	PUNCT
ajlm-1458	29	35	south	south	PROPN
ajlm-1458	29	36	africa	africa	PROPN
ajlm-1458	29	37	.	.	PUNCT
ajlm-1458	30	1	the	the	DET
ajlm-1458	30	2	unit	unit	NOUN
ajlm-1458	30	3	is	be	AUX
ajlm-1458	30	4	an	an	DET
ajlm-1458	30	5	academic	academic	ADJ
ajlm-1458	30	6	testing	testing	NOUN
ajlm-1458	30	7	facility	facility	NOUN
ajlm-1458	30	8	with	with	ADP
ajlm-1458	30	9	a	a	DET
ajlm-1458	30	10	300	300	NUM
ajlm-1458	30	11	-	-	PUNCT
ajlm-1458	30	12	sample	sample	NOUN
ajlm-1458	30	13	monthly	monthly	ADJ
ajlm-1458	30	14	workload	workload	NOUN
ajlm-1458	30	15	,	,	PUNCT
ajlm-1458	30	16	referred	refer	VERB
ajlm-1458	30	17	from	from	ADP
ajlm-1458	30	18	four	four	NUM
ajlm-1458	30	19	large	large	ADJ
ajlm-1458	30	20	sister	sister	NOUN
ajlm-1458	30	21	academic	academic	ADJ
ajlm-1458	30	22	hospitals	hospital	NOUN
ajlm-1458	30	23	,	,	PUNCT
ajlm-1458	30	24	other	other	ADJ
ajlm-1458	30	25	district	district	NOUN
ajlm-1458	30	26	-	-	PUNCT
ajlm-1458	30	27	level	level	NOUN
ajlm-1458	30	28	facilities	facility	NOUN
ajlm-1458	30	29	,	,	PUNCT
ajlm-1458	30	30	and	and	CCONJ
ajlm-1458	30	31	other	other	ADJ
ajlm-1458	30	32	regional	regional	ADJ
ajlm-1458	30	33	centres	centre	NOUN
ajlm-1458	30	34	across	across	ADP
ajlm-1458	30	35	the	the	DET
ajlm-1458	30	36	national	national	ADJ
ajlm-1458	30	37	network	network	NOUN
ajlm-1458	30	38	.	.	PUNCT
ajlm-1458	31	1	in	in	ADP
ajlm-1458	31	2	addition	addition	NOUN
ajlm-1458	31	3	,	,	PUNCT
ajlm-1458	31	4	the	the	DET
ajlm-1458	31	5	laboratory	laboratory	NOUN
ajlm-1458	31	6	participates	participate	VERB
ajlm-1458	31	7	in	in	ADP
ajlm-1458	31	8	the	the	DET
ajlm-1458	31	9	united	united	PROPN
ajlm-1458	31	10	kingdom	kingdom	PROPN
ajlm-1458	31	11	national	national	ADJ
ajlm-1458	31	12	external	external	ADJ
ajlm-1458	31	13	quality	quality	NOUN
ajlm-1458	31	14	assessment	assessment	NOUN
ajlm-1458	31	15	scheme	scheme	NOUN
ajlm-1458	31	16	(	(	PUNCT
ajlm-1458	31	17	sheffield	sheffield	PROPN
ajlm-1458	31	18	,	,	PUNCT
ajlm-1458	31	19	united	united	ADJ
ajlm-1458	31	20	kingdom	kingdom	PROPN
ajlm-1458	31	21	)	)	PUNCT
ajlm-1458	31	22	proficiency	proficiency	NOUN
ajlm-1458	31	23	testing	testing	NOUN
ajlm-1458	31	24	scheme	scheme	NOUN
ajlm-1458	31	25	for	for	ADP
ajlm-1458	31	26	leukaemia	leukaemia	NOUN
ajlm-1458	31	27	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	31	28	(	(	PUNCT
ajlm-1458	31	29	part	part	NOUN
ajlm-1458	31	30	1	1	NUM
ajlm-1458	31	31	)	)	PUNCT
ajlm-1458	31	32	and	and	CCONJ
ajlm-1458	31	33	leukaemia	leukaemia	VERB
ajlm-1458	31	34	diagnostic	diagnostic	ADJ
ajlm-1458	31	35	interpretation	interpretation	NOUN
ajlm-1458	31	36	(	(	PUNCT
ajlm-1458	31	37	part	part	NOUN
ajlm-1458	31	38	2).30	2).30	NUM
ajlm-1458	31	39	specimens	specimen	NOUN
ajlm-1458	31	40	bodily	bodily	ADJ
ajlm-1458	31	41	specimens	specimen	NOUN
ajlm-1458	31	42	,	,	PUNCT
ajlm-1458	31	43	including	include	VERB
ajlm-1458	31	44	bone	bone	NOUN
ajlm-1458	31	45	marrow	marrow	NOUN
ajlm-1458	31	46	aspirates	aspirate	NOUN
ajlm-1458	31	47	,	,	PUNCT
ajlm-1458	31	48	peripheral	peripheral	ADJ
ajlm-1458	31	49	blood	blood	NOUN
ajlm-1458	31	50	,	,	PUNCT
ajlm-1458	31	51	cerebrospinal	cerebrospinal	ADJ
ajlm-1458	31	52	and	and	CCONJ
ajlm-1458	31	53	pleural	pleural	ADJ
ajlm-1458	31	54	fluid	fluid	NOUN
ajlm-1458	31	55	,	,	PUNCT
ajlm-1458	31	56	and	and	CCONJ
ajlm-1458	31	57	lymph	lymph	NOUN
ajlm-1458	31	58	node	node	ADJ
ajlm-1458	31	59	tissue	tissue	NOUN
ajlm-1458	31	60	,	,	PUNCT
ajlm-1458	31	61	referred	refer	VERB
ajlm-1458	31	62	to	to	ADP
ajlm-1458	31	63	the	the	DET
ajlm-1458	31	64	national	national	PROPN
ajlm-1458	31	65	health	health	PROPN
ajlm-1458	31	66	laboratory	laboratory	PROPN
ajlm-1458	31	67	service	service	NOUN
ajlm-1458	31	68	in	in	ADP
ajlm-1458	31	69	johannesburg	johannesburg	PROPN
ajlm-1458	31	70	,	,	PUNCT
ajlm-1458	31	71	south	south	PROPN
ajlm-1458	31	72	africa	africa	PROPN
ajlm-1458	31	73	,	,	PUNCT
ajlm-1458	31	74	for	for	ADP
ajlm-1458	31	75	leukaemia	leukaemia	NOUN
ajlm-1458	31	76	immunophenotyping	immunophenotype	VERB
ajlm-1458	31	77	by	by	ADP
ajlm-1458	31	78	local	local	ADJ
ajlm-1458	31	79	sister	sister	NOUN
ajlm-1458	31	80	hospitals	hospital	NOUN
ajlm-1458	31	81	were	be	AUX
ajlm-1458	31	82	included	include	VERB
ajlm-1458	31	83	in	in	ADP
ajlm-1458	31	84	the	the	DET
ajlm-1458	31	85	study	study	NOUN
ajlm-1458	31	86	.	.	PUNCT
ajlm-1458	32	1	after	after	SCONJ
ajlm-1458	32	2	diagnostic	diagnostic	ADJ
ajlm-1458	32	3	testing	testing	NOUN
ajlm-1458	32	4	with	with	ADP
ajlm-1458	32	5	the	the	DET
ajlm-1458	32	6	laboratory	laboratory	NOUN
ajlm-1458	32	7	developed	develop	VERB
ajlm-1458	32	8	test	test	NOUN
ajlm-1458	32	9	(	(	PUNCT
ajlm-1458	32	10	ldt	ldt	PROPN
ajlm-1458	32	11	)	)	PUNCT
ajlm-1458	32	12	was	be	AUX
ajlm-1458	32	13	completed	complete	VERB
ajlm-1458	32	14	,	,	PUNCT
ajlm-1458	32	15	the	the	DET
ajlm-1458	32	16	same	same	ADJ
ajlm-1458	32	17	sample	sample	NOUN
ajlm-1458	32	18	was	be	AUX
ajlm-1458	32	19	tested	test	VERB
ajlm-1458	32	20	using	use	VERB
ajlm-1458	32	21	the	the	DET
ajlm-1458	32	22	index	index	NOUN
ajlm-1458	32	23	method	method	NOUN
ajlm-1458	32	24	(	(	PUNCT
ajlm-1458	32	25	clearllab	clearllab	NOUN
ajlm-1458	32	26	10c	10c	NOUN
ajlm-1458	32	27	)	)	PUNCT
ajlm-1458	32	28	,	,	PUNCT
ajlm-1458	32	29	provided	provide	VERB
ajlm-1458	32	30	that	that	SCONJ
ajlm-1458	32	31	sufficient	sufficient	ADJ
ajlm-1458	32	32	prepared	prepared	ADJ
ajlm-1458	32	33	cell	cell	NOUN
ajlm-1458	32	34	concentrate	concentrate	NOUN
ajlm-1458	32	35	for	for	ADP
ajlm-1458	32	36	at	at	ADV
ajlm-1458	32	37	least	least	ADV
ajlm-1458	32	38	4	4	NUM
ajlm-1458	32	39	aliquots	aliquot	NOUN
ajlm-1458	32	40	of	of	ADP
ajlm-1458	32	41	concentrated	concentrated	ADJ
ajlm-1458	32	42	sample	sample	NOUN
ajlm-1458	32	43	,	,	PUNCT
ajlm-1458	32	44	or	or	CCONJ
ajlm-1458	32	45	at	at	ADV
ajlm-1458	32	46	least	least	ADJ
ajlm-1458	32	47	1	1	NUM
ajlm-1458	32	48	ml	ml	NOUN
ajlm-1458	32	49	of	of	ADP
ajlm-1458	32	50	the	the	DET
ajlm-1458	32	51	whole	whole	ADJ
ajlm-1458	32	52	sample	sample	NOUN
ajlm-1458	32	53	,	,	PUNCT
ajlm-1458	32	54	remained	remain	VERB
ajlm-1458	32	55	.	.	PUNCT
ajlm-1458	33	1	all	all	DET
ajlm-1458	33	2	specimens	specimen	NOUN
ajlm-1458	33	3	for	for	ADP
ajlm-1458	33	4	clearllab	clearllab	NOUN
ajlm-1458	33	5	10c	10c	NOUN
ajlm-1458	33	6	evaluation	evaluation	NOUN
ajlm-1458	33	7	were	be	AUX
ajlm-1458	33	8	selected	select	VERB
ajlm-1458	33	9	per	per	ADP
ajlm-1458	33	10	the	the	DET
ajlm-1458	33	11	bethesda	bethesda	NOUN
ajlm-1458	33	12	guidelines.2	guidelines.2	PROPN
ajlm-1458	33	13	the	the	DET
ajlm-1458	33	14	guideline	guideline	NOUN
ajlm-1458	33	15	explicitly	explicitly	ADV
ajlm-1458	33	16	outlines	outline	VERB
ajlm-1458	33	17	the	the	DET
ajlm-1458	33	18	appropriate	appropriate	ADJ
ajlm-1458	33	19	use	use	NOUN
ajlm-1458	33	20	of	of	ADP
ajlm-1458	33	21	flow	flow	NOUN
ajlm-1458	33	22	cytometry	cytometry	NOUN
ajlm-1458	33	23	for	for	ADP
ajlm-1458	33	24	patients	patient	NOUN
ajlm-1458	33	25	with	with	ADP
ajlm-1458	33	26	clinically	clinically	ADV
ajlm-1458	33	27	suspected	suspect	VERB
ajlm-1458	33	28	oncological	oncological	ADJ
ajlm-1458	33	29	haematolymphoid	haematolymphoid	ADJ
ajlm-1458	33	30	neoplasms	neoplasm	NOUN
ajlm-1458	33	31	or	or	CCONJ
ajlm-1458	33	32	patients	patient	NOUN
ajlm-1458	33	33	with	with	ADP
ajlm-1458	33	34	previously	previously	ADV
ajlm-1458	33	35	diagnosed	diagnose	VERB
ajlm-1458	33	36	oncological	oncological	ADJ
ajlm-1458	33	37	haematolymphoid	haematolymphoid	ADJ
ajlm-1458	33	38	disease	disease	NOUN
ajlm-1458	33	39	enrolled	enrol	VERB
ajlm-1458	33	40	for	for	ADP
ajlm-1458	33	41	treatment	treatment	NOUN
ajlm-1458	33	42	.	.	PUNCT
ajlm-1458	34	1	samples	sample	NOUN
ajlm-1458	34	2	with	with	ADP
ajlm-1458	34	3	no	no	DET
ajlm-1458	34	4	pertinent	pertinent	ADJ
ajlm-1458	34	5	history	history	NOUN
ajlm-1458	34	6	or	or	CCONJ
ajlm-1458	34	7	clinical	clinical	ADJ
ajlm-1458	34	8	suspicion	suspicion	NOUN
ajlm-1458	34	9	of	of	ADP
ajlm-1458	34	10	haematological	haematological	ADJ
ajlm-1458	34	11	disease	disease	NOUN
ajlm-1458	34	12	,	,	PUNCT
ajlm-1458	34	13	older	old	ADJ
ajlm-1458	34	14	than	than	ADP
ajlm-1458	34	15	24	24	NUM
ajlm-1458	34	16	h	h	NOUN
ajlm-1458	34	17	,	,	PUNCT
ajlm-1458	34	18	visibly	visibly	ADV
ajlm-1458	34	19	haemolysed	haemolyse	VERB
ajlm-1458	34	20	or	or	CCONJ
ajlm-1458	34	21	clotted	clot	VERB
ajlm-1458	34	22	,	,	PUNCT
ajlm-1458	34	23	with	with	ADP
ajlm-1458	34	24	insufficient	insufficient	ADJ
ajlm-1458	34	25	volume	volume	NOUN
ajlm-1458	34	26	at	at	ADP
ajlm-1458	34	27	receipt	receipt	NOUN
ajlm-1458	34	28	of	of	ADP
ajlm-1458	34	29	the	the	DET
ajlm-1458	34	30	sample	sample	NOUN
ajlm-1458	34	31	,	,	PUNCT
ajlm-1458	34	32	or	or	CCONJ
ajlm-1458	34	33	insufficient	insufficient	ADJ
ajlm-1458	34	34	remnant	remnant	ADJ
ajlm-1458	34	35	sample	sample	NOUN
ajlm-1458	34	36	to	to	PART
ajlm-1458	34	37	undertake	undertake	VERB
ajlm-1458	34	38	index	index	NOUN
ajlm-1458	34	39	testing	testing	NOUN
ajlm-1458	34	40	,	,	PUNCT
ajlm-1458	34	41	were	be	AUX
ajlm-1458	34	42	excluded	exclude	VERB
ajlm-1458	34	43	from	from	ADP
ajlm-1458	34	44	the	the	DET
ajlm-1458	34	45	study	study	NOUN
ajlm-1458	34	46	.	.	PUNCT
ajlm-1458	35	1	one	one	NUM
ajlm-1458	35	2	hundred	hundred	NUM
ajlm-1458	35	3	and	and	CCONJ
ajlm-1458	35	4	one	one	NUM
ajlm-1458	35	5	remnant	remnant	ADJ
ajlm-1458	35	6	specimens	specimen	NOUN
ajlm-1458	35	7	(	(	PUNCT
ajlm-1458	35	8	from	from	ADP
ajlm-1458	35	9	36	36	NUM
ajlm-1458	35	10	children	child	NOUN
ajlm-1458	35	11	and	and	CCONJ
ajlm-1458	35	12	65	65	NUM
ajlm-1458	35	13	adults	adult	NOUN
ajlm-1458	35	14	from	from	ADP
ajlm-1458	35	15	any	any	DET
ajlm-1458	35	16	ethnic	ethnic	ADJ
ajlm-1458	35	17	or	or	CCONJ
ajlm-1458	35	18	racial	racial	ADJ
ajlm-1458	35	19	background	background	NOUN
ajlm-1458	35	20	)	)	PUNCT
ajlm-1458	35	21	were	be	AUX
ajlm-1458	35	22	processed	process	VERB
ajlm-1458	35	23	for	for	ADP
ajlm-1458	35	24	clearllab	clearllab	NOUN
ajlm-1458	35	25	10c	10c	NOUN
ajlm-1458	35	26	from	from	ADP
ajlm-1458	35	27	august	august	PROPN
ajlm-1458	35	28	through	through	ADP
ajlm-1458	35	29	november	november	PROPN
ajlm-1458	35	30	2019	2019	NUM
ajlm-1458	35	31	:	:	PUNCT
ajlm-1458	35	32	82	82	NUM
ajlm-1458	35	33	bone	bone	NOUN
ajlm-1458	35	34	marrow	marrow	NOUN
ajlm-1458	35	35	aspirate	aspirate	NOUN
ajlm-1458	35	36	samples	sample	NOUN
ajlm-1458	35	37	and	and	CCONJ
ajlm-1458	35	38	15	15	NUM
ajlm-1458	35	39	peripheral	peripheral	ADJ
ajlm-1458	35	40	blood	blood	NOUN
ajlm-1458	35	41	samples	sample	NOUN
ajlm-1458	35	42	were	be	AUX
ajlm-1458	35	43	collected	collect	VERB
ajlm-1458	35	44	into	into	ADP
ajlm-1458	35	45	dipotassium	dipotassium	NOUN
ajlm-1458	35	46	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-1458	35	47	acid	acid	NOUN
ajlm-1458	35	48	.	.	PUNCT
ajlm-1458	36	1	three	three	NUM
ajlm-1458	36	2	bodily	bodily	ADJ
ajlm-1458	36	3	fluid	fluid	ADJ
ajlm-1458	36	4	samples	sample	NOUN
ajlm-1458	36	5	(	(	PUNCT
ajlm-1458	36	6	two	two	NUM
ajlm-1458	36	7	cerebrospinal	cerebrospinal	ADJ
ajlm-1458	36	8	and	and	CCONJ
ajlm-1458	36	9	one	one	NUM
ajlm-1458	36	10	pleural	pleural	ADJ
ajlm-1458	36	11	fluid	fluid	NOUN
ajlm-1458	36	12	)	)	PUNCT
ajlm-1458	36	13	were	be	AUX
ajlm-1458	36	14	submitted	submit	VERB
ajlm-1458	36	15	;	;	PUNCT
ajlm-1458	36	16	a	a	DET
ajlm-1458	36	17	single	single	ADJ
ajlm-1458	36	18	lymph	lymph	NOUN
ajlm-1458	36	19	node	node	ADJ
ajlm-1458	36	20	biopsy	biopsy	NOUN
ajlm-1458	36	21	was	be	AUX
ajlm-1458	36	22	collected	collect	VERB
ajlm-1458	36	23	into	into	ADP
ajlm-1458	36	24	saline	saline	NOUN
ajlm-1458	36	25	.	.	PUNCT
ajlm-1458	37	1	sample	sample	NOUN
ajlm-1458	37	2	preparation	preparation	NOUN
ajlm-1458	37	3	and	and	CCONJ
ajlm-1458	37	4	cell	cell	NOUN
ajlm-1458	37	5	concentrates	concentrate	VERB
ajlm-1458	37	6	for	for	ADP
ajlm-1458	37	7	this	this	DET
ajlm-1458	37	8	study	study	NOUN
ajlm-1458	37	9	,	,	PUNCT
ajlm-1458	37	10	the	the	DET
ajlm-1458	37	11	existing	exist	VERB
ajlm-1458	37	12	predicate	predicate	NOUN
ajlm-1458	37	13	method	method	NOUN
ajlm-1458	37	14	is	be	AUX
ajlm-1458	37	15	the	the	DET
ajlm-1458	37	16	ldt	ldt	NOUN
ajlm-1458	37	17	;	;	PUNCT
ajlm-1458	37	18	samples	sample	NOUN
ajlm-1458	37	19	were	be	AUX
ajlm-1458	37	20	analysed	analyse	VERB
ajlm-1458	37	21	on	on	ADP
ajlm-1458	37	22	the	the	DET
ajlm-1458	37	23	becton	becton	PROPN
ajlm-1458	37	24	dickinson	dickinson	PROPN
ajlm-1458	37	25	(	(	PUNCT
ajlm-1458	37	26	bd	bd	PROPN
ajlm-1458	37	27	)	)	PUNCT
ajlm-1458	37	28	facscalibur	facscalibur	NOUN
ajlm-1458	37	29	(	(	PUNCT
ajlm-1458	37	30	san	san	PROPN
ajlm-1458	37	31	hose	hose	PROPN
ajlm-1458	37	32	,	,	PUNCT
ajlm-1458	37	33	california	california	PROPN
ajlm-1458	37	34	,	,	PUNCT
ajlm-1458	37	35	united	united	PROPN
ajlm-1458	37	36	states	states	PROPN
ajlm-1458	37	37	)	)	PUNCT
ajlm-1458	37	38	.	.	PUNCT
ajlm-1458	38	1	the	the	DET
ajlm-1458	38	2	index	index	NOUN
ajlm-1458	38	3	method	method	NOUN
ajlm-1458	38	4	is	be	AUX
ajlm-1458	38	5	the	the	DET
ajlm-1458	38	6	clearllab	clearllab	PROPN
ajlm-1458	38	7	10c	10c	NOUN
ajlm-1458	38	8	panel	panel	NOUN
ajlm-1458	38	9	;	;	PUNCT
ajlm-1458	38	10	samples	sample	NOUN
ajlm-1458	38	11	were	be	AUX
ajlm-1458	38	12	analysed	analyse	VERB
ajlm-1458	38	13	on	on	ADP
ajlm-1458	38	14	a	a	DET
ajlm-1458	38	15	beckman	beckman	NOUN
ajlm-1458	38	16	navios	navio	NOUN
ajlm-1458	38	17	flow	flow	NOUN
ajlm-1458	38	18	cytometer	cytometer	NOUN
ajlm-1458	38	19	(	(	PUNCT
ajlm-1458	38	20	bc	bc	PROPN
ajlm-1458	38	21	,	,	PUNCT
ajlm-1458	38	22	miami	miami	PROPN
ajlm-1458	38	23	,	,	PUNCT
ajlm-1458	38	24	florida	florida	PROPN
ajlm-1458	38	25	,	,	PUNCT
ajlm-1458	38	26	united	united	PROPN
ajlm-1458	38	27	states	states	PROPN
ajlm-1458	38	28	)	)	PUNCT
ajlm-1458	38	29	.	.	PUNCT
ajlm-1458	39	1	all	all	DET
ajlm-1458	39	2	sample	sample	NOUN
ajlm-1458	39	3	cell	cell	NOUN
ajlm-1458	39	4	concentrates	concentrate	NOUN
ajlm-1458	39	5	were	be	AUX
ajlm-1458	39	6	prepared	prepare	VERB
ajlm-1458	39	7	for	for	ADP
ajlm-1458	39	8	flow	flow	NOUN
ajlm-1458	39	9	cytometric	cytometric	ADJ
ajlm-1458	39	10	analysis	analysis	NOUN
ajlm-1458	39	11	according	accord	VERB
ajlm-1458	39	12	to	to	ADP
ajlm-1458	39	13	current	current	ADJ
ajlm-1458	39	14	local	local	ADJ
ajlm-1458	39	15	standard	standard	ADJ
ajlm-1458	39	16	operating	operating	NOUN
ajlm-1458	39	17	procedures	procedure	NOUN
ajlm-1458	39	18	,	,	PUNCT
ajlm-1458	39	19	irrespective	irrespective	ADV
ajlm-1458	39	20	of	of	ADP
ajlm-1458	39	21	reagents	reagent	NOUN
ajlm-1458	39	22	used	use	VERB
ajlm-1458	39	23	.	.	PUNCT
ajlm-1458	40	1	two	two	NUM
ajlm-1458	40	2	to	to	PART
ajlm-1458	40	3	four	four	NUM
ajlm-1458	40	4	500	500	NUM
ajlm-1458	40	5	µl	µl	ADP
ajlm-1458	40	6	aliquots	aliquot	NOUN
ajlm-1458	40	7	of	of	ADP
ajlm-1458	40	8	blood	blood	NOUN
ajlm-1458	40	9	or	or	CCONJ
ajlm-1458	40	10	bone	bone	NOUN
ajlm-1458	40	11	marrow	marrow	NOUN
ajlm-1458	40	12	per	per	ADP
ajlm-1458	40	13	patient	patient	NOUN
ajlm-1458	40	14	were	be	AUX
ajlm-1458	40	15	prepared	prepare	VERB
ajlm-1458	40	16	depending	depend	VERB
ajlm-1458	40	17	on	on	ADP
ajlm-1458	40	18	the	the	DET
ajlm-1458	40	19	initial	initial	ADJ
ajlm-1458	40	20	white	white	ADJ
ajlm-1458	40	21	blood	blood	NOUN
ajlm-1458	40	22	cell	cell	NOUN
ajlm-1458	40	23	count	count	NOUN
ajlm-1458	40	24	.	.	PUNCT
ajlm-1458	41	1	the	the	DET
ajlm-1458	41	2	aliquots	aliquot	NOUN
ajlm-1458	41	3	of	of	ADP
ajlm-1458	41	4	the	the	DET
ajlm-1458	41	5	sample	sample	NOUN
ajlm-1458	41	6	were	be	AUX
ajlm-1458	41	7	placed	place	VERB
ajlm-1458	41	8	in	in	ADP
ajlm-1458	41	9	conical	conical	NOUN
ajlm-1458	41	10	centrifuge	centrifuge	NOUN
ajlm-1458	41	11	tubes	tube	NOUN
ajlm-1458	41	12	to	to	ADP
ajlm-1458	41	13	which	which	PRON
ajlm-1458	41	14	14.5	14.5	NUM
ajlm-1458	41	15	ml	ml	NOUN
ajlm-1458	41	16	of	of	ADP
ajlm-1458	41	17	0.899	0.899	NUM
ajlm-1458	41	18	%	%	NOUN
ajlm-1458	41	19	solution	solution	NOUN
ajlm-1458	41	20	of	of	ADP
ajlm-1458	41	21	ammonium	ammonium	NOUN
ajlm-1458	41	22	chloride	chloride	NOUN
ajlm-1458	41	23	(	(	PUNCT
ajlm-1458	41	24	nh4cl	nh4cl	NOUN
ajlm-1458	41	25	)	)	PUNCT
ajlm-1458	41	26	containing	contain	VERB
ajlm-1458	41	27	0.084	0.084	NUM
ajlm-1458	41	28	%	%	NOUN
ajlm-1458	41	29	sodium	sodium	NOUN
ajlm-1458	41	30	bicarbonate	bicarbonate	NOUN
ajlm-1458	41	31	and	and	CCONJ
ajlm-1458	41	32	0.0037	0.0037	NUM
ajlm-1458	41	33	%	%	NOUN
ajlm-1458	41	34	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-1458	41	35	acid	acid	NOUN
ajlm-1458	41	36	(	(	PUNCT
ajlm-1458	41	37	merck	merck	PROPN
ajlm-1458	41	38	,	,	PUNCT
ajlm-1458	41	39	darmstadt	darmstadt	PROPN
ajlm-1458	41	40	,	,	PUNCT
ajlm-1458	41	41	germany	germany	PROPN
ajlm-1458	41	42	)	)	PUNCT
ajlm-1458	41	43	was	be	AUX
ajlm-1458	41	44	added	add	VERB
ajlm-1458	41	45	to	to	AUX
ajlm-1458	41	46	lyse	lyse	VERB
ajlm-1458	41	47	the	the	DET
ajlm-1458	41	48	red	red	ADJ
ajlm-1458	41	49	blood	blood	NOUN
ajlm-1458	41	50	cells	cell	NOUN
ajlm-1458	41	51	.	.	PUNCT
ajlm-1458	42	1	this	this	PRON
ajlm-1458	42	2	was	be	AUX
ajlm-1458	42	3	allowed	allow	VERB
ajlm-1458	42	4	to	to	PART
ajlm-1458	42	5	stand	stand	VERB
ajlm-1458	42	6	for	for	ADP
ajlm-1458	42	7	15	15	NUM
ajlm-1458	42	8	min	min	NOUN
ajlm-1458	42	9	,	,	PUNCT
ajlm-1458	42	10	followed	follow	VERB
ajlm-1458	42	11	by	by	ADP
ajlm-1458	42	12	a	a	DET
ajlm-1458	42	13	short	short	ADJ
ajlm-1458	42	14	3	3	NUM
ajlm-1458	42	15	-	-	PUNCT
ajlm-1458	42	16	min	min	NOUN
ajlm-1458	42	17	spin	spin	NOUN
ajlm-1458	42	18	at	at	ADP
ajlm-1458	42	19	3000	3000	NUM
ajlm-1458	42	20	rpm	rpm	NOUN
ajlm-1458	42	21	.	.	PUNCT
ajlm-1458	43	1	a	a	DET
ajlm-1458	43	2	further	further	ADJ
ajlm-1458	43	3	5	5	NUM
ajlm-1458	43	4	-	-	PUNCT
ajlm-1458	43	5	min	min	NOUN
ajlm-1458	43	6	incubation	incubation	NOUN
ajlm-1458	43	7	time	time	NOUN
ajlm-1458	43	8	in	in	ADP
ajlm-1458	43	9	the	the	DET
ajlm-1458	43	10	nh4cl	nh4cl	PROPN
ajlm-1458	43	11	solution	solution	NOUN
ajlm-1458	43	12	,	,	PUNCT
ajlm-1458	43	13	followed	follow	VERB
ajlm-1458	43	14	by	by	ADP
ajlm-1458	43	15	a	a	DET
ajlm-1458	43	16	3	3	NUM
ajlm-1458	43	17	-	-	PUNCT
ajlm-1458	43	18	min	min	NOUN
ajlm-1458	43	19	spin	spin	NOUN
ajlm-1458	43	20	,	,	PUNCT
ajlm-1458	43	21	was	be	AUX
ajlm-1458	43	22	performed	perform	VERB
ajlm-1458	43	23	if	if	SCONJ
ajlm-1458	43	24	the	the	DET
ajlm-1458	43	25	red	red	ADJ
ajlm-1458	43	26	cells	cell	NOUN
ajlm-1458	43	27	were	be	AUX
ajlm-1458	43	28	macroscopically	macroscopically	ADV
ajlm-1458	43	29	visible	visible	ADJ
ajlm-1458	43	30	on	on	ADP
ajlm-1458	43	31	the	the	DET
ajlm-1458	43	32	cell	cell	NOUN
ajlm-1458	43	33	pellet	pellet	NOUN
ajlm-1458	43	34	.	.	PUNCT
ajlm-1458	44	1	samples	sample	NOUN
ajlm-1458	44	2	were	be	AUX
ajlm-1458	44	3	subsequently	subsequently	ADV
ajlm-1458	44	4	washed	wash	VERB
ajlm-1458	44	5	three	three	NUM
ajlm-1458	44	6	times	time	NOUN
ajlm-1458	44	7	with	with	ADP
ajlm-1458	44	8	a	a	DET
ajlm-1458	44	9	commercial	commercial	ADJ
ajlm-1458	44	10	phosphate	phosphate	NOUN
ajlm-1458	44	11	-	-	PUNCT
ajlm-1458	44	12	buffered	buffer	VERB
ajlm-1458	44	13	saline	saline	NOUN
ajlm-1458	44	14	(	(	PUNCT
ajlm-1458	44	15	pbs	pbs	PROPN
ajlm-1458	44	16	)	)	PUNCT
ajlm-1458	44	17	solution	solution	NOUN
ajlm-1458	44	18	at	at	ADP
ajlm-1458	44	19	ph	ph	PROPN
ajlm-1458	44	20	7.3	7.3	NUM
ajlm-1458	44	21	±	±	NUM
ajlm-1458	44	22	2	2	NUM
ajlm-1458	44	23	(	(	PUNCT
ajlm-1458	44	24	oxoid	oxoid	PROPN
ajlm-1458	44	25	ltd	ltd	PROPN
ajlm-1458	44	26	,	,	PUNCT
ajlm-1458	44	27	basingstoke	basingstoke	PROPN
ajlm-1458	44	28	,	,	PUNCT
ajlm-1458	44	29	united	united	ADJ
ajlm-1458	44	30	kingdom	kingdom	PROPN
ajlm-1458	44	31	)	)	PUNCT
ajlm-1458	44	32	containing	contain	VERB
ajlm-1458	44	33	0.09	0.09	NUM
ajlm-1458	44	34	%	%	NOUN
ajlm-1458	44	35	sodium	sodium	NOUN
ajlm-1458	44	36	azide	azide	NOUN
ajlm-1458	44	37	(	(	PUNCT
ajlm-1458	44	38	merck	merck	PROPN
ajlm-1458	44	39	,	,	PUNCT
ajlm-1458	44	40	darmstadt	darmstadt	PROPN
ajlm-1458	44	41	,	,	PUNCT
ajlm-1458	44	42	germany	germany	PROPN
ajlm-1458	44	43	)	)	PUNCT
ajlm-1458	44	44	and	and	CCONJ
ajlm-1458	44	45	0.2	0.2	NUM
ajlm-1458	44	46	%	%	NOUN
ajlm-1458	44	47	bovine	bovine	NOUN
ajlm-1458	44	48	serum	serum	NOUN
ajlm-1458	44	49	albumin	albumin	PROPN
ajlm-1458	44	50	(	(	PUNCT
ajlm-1458	44	51	biowest	biow	ADJ
ajlm-1458	44	52	,	,	PUNCT
ajlm-1458	44	53	nuaille	nuaille	PROPN
ajlm-1458	44	54	,	,	PUNCT
ajlm-1458	44	55	france	france	PROPN
ajlm-1458	44	56	)	)	PUNCT
ajlm-1458	44	57	.	.	PUNCT
ajlm-1458	45	1	cell	cell	NOUN
ajlm-1458	45	2	pellets	pellet	NOUN
ajlm-1458	45	3	were	be	AUX
ajlm-1458	45	4	resuspended	resuspend	VERB
ajlm-1458	45	5	with	with	ADP
ajlm-1458	45	6	1	1	NUM
ajlm-1458	45	7	ml	ml	NOUN
ajlm-1458	45	8	pbs	pbs	PROPN
ajlm-1458	45	9	.	.	PUNCT
ajlm-1458	46	1	white	white	PROPN
ajlm-1458	46	2	cell	cell	NOUN
ajlm-1458	46	3	count	count	NOUN
ajlm-1458	46	4	was	be	AUX
ajlm-1458	46	5	obtained	obtain	VERB
ajlm-1458	46	6	for	for	ADP
ajlm-1458	46	7	each	each	DET
ajlm-1458	46	8	sample	sample	NOUN
ajlm-1458	46	9	using	use	VERB
ajlm-1458	46	10	100	100	NUM
ajlm-1458	46	11	µl	µl	NOUN
ajlm-1458	46	12	of	of	ADP
ajlm-1458	46	13	the	the	DET
ajlm-1458	46	14	cell	cell	NOUN
ajlm-1458	46	15	concentrate	concentrate	NOUN
ajlm-1458	46	16	and	and	CCONJ
ajlm-1458	46	17	100	100	NUM
ajlm-1458	46	18	µl	µl	NOUN
ajlm-1458	46	19	of	of	ADP
ajlm-1458	46	20	bc	bc	PROPN
ajlm-1458	46	21	flowcount	flowcount	PROPN
ajlm-1458	46	22	™	™	PROPN
ajlm-1458	46	23	31,32	31,32	NUM
ajlm-1458	46	24	beads	bead	NOUN
ajlm-1458	46	25	(	(	PUNCT
ajlm-1458	46	26	bc	bc	PROPN
ajlm-1458	46	27	,	,	PUNCT
ajlm-1458	46	28	miami	miami	PROPN
ajlm-1458	46	29	,	,	PUNCT
ajlm-1458	46	30	florida	florida	PROPN
ajlm-1458	46	31	,	,	PUNCT
ajlm-1458	46	32	united	united	PROPN
ajlm-1458	46	33	states	states	PROPN
ajlm-1458	46	34	)	)	PUNCT
ajlm-1458	46	35	in	in	ADP
ajlm-1458	46	36	a	a	DET
ajlm-1458	46	37	1	1	NUM
ajlm-1458	46	38	ml	ml	NOUN
ajlm-1458	46	39	pbs	pbs	PROPN
ajlm-1458	46	40	solution	solution	NOUN
ajlm-1458	46	41	on	on	ADP
ajlm-1458	46	42	the	the	DET
ajlm-1458	46	43	navios	navio	NOUN
ajlm-1458	46	44	flow	flow	NOUN
ajlm-1458	46	45	cytometer	cytometer	NOUN
ajlm-1458	46	46	.	.	PUNCT
ajlm-1458	47	1	the	the	DET
ajlm-1458	47	2	volume	volume	NOUN
ajlm-1458	47	3	of	of	ADP
ajlm-1458	47	4	cell	cell	NOUN
ajlm-1458	47	5	concentrate	concentrate	NOUN
ajlm-1458	47	6	estimated	estimate	VERB
ajlm-1458	47	7	to	to	PART
ajlm-1458	47	8	contain	contain	VERB
ajlm-1458	47	9	~1	~1	NUM
ajlm-1458	47	10	×	×	NOUN
ajlm-1458	47	11	106	106	NUM
ajlm-1458	47	12	cells	cell	NOUN
ajlm-1458	47	13	per	per	ADP
ajlm-1458	47	14	aliquot	aliquot	NOUN
ajlm-1458	47	15	was	be	AUX
ajlm-1458	47	16	calculated	calculate	VERB
ajlm-1458	47	17	,	,	PUNCT
ajlm-1458	47	18	and	and	CCONJ
ajlm-1458	47	19	this	this	DET
ajlm-1458	47	20	predetermined	predetermine	VERB
ajlm-1458	47	21	cell	cell	NOUN
ajlm-1458	47	22	concentrate	concentrate	NOUN
ajlm-1458	47	23	volume	volume	NOUN
ajlm-1458	47	24	was	be	AUX
ajlm-1458	47	25	added	add	VERB
ajlm-1458	47	26	to	to	ADP
ajlm-1458	47	27	each	each	DET
ajlm-1458	47	28	labelled	label	VERB
ajlm-1458	47	29	marker	marker	NOUN
ajlm-1458	47	30	tube	tube	NOUN
ajlm-1458	47	31	of	of	ADP
ajlm-1458	47	32	the	the	DET
ajlm-1458	47	33	ldt	ldt	PROPN
ajlm-1458	47	34	panel	panel	NOUN
ajlm-1458	47	35	first	first	ADV
ajlm-1458	47	36	.	.	PUNCT
ajlm-1458	48	1	remnant	remnant	ADJ
ajlm-1458	48	2	cell	cell	NOUN
ajlm-1458	48	3	concentrates	concentrate	VERB
ajlm-1458	48	4	,	,	PUNCT
ajlm-1458	48	5	or	or	CCONJ
ajlm-1458	48	6	cell	cell	NOUN
ajlm-1458	48	7	concentrates	concentrate	NOUN
ajlm-1458	48	8	harvested	harvest	VERB
ajlm-1458	48	9	from	from	ADP
ajlm-1458	48	10	whole	whole	ADJ
ajlm-1458	48	11	remnant	remnant	ADJ
ajlm-1458	48	12	samples	sample	NOUN
ajlm-1458	48	13	,	,	PUNCT
ajlm-1458	48	14	were	be	AUX
ajlm-1458	48	15	aliquoted	aliquote	VERB
ajlm-1458	48	16	into	into	ADP
ajlm-1458	48	17	the	the	DET
ajlm-1458	48	18	clearllab	clearllab	NOUN
ajlm-1458	48	19	tubes	tube	NOUN
ajlm-1458	48	20	.	.	PUNCT
ajlm-1458	49	1	each	each	DET
ajlm-1458	49	2	sample	sample	NOUN
ajlm-1458	49	3	aliquot	aliquot	NOUN
ajlm-1458	49	4	was	be	AUX
ajlm-1458	49	5	incubated	incubate	VERB
ajlm-1458	49	6	in	in	ADP
ajlm-1458	49	7	the	the	DET
ajlm-1458	49	8	dark	dark	NOUN
ajlm-1458	49	9	at	at	ADP
ajlm-1458	49	10	room	room	NOUN
ajlm-1458	49	11	temperature	temperature	NOUN
ajlm-1458	49	12	(	(	PUNCT
ajlm-1458	49	13	22	22	NUM
ajlm-1458	49	14	°	°	NOUN
ajlm-1458	49	15	c	c	NOUN
ajlm-1458	49	16	)	)	PUNCT
ajlm-1458	49	17	for	for	ADP
ajlm-1458	49	18	15	15	NUM
ajlm-1458	49	19	min	min	NOUN
ajlm-1458	49	20	,	,	PUNCT
ajlm-1458	49	21	followed	follow	VERB
ajlm-1458	49	22	by	by	ADP
ajlm-1458	49	23	a	a	DET
ajlm-1458	49	24	final	final	ADJ
ajlm-1458	49	25	wash	wash	NOUN
ajlm-1458	49	26	in	in	ADP
ajlm-1458	49	27	pbs	pbs	PROPN
ajlm-1458	49	28	.	.	PUNCT
ajlm-1458	50	1	the	the	DET
ajlm-1458	50	2	cell	cell	NOUN
ajlm-1458	50	3	pellet	pellet	NOUN
ajlm-1458	50	4	was	be	AUX
ajlm-1458	50	5	reconstituted	reconstitute	VERB
ajlm-1458	50	6	with	with	ADP
ajlm-1458	50	7	700	700	NUM
ajlm-1458	50	8	µl	µl	NOUN
ajlm-1458	50	9	of	of	ADP
ajlm-1458	50	10	pbs	pb	NOUN
ajlm-1458	50	11	and	and	CCONJ
ajlm-1458	50	12	immediately	immediately	ADV
ajlm-1458	50	13	run	run	VERB
ajlm-1458	50	14	on	on	ADP
ajlm-1458	50	15	either	either	CCONJ
ajlm-1458	50	16	the	the	DET
ajlm-1458	50	17	facscalibur	facscalibur	NOUN
ajlm-1458	50	18	flow	flow	NOUN
ajlm-1458	50	19	cytometer	cytometer	NOUN
ajlm-1458	50	20	(	(	PUNCT
ajlm-1458	50	21	bd	bd	PROPN
ajlm-1458	50	22	biosciences	bioscience	NOUN
ajlm-1458	50	23	,	,	PUNCT
ajlm-1458	50	24	san	san	PROPN
ajlm-1458	50	25	jose	jose	PROPN
ajlm-1458	50	26	,	,	PUNCT
ajlm-1458	50	27	california	california	PROPN
ajlm-1458	50	28	,	,	PUNCT
ajlm-1458	50	29	united	united	PROPN
ajlm-1458	50	30	states	states	PROPN
ajlm-1458	50	31	)	)	PUNCT
ajlm-1458	50	32	for	for	ADP
ajlm-1458	50	33	the	the	DET
ajlm-1458	50	34	ldt	ldt	PROPN
ajlm-1458	50	35	or	or	CCONJ
ajlm-1458	50	36	the	the	DET
ajlm-1458	50	37	navios	navio	NOUN
ajlm-1458	50	38	flow	flow	NOUN
ajlm-1458	50	39	cytometer	cytometer	NOUN
ajlm-1458	50	40	(	(	PUNCT
ajlm-1458	50	41	bc	bc	PROPN
ajlm-1458	50	42	,	,	PUNCT
ajlm-1458	50	43	miami	miami	PROPN
ajlm-1458	50	44	,	,	PUNCT
ajlm-1458	50	45	florida	florida	PROPN
ajlm-1458	50	46	,	,	PUNCT
ajlm-1458	50	47	united	united	PROPN
ajlm-1458	50	48	states	states	PROPN
ajlm-1458	50	49	)	)	PUNCT
ajlm-1458	50	50	for	for	ADP
ajlm-1458	50	51	the	the	DET
ajlm-1458	50	52	clearllab	clearllab	NOUN
ajlm-1458	50	53	samples	sample	NOUN
ajlm-1458	50	54	.	.	PUNCT
ajlm-1458	51	1	whole	whole	ADJ
ajlm-1458	51	2	samples	sample	NOUN
ajlm-1458	51	3	(	(	PUNCT
ajlm-1458	51	4	remaining	remain	VERB
ajlm-1458	51	5	after	after	ADP
ajlm-1458	51	6	cell	cell	NOUN
ajlm-1458	51	7	concentrate	concentrate	NOUN
ajlm-1458	51	8	preparation	preparation	NOUN
ajlm-1458	51	9	)	)	PUNCT
ajlm-1458	51	10	were	be	AUX
ajlm-1458	51	11	stored	store	VERB
ajlm-1458	51	12	on	on	ADP
ajlm-1458	51	13	the	the	DET
ajlm-1458	51	14	bench	bench	NOUN
ajlm-1458	51	15	at	at	ADP
ajlm-1458	51	16	room	room	NOUN
ajlm-1458	51	17	temperature	temperature	NOUN
ajlm-1458	51	18	(	(	PUNCT
ajlm-1458	51	19	~22	~22	INTJ
ajlm-1458	51	20	°	°	ADP
ajlm-1458	51	21	c	c	NOUN
ajlm-1458	51	22	)	)	PUNCT
ajlm-1458	51	23	during	during	ADP
ajlm-1458	51	24	testing	testing	NOUN
ajlm-1458	51	25	;	;	PUNCT
ajlm-1458	51	26	after	after	SCONJ
ajlm-1458	51	27	analysis	analysis	NOUN
ajlm-1458	51	28	was	be	AUX
ajlm-1458	51	29	completed	complete	VERB
ajlm-1458	51	30	,	,	PUNCT
ajlm-1458	51	31	remnants	remnant	NOUN
ajlm-1458	51	32	of	of	ADP
ajlm-1458	51	33	both	both	CCONJ
ajlm-1458	51	34	the	the	DET
ajlm-1458	51	35	whole	whole	ADJ
ajlm-1458	51	36	sample	sample	NOUN
ajlm-1458	51	37	and	and	CCONJ
ajlm-1458	51	38	the	the	DET
ajlm-1458	51	39	prepared	prepare	VERB
ajlm-1458	51	40	samples	sample	NOUN
ajlm-1458	51	41	were	be	AUX
ajlm-1458	51	42	refrigerated	refrigerate	VERB
ajlm-1458	51	43	at	at	ADP
ajlm-1458	51	44	4	4	NUM
ajlm-1458	51	45	°	°	NOUN
ajlm-1458	51	46	c	c	NOUN
ajlm-1458	51	47	.	.	PUNCT
ajlm-1458	52	1	flow	flow	NOUN
ajlm-1458	52	2	cytometer	cytometer	NOUN
ajlm-1458	52	3	quality	quality	NOUN
ajlm-1458	52	4	control	control	NOUN
ajlm-1458	52	5	and	and	CCONJ
ajlm-1458	52	6	immunophenotyping	immunophenotype	VERB
ajlm-1458	52	7	laboratory	laboratory	NOUN
ajlm-1458	52	8	developed	develop	VERB
ajlm-1458	52	9	test	test	NOUN
ajlm-1458	52	10	method	method	NOUN
ajlm-1458	52	11	before	before	ADP
ajlm-1458	52	12	march	march	PROPN
ajlm-1458	52	13	2020	2020	NUM
ajlm-1458	52	14	,	,	PUNCT
ajlm-1458	52	15	the	the	DET
ajlm-1458	52	16	ldt	ldt	PROPN
ajlm-1458	52	17	used	use	VERB
ajlm-1458	52	18	the	the	DET
ajlm-1458	52	19	bd	bd	PROPN
ajlm-1458	52	20	facscalibur	facscalibur	PROPN
ajlm-1458	52	21	™	™	ADJ
ajlm-1458	52	22	flow	flow	NOUN
ajlm-1458	52	23	cytometer	cytometer	NOUN
ajlm-1458	52	24	.	.	PUNCT
ajlm-1458	53	1	daily	daily	ADJ
ajlm-1458	53	2	quality	quality	NOUN
ajlm-1458	53	3	control	control	NOUN
ajlm-1458	53	4	for	for	ADP
ajlm-1458	53	5	the	the	DET
ajlm-1458	53	6	ldt	ldt	PROPN
ajlm-1458	53	7	on	on	ADP
ajlm-1458	53	8	the	the	DET
ajlm-1458	53	9	bd	bd	PROPN
ajlm-1458	53	10	facscalibur	facscalibur	PROPN
ajlm-1458	53	11	included	include	VERB
ajlm-1458	53	12	assessment	assessment	NOUN
ajlm-1458	53	13	of	of	ADP
ajlm-1458	53	14	background	background	NOUN
ajlm-1458	53	15	contamination	contamination	NOUN
ajlm-1458	53	16	,	,	PUNCT
ajlm-1458	53	17	carryover	carryover	NOUN
ajlm-1458	53	18	,	,	PUNCT
ajlm-1458	53	19	acquisition	acquisition	NOUN
ajlm-1458	53	20	and	and	CCONJ
ajlm-1458	53	21	analysis	analysis	NOUN
ajlm-1458	53	22	of	of	ADP
ajlm-1458	53	23	manufacturer	manufacturer	NOUN
ajlm-1458	53	24	-	-	PUNCT
ajlm-1458	53	25	recommended	recommend	VERB
ajlm-1458	53	26	3	3	NUM
ajlm-1458	53	27	-	-	PUNCT
ajlm-1458	53	28	colour	colour	NOUN
ajlm-1458	53	29	and	and	CCONJ
ajlm-1458	53	30	apc	apc	PROPN
ajlm-1458	53	31	calibrite	calibrite	PROPN
ajlm-1458	53	32	beads	bead	NOUN
ajlm-1458	53	33	(	(	PUNCT
ajlm-1458	53	34	bd	bd	PROPN
ajlm-1458	53	35	biosciences	bioscience	NOUN
ajlm-1458	53	36	,	,	PUNCT
ajlm-1458	53	37	san	san	PROPN
ajlm-1458	53	38	jose	jose	PROPN
ajlm-1458	53	39	,	,	PUNCT
ajlm-1458	53	40	california	california	PROPN
ajlm-1458	53	41	,	,	PUNCT
ajlm-1458	53	42	united	united	PROPN
ajlm-1458	53	43	states	states	PROPN
ajlm-1458	53	44	)	)	PUNCT
ajlm-1458	53	45	and	and	CCONJ
ajlm-1458	53	46	acquisition	acquisition	NOUN
ajlm-1458	53	47	and	and	CCONJ
ajlm-1458	53	48	analysis	analysis	NOUN
ajlm-1458	53	49	of	of	ADP
ajlm-1458	53	50	immunotroltm	immunotroltm	NOUN
ajlm-1458	53	51	process	process	NOUN
ajlm-1458	53	52	control	control	NOUN
ajlm-1458	53	53	(	(	PUNCT
ajlm-1458	53	54	bc	bc	PROPN
ajlm-1458	53	55	inc	inc	PROPN
ajlm-1458	53	56	.	.	PROPN
ajlm-1458	53	57	,	,	PUNCT
ajlm-1458	53	58	brea	brea	PROPN
ajlm-1458	53	59	,	,	PUNCT
ajlm-1458	53	60	california	california	PROPN
ajlm-1458	53	61	,	,	PUNCT
ajlm-1458	53	62	united	united	PROPN
ajlm-1458	53	63	states	states	PROPN
ajlm-1458	53	64	)	)	PUNCT
ajlm-1458	53	65	,	,	PUNCT
ajlm-1458	53	66	using	use	VERB
ajlm-1458	53	67	four	four	NUM
ajlm-1458	53	68	monoclonal	monoclonal	NOUN
ajlm-1458	53	69	antibodies	antibody	NOUN
ajlm-1458	53	70	namely	namely	ADV
ajlm-1458	53	71	cd45	cd45	PROPN
ajlm-1458	53	72	(	(	PUNCT
ajlm-1458	53	73	percp	percp	PROPN
ajlm-1458	53	74	)	)	PUNCT
ajlm-1458	53	75	,	,	PUNCT
ajlm-1458	53	76	cd3	cd3	PROPN
ajlm-1458	53	77	(	(	PUNCT
ajlm-1458	53	78	apc	apc	PROPN
ajlm-1458	53	79	)	)	PUNCT
ajlm-1458	53	80	,	,	PUNCT
ajlm-1458	53	81	cd14	cd14	PROPN
ajlm-1458	53	82	(	(	PUNCT
ajlm-1458	53	83	fitc	fitc	PROPN
ajlm-1458	53	84	)	)	PUNCT
ajlm-1458	53	85	and	and	CCONJ
ajlm-1458	53	86	cd13	cd13	PROPN
ajlm-1458	53	87	(	(	PUNCT
ajlm-1458	53	88	pe	pe	NOUN
ajlm-1458	53	89	)	)	PUNCT
ajlm-1458	53	90	.	.	PUNCT
ajlm-1458	54	1	liquid	liquid	ADJ
ajlm-1458	54	2	monoclonals	monoclonal	NOUN
ajlm-1458	54	3	were	be	AUX
ajlm-1458	54	4	used	use	VERB
ajlm-1458	54	5	according	accord	VERB
ajlm-1458	54	6	to	to	ADP
ajlm-1458	54	7	the	the	DET
ajlm-1458	54	8	manufacturer	manufacturer	NOUN
ajlm-1458	54	9	specifications	specification	NOUN
ajlm-1458	54	10	and	and	CCONJ
ajlm-1458	54	11	manually	manually	ADV
ajlm-1458	54	12	pipetted	pipette	VERB
ajlm-1458	54	13	individually	individually	ADV
ajlm-1458	54	14	to	to	PART
ajlm-1458	54	15	constitute	constitute	VERB
ajlm-1458	54	16	2–4	2–4	NUM
ajlm-1458	54	17	-	-	PUNCT
ajlm-1458	54	18	colour	colour	NOUN
ajlm-1458	54	19	assembled	assemble	VERB
ajlm-1458	54	20	panels	panel	NOUN
ajlm-1458	54	21	using	use	VERB
ajlm-1458	54	22	varying	vary	VERB
ajlm-1458	54	23	combinations	combination	NOUN
ajlm-1458	54	24	of	of	ADP
ajlm-1458	54	25	cell	cell	NOUN
ajlm-1458	54	26	markers	marker	NOUN
ajlm-1458	54	27	chosen	choose	VERB
ajlm-1458	54	28	by	by	ADP
ajlm-1458	54	29	attending	attend	VERB
ajlm-1458	54	30	pathologists	pathologist	NOUN
ajlm-1458	54	31	according	accord	VERB
ajlm-1458	54	32	to	to	ADP
ajlm-1458	54	33	the	the	DET
ajlm-1458	54	34	merits	merit	NOUN
ajlm-1458	54	35	of	of	ADP
ajlm-1458	54	36	the	the	DET
ajlm-1458	54	37	patient	patient	NOUN
ajlm-1458	54	38	’s	’s	PART
ajlm-1458	54	39	presenting	present	VERB
ajlm-1458	54	40	case	case	NOUN
ajlm-1458	54	41	history	history	NOUN
ajlm-1458	54	42	(	(	PUNCT
ajlm-1458	54	43	table	table	NOUN
ajlm-1458	54	44	1	1	NUM
ajlm-1458	54	45	)	)	PUNCT
ajlm-1458	54	46	.	.	PUNCT
ajlm-1458	55	1	the	the	DET
ajlm-1458	55	2	patients	patient	NOUN
ajlm-1458	55	3	’	'	PUNCT
ajlm-1458	55	4	samples	sample	NOUN
ajlm-1458	55	5	were	be	AUX
ajlm-1458	55	6	acquired	acquire	VERB
ajlm-1458	55	7	on	on	ADP
ajlm-1458	55	8	bd	bd	PROPN
ajlm-1458	55	9	facscalibur	facscalibur	PROPN
ajlm-1458	55	10	™	™	PROPN
ajlm-1458	55	11	using	use	VERB
ajlm-1458	55	12	cellquest	cellquest	ADJ
ajlm-1458	55	13	™	™	ADJ
ajlm-1458	55	14	software	software	NOUN
ajlm-1458	55	15	(	(	PUNCT
ajlm-1458	55	16	bd	bd	PROPN
ajlm-1458	55	17	biosciences	bioscience	NOUN
ajlm-1458	55	18	,	,	PUNCT
ajlm-1458	55	19	san	san	PROPN
ajlm-1458	55	20	jose	jose	PROPN
ajlm-1458	55	21	,	,	PUNCT
ajlm-1458	55	22	california	california	PROPN
ajlm-1458	55	23	,	,	PUNCT
ajlm-1458	55	24	united	united	PROPN
ajlm-1458	55	25	states	states	PROPN
ajlm-1458	55	26	)	)	PUNCT
ajlm-1458	55	27	;	;	PUNCT
ajlm-1458	55	28	the	the	DET
ajlm-1458	55	29	instrument	instrument	NOUN
ajlm-1458	55	30	typically	typically	ADV
ajlm-1458	55	31	stops	stop	VERB
ajlm-1458	55	32	counting	count	VERB
ajlm-1458	55	33	at	at	ADP
ajlm-1458	55	34	5000	5000	NUM
ajlm-1458	55	35	events	event	NOUN
ajlm-1458	55	36	.	.	PUNCT
ajlm-1458	56	1	in	in	ADP
ajlm-1458	56	2	the	the	DET
ajlm-1458	56	3	event	event	NOUN
ajlm-1458	56	4	of	of	ADP
ajlm-1458	56	5	a	a	DET
ajlm-1458	56	6	paucicellular	paucicellular	ADJ
ajlm-1458	56	7	sample	sample	NOUN
ajlm-1458	56	8	,	,	PUNCT
ajlm-1458	56	9	the	the	DET
ajlm-1458	56	10	tube	tube	NOUN
ajlm-1458	56	11	would	would	AUX
ajlm-1458	56	12	run	run	VERB
ajlm-1458	56	13	for	for	ADP
ajlm-1458	56	14	the	the	DET
ajlm-1458	56	15	maximum	maximum	ADJ
ajlm-1458	56	16	time	time	NOUN
ajlm-1458	56	17	permissible	permissible	ADJ
ajlm-1458	56	18	~300	~300	NUM
ajlm-1458	56	19	s	s	NOUN
ajlm-1458	56	20	,	,	PUNCT
ajlm-1458	56	21	to	to	PART
ajlm-1458	56	22	ensure	ensure	VERB
ajlm-1458	56	23	as	as	SCONJ
ajlm-1458	56	24	many	many	ADJ
ajlm-1458	56	25	cells	cell	NOUN
ajlm-1458	56	26	as	as	ADP
ajlm-1458	56	27	possible	possible	ADJ
ajlm-1458	56	28	could	could	AUX
ajlm-1458	56	29	be	be	AUX
ajlm-1458	56	30	counted	count	VERB
ajlm-1458	56	31	,	,	PUNCT
ajlm-1458	56	32	but	but	CCONJ
ajlm-1458	56	33	consequently	consequently	ADV
ajlm-1458	56	34	with	with	SCONJ
ajlm-1458	56	35	total	total	ADJ
ajlm-1458	56	36	variable	variable	ADJ
ajlm-1458	56	37	events	event	NOUN
ajlm-1458	56	38	counted	count	VERB
ajlm-1458	56	39	.	.	PUNCT
ajlm-1458	57	1	listmode	listmode	PROPN
ajlm-1458	57	2	(	(	PUNCT
ajlm-1458	57	3	.fcs	.fc	NOUN
ajlm-1458	57	4	)	)	PUNCT
ajlm-1458	57	5	data	datum	NOUN
ajlm-1458	57	6	files	file	NOUN
ajlm-1458	57	7	were	be	AUX
ajlm-1458	57	8	analysed	analyse	VERB
ajlm-1458	57	9	and	and	CCONJ
ajlm-1458	57	10	interpreted	interpret	VERB
ajlm-1458	57	11	by	by	ADP
ajlm-1458	57	12	consultant	consultant	NOUN
ajlm-1458	57	13	hematopathologists	hematopathologist	NOUN
ajlm-1458	57	14	using	use	VERB
ajlm-1458	57	15	bd	bd	PROPN
ajlm-1458	57	16	paint	paint	VERB
ajlm-1458	57	17	-	-	PUNCT
ajlm-1458	57	18	a	a	DET
ajlm-1458	57	19	-	-	PUNCT
ajlm-1458	57	20	gate	gate	NOUN
ajlm-1458	57	21	™	™	ADJ
ajlm-1458	57	22	software	software	NOUN
ajlm-1458	57	23	(	(	PUNCT
ajlm-1458	57	24	bd	bd	PROPN
ajlm-1458	57	25	biosciences	bioscience	NOUN
ajlm-1458	57	26	,	,	PUNCT
ajlm-1458	57	27	san	san	PROPN
ajlm-1458	57	28	jose	jose	PROPN
ajlm-1458	57	29	,	,	PUNCT
ajlm-1458	57	30	california	california	PROPN
ajlm-1458	57	31	,	,	PUNCT
ajlm-1458	57	32	united	united	PROPN
ajlm-1458	57	33	states	states	PROPN
ajlm-1458	57	34	)	)	PUNCT
ajlm-1458	57	35	.	.	PUNCT
ajlm-1458	58	1	table	table	NOUN
ajlm-1458	58	2	1	1	NUM
ajlm-1458	58	3	:	:	PUNCT
ajlm-1458	58	4	 	 	SPACE
ajlm-1458	58	5	summary	summary	NOUN
ajlm-1458	58	6	of	of	ADP
ajlm-1458	58	7	the	the	DET
ajlm-1458	58	8	laboratory	laboratory	NOUN
ajlm-1458	58	9	developed	develop	VERB
ajlm-1458	58	10	test	test	NOUN
ajlm-1458	58	11	panels	panel	NOUN
ajlm-1458	58	12	and	and	CCONJ
ajlm-1458	58	13	monoclonal	monoclonal	NOUN
ajlm-1458	58	14	antibody	antibody	NOUN
ajlm-1458	58	15	combinations	combination	NOUN
ajlm-1458	58	16	and	and	CCONJ
ajlm-1458	58	17	respective	respective	ADJ
ajlm-1458	58	18	fluorochromes	fluorochrome	NOUN
ajlm-1458	58	19	used	use	VERB
ajlm-1458	58	20	during	during	ADP
ajlm-1458	58	21	routine	routine	ADJ
ajlm-1458	58	22	diagnostic	diagnostic	ADJ
ajlm-1458	58	23	workup	workup	NOUN
ajlm-1458	58	24	at	at	ADP
ajlm-1458	58	25	the	the	DET
ajlm-1458	58	26	charlotte	charlotte	PROPN
ajlm-1458	58	27	maxeke	maxeke	PROPN
ajlm-1458	58	28	johannesburg	johannesburg	PROPN
ajlm-1458	58	29	academic	academic	PROPN
ajlm-1458	58	30	laboratory	laboratory	PROPN
ajlm-1458	58	31	in	in	ADP
ajlm-1458	58	32	johannesburg	johannesburg	PROPN
ajlm-1458	58	33	,	,	PUNCT
ajlm-1458	58	34	south	south	PROPN
ajlm-1458	58	35	africa	africa	PROPN
ajlm-1458	58	36	,	,	PUNCT
ajlm-1458	58	37	august	august	PROPN
ajlm-1458	58	38	2019	2019	NUM
ajlm-1458	58	39	–	–	PUNCT
ajlm-1458	58	40	november	november	PROPN
ajlm-1458	58	41	2019	2019	NUM
ajlm-1458	58	42	.	.	PUNCT
ajlm-1458	59	1	clearllab	clearllab	PROPN
ajlm-1458	59	2	10c	10c	PROPN
ajlm-1458	59	3	panel	panel	NOUN
ajlm-1458	59	4	method	method	NOUN
ajlm-1458	59	5	before	before	ADP
ajlm-1458	59	6	starting	start	VERB
ajlm-1458	59	7	the	the	DET
ajlm-1458	59	8	study	study	NOUN
ajlm-1458	59	9	,	,	PUNCT
ajlm-1458	59	10	bc	bc	PROPN
ajlm-1458	59	11	provided	provide	VERB
ajlm-1458	59	12	training	training	NOUN
ajlm-1458	59	13	for	for	ADP
ajlm-1458	59	14	the	the	DET
ajlm-1458	59	15	navios	navio	NOUN
ajlm-1458	59	16	instrument	instrument	NOUN
ajlm-1458	59	17	,	,	PUNCT
ajlm-1458	59	18	including	include	VERB
ajlm-1458	59	19	application	application	NOUN
ajlm-1458	59	20	setup	setup	NOUN
ajlm-1458	59	21	,	,	PUNCT
ajlm-1458	59	22	control	control	NOUN
ajlm-1458	59	23	runs	run	NOUN
ajlm-1458	59	24	and	and	CCONJ
ajlm-1458	59	25	panel	panel	NOUN
ajlm-1458	59	26	acquisition	acquisition	NOUN
ajlm-1458	59	27	.	.	PUNCT
ajlm-1458	60	1	colour	colour	NOUN
ajlm-1458	60	2	compensation	compensation	NOUN
ajlm-1458	60	3	for	for	ADP
ajlm-1458	60	4	clearllab	clearllab	NOUN
ajlm-1458	60	5	testing	testing	NOUN
ajlm-1458	60	6	was	be	AUX
ajlm-1458	60	7	performed	perform	VERB
ajlm-1458	60	8	according	accord	VERB
ajlm-1458	60	9	to	to	ADP
ajlm-1458	60	10	manufacturer	manufacturer	NOUN
ajlm-1458	60	11	specifications.28	specifications.28	NOUN
ajlm-1458	60	12	before	before	ADP
ajlm-1458	60	13	commencing	commence	VERB
ajlm-1458	60	14	the	the	DET
ajlm-1458	60	15	validation	validation	NOUN
ajlm-1458	60	16	study	study	NOUN
ajlm-1458	60	17	,	,	PUNCT
ajlm-1458	60	18	an	an	DET
ajlm-1458	60	19	initial	initial	ADJ
ajlm-1458	60	20	reproducibility	reproducibility	NOUN
ajlm-1458	60	21	study	study	NOUN
ajlm-1458	60	22	was	be	AUX
ajlm-1458	60	23	performed	perform	VERB
ajlm-1458	60	24	(	(	PUNCT
ajlm-1458	60	25	data	datum	NOUN
ajlm-1458	60	26	not	not	PART
ajlm-1458	60	27	shown	show	VERB
ajlm-1458	60	28	)	)	PUNCT
ajlm-1458	60	29	,	,	PUNCT
ajlm-1458	60	30	utilising	utilise	VERB
ajlm-1458	60	31	both	both	CCONJ
ajlm-1458	60	32	the	the	DET
ajlm-1458	60	33	normal	normal	ADJ
ajlm-1458	60	34	and	and	CCONJ
ajlm-1458	60	35	abnormal	abnormal	ADJ
ajlm-1458	60	36	controls	control	NOUN
ajlm-1458	60	37	(	(	PUNCT
ajlm-1458	60	38	10	10	NUM
ajlm-1458	60	39	for	for	ADP
ajlm-1458	60	40	each	each	PRON
ajlm-1458	60	41	of	of	ADP
ajlm-1458	60	42	the	the	DET
ajlm-1458	60	43	respective	respective	ADJ
ajlm-1458	60	44	clearllab	clearllab	NOUN
ajlm-1458	60	45	tubes	tube	NOUN
ajlm-1458	60	46	;	;	PUNCT
ajlm-1458	60	47	see	see	VERB
ajlm-1458	60	48	table	table	NOUN
ajlm-1458	60	49	2	2	NUM
ajlm-1458	60	50	for	for	ADP
ajlm-1458	60	51	details	detail	NOUN
ajlm-1458	60	52	of	of	ADP
ajlm-1458	60	53	markers	marker	NOUN
ajlm-1458	60	54	included	include	VERB
ajlm-1458	60	55	in	in	ADP
ajlm-1458	60	56	the	the	DET
ajlm-1458	60	57	clearllab	clearllab	NOUN
ajlm-1458	60	58	tubes	tube	NOUN
ajlm-1458	60	59	)	)	PUNCT
ajlm-1458	60	60	.	.	PUNCT
ajlm-1458	61	1	the	the	DET
ajlm-1458	61	2	assay	assay	ADJ
ajlm-1458	61	3	values	value	NOUN
ajlm-1458	61	4	obtained	obtain	VERB
ajlm-1458	61	5	were	be	AUX
ajlm-1458	61	6	within	within	ADP
ajlm-1458	61	7	the	the	DET
ajlm-1458	61	8	published	publish	VERB
ajlm-1458	61	9	expected	expect	VERB
ajlm-1458	61	10	ranges	range	NOUN
ajlm-1458	61	11	of	of	ADP
ajlm-1458	61	12	the	the	DET
ajlm-1458	61	13	package	package	NOUN
ajlm-1458	61	14	inserts	insert	NOUN
ajlm-1458	61	15	;	;	PUNCT
ajlm-1458	61	16	the	the	DET
ajlm-1458	61	17	reproducibility	reproducibility	NOUN
ajlm-1458	61	18	of	of	ADP
ajlm-1458	61	19	the	the	DET
ajlm-1458	61	20	process	process	NOUN
ajlm-1458	61	21	controls	control	NOUN
ajlm-1458	61	22	met	meet	VERB
ajlm-1458	61	23	the	the	DET
ajlm-1458	61	24	manufacturer	manufacturer	NOUN
ajlm-1458	61	25	’s	’s	PART
ajlm-1458	61	26	percentage	percentage	NOUN
ajlm-1458	61	27	coefficient	coefficient	NOUN
ajlm-1458	61	28	of	of	ADP
ajlm-1458	61	29	variation	variation	NOUN
ajlm-1458	61	30	(	(	PUNCT
ajlm-1458	61	31	%	%	INTJ
ajlm-1458	61	32	cv	cv	NOUN
ajlm-1458	61	33	)	)	PUNCT
ajlm-1458	61	34	of	of	ADP
ajlm-1458	61	35	≤	≤	NUM
ajlm-1458	61	36	10	10	NUM
ajlm-1458	61	37	%	%	NOUN
ajlm-1458	61	38	for	for	ADP
ajlm-1458	61	39	all	all	DET
ajlm-1458	61	40	targeted	target	VERB
ajlm-1458	61	41	populations	population	NOUN
ajlm-1458	61	42	and	and	CCONJ
ajlm-1458	61	43	repeatability	repeatability	NOUN
ajlm-1458	61	44	of	of	ADP
ajlm-1458	61	45	≤	≤	ADJ
ajlm-1458	61	46	20%cv	20%cv	NUM
ajlm-1458	61	47	for	for	ADP
ajlm-1458	61	48	all	all	DET
ajlm-1458	61	49	targeted	target	VERB
ajlm-1458	61	50	populations.33	populations.33	NOUN
ajlm-1458	61	51	daily	daily	ADJ
ajlm-1458	61	52	internal	internal	ADJ
ajlm-1458	61	53	quality	quality	NOUN
ajlm-1458	61	54	control	control	NOUN
ajlm-1458	61	55	for	for	ADP
ajlm-1458	61	56	the	the	DET
ajlm-1458	61	57	navios	navio	NOUN
ajlm-1458	61	58	flow	flow	NOUN
ajlm-1458	61	59	cytometer	cytometer	NOUN
ajlm-1458	61	60	included	include	VERB
ajlm-1458	61	61	a	a	DET
ajlm-1458	61	62	daily	daily	ADJ
ajlm-1458	61	63	background	background	NOUN
ajlm-1458	61	64	count	count	NOUN
ajlm-1458	61	65	(	(	PUNCT
ajlm-1458	61	66	with	with	ADP
ajlm-1458	61	67	locally	locally	ADV
ajlm-1458	61	68	established	establish	VERB
ajlm-1458	61	69	target	target	NOUN
ajlm-1458	61	70	values	value	NOUN
ajlm-1458	61	71	of	of	ADP
ajlm-1458	61	72	<	<	X
ajlm-1458	61	73	100	100	NUM
ajlm-1458	61	74	events/100	events/100	PROPN
ajlm-1458	61	75	s	s	NOUN
ajlm-1458	61	76	)	)	PUNCT
ajlm-1458	61	77	and	and	CCONJ
ajlm-1458	61	78	daily	daily	ADJ
ajlm-1458	61	79	carryover	carryover	NOUN
ajlm-1458	61	80	(	(	PUNCT
ajlm-1458	61	81	locally	locally	ADV
ajlm-1458	61	82	established	establish	VERB
ajlm-1458	61	83	target	target	NOUN
ajlm-1458	61	84	value	value	NOUN
ajlm-1458	61	85	<	<	X
ajlm-1458	61	86	1	1	NUM
ajlm-1458	61	87	%	%	NOUN
ajlm-1458	61	88	carryover	carryover	NOUN
ajlm-1458	61	89	)	)	PUNCT
ajlm-1458	61	90	.	.	PUNCT
ajlm-1458	62	1	daily	daily	ADJ
ajlm-1458	62	2	flow	flow	NOUN
ajlm-1458	62	3	check	check	NOUN
ajlm-1458	62	4	pro	pro	X
ajlm-1458	62	5	(	(	PUNCT
ajlm-1458	62	6	target	target	VERB
ajlm-1458	62	7	hpcv	hpcv	NOUN
ajlm-1458	62	8	<	<	X
ajlm-1458	62	9	2.0	2.0	NUM
ajlm-1458	62	10	%	%	NOUN
ajlm-1458	62	11	for	for	ADP
ajlm-1458	62	12	fl1	fl1	ADV
ajlm-1458	62	13	-	-	PUNCT
ajlm-1458	62	14	fl5	fl5	NOUN
ajlm-1458	62	15	,	,	PUNCT
ajlm-1458	62	16	<	<	X
ajlm-1458	62	17	3	3	NUM
ajlm-1458	62	18	%	%	NOUN
ajlm-1458	62	19	for	for	ADP
ajlm-1458	62	20	fl7	fl7	VERB
ajlm-1458	62	21	-	-	PUNCT
ajlm-1458	62	22	fl8	fl8	NOUN
ajlm-1458	62	23	and	and	CCONJ
ajlm-1458	62	24	<	<	X
ajlm-1458	62	25	4	4	NUM
ajlm-1458	62	26	%	%	NOUN
ajlm-1458	62	27	for	for	ADP
ajlm-1458	62	28	fl9	fl9	NOUN
ajlm-1458	62	29	-	-	PUNCT
ajlm-1458	62	30	fl10	fl10	PROPN
ajlm-1458	62	31	)	)	PUNCT
ajlm-1458	62	32	was	be	AUX
ajlm-1458	62	33	used	use	VERB
ajlm-1458	62	34	to	to	PART
ajlm-1458	62	35	verify	verify	VERB
ajlm-1458	62	36	optical	optical	ADJ
ajlm-1458	62	37	alignment	alignment	NOUN
ajlm-1458	62	38	and	and	CCONJ
ajlm-1458	62	39	fluidics	fluidic	NOUN
ajlm-1458	62	40	(	(	PUNCT
ajlm-1458	62	41	bc	bc	PROPN
ajlm-1458	62	42	,	,	PUNCT
ajlm-1458	62	43	lismeehan	lismeehan	PROPN
ajlm-1458	62	44	,	,	PUNCT
ajlm-1458	62	45	ireland	ireland	PROPN
ajlm-1458	62	46	)	)	PUNCT
ajlm-1458	62	47	on	on	ADP
ajlm-1458	62	48	the	the	DET
ajlm-1458	62	49	navios	navio	NOUN
ajlm-1458	62	50	,	,	PUNCT
ajlm-1458	62	51	as	as	ADV
ajlm-1458	62	52	well	well	ADV
ajlm-1458	62	53	as	as	ADP
ajlm-1458	62	54	standardise	standardise	VERB
ajlm-1458	62	55	the	the	DET
ajlm-1458	62	56	optical	optical	ADJ
ajlm-1458	62	57	and	and	CCONJ
ajlm-1458	62	58	fluorescence	fluorescence	NOUN
ajlm-1458	62	59	settings	setting	NOUN
ajlm-1458	62	60	(	(	PUNCT
ajlm-1458	62	61	flow	flow	NOUN
ajlm-1458	62	62	-	-	PUNCT
ajlm-1458	62	63	set	set	VERB
ajlm-1458	62	64	pro	pro	ADJ
ajlm-1458	62	65	,	,	PUNCT
ajlm-1458	62	66	bc	bc	PROPN
ajlm-1458	62	67	,	,	PUNCT
ajlm-1458	62	68	lismeehan	lismeehan	PROPN
ajlm-1458	62	69	,	,	PUNCT
ajlm-1458	62	70	ireland	ireland	PROPN
ajlm-1458	62	71	)	)	PUNCT
ajlm-1458	62	72	.	.	PUNCT
ajlm-1458	63	1	clearllab	clearllab	PROPN
ajlm-1458	63	2	‘	'	PUNCT
ajlm-1458	63	3	normal	normal	ADJ
ajlm-1458	63	4	’	'	PUNCT
ajlm-1458	63	5	and	and	CCONJ
ajlm-1458	63	6	‘	'	PUNCT
ajlm-1458	63	7	abnormal	abnormal	ADJ
ajlm-1458	63	8	’	'	PUNCT
ajlm-1458	63	9	process	process	NOUN
ajlm-1458	63	10	control	control	NOUN
ajlm-1458	63	11	cells	cell	NOUN
ajlm-1458	63	12	(	(	PUNCT
ajlm-1458	63	13	bc	bc	PROPN
ajlm-1458	63	14	,	,	PUNCT
ajlm-1458	63	15	lismeehan	lismeehan	PROPN
ajlm-1458	63	16	,	,	PUNCT
ajlm-1458	63	17	ireland	ireland	PROPN
ajlm-1458	63	18	)	)	PUNCT
ajlm-1458	63	19	were	be	AUX
ajlm-1458	63	20	used	use	VERB
ajlm-1458	63	21	to	to	PART
ajlm-1458	63	22	verify	verify	VERB
ajlm-1458	63	23	sample	sample	NOUN
ajlm-1458	63	24	processing	processing	NOUN
ajlm-1458	63	25	,	,	PUNCT
ajlm-1458	63	26	acquisition	acquisition	NOUN
ajlm-1458	63	27	and	and	CCONJ
ajlm-1458	63	28	analysis	analysis	NOUN
ajlm-1458	63	29	against	against	ADP
ajlm-1458	63	30	established	establish	VERB
ajlm-1458	63	31	package	package	NOUN
ajlm-1458	63	32	insert	insert	NOUN
ajlm-1458	63	33	values	value	NOUN
ajlm-1458	63	34	and	and	CCONJ
ajlm-1458	63	35	assess	assess	VERB
ajlm-1458	63	36	repeatability	repeatability	NOUN
ajlm-1458	63	37	over	over	ADP
ajlm-1458	63	38	time	time	NOUN
ajlm-1458	63	39	(	(	PUNCT
ajlm-1458	63	40	data	datum	NOUN
ajlm-1458	63	41	not	not	PART
ajlm-1458	63	42	shown	show	VERB
ajlm-1458	63	43	)	)	PUNCT
ajlm-1458	63	44	.	.	PUNCT
ajlm-1458	64	1	weekly	weekly	ADJ
ajlm-1458	64	2	reproducibility	reproducibility	NOUN
ajlm-1458	64	3	was	be	AUX
ajlm-1458	64	4	ensured	ensure	VERB
ajlm-1458	64	5	through	through	ADP
ajlm-1458	64	6	locally	locally	ADV
ajlm-1458	64	7	established	establish	VERB
ajlm-1458	64	8	target	target	NOUN
ajlm-1458	64	9	values	value	NOUN
ajlm-1458	64	10	for	for	ADP
ajlm-1458	64	11	the	the	DET
ajlm-1458	64	12	bead	bead	NOUN
ajlm-1458	64	13	count	count	NOUN
ajlm-1458	64	14	rate31,32	rate31,32	VERB
ajlm-1458	64	15	and	and	CCONJ
ajlm-1458	64	16	cell	cell	NOUN
ajlm-1458	64	17	counts.33	counts.33	NOUN
ajlm-1458	64	18	the	the	DET
ajlm-1458	64	19	sensitivity	sensitivity	NOUN
ajlm-1458	64	20	and	and	CCONJ
ajlm-1458	64	21	specificity	specificity	NOUN
ajlm-1458	64	22	of	of	ADP
ajlm-1458	64	23	the	the	DET
ajlm-1458	64	24	clearllab	clearllab	NOUN
ajlm-1458	64	25	were	be	AUX
ajlm-1458	64	26	expected	expect	VERB
ajlm-1458	64	27	to	to	PART
ajlm-1458	64	28	match	match	VERB
ajlm-1458	64	29	or	or	CCONJ
ajlm-1458	64	30	exceed	exceed	VERB
ajlm-1458	64	31	the	the	DET
ajlm-1458	64	32	published	publish	VERB
ajlm-1458	64	33	bc	bc	PROPN
ajlm-1458	64	34	clearllab	clearllab	PROPN
ajlm-1458	64	35	10c	10c	PROPN
ajlm-1458	64	36	acceptance	acceptance	NOUN
ajlm-1458	64	37	limits	limit	NOUN
ajlm-1458	64	38	of	of	ADP
ajlm-1458	64	39	>	>	DET
ajlm-1458	64	40	70	70	NUM
ajlm-1458	64	41	%	%	NOUN
ajlm-1458	64	42	sensitivity	sensitivity	NOUN
ajlm-1458	64	43	and	and	CCONJ
ajlm-1458	64	44	>	>	X
ajlm-1458	64	45	80	80	NUM
ajlm-1458	64	46	%	%	NOUN
ajlm-1458	64	47	,	,	PUNCT
ajlm-1458	64	48	specificity	specificity	NOUN
ajlm-1458	64	49	.	.	PUNCT
ajlm-1458	65	1	table	table	NOUN
ajlm-1458	65	2	2	2	NUM
ajlm-1458	65	3	:	:	PUNCT
ajlm-1458	65	4	 	 	SPACE
ajlm-1458	65	5	reagents	reagent	NOUN
ajlm-1458	65	6	used	use	VERB
ajlm-1458	65	7	with	with	ADP
ajlm-1458	65	8	the	the	DET
ajlm-1458	65	9	clearllab	clearllab	NOUN
ajlm-1458	65	10	10c	10c	NUM
ajlm-1458	65	11	panels	panel	NOUN
ajlm-1458	65	12	verified	verify	VERB
ajlm-1458	65	13	at	at	ADP
ajlm-1458	65	14	the	the	DET
ajlm-1458	65	15	charlotte	charlotte	PROPN
ajlm-1458	65	16	maxeke	maxeke	PROPN
ajlm-1458	65	17	johannesburg	johannesburg	PROPN
ajlm-1458	65	18	academic	academic	PROPN
ajlm-1458	65	19	laboratory	laboratory	PROPN
ajlm-1458	65	20	in	in	ADP
ajlm-1458	65	21	johannesburg	johannesburg	PROPN
ajlm-1458	65	22	,	,	PUNCT
ajlm-1458	65	23	south	south	PROPN
ajlm-1458	65	24	africa	africa	PROPN
ajlm-1458	65	25	,	,	PUNCT
ajlm-1458	65	26	august	august	PROPN
ajlm-1458	65	27	2019	2019	NUM
ajlm-1458	65	28	–	–	PUNCT
ajlm-1458	65	29	november	november	PROPN
ajlm-1458	65	30	2019	2019	NUM
ajlm-1458	65	31	.	.	PUNCT
ajlm-1458	66	1	samples	sample	NOUN
ajlm-1458	66	2	were	be	AUX
ajlm-1458	66	3	prepared	prepare	VERB
ajlm-1458	66	4	according	accord	VERB
ajlm-1458	66	5	to	to	ADP
ajlm-1458	66	6	manufacturer	manufacturer	NOUN
ajlm-1458	66	7	specifications	specification	NOUN
ajlm-1458	66	8	but	but	CCONJ
ajlm-1458	66	9	with	with	ADP
ajlm-1458	66	10	a	a	DET
ajlm-1458	66	11	modification	modification	NOUN
ajlm-1458	66	12	;	;	PUNCT
ajlm-1458	66	13	the	the	DET
ajlm-1458	66	14	iotest3	iotest3	NOUN
ajlm-1458	66	15	lysing	lysing	NOUN
ajlm-1458	66	16	solution	solution	NOUN
ajlm-1458	66	17	was	be	AUX
ajlm-1458	66	18	replaced	replace	VERB
ajlm-1458	66	19	with	with	ADP
ajlm-1458	66	20	an	an	DET
ajlm-1458	66	21	nh4cl	nh4cl	NUM
ajlm-1458	66	22	solution	solution	NOUN
ajlm-1458	66	23	.	.	PUNCT
ajlm-1458	67	1	following	follow	VERB
ajlm-1458	67	2	red	red	ADJ
ajlm-1458	67	3	cell	cell	NOUN
ajlm-1458	67	4	lysis	lysis	NOUN
ajlm-1458	67	5	and	and	CCONJ
ajlm-1458	67	6	wash	wash	VERB
ajlm-1458	67	7	steps	step	NOUN
ajlm-1458	67	8	,	,	PUNCT
ajlm-1458	67	9	prepared	prepare	VERB
ajlm-1458	67	10	~106	~106	PUNCT
ajlm-1458	67	11	cell	cell	NOUN
ajlm-1458	67	12	aliquots	aliquot	NOUN
ajlm-1458	67	13	were	be	AUX
ajlm-1458	67	14	added	add	VERB
ajlm-1458	67	15	to	to	ADP
ajlm-1458	67	16	each	each	PRON
ajlm-1458	67	17	of	of	ADP
ajlm-1458	67	18	the	the	DET
ajlm-1458	67	19	clearllab	clearllab	NOUN
ajlm-1458	67	20	™	™	PROPN
ajlm-1458	67	21	10c	10c	PROPN
ajlm-1458	67	22	b	b	PROPN
ajlm-1458	67	23	,	,	PUNCT
ajlm-1458	67	24	t	t	PROPN
ajlm-1458	67	25	,	,	PUNCT
ajlm-1458	67	26	m1	m1	PROPN
ajlm-1458	67	27	and	and	CCONJ
ajlm-1458	67	28	m2	m2	PROPN
ajlm-1458	67	29	tubes	tube	NOUN
ajlm-1458	67	30	(	(	PUNCT
ajlm-1458	67	31	table	table	NOUN
ajlm-1458	67	32	2	2	NUM
ajlm-1458	67	33	)	)	PUNCT
ajlm-1458	67	34	.	.	PUNCT
ajlm-1458	68	1	after	after	ADP
ajlm-1458	68	2	a	a	DET
ajlm-1458	68	3	15	15	NUM
ajlm-1458	68	4	-	-	PUNCT
ajlm-1458	68	5	min	min	NOUN
ajlm-1458	68	6	incubation	incubation	NOUN
ajlm-1458	68	7	in	in	ADP
ajlm-1458	68	8	the	the	DET
ajlm-1458	68	9	dark	dark	NOUN
ajlm-1458	68	10	,	,	PUNCT
ajlm-1458	68	11	tubes	tube	NOUN
ajlm-1458	68	12	were	be	AUX
ajlm-1458	68	13	again	again	ADV
ajlm-1458	68	14	washed	wash	VERB
ajlm-1458	68	15	.	.	PUNCT
ajlm-1458	69	1	all	all	DET
ajlm-1458	69	2	samples	sample	NOUN
ajlm-1458	69	3	were	be	AUX
ajlm-1458	69	4	acquired	acquire	VERB
ajlm-1458	69	5	on	on	ADP
ajlm-1458	69	6	a	a	DET
ajlm-1458	69	7	bc	bc	PROPN
ajlm-1458	69	8	navios	navio	NOUN
ajlm-1458	69	9	™	™	VERB
ajlm-1458	69	10	flow	flow	NOUN
ajlm-1458	69	11	cytometer	cytometer	NOUN
ajlm-1458	69	12	.	.	PUNCT
ajlm-1458	70	1	at	at	ADP
ajlm-1458	70	2	minimum	minimum	NOUN
ajlm-1458	70	3	,	,	PUNCT
ajlm-1458	70	4	50	50	NUM
ajlm-1458	70	5	000	000	NUM
ajlm-1458	70	6	to	to	PART
ajlm-1458	70	7	100	100	NUM
ajlm-1458	70	8	000	000	NUM
ajlm-1458	70	9	events	event	NOUN
ajlm-1458	70	10	were	be	AUX
ajlm-1458	70	11	acquired	acquire	VERB
ajlm-1458	70	12	on	on	ADP
ajlm-1458	70	13	all	all	DET
ajlm-1458	70	14	samples	sample	NOUN
ajlm-1458	70	15	.	.	PUNCT
ajlm-1458	71	1	data	datum	NOUN
ajlm-1458	71	2	files	file	NOUN
ajlm-1458	71	3	were	be	AUX
ajlm-1458	71	4	analysed	analyse	VERB
ajlm-1458	71	5	offline	offline	ADJ
ajlm-1458	71	6	by	by	ADP
ajlm-1458	71	7	trained	train	VERB
ajlm-1458	71	8	attending	attend	VERB
ajlm-1458	71	9	hematopathologists	hematopathologist	NOUN
ajlm-1458	71	10	using	use	VERB
ajlm-1458	71	11	bc	bc	PROPN
ajlm-1458	71	12	kaluza	kaluza	PROPN
ajlm-1458	71	13	c	c	PROPN
ajlm-1458	71	14	™	™	ADJ
ajlm-1458	71	15	software	software	NOUN
ajlm-1458	71	16	(	(	PUNCT
ajlm-1458	71	17	bc	bc	PROPN
ajlm-1458	71	18	,	,	PUNCT
ajlm-1458	71	19	miami	miami	PROPN
ajlm-1458	71	20	,	,	PUNCT
ajlm-1458	71	21	florida	florida	PROPN
ajlm-1458	71	22	,	,	PUNCT
ajlm-1458	71	23	united	united	PROPN
ajlm-1458	71	24	states	states	PROPN
ajlm-1458	71	25	)	)	PUNCT
ajlm-1458	71	26	.	.	PUNCT
ajlm-1458	72	1	assessment	assessment	NOUN
ajlm-1458	72	2	of	of	ADP
ajlm-1458	72	3	immunophenotype	immunophenotype	NOUN
ajlm-1458	72	4	immunophenotypes	immunophenotype	NOUN
ajlm-1458	72	5	were	be	AUX
ajlm-1458	72	6	established	establish	VERB
ajlm-1458	72	7	using	use	VERB
ajlm-1458	72	8	appropriately	appropriately	ADV
ajlm-1458	72	9	applied	apply	VERB
ajlm-1458	72	10	,	,	PUNCT
ajlm-1458	72	11	pathologist	pathologist	NOUN
ajlm-1458	72	12	-	-	PUNCT
ajlm-1458	72	13	defined	define	VERB
ajlm-1458	72	14	,	,	PUNCT
ajlm-1458	72	15	sub	sub	ADJ
ajlm-1458	72	16	-	-	ADJ
ajlm-1458	72	17	population	population	ADJ
ajlm-1458	72	18	gates	gate	NOUN
ajlm-1458	72	19	that	that	PRON
ajlm-1458	72	20	were	be	AUX
ajlm-1458	72	21	unique	unique	ADJ
ajlm-1458	72	22	to	to	ADP
ajlm-1458	72	23	each	each	DET
ajlm-1458	72	24	case	case	NOUN
ajlm-1458	72	25	analysed	analyse	VERB
ajlm-1458	72	26	.	.	PUNCT
ajlm-1458	73	1	for	for	ADP
ajlm-1458	73	2	the	the	DET
ajlm-1458	73	3	ldt	ldt	PROPN
ajlm-1458	73	4	data	data	PROPN
ajlm-1458	73	5	,	,	PUNCT
ajlm-1458	73	6	a	a	DET
ajlm-1458	73	7	combination	combination	NOUN
ajlm-1458	73	8	of	of	ADP
ajlm-1458	73	9	light	light	ADJ
ajlm-1458	73	10	scatter	scatter	NOUN
ajlm-1458	73	11	and	and	CCONJ
ajlm-1458	73	12	cd45	cd45	PROPN
ajlm-1458	73	13	or	or	CCONJ
ajlm-1458	73	14	cd19	cd19	PROPN
ajlm-1458	73	15	gating	gating	NOUN
ajlm-1458	73	16	was	be	AUX
ajlm-1458	73	17	used	use	VERB
ajlm-1458	73	18	to	to	PART
ajlm-1458	73	19	identify	identify	VERB
ajlm-1458	73	20	target	target	NOUN
ajlm-1458	73	21	cell	cell	NOUN
ajlm-1458	73	22	(	(	PUNCT
ajlm-1458	73	23	neoplastic	neoplastic	ADJ
ajlm-1458	73	24	)	)	PUNCT
ajlm-1458	73	25	populations	population	NOUN
ajlm-1458	73	26	.	.	PUNCT
ajlm-1458	74	1	for	for	ADP
ajlm-1458	74	2	the	the	DET
ajlm-1458	74	3	clearllab	clearllab	NOUN
ajlm-1458	74	4	10c	10c	NOUN
ajlm-1458	74	5	,	,	PUNCT
ajlm-1458	74	6	initial	initial	ADJ
ajlm-1458	74	7	gating	gating	NOUN
ajlm-1458	74	8	included	include	VERB
ajlm-1458	74	9	isolation	isolation	NOUN
ajlm-1458	74	10	of	of	ADP
ajlm-1458	74	11	singlets	singlet	NOUN
ajlm-1458	74	12	followed	follow	VERB
ajlm-1458	74	13	by	by	ADP
ajlm-1458	74	14	primary	primary	ADJ
ajlm-1458	74	15	gating	gating	NOUN
ajlm-1458	74	16	on	on	ADP
ajlm-1458	74	17	cd45	cd45	PROPN
ajlm-1458	74	18	positive	positive	ADJ
ajlm-1458	74	19	events	event	NOUN
ajlm-1458	74	20	,	,	PUNCT
ajlm-1458	74	21	with	with	SCONJ
ajlm-1458	74	22	secondary	secondary	ADJ
ajlm-1458	74	23	gating	gating	NOUN
ajlm-1458	74	24	applied	apply	VERB
ajlm-1458	74	25	to	to	ADP
ajlm-1458	74	26	the	the	DET
ajlm-1458	74	27	identified	identify	VERB
ajlm-1458	74	28	target	target	NOUN
ajlm-1458	74	29	population	population	NOUN
ajlm-1458	74	30	.	.	PUNCT
ajlm-1458	75	1	the	the	DET
ajlm-1458	75	2	specific	specific	ADJ
ajlm-1458	75	3	antigen	antigen	NOUN
ajlm-1458	75	4	expression	expression	NOUN
ajlm-1458	75	5	was	be	AUX
ajlm-1458	75	6	documented	document	VERB
ajlm-1458	75	7	for	for	ADP
ajlm-1458	75	8	both	both	CCONJ
ajlm-1458	75	9	the	the	DET
ajlm-1458	75	10	haematological	haematological	ADJ
ajlm-1458	75	11	neoplasm	neoplasm	NOUN
ajlm-1458	75	12	present	present	ADJ
ajlm-1458	75	13	as	as	ADV
ajlm-1458	75	14	well	well	ADV
ajlm-1458	75	15	as	as	ADP
ajlm-1458	75	16	the	the	DET
ajlm-1458	75	17	normal	normal	ADJ
ajlm-1458	75	18	haematological	haematological	ADJ
ajlm-1458	75	19	populations	population	NOUN
ajlm-1458	75	20	in	in	ADP
ajlm-1458	75	21	the	the	DET
ajlm-1458	75	22	background	background	NOUN
ajlm-1458	75	23	(	(	PUNCT
ajlm-1458	75	24	as	as	ADP
ajlm-1458	75	25	an	an	DET
ajlm-1458	75	26	internal	internal	ADJ
ajlm-1458	75	27	control	control	NOUN
ajlm-1458	75	28	of	of	ADP
ajlm-1458	75	29	marker	marker	NOUN
ajlm-1458	75	30	expression	expression	NOUN
ajlm-1458	75	31	)	)	PUNCT
ajlm-1458	75	32	,	,	PUNCT
ajlm-1458	75	33	based	base	VERB
ajlm-1458	75	34	on	on	ADP
ajlm-1458	75	35	the	the	DET
ajlm-1458	75	36	expression	expression	NOUN
ajlm-1458	75	37	of	of	ADP
ajlm-1458	75	38	all	all	DET
ajlm-1458	75	39	the	the	DET
ajlm-1458	75	40	available	available	ADJ
ajlm-1458	75	41	markers	marker	NOUN
ajlm-1458	75	42	(	(	PUNCT
ajlm-1458	75	43	antigens	antigen	NOUN
ajlm-1458	75	44	)	)	PUNCT
ajlm-1458	75	45	across	across	ADP
ajlm-1458	75	46	the	the	DET
ajlm-1458	75	47	four	four	NUM
ajlm-1458	75	48	panels	panel	NOUN
ajlm-1458	75	49	included	include	VERB
ajlm-1458	75	50	in	in	ADP
ajlm-1458	75	51	the	the	DET
ajlm-1458	75	52	clearllab	clearllab	NOUN
ajlm-1458	75	53	10c	10c	PROPN
ajlm-1458	75	54	panel	panel	NOUN
ajlm-1458	75	55	set	set	VERB
ajlm-1458	75	56	.	.	PUNCT
ajlm-1458	76	1	the	the	DET
ajlm-1458	76	2	specific	specific	ADJ
ajlm-1458	76	3	presence	presence	NOUN
ajlm-1458	76	4	or	or	CCONJ
ajlm-1458	76	5	absence	absence	NOUN
ajlm-1458	76	6	of	of	ADP
ajlm-1458	76	7	antigens	antigen	NOUN
ajlm-1458	76	8	,	,	PUNCT
ajlm-1458	76	9	and	and	CCONJ
ajlm-1458	76	10	the	the	DET
ajlm-1458	76	11	respective	respective	ADJ
ajlm-1458	76	12	specific	specific	ADJ
ajlm-1458	76	13	intensity	intensity	NOUN
ajlm-1458	76	14	of	of	ADP
ajlm-1458	76	15	staining	stain	VERB
ajlm-1458	76	16	of	of	ADP
ajlm-1458	76	17	each	each	DET
ajlm-1458	76	18	antigen	antigen	NOUN
ajlm-1458	76	19	,	,	PUNCT
ajlm-1458	76	20	was	be	AUX
ajlm-1458	76	21	used	use	VERB
ajlm-1458	76	22	to	to	PART
ajlm-1458	76	23	establish	establish	VERB
ajlm-1458	76	24	the	the	DET
ajlm-1458	76	25	diagnosis	diagnosis	NOUN
ajlm-1458	76	26	of	of	ADP
ajlm-1458	76	27	specific	specific	ADJ
ajlm-1458	76	28	subtypes	subtype	NOUN
ajlm-1458	76	29	of	of	ADP
ajlm-1458	76	30	leukaemia	leukaemia	NOUN
ajlm-1458	76	31	or	or	CCONJ
ajlm-1458	76	32	lymphoma	lymphoma	NOUN
ajlm-1458	76	33	per	per	ADP
ajlm-1458	76	34	the	the	DET
ajlm-1458	76	35	world	world	PROPN
ajlm-1458	76	36	health	health	PROPN
ajlm-1458	76	37	organization	organization	PROPN
ajlm-1458	76	38	’s	’s	PART
ajlm-1458	76	39	classification	classification	NOUN
ajlm-1458	76	40	of	of	ADP
ajlm-1458	76	41	haemopoietic	haemopoietic	ADJ
ajlm-1458	76	42	and	and	CCONJ
ajlm-1458	76	43	lymphoid	lymphoid	ADJ
ajlm-1458	76	44	tissues7,8	tissues7,8	PROPN
ajlm-1458	76	45	.	.	PUNCT
ajlm-1458	77	1	also	also	ADV
ajlm-1458	77	2	,	,	PUNCT
ajlm-1458	77	3	the	the	DET
ajlm-1458	77	4	clinical	clinical	ADJ
ajlm-1458	77	5	history	history	NOUN
ajlm-1458	77	6	,	,	PUNCT
ajlm-1458	77	7	other	other	ADJ
ajlm-1458	77	8	laboratory	laboratory	NOUN
ajlm-1458	77	9	parameters	parameter	NOUN
ajlm-1458	77	10	(	(	PUNCT
ajlm-1458	77	11	e.g.	e.g.	ADV
ajlm-1458	77	12	full	full	ADJ
ajlm-1458	77	13	blood	blood	NOUN
ajlm-1458	77	14	count	count	NOUN
ajlm-1458	77	15	and	and	CCONJ
ajlm-1458	77	16	white	white	ADJ
ajlm-1458	77	17	blood	blood	NOUN
ajlm-1458	77	18	cells	cell	NOUN
ajlm-1458	77	19	differential	differential	VERB
ajlm-1458	77	20	counts	count	NOUN
ajlm-1458	77	21	)	)	PUNCT
ajlm-1458	77	22	,	,	PUNCT
ajlm-1458	77	23	and	and	CCONJ
ajlm-1458	77	24	bone	bone	NOUN
ajlm-1458	77	25	marrow	marrow	NOUN
ajlm-1458	77	26	aspirate	aspirate	NOUN
ajlm-1458	77	27	morphology	morphology	NOUN
ajlm-1458	77	28	were	be	AUX
ajlm-1458	77	29	taken	take	VERB
ajlm-1458	77	30	into	into	ADP
ajlm-1458	77	31	account	account	NOUN
ajlm-1458	77	32	.	.	PUNCT
ajlm-1458	78	1	statistical	statistical	ADJ
ajlm-1458	78	2	analysis	analysis	NOUN
ajlm-1458	78	3	data	datum	NOUN
ajlm-1458	78	4	were	be	AUX
ajlm-1458	78	5	collected	collect	VERB
ajlm-1458	78	6	and	and	CCONJ
ajlm-1458	78	7	collated	collate	VERB
ajlm-1458	78	8	into	into	ADP
ajlm-1458	78	9	microsoft	microsoft	PROPN
ajlm-1458	78	10	excel	excel	PROPN
ajlm-1458	78	11	(	(	PUNCT
ajlm-1458	78	12	redmond	redmond	PROPN
ajlm-1458	78	13	,	,	PUNCT
ajlm-1458	78	14	washington	washington	PROPN
ajlm-1458	78	15	,	,	PUNCT
ajlm-1458	78	16	united	united	PROPN
ajlm-1458	78	17	states	states	PROPN
ajlm-1458	78	18	)	)	PUNCT
ajlm-1458	78	19	spreadsheets	spreadsheet	NOUN
ajlm-1458	78	20	for	for	ADP
ajlm-1458	78	21	data	datum	NOUN
ajlm-1458	78	22	analysis	analysis	NOUN
ajlm-1458	78	23	.	.	PUNCT
ajlm-1458	79	1	sensitivity	sensitivity	NOUN
ajlm-1458	79	2	outcomes	outcome	NOUN
ajlm-1458	79	3	were	be	AUX
ajlm-1458	79	4	calculated	calculate	VERB
ajlm-1458	79	5	;	;	PUNCT
ajlm-1458	79	6	the	the	DET
ajlm-1458	79	7	clinical	clinical	ADJ
ajlm-1458	79	8	accuracy	accuracy	NOUN
ajlm-1458	79	9	of	of	ADP
ajlm-1458	79	10	the	the	DET
ajlm-1458	79	11	qualitative	qualitative	ADJ
ajlm-1458	79	12	flow	flow	NOUN
ajlm-1458	79	13	cytometric	cytometric	ADJ
ajlm-1458	79	14	results	result	NOUN
ajlm-1458	79	15	(	(	PUNCT
ajlm-1458	79	16	concordance	concordance	NOUN
ajlm-1458	79	17	of	of	ADP
ajlm-1458	79	18	diagnosis	diagnosis	NOUN
ajlm-1458	79	19	as	as	ADP
ajlm-1458	79	20	normal	normal	ADJ
ajlm-1458	79	21	or	or	CCONJ
ajlm-1458	79	22	abnormal	abnormal	ADJ
ajlm-1458	79	23	)	)	PUNCT
ajlm-1458	79	24	between	between	ADP
ajlm-1458	79	25	the	the	DET
ajlm-1458	79	26	ldt	ldt	PROPN
ajlm-1458	79	27	and	and	CCONJ
ajlm-1458	79	28	clearllab	clearllab	PROPN
ajlm-1458	79	29	10c	10c	NOUN
ajlm-1458	79	30	outcomes	outcome	NOUN
ajlm-1458	79	31	were	be	AUX
ajlm-1458	79	32	assessed	assess	VERB
ajlm-1458	79	33	for	for	ADP
ajlm-1458	79	34	samples	sample	NOUN
ajlm-1458	79	35	tested	test	VERB
ajlm-1458	79	36	,	,	PUNCT
ajlm-1458	79	37	and	and	CCONJ
ajlm-1458	79	38	a	a	DET
ajlm-1458	79	39	contingency	contingency	NOUN
ajlm-1458	79	40	sensitivity	sensitivity	NOUN
ajlm-1458	79	41	(	(	PUNCT
ajlm-1458	79	42	as	as	ADP
ajlm-1458	79	43	the	the	DET
ajlm-1458	79	44	percentage	percentage	NOUN
ajlm-1458	79	45	of	of	ADP
ajlm-1458	79	46	patients	patient	NOUN
ajlm-1458	79	47	with	with	ADP
ajlm-1458	79	48	malignancy	malignancy	NOUN
ajlm-1458	79	49	)	)	PUNCT
ajlm-1458	79	50	and	and	CCONJ
ajlm-1458	79	51	specificity	specificity	NOUN
ajlm-1458	79	52	(	(	PUNCT
ajlm-1458	79	53	the	the	DET
ajlm-1458	79	54	percentage	percentage	NOUN
ajlm-1458	79	55	of	of	ADP
ajlm-1458	79	56	patients	patient	NOUN
ajlm-1458	79	57	with	with	ADP
ajlm-1458	79	58	no	no	DET
ajlm-1458	79	59	malignancy	malignancy	NOUN
ajlm-1458	79	60	)	)	PUNCT
ajlm-1458	79	61	table	table	NOUN
ajlm-1458	79	62	was	be	AUX
ajlm-1458	79	63	constructed	construct	VERB
ajlm-1458	79	64	.	.	PUNCT
ajlm-1458	80	1	in	in	ADP
ajlm-1458	80	2	addition	addition	NOUN
ajlm-1458	80	3	,	,	PUNCT
ajlm-1458	80	4	the	the	DET
ajlm-1458	80	5	positive	positive	ADJ
ajlm-1458	80	6	predictive	predictive	ADJ
ajlm-1458	80	7	value	value	NOUN
ajlm-1458	80	8	,	,	PUNCT
ajlm-1458	80	9	as	as	ADP
ajlm-1458	80	10	the	the	DET
ajlm-1458	80	11	probability	probability	NOUN
ajlm-1458	80	12	of	of	ADP
ajlm-1458	80	13	malignant	malignant	ADJ
ajlm-1458	80	14	outcomes	outcome	NOUN
ajlm-1458	80	15	with	with	ADP
ajlm-1458	80	16	an	an	DET
ajlm-1458	80	17	abnormal	abnormal	ADJ
ajlm-1458	80	18	immunophenotype	immunophenotype	NOUN
ajlm-1458	80	19	detected	detect	VERB
ajlm-1458	80	20	,	,	PUNCT
ajlm-1458	80	21	as	as	ADV
ajlm-1458	80	22	well	well	ADV
ajlm-1458	80	23	as	as	ADP
ajlm-1458	80	24	negative	negative	ADJ
ajlm-1458	80	25	predictive	predictive	ADJ
ajlm-1458	80	26	value	value	NOUN
ajlm-1458	80	27	as	as	ADP
ajlm-1458	80	28	the	the	DET
ajlm-1458	80	29	probability	probability	NOUN
ajlm-1458	80	30	of	of	ADP
ajlm-1458	80	31	non	non	ADJ
ajlm-1458	80	32	-	-	ADJ
ajlm-1458	80	33	malignant	malignant	ADJ
ajlm-1458	80	34	outcomes	outcome	NOUN
ajlm-1458	80	35	in	in	ADP
ajlm-1458	80	36	a	a	DET
ajlm-1458	80	37	patient	patient	NOUN
ajlm-1458	80	38	with	with	ADP
ajlm-1458	80	39	no	no	DET
ajlm-1458	80	40	disease	disease	NOUN
ajlm-1458	80	41	,	,	PUNCT
ajlm-1458	80	42	were	be	AUX
ajlm-1458	80	43	also	also	ADV
ajlm-1458	80	44	calculated	calculate	VERB
ajlm-1458	80	45	.	.	PUNCT
ajlm-1458	81	1	thereafter	thereafter	ADV
ajlm-1458	81	2	,	,	PUNCT
ajlm-1458	81	3	the	the	DET
ajlm-1458	81	4	clearllab	clearllab	NOUN
ajlm-1458	81	5	results	result	NOUN
ajlm-1458	81	6	of	of	ADP
ajlm-1458	81	7	each	each	DET
ajlm-1458	81	8	patient	patient	NOUN
ajlm-1458	81	9	were	be	AUX
ajlm-1458	81	10	compared	compare	VERB
ajlm-1458	81	11	to	to	ADP
ajlm-1458	81	12	their	their	PRON
ajlm-1458	81	13	clinicopathological	clinicopathological	ADJ
ajlm-1458	81	14	or	or	CCONJ
ajlm-1458	81	15	haematological	haematological	ADJ
ajlm-1458	81	16	diagnosis	diagnosis	NOUN
ajlm-1458	81	17	based	base	VERB
ajlm-1458	81	18	on	on	ADP
ajlm-1458	81	19	a	a	DET
ajlm-1458	81	20	similar	similar	ADJ
ajlm-1458	81	21	approach	approach	NOUN
ajlm-1458	81	22	by	by	ADP
ajlm-1458	81	23	hedley	hedley	PROPN
ajlm-1458	81	24	et	et	PROPN
ajlm-1458	81	25	al.28	al.28	PROPN
ajlm-1458	81	26	to	to	PART
ajlm-1458	81	27	demonstrate	demonstrate	VERB
ajlm-1458	81	28	the	the	DET
ajlm-1458	81	29	objectivity	objectivity	NOUN
ajlm-1458	81	30	of	of	ADP
ajlm-1458	81	31	a	a	DET
ajlm-1458	81	32	comprehensive	comprehensive	ADJ
ajlm-1458	81	33	clearllab	clearllab	NOUN
ajlm-1458	81	34	10c	10c	NUM
ajlm-1458	81	35	diagnostic	diagnostic	ADJ
ajlm-1458	81	36	approach	approach	NOUN
ajlm-1458	81	37	.	.	PUNCT
ajlm-1458	82	1	clinical	clinical	ADJ
ajlm-1458	82	2	concordance	concordance	NOUN
ajlm-1458	82	3	was	be	AUX
ajlm-1458	82	4	achieved	achieve	VERB
ajlm-1458	82	5	using	use	VERB
ajlm-1458	82	6	the	the	DET
ajlm-1458	82	7	categories	category	NOUN
ajlm-1458	82	8	of	of	ADP
ajlm-1458	82	9	‘	'	PUNCT
ajlm-1458	82	10	haematologically	haematologically	ADV
ajlm-1458	82	11	malignant	malignant	ADJ
ajlm-1458	82	12	’	'	PUNCT
ajlm-1458	82	13	or	or	CCONJ
ajlm-1458	82	14	‘	'	PUNCT
ajlm-1458	82	15	haematologically	haematologically	ADV
ajlm-1458	82	16	non	non	ADJ
ajlm-1458	82	17	-	-	ADJ
ajlm-1458	82	18	malignant	malignant	ADJ
ajlm-1458	82	19	’	'	PUNCT
ajlm-1458	82	20	,	,	PUNCT
ajlm-1458	82	21	as	as	SCONJ
ajlm-1458	82	22	suggested	suggest	VERB
ajlm-1458	82	23	by	by	ADP
ajlm-1458	82	24	the	the	DET
ajlm-1458	82	25	presence	presence	NOUN
ajlm-1458	82	26	or	or	CCONJ
ajlm-1458	82	27	absence	absence	NOUN
ajlm-1458	82	28	of	of	ADP
ajlm-1458	82	29	an	an	DET
ajlm-1458	82	30	abnormal	abnormal	ADJ
ajlm-1458	82	31	immunophenotype	immunophenotype	NOUN
ajlm-1458	82	32	.	.	PUNCT
ajlm-1458	83	1	in	in	ADP
ajlm-1458	83	2	this	this	DET
ajlm-1458	83	3	comparative	comparative	ADJ
ajlm-1458	83	4	analysis	analysis	NOUN
ajlm-1458	83	5	,	,	PUNCT
ajlm-1458	83	6	both	both	DET
ajlm-1458	83	7	false	false	ADJ
ajlm-1458	83	8	positives	positive	NOUN
ajlm-1458	83	9	and	and	CCONJ
ajlm-1458	83	10	negatives	negative	NOUN
ajlm-1458	83	11	,	,	PUNCT
ajlm-1458	83	12	and	and	CCONJ
ajlm-1458	83	13	true	true	ADJ
ajlm-1458	83	14	positives	positive	NOUN
ajlm-1458	83	15	and	and	CCONJ
ajlm-1458	83	16	negatives	negative	NOUN
ajlm-1458	83	17	,	,	PUNCT
ajlm-1458	83	18	as	as	ADV
ajlm-1458	83	19	well	well	ADV
ajlm-1458	83	20	as	as	ADP
ajlm-1458	83	21	both	both	CCONJ
ajlm-1458	83	22	positive	positive	ADJ
ajlm-1458	83	23	predictive	predictive	ADJ
ajlm-1458	83	24	value	value	NOUN
ajlm-1458	83	25	and	and	CCONJ
ajlm-1458	83	26	negative	negative	ADJ
ajlm-1458	83	27	predictive	predictive	ADJ
ajlm-1458	83	28	value	value	NOUN
ajlm-1458	83	29	outcomes	outcome	NOUN
ajlm-1458	83	30	,	,	PUNCT
ajlm-1458	83	31	were	be	AUX
ajlm-1458	83	32	reported	report	VERB
ajlm-1458	83	33	using	use	VERB
ajlm-1458	83	34	clearllab	clearllab	NOUN
ajlm-1458	83	35	outcomes	outcome	NOUN
ajlm-1458	83	36	as	as	ADP
ajlm-1458	83	37	the	the	DET
ajlm-1458	83	38	objective	objective	ADJ
ajlm-1458	83	39	standard	standard	NOUN
ajlm-1458	83	40	.	.	PUNCT
ajlm-1458	84	1	results	result	VERB
ajlm-1458	84	2	daily	daily	ADJ
ajlm-1458	84	3	quality	quality	NOUN
ajlm-1458	84	4	control	control	VERB
ajlm-1458	84	5	the	the	DET
ajlm-1458	84	6	daily	daily	ADJ
ajlm-1458	84	7	quality	quality	NOUN
ajlm-1458	84	8	control	control	NOUN
ajlm-1458	84	9	results	result	VERB
ajlm-1458	84	10	over	over	ADP
ajlm-1458	84	11	the	the	DET
ajlm-1458	84	12	study	study	NOUN
ajlm-1458	84	13	period	period	NOUN
ajlm-1458	84	14	confirmed	confirm	VERB
ajlm-1458	84	15	that	that	SCONJ
ajlm-1458	84	16	daily	daily	ADJ
ajlm-1458	84	17	background	background	NOUN
ajlm-1458	84	18	counts	count	NOUN
ajlm-1458	84	19	were	be	AUX
ajlm-1458	84	20	consistently	consistently	ADV
ajlm-1458	84	21	<	<	X
ajlm-1458	84	22	100	100	NUM
ajlm-1458	84	23	events	event	NOUN
ajlm-1458	84	24	in	in	ADP
ajlm-1458	84	25	100	100	NUM
ajlm-1458	84	26	s	s	NOUN
ajlm-1458	84	27	,	,	PUNCT
ajlm-1458	84	28	carryover	carryover	NOUN
ajlm-1458	84	29	<	<	X
ajlm-1458	84	30	1	1	NUM
ajlm-1458	84	31	%	%	NOUN
ajlm-1458	84	32	and	and	CCONJ
ajlm-1458	84	33	flow	flow	NOUN
ajlm-1458	84	34	check	check	NOUN
ajlm-1458	84	35	pro	pro	ADJ
ajlm-1458	84	36	results	result	NOUN
ajlm-1458	84	37	acceptable	acceptable	ADJ
ajlm-1458	84	38	with	with	ADP
ajlm-1458	84	39	hpcv	hpcv	NOUN
ajlm-1458	84	40	<	<	X
ajlm-1458	84	41	2	2	NUM
ajlm-1458	84	42	for	for	ADP
ajlm-1458	84	43	fl1	fl1	ADV
ajlm-1458	84	44	to	to	ADP
ajlm-1458	84	45	fl5	fl5	NOUN
ajlm-1458	84	46	,	,	PUNCT
ajlm-1458	84	47	hpcv	hpcv	NOUN
ajlm-1458	84	48	<	<	X
ajlm-1458	84	49	3	3	NUM
ajlm-1458	84	50	for	for	SCONJ
ajlm-1458	84	51	fl6	fl6	PROPN
ajlm-1458	84	52	to	to	PART
ajlm-1458	84	53	fl8	fl8	VERB
ajlm-1458	84	54	and	and	CCONJ
ajlm-1458	84	55	<	<	X
ajlm-1458	84	56	4	4	NUM
ajlm-1458	84	57	for	for	ADP
ajlm-1458	84	58	fl9	fl9	NOUN
ajlm-1458	84	59	and	and	CCONJ
ajlm-1458	84	60	fl10	fl10	PROPN
ajlm-1458	84	61	for	for	ADP
ajlm-1458	84	62	the	the	DET
ajlm-1458	84	63	days	day	NOUN
ajlm-1458	84	64	that	that	SCONJ
ajlm-1458	84	65	the	the	DET
ajlm-1458	84	66	patient	patient	NOUN
ajlm-1458	84	67	samples	sample	NOUN
ajlm-1458	84	68	were	be	AUX
ajlm-1458	84	69	tested	test	VERB
ajlm-1458	84	70	;	;	PUNCT
ajlm-1458	84	71	flow	flow	NOUN
ajlm-1458	84	72	-	-	PUNCT
ajlm-1458	84	73	set	set	VERB
ajlm-1458	84	74	pro	pro	NOUN
ajlm-1458	84	75	also	also	ADV
ajlm-1458	84	76	confirmed	confirm	VERB
ajlm-1458	84	77	acceptable	acceptable	ADJ
ajlm-1458	84	78	fluorescence	fluorescence	NOUN
ajlm-1458	84	79	stability	stability	NOUN
ajlm-1458	84	80	,	,	PUNCT
ajlm-1458	84	81	with	with	ADP
ajlm-1458	84	82	%	%	PROPN
ajlm-1458	84	83	cvs	cvs	NOUN
ajlm-1458	84	84	<	<	X
ajlm-1458	84	85	5	5	NUM
ajlm-1458	84	86	%	%	NOUN
ajlm-1458	84	87	for	for	ADP
ajlm-1458	84	88	the	the	DET
ajlm-1458	84	89	blue	blue	ADJ
ajlm-1458	84	90	and	and	CCONJ
ajlm-1458	84	91	violet	violet	ADJ
ajlm-1458	84	92	laser	laser	NOUN
ajlm-1458	84	93	(	(	PUNCT
ajlm-1458	84	94	fl1	fl1	ADV
ajlm-1458	84	95	–	–	PUNCT
ajlm-1458	84	96	fl5	fl5	NOUN
ajlm-1458	84	97	and	and	CCONJ
ajlm-1458	84	98	fl9	fl9	PROPN
ajlm-1458	84	99	–	–	PUNCT
ajlm-1458	84	100	fl10	fl10	PROPN
ajlm-1458	84	101	)	)	PUNCT
ajlm-1458	84	102	and	and	CCONJ
ajlm-1458	84	103	<	<	X
ajlm-1458	84	104	8	8	NUM
ajlm-1458	84	105	%	%	NOUN
ajlm-1458	84	106	for	for	ADP
ajlm-1458	84	107	the	the	DET
ajlm-1458	84	108	red	red	ADJ
ajlm-1458	84	109	laser	laser	NOUN
ajlm-1458	84	110	(	(	PUNCT
ajlm-1458	84	111	fl6	fl6	PROPN
ajlm-1458	84	112	–	–	PUNCT
ajlm-1458	84	113	fl8	fl8	NOUN
ajlm-1458	84	114	)	)	PUNCT
ajlm-1458	84	115	.	.	PUNCT
ajlm-1458	85	1	further	further	ADJ
ajlm-1458	85	2	weekly	weekly	ADJ
ajlm-1458	85	3	cd4	cd4	PROPN
ajlm-1458	85	4	reproducibility	reproducibility	NOUN
ajlm-1458	85	5	studies	study	NOUN
ajlm-1458	85	6	on	on	ADP
ajlm-1458	85	7	the	the	DET
ajlm-1458	85	8	navios	navio	NOUN
ajlm-1458	85	9	confirmed	confirm	VERB
ajlm-1458	85	10	that	that	SCONJ
ajlm-1458	85	11	the	the	DET
ajlm-1458	85	12	flow	flow	NOUN
ajlm-1458	85	13	count	count	NOUN
ajlm-1458	85	14	rate	rate	NOUN
ajlm-1458	85	15	and	and	CCONJ
ajlm-1458	85	16	absolute	absolute	ADJ
ajlm-1458	85	17	counts	count	NOUN
ajlm-1458	85	18	had	have	VERB
ajlm-1458	85	19	a	a	DET
ajlm-1458	85	20	%	%	NOUN
ajlm-1458	85	21	cv	cv	NOUN
ajlm-1458	85	22	<	<	X
ajlm-1458	85	23	5	5	NUM
ajlm-1458	85	24	%	%	NOUN
ajlm-1458	85	25	for	for	ADP
ajlm-1458	85	26	the	the	DET
ajlm-1458	85	27	duration	duration	NOUN
ajlm-1458	85	28	of	of	ADP
ajlm-1458	85	29	the	the	DET
ajlm-1458	85	30	validation	validation	NOUN
ajlm-1458	85	31	.	.	PUNCT
ajlm-1458	86	1	precision	precision	NOUN
ajlm-1458	86	2	and	and	CCONJ
ajlm-1458	86	3	accuracy	accuracy	NOUN
ajlm-1458	86	4	of	of	ADP
ajlm-1458	86	5	clearllab	clearllab	NOUN
ajlm-1458	86	6	controls	control	NOUN
ajlm-1458	86	7	were	be	AUX
ajlm-1458	86	8	in	in	ADP
ajlm-1458	86	9	agreement	agreement	NOUN
ajlm-1458	86	10	with	with	ADP
ajlm-1458	86	11	the	the	DET
ajlm-1458	86	12	manufacturer	manufacturer	NOUN
ajlm-1458	86	13	’s	’s	PART
ajlm-1458	86	14	claims	claim	NOUN
ajlm-1458	86	15	for	for	ADP
ajlm-1458	86	16	repeatability	repeatability	NOUN
ajlm-1458	86	17	and	and	CCONJ
ajlm-1458	86	18	accuracy	accuracy	NOUN
ajlm-1458	86	19	of	of	ADP
ajlm-1458	86	20	clearllab	clearllab	NOUN
ajlm-1458	86	21	control	control	NOUN
ajlm-1458	86	22	cells	cell	NOUN
ajlm-1458	86	23	(	(	PUNCT
ajlm-1458	86	24	i.e.	i.e.	X
ajlm-1458	86	25	control	control	NOUN
ajlm-1458	86	26	cells	cell	NOUN
ajlm-1458	86	27	assay	assay	VERB
ajlm-1458	86	28	values	value	NOUN
ajlm-1458	86	29	fell	fall	VERB
ajlm-1458	86	30	within	within	ADP
ajlm-1458	86	31	the	the	DET
ajlm-1458	86	32	package	package	NOUN
ajlm-1458	86	33	insert	insert	NOUN
ajlm-1458	86	34	limits	limit	NOUN
ajlm-1458	86	35	and	and	CCONJ
ajlm-1458	86	36	%	%	INTJ
ajlm-1458	86	37	cvs	cvs	NOUN
ajlm-1458	86	38	were	be	AUX
ajlm-1458	86	39	consistently	consistently	ADV
ajlm-1458	86	40	<	<	X
ajlm-1458	86	41	10	10	NUM
ajlm-1458	86	42	%	%	NOUN
ajlm-1458	86	43	)	)	PUNCT
ajlm-1458	86	44	.	.	PUNCT
ajlm-1458	87	1	comparing	compare	VERB
ajlm-1458	87	2	clearllab	clearllab	NOUN
ajlm-1458	87	3	10c	10c	NOUN
ajlm-1458	87	4	against	against	ADP
ajlm-1458	87	5	predicate	predicate	NOUN
ajlm-1458	87	6	laboratory	laboratory	NOUN
ajlm-1458	87	7	developed	develop	VERB
ajlm-1458	87	8	test	test	NOUN
ajlm-1458	87	9	one	one	NUM
ajlm-1458	87	10	hundred	hundred	NUM
ajlm-1458	87	11	and	and	CCONJ
ajlm-1458	87	12	one	one	NUM
ajlm-1458	87	13	bodily	bodily	ADV
ajlm-1458	87	14	specimens	specimen	NOUN
ajlm-1458	87	15	from	from	ADP
ajlm-1458	87	16	36	36	NUM
ajlm-1458	87	17	children	child	NOUN
ajlm-1458	87	18	and	and	CCONJ
ajlm-1458	87	19	65	65	NUM
ajlm-1458	87	20	adults	adult	NOUN
ajlm-1458	87	21	,	,	PUNCT
ajlm-1458	87	22	irrespective	irrespective	ADV
ajlm-1458	87	23	of	of	ADP
ajlm-1458	87	24	ethnic	ethnic	ADJ
ajlm-1458	87	25	or	or	CCONJ
ajlm-1458	87	26	racial	racial	ADJ
ajlm-1458	87	27	background	background	NOUN
ajlm-1458	87	28	,	,	PUNCT
ajlm-1458	87	29	were	be	AUX
ajlm-1458	87	30	enrolled	enrol	VERB
ajlm-1458	87	31	into	into	ADP
ajlm-1458	87	32	the	the	DET
ajlm-1458	87	33	study	study	NOUN
ajlm-1458	87	34	.	.	PUNCT
ajlm-1458	88	1	these	these	PRON
ajlm-1458	88	2	included	include	VERB
ajlm-1458	88	3	:	:	PUNCT
ajlm-1458	88	4	82	82	NUM
ajlm-1458	88	5	bone	bone	NOUN
ajlm-1458	88	6	marrow	marrow	NOUN
ajlm-1458	88	7	aspirates	aspirate	NOUN
ajlm-1458	88	8	,	,	PUNCT
ajlm-1458	88	9	15	15	NUM
ajlm-1458	88	10	peripheral	peripheral	ADJ
ajlm-1458	88	11	blood	blood	NOUN
ajlm-1458	88	12	samples	sample	NOUN
ajlm-1458	88	13	,	,	PUNCT
ajlm-1458	88	14	one	one	NUM
ajlm-1458	88	15	pleural	pleural	ADJ
ajlm-1458	88	16	and	and	CCONJ
ajlm-1458	88	17	two	two	NUM
ajlm-1458	88	18	cerebrospinal	cerebrospinal	ADJ
ajlm-1458	88	19	fluids	fluid	NOUN
ajlm-1458	88	20	,	,	PUNCT
ajlm-1458	88	21	and	and	CCONJ
ajlm-1458	88	22	one	one	NUM
ajlm-1458	88	23	lymph	lymph	NOUN
ajlm-1458	88	24	node	node	NOUN
ajlm-1458	88	25	biopsy	biopsy	NOUN
ajlm-1458	88	26	.	.	PUNCT
ajlm-1458	89	1	sixty	sixty	NUM
ajlm-1458	89	2	seven	seven	NUM
ajlm-1458	89	3	of	of	ADP
ajlm-1458	89	4	the	the	DET
ajlm-1458	89	5	101	101	NUM
ajlm-1458	89	6	cases	case	NOUN
ajlm-1458	89	7	tested	test	VERB
ajlm-1458	89	8	had	have	VERB
ajlm-1458	89	9	haematological	haematological	ADJ
ajlm-1458	89	10	malignancy	malignancy	NOUN
ajlm-1458	89	11	,	,	PUNCT
ajlm-1458	89	12	while	while	SCONJ
ajlm-1458	89	13	34	34	NUM
ajlm-1458	89	14	cases	case	NOUN
ajlm-1458	89	15	had	have	VERB
ajlm-1458	89	16	no	no	DET
ajlm-1458	89	17	evidence	evidence	NOUN
ajlm-1458	89	18	of	of	ADP
ajlm-1458	89	19	malignancy	malignancy	NOUN
ajlm-1458	89	20	despite	despite	SCONJ
ajlm-1458	89	21	a	a	DET
ajlm-1458	89	22	clinical	clinical	ADJ
ajlm-1458	89	23	suspicion	suspicion	NOUN
ajlm-1458	89	24	(	(	PUNCT
ajlm-1458	89	25	figure	figure	NOUN
ajlm-1458	89	26	1	1	NUM
ajlm-1458	89	27	)	)	PUNCT
ajlm-1458	89	28	.	.	PUNCT
ajlm-1458	90	1	among	among	ADP
ajlm-1458	90	2	three	three	NUM
ajlm-1458	90	3	bodily	bodily	ADJ
ajlm-1458	90	4	fluid	fluid	ADJ
ajlm-1458	90	5	samples	sample	NOUN
ajlm-1458	90	6	tested	test	VERB
ajlm-1458	90	7	,	,	PUNCT
ajlm-1458	90	8	two	two	NUM
ajlm-1458	90	9	cerebrospinal	cerebrospinal	ADJ
ajlm-1458	90	10	fluid	fluid	NOUN
ajlm-1458	90	11	samples	sample	NOUN
ajlm-1458	90	12	showed	show	VERB
ajlm-1458	90	13	evidence	evidence	NOUN
ajlm-1458	90	14	of	of	ADP
ajlm-1458	90	15	tumour	tumour	NOUN
ajlm-1458	90	16	infiltration	infiltration	NOUN
ajlm-1458	90	17	,	,	PUNCT
ajlm-1458	90	18	one	one	NUM
ajlm-1458	90	19	with	with	ADP
ajlm-1458	90	20	t	t	NOUN
ajlm-1458	90	21	-	-	PUNCT
ajlm-1458	90	22	cell	cell	NOUN
ajlm-1458	90	23	acute	acute	ADJ
ajlm-1458	90	24	lymphoblastic	lymphoblastic	ADJ
ajlm-1458	90	25	leukaemia	leukaemia	NOUN
ajlm-1458	90	26	,	,	PUNCT
ajlm-1458	90	27	and	and	CCONJ
ajlm-1458	90	28	another	another	PRON
ajlm-1458	90	29	infiltrated	infiltrate	VERB
ajlm-1458	90	30	with	with	ADP
ajlm-1458	90	31	acute	acute	ADJ
ajlm-1458	90	32	myeloid	myeloid	ADJ
ajlm-1458	90	33	leukaemia	leukaemia	NOUN
ajlm-1458	90	34	;	;	PUNCT
ajlm-1458	90	35	a	a	DET
ajlm-1458	90	36	separate	separate	ADJ
ajlm-1458	90	37	(	(	PUNCT
ajlm-1458	90	38	third	third	ADJ
ajlm-1458	90	39	)	)	PUNCT
ajlm-1458	90	40	pleural	pleural	ADJ
ajlm-1458	90	41	fluid	fluid	ADJ
ajlm-1458	90	42	sample	sample	NOUN
ajlm-1458	90	43	showed	show	VERB
ajlm-1458	90	44	infiltration	infiltration	NOUN
ajlm-1458	90	45	by	by	ADP
ajlm-1458	90	46	follicular	follicular	ADJ
ajlm-1458	90	47	lymphoma	lymphoma	NOUN
ajlm-1458	90	48	,	,	PUNCT
ajlm-1458	90	49	confirmed	confirm	VERB
ajlm-1458	90	50	with	with	ADP
ajlm-1458	90	51	cd10	cd10	PROPN
ajlm-1458	90	52	expression	expression	NOUN
ajlm-1458	90	53	and	and	CCONJ
ajlm-1458	90	54	other	other	ADJ
ajlm-1458	90	55	markers	marker	NOUN
ajlm-1458	90	56	suggesting	suggest	VERB
ajlm-1458	90	57	b	b	NUM
ajlm-1458	90	58	-	-	PUNCT
ajlm-1458	90	59	cell	cell	NOUN
ajlm-1458	90	60	maturity	maturity	NOUN
ajlm-1458	90	61	.	.	PUNCT
ajlm-1458	91	1	the	the	DET
ajlm-1458	91	2	lymph	lymph	NOUN
ajlm-1458	91	3	node	node	PROPN
ajlm-1458	91	4	biopsy	biopsy	NOUN
ajlm-1458	91	5	had	have	VERB
ajlm-1458	91	6	a	a	DET
ajlm-1458	91	7	large	large	ADJ
ajlm-1458	91	8	t	t	NOUN
ajlm-1458	91	9	-	-	PUNCT
ajlm-1458	91	10	cell	cell	NOUN
ajlm-1458	91	11	lymphoproliferative	lymphoproliferative	ADJ
ajlm-1458	91	12	disorder	disorder	NOUN
ajlm-1458	91	13	;	;	PUNCT
ajlm-1458	91	14	additional	additional	ADJ
ajlm-1458	91	15	ldt	ldt	PROPN
ajlm-1458	91	16	testing	testing	NOUN
ajlm-1458	91	17	revealed	reveal	VERB
ajlm-1458	91	18	an	an	DET
ajlm-1458	91	19	anaplastic	anaplastic	ADJ
ajlm-1458	91	20	large	large	ADJ
ajlm-1458	91	21	cell	cell	NOUN
ajlm-1458	91	22	lymphoma	lymphoma	NOUN
ajlm-1458	91	23	(	(	PUNCT
ajlm-1458	91	24	confirmed	confirm	VERB
ajlm-1458	91	25	with	with	ADP
ajlm-1458	91	26	cd30	cd30	PROPN
ajlm-1458	91	27	expression	expression	NOUN
ajlm-1458	91	28	)	)	PUNCT
ajlm-1458	91	29	.	.	PUNCT
ajlm-1458	92	1	a	a	DET
ajlm-1458	92	2	diagnostic	diagnostic	ADJ
ajlm-1458	92	3	concordance	concordance	NOUN
ajlm-1458	92	4	of	of	ADP
ajlm-1458	92	5	100	100	NUM
ajlm-1458	92	6	%	%	NOUN
ajlm-1458	92	7	was	be	AUX
ajlm-1458	92	8	noted	note	VERB
ajlm-1458	92	9	between	between	ADP
ajlm-1458	92	10	the	the	DET
ajlm-1458	92	11	clearllab	clearllab	NOUN
ajlm-1458	92	12	outcomes	outcome	NOUN
ajlm-1458	92	13	and	and	CCONJ
ajlm-1458	92	14	the	the	DET
ajlm-1458	92	15	ldt	ldt	PROPN
ajlm-1458	92	16	,	,	PUNCT
ajlm-1458	92	17	revealing	reveal	VERB
ajlm-1458	92	18	identical	identical	ADJ
ajlm-1458	92	19	diagnostic	diagnostic	ADJ
ajlm-1458	92	20	outcomes	outcome	NOUN
ajlm-1458	92	21	(	(	PUNCT
ajlm-1458	92	22	figure	figure	NOUN
ajlm-1458	92	23	2	2	NUM
ajlm-1458	92	24	)	)	PUNCT
ajlm-1458	92	25	.	.	PUNCT
ajlm-1458	93	1	these	these	DET
ajlm-1458	93	2	findings	finding	NOUN
ajlm-1458	93	3	exceeded	exceed	VERB
ajlm-1458	93	4	the	the	DET
ajlm-1458	93	5	manufacturer	manufacturer	NOUN
ajlm-1458	93	6	acceptance	acceptance	NOUN
ajlm-1458	93	7	limits	limit	NOUN
ajlm-1458	93	8	of	of	ADP
ajlm-1458	93	9	>	>	DET
ajlm-1458	93	10	70	70	NUM
ajlm-1458	93	11	%	%	NOUN
ajlm-1458	93	12	sensitivity	sensitivity	NOUN
ajlm-1458	93	13	and	and	CCONJ
ajlm-1458	93	14	>	>	SYM
ajlm-1458	93	15	80	80	NUM
ajlm-1458	93	16	%	%	NOUN
ajlm-1458	93	17	specificity	specificity	NOUN
ajlm-1458	93	18	for	for	ADP
ajlm-1458	93	19	the	the	DET
ajlm-1458	93	20	clearllab	clearllab	NOUN
ajlm-1458	93	21	testing	testing	NOUN
ajlm-1458	93	22	system	system	NOUN
ajlm-1458	93	23	.	.	PUNCT
ajlm-1458	94	1	all	all	DET
ajlm-1458	94	2	markers	marker	NOUN
ajlm-1458	94	3	met	meet	VERB
ajlm-1458	94	4	the	the	DET
ajlm-1458	94	5	manufacturer	manufacturer	NOUN
ajlm-1458	94	6	’s	’s	PART
ajlm-1458	94	7	specifications	specification	NOUN
ajlm-1458	94	8	and	and	CCONJ
ajlm-1458	94	9	claims	claim	NOUN
ajlm-1458	94	10	,	,	PUNCT
ajlm-1458	94	11	specifically	specifically	ADV
ajlm-1458	94	12	those	those	PRON
ajlm-1458	94	13	not	not	PART
ajlm-1458	94	14	typically	typically	ADV
ajlm-1458	94	15	included	include	VERB
ajlm-1458	94	16	in	in	ADP
ajlm-1458	94	17	first	first	ADJ
ajlm-1458	94	18	-	-	PUNCT
ajlm-1458	94	19	line	line	NOUN
ajlm-1458	94	20	ldt	ldt	PROPN
ajlm-1458	94	21	testing	testing	NOUN
ajlm-1458	94	22	,	,	PUNCT
ajlm-1458	94	23	including	include	VERB
ajlm-1458	94	24	cd16	cd16	PROPN
ajlm-1458	94	25	,	,	PUNCT
ajlm-1458	94	26	cd38	cd38	PROPN
ajlm-1458	94	27	,	,	PUNCT
ajlm-1458	94	28	cd56	cd56	PROPN
ajlm-1458	94	29	,	,	PUNCT
ajlm-1458	94	30	cd64	cd64	PROPN
ajlm-1458	94	31	,	,	PUNCT
ajlm-1458	94	32	cd123	cd123	PROPN
ajlm-1458	94	33	,	,	PUNCT
ajlm-1458	94	34	cd200	cd200	PROPN
ajlm-1458	94	35	and	and	CCONJ
ajlm-1458	94	36	tcrγδ	tcrγδ	INTJ
ajlm-1458	94	37	.	.	PUNCT
ajlm-1458	95	1	cases	case	NOUN
ajlm-1458	95	2	tested	test	VERB
ajlm-1458	95	3	and	and	CCONJ
ajlm-1458	95	4	reviewed	review	VERB
ajlm-1458	95	5	using	use	VERB
ajlm-1458	95	6	clearllab	clearllab	NOUN
ajlm-1458	95	7	10c	10c	NOUN
ajlm-1458	95	8	were	be	AUX
ajlm-1458	95	9	shown	show	VERB
ajlm-1458	95	10	to	to	PART
ajlm-1458	95	11	have	have	VERB
ajlm-1458	95	12	essentially	essentially	ADV
ajlm-1458	95	13	similar	similar	ADJ
ajlm-1458	95	14	immunophenotypes	immunophenotype	NOUN
ajlm-1458	95	15	observed	observe	VERB
ajlm-1458	95	16	with	with	ADP
ajlm-1458	95	17	the	the	DET
ajlm-1458	95	18	use	use	NOUN
ajlm-1458	95	19	of	of	ADP
ajlm-1458	95	20	the	the	DET
ajlm-1458	95	21	ldt	ldt	PROPN
ajlm-1458	95	22	,	,	PUNCT
ajlm-1458	95	23	leading	lead	VERB
ajlm-1458	95	24	to	to	ADP
ajlm-1458	95	25	the	the	DET
ajlm-1458	95	26	same	same	ADJ
ajlm-1458	95	27	overall	overall	ADJ
ajlm-1458	95	28	diagnostic	diagnostic	ADJ
ajlm-1458	95	29	outcome	outcome	NOUN
ajlm-1458	95	30	.	.	PUNCT
ajlm-1458	96	1	in	in	ADP
ajlm-1458	96	2	certain	certain	ADJ
ajlm-1458	96	3	categories	category	NOUN
ajlm-1458	96	4	,	,	PUNCT
ajlm-1458	96	5	however	however	ADV
ajlm-1458	96	6	,	,	PUNCT
ajlm-1458	96	7	diagnostic	diagnostic	ADJ
ajlm-1458	96	8	specificity	specificity	NOUN
ajlm-1458	96	9	matched	match	VERB
ajlm-1458	96	10	diagnostic	diagnostic	ADJ
ajlm-1458	96	11	outcomes	outcome	NOUN
ajlm-1458	96	12	exactly	exactly	ADV
ajlm-1458	96	13	,	,	PUNCT
ajlm-1458	96	14	that	that	ADV
ajlm-1458	96	15	is	is	ADV
ajlm-1458	96	16	,	,	PUNCT
ajlm-1458	96	17	there	there	PRON
ajlm-1458	96	18	was	be	VERB
ajlm-1458	96	19	100	100	NUM
ajlm-1458	96	20	%	%	NOUN
ajlm-1458	96	21	concordance	concordance	NOUN
ajlm-1458	96	22	of	of	ADP
ajlm-1458	96	23	measured	measured	ADJ
ajlm-1458	96	24	markers	marker	NOUN
ajlm-1458	96	25	.	.	PUNCT
ajlm-1458	97	1	such	such	ADJ
ajlm-1458	97	2	examples	example	NOUN
ajlm-1458	97	3	include	include	VERB
ajlm-1458	97	4	cd19	cd19	PROPN
ajlm-1458	97	5	/	/	SYM
ajlm-1458	97	6	cd5	cd5	PROPN
ajlm-1458	97	7	dual	dual	ADJ
ajlm-1458	97	8	positivity	positivity	NOUN
ajlm-1458	97	9	for	for	ADP
ajlm-1458	97	10	diagnosis	diagnosis	NOUN
ajlm-1458	97	11	of	of	ADP
ajlm-1458	97	12	chronic	chronic	ADJ
ajlm-1458	97	13	lymphocytic	lymphocytic	ADJ
ajlm-1458	97	14	leukaemia	leukaemia	NOUN
ajlm-1458	97	15	or	or	CCONJ
ajlm-1458	97	16	cd19	cd19	PROPN
ajlm-1458	97	17	/	/	SYM
ajlm-1458	97	18	cd10	cd10	PROPN
ajlm-1458	97	19	+	+	CCONJ
ajlm-1458	97	20	dual	dual	ADJ
ajlm-1458	97	21	positivity	positivity	NOUN
ajlm-1458	97	22	for	for	ADP
ajlm-1458	97	23	a	a	DET
ajlm-1458	97	24	common	common	ADJ
ajlm-1458	97	25	acute	acute	ADJ
ajlm-1458	97	26	lymphoblastic	lymphoblastic	ADJ
ajlm-1458	97	27	leukaemia	leukaemia	NOUN
ajlm-1458	97	28	.	.	PUNCT
ajlm-1458	98	1	although	although	SCONJ
ajlm-1458	98	2	overall	overall	ADJ
ajlm-1458	98	3	diagnostic	diagnostic	ADJ
ajlm-1458	98	4	concordance	concordance	NOUN
ajlm-1458	98	5	was	be	AUX
ajlm-1458	98	6	100	100	NUM
ajlm-1458	98	7	%	%	NOUN
ajlm-1458	98	8	,	,	PUNCT
ajlm-1458	98	9	the	the	DET
ajlm-1458	98	10	four	four	NUM
ajlm-1458	98	11	compact	compact	ADJ
ajlm-1458	98	12	clearllab	clearllab	NOUN
ajlm-1458	98	13	panels	panel	NOUN
ajlm-1458	98	14	offered	offer	VERB
ajlm-1458	98	15	timely	timely	ADV
ajlm-1458	98	16	simultaneous	simultaneous	ADJ
ajlm-1458	98	17	,	,	PUNCT
ajlm-1458	98	18	collated	collate	VERB
ajlm-1458	98	19	,	,	PUNCT
ajlm-1458	98	20	and	and	CCONJ
ajlm-1458	98	21	concise	concise	ADJ
ajlm-1458	98	22	interpretation	interpretation	NOUN
ajlm-1458	98	23	for	for	ADP
ajlm-1458	98	24	both	both	DET
ajlm-1458	98	25	tumour	tumour	NOUN
ajlm-1458	98	26	and	and	CCONJ
ajlm-1458	98	27	normal	normal	ADJ
ajlm-1458	98	28	background	background	NOUN
ajlm-1458	98	29	populations	population	NOUN
ajlm-1458	98	30	.	.	PUNCT
ajlm-1458	99	1	this	this	DET
ajlm-1458	99	2	improved	improved	ADJ
ajlm-1458	99	3	efficiency	efficiency	NOUN
ajlm-1458	99	4	was	be	AUX
ajlm-1458	99	5	difficult	difficult	ADJ
ajlm-1458	99	6	to	to	PART
ajlm-1458	99	7	achieve	achieve	VERB
ajlm-1458	99	8	,	,	PUNCT
ajlm-1458	99	9	during	during	ADP
ajlm-1458	99	10	interpretation	interpretation	NOUN
ajlm-1458	99	11	and	and	CCONJ
ajlm-1458	99	12	analysis	analysis	NOUN
ajlm-1458	99	13	of	of	ADP
ajlm-1458	99	14	the	the	DET
ajlm-1458	99	15	predicate	predicate	NOUN
ajlm-1458	99	16	ldt	ldt	PROPN
ajlm-1458	99	17	,	,	PUNCT
ajlm-1458	99	18	where	where	SCONJ
ajlm-1458	99	19	limited	limited	ADJ
ajlm-1458	99	20	2–4	2–4	NUM
ajlm-1458	99	21	-	-	PUNCT
ajlm-1458	99	22	colour	colour	NOUN
ajlm-1458	99	23	marker	marker	NOUN
ajlm-1458	99	24	combinations	combination	NOUN
ajlm-1458	99	25	had	have	VERB
ajlm-1458	99	26	to	to	PART
ajlm-1458	99	27	be	be	AUX
ajlm-1458	99	28	interpreted	interpret	VERB
ajlm-1458	99	29	across	across	ADV
ajlm-1458	99	30	in	in	ADP
ajlm-1458	99	31	at	at	ADV
ajlm-1458	99	32	least	least	ADJ
ajlm-1458	99	33	10–12	10–12	NUM
ajlm-1458	99	34	,	,	PUNCT
ajlm-1458	99	35	but	but	CCONJ
ajlm-1458	99	36	often	often	ADV
ajlm-1458	99	37	as	as	ADV
ajlm-1458	99	38	many	many	ADJ
ajlm-1458	99	39	as	as	ADP
ajlm-1458	99	40	20	20	NUM
ajlm-1458	99	41	,	,	PUNCT
ajlm-1458	99	42	separate	separate	ADJ
ajlm-1458	99	43	panels	panel	NOUN
ajlm-1458	99	44	.	.	PUNCT
ajlm-1458	100	1	figure	figure	VERB
ajlm-1458	100	2	1	1	NUM
ajlm-1458	100	3	:	:	PUNCT
ajlm-1458	100	4	comparison	comparison	NOUN
ajlm-1458	100	5	of	of	ADP
ajlm-1458	100	6	diagnostic	diagnostic	ADJ
ajlm-1458	100	7	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	100	8	outcomes	outcome	NOUN
ajlm-1458	100	9	of	of	ADP
ajlm-1458	100	10	cases	case	NOUN
ajlm-1458	100	11	tested	test	VERB
ajlm-1458	100	12	by	by	ADP
ajlm-1458	100	13	laboratory	laboratory	NOUN
ajlm-1458	100	14	developed	develop	VERB
ajlm-1458	100	15	test	test	NOUN
ajlm-1458	100	16	and	and	CCONJ
ajlm-1458	100	17	clearllab	clearllab	NOUN
ajlm-1458	100	18	10c	10c	NOUN
ajlm-1458	100	19	at	at	ADP
ajlm-1458	100	20	the	the	DET
ajlm-1458	100	21	charlotte	charlotte	PROPN
ajlm-1458	100	22	maxeke	maxeke	PROPN
ajlm-1458	100	23	johannesburg	johannesburg	PROPN
ajlm-1458	100	24	academic	academic	PROPN
ajlm-1458	100	25	laboratory	laboratory	PROPN
ajlm-1458	100	26	in	in	ADP
ajlm-1458	100	27	johannesburg	johannesburg	PROPN
ajlm-1458	100	28	,	,	PUNCT
ajlm-1458	100	29	south	south	PROPN
ajlm-1458	100	30	africa	africa	PROPN
ajlm-1458	100	31	,	,	PUNCT
ajlm-1458	100	32	august	august	PROPN
ajlm-1458	100	33	2019	2019	NUM
ajlm-1458	100	34	–	–	PUNCT
ajlm-1458	100	35	november	november	PROPN
ajlm-1458	100	36	2019	2019	NUM
ajlm-1458	100	37	.	.	PUNCT
ajlm-1458	101	1	figure	figure	VERB
ajlm-1458	101	2	2	2	NUM
ajlm-1458	101	3	:	:	PUNCT
ajlm-1458	101	4	part	part	NOUN
ajlm-1458	102	1	i	i	PRON
ajlm-1458	102	2	:	:	PUNCT
ajlm-1458	102	3	comparison	comparison	NOUN
ajlm-1458	102	4	of	of	ADP
ajlm-1458	102	5	diagnostic	diagnostic	ADJ
ajlm-1458	102	6	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	102	7	outcomes	outcome	NOUN
ajlm-1458	102	8	of	of	ADP
ajlm-1458	102	9	cases	case	NOUN
ajlm-1458	102	10	tested	test	VERB
ajlm-1458	102	11	by	by	ADP
ajlm-1458	102	12	the	the	DET
ajlm-1458	102	13	predicate	predicate	NOUN
ajlm-1458	102	14	laboratory	laboratory	NOUN
ajlm-1458	102	15	developed	develop	VERB
ajlm-1458	102	16	test	test	NOUN
ajlm-1458	102	17	and	and	CCONJ
ajlm-1458	102	18	clearllab	clearllab	NOUN
ajlm-1458	102	19	10c	10c	NOUN
ajlm-1458	102	20	at	at	ADP
ajlm-1458	102	21	the	the	DET
ajlm-1458	102	22	charlotte	charlotte	PROPN
ajlm-1458	102	23	maxeke	maxeke	PROPN
ajlm-1458	102	24	johannesburg	johannesburg	PROPN
ajlm-1458	102	25	academic	academic	PROPN
ajlm-1458	102	26	laboratory	laboratory	PROPN
ajlm-1458	102	27	in	in	ADP
ajlm-1458	102	28	johannesburg	johannesburg	PROPN
ajlm-1458	102	29	,	,	PUNCT
ajlm-1458	102	30	south	south	PROPN
ajlm-1458	102	31	africa	africa	PROPN
ajlm-1458	102	32	,	,	PUNCT
ajlm-1458	102	33	during	during	ADP
ajlm-1458	102	34	the	the	DET
ajlm-1458	102	35	period	period	NOUN
ajlm-1458	102	36	from	from	ADP
ajlm-1458	102	37	august	august	PROPN
ajlm-1458	102	38	2019	2019	NUM
ajlm-1458	102	39	–	–	PUNCT
ajlm-1458	102	40	november	november	PROPN
ajlm-1458	102	41	2019	2019	NUM
ajlm-1458	102	42	.	.	PUNCT
ajlm-1458	103	1	comparing	compare	VERB
ajlm-1458	103	2	clearllab	clearllab	NOUN
ajlm-1458	103	3	10c	10c	NOUN
ajlm-1458	103	4	results	result	NOUN
ajlm-1458	103	5	with	with	ADP
ajlm-1458	103	6	clinicopathological	clinicopathological	ADJ
ajlm-1458	103	7	outcomes	outcome	NOUN
ajlm-1458	103	8	the	the	DET
ajlm-1458	103	9	overall	overall	ADJ
ajlm-1458	103	10	diagnostic	diagnostic	ADJ
ajlm-1458	103	11	sensitivity	sensitivity	NOUN
ajlm-1458	103	12	and	and	CCONJ
ajlm-1458	103	13	specificity	specificity	NOUN
ajlm-1458	103	14	were	be	AUX
ajlm-1458	103	15	comparable	comparable	ADJ
ajlm-1458	103	16	for	for	ADP
ajlm-1458	103	17	the	the	DET
ajlm-1458	103	18	outcomes	outcome	NOUN
ajlm-1458	103	19	reported	report	VERB
ajlm-1458	103	20	on	on	ADP
ajlm-1458	103	21	corresponding	correspond	VERB
ajlm-1458	103	22	clinicopathological	clinicopathological	ADJ
ajlm-1458	103	23	bone	bone	NOUN
ajlm-1458	103	24	marrow	marrow	NOUN
ajlm-1458	103	25	aspirate	aspirate	NOUN
ajlm-1458	103	26	or	or	CCONJ
ajlm-1458	103	27	trephine	trephine	NOUN
ajlm-1458	103	28	findings	finding	NOUN
ajlm-1458	103	29	(	(	PUNCT
ajlm-1458	103	30	figure	figure	NOUN
ajlm-1458	103	31	3	3	NUM
ajlm-1458	103	32	)	)	PUNCT
ajlm-1458	103	33	.	.	PUNCT
ajlm-1458	104	1	the	the	DET
ajlm-1458	104	2	clearllab	clearllab	NOUN
ajlm-1458	104	3	10c	10c	NOUN
ajlm-1458	104	4	system	system	NOUN
ajlm-1458	104	5	reliably	reliably	ADV
ajlm-1458	104	6	identified	identify	VERB
ajlm-1458	104	7	and	and	CCONJ
ajlm-1458	104	8	excluded	exclude	VERB
ajlm-1458	104	9	all	all	DET
ajlm-1458	104	10	diseases	disease	NOUN
ajlm-1458	104	11	and	and	CCONJ
ajlm-1458	104	12	,	,	PUNCT
ajlm-1458	104	13	in	in	ADP
ajlm-1458	104	14	two	two	NUM
ajlm-1458	104	15	cases	case	NOUN
ajlm-1458	104	16	,	,	PUNCT
ajlm-1458	104	17	detected	detect	VERB
ajlm-1458	104	18	the	the	DET
ajlm-1458	104	19	presence	presence	NOUN
ajlm-1458	104	20	of	of	ADP
ajlm-1458	104	21	a	a	DET
ajlm-1458	104	22	b	b	NOUN
ajlm-1458	104	23	-	-	PUNCT
ajlm-1458	104	24	cell	cell	NOUN
ajlm-1458	104	25	lymphoproliferative	lymphoproliferative	ADJ
ajlm-1458	104	26	neoplasm	neoplasm	NOUN
ajlm-1458	104	27	that	that	PRON
ajlm-1458	104	28	was	be	AUX
ajlm-1458	104	29	not	not	PART
ajlm-1458	104	30	detected	detect	VERB
ajlm-1458	104	31	morphologically	morphologically	ADV
ajlm-1458	104	32	on	on	ADP
ajlm-1458	104	33	the	the	DET
ajlm-1458	104	34	corresponding	corresponding	ADJ
ajlm-1458	104	35	bone	bone	NOUN
ajlm-1458	104	36	marrow	marrow	NOUN
ajlm-1458	104	37	aspirate	aspirate	NOUN
ajlm-1458	104	38	.	.	PUNCT
ajlm-1458	105	1	figure	figure	VERB
ajlm-1458	105	2	3	3	NUM
ajlm-1458	105	3	:	:	PUNCT
ajlm-1458	105	4	part	part	NOUN
ajlm-1458	105	5	2	2	NUM
ajlm-1458	105	6	:	:	PUNCT
ajlm-1458	105	7	contingency	contingency	NOUN
ajlm-1458	105	8	table34	table34	NOUN
ajlm-1458	105	9	comparing	compare	VERB
ajlm-1458	105	10	the	the	DET
ajlm-1458	105	11	clearllab	clearllab	NOUN
ajlm-1458	105	12	10c	10c	PROPN
ajlm-1458	105	13	test	test	NOUN
ajlm-1458	105	14	method	method	NOUN
ajlm-1458	105	15	(	(	PUNCT
ajlm-1458	105	16	as	as	ADP
ajlm-1458	105	17	an	an	DET
ajlm-1458	105	18	objective	objective	ADJ
ajlm-1458	105	19	standard	standard	NOUN
ajlm-1458	105	20	)	)	PUNCT
ajlm-1458	105	21	versus	versus	ADP
ajlm-1458	105	22	clinicopathological	clinicopathological	ADJ
ajlm-1458	105	23	outcomes	outcome	NOUN
ajlm-1458	105	24	reported	report	VERB
ajlm-1458	105	25	at	at	ADP
ajlm-1458	105	26	the	the	DET
ajlm-1458	105	27	charlotte	charlotte	PROPN
ajlm-1458	105	28	maxeke	maxeke	PROPN
ajlm-1458	105	29	johannesburg	johannesburg	PROPN
ajlm-1458	105	30	academic	academic	PROPN
ajlm-1458	105	31	laboratory	laboratory	PROPN
ajlm-1458	105	32	in	in	ADP
ajlm-1458	105	33	johannesburg	johannesburg	PROPN
ajlm-1458	105	34	,	,	PUNCT
ajlm-1458	105	35	south	south	PROPN
ajlm-1458	105	36	africa	africa	PROPN
ajlm-1458	105	37	,	,	PUNCT
ajlm-1458	105	38	august	august	PROPN
ajlm-1458	105	39	2019	2019	NUM
ajlm-1458	105	40	–	–	PUNCT
ajlm-1458	105	41	november	november	PROPN
ajlm-1458	105	42	2019	2019	NUM
ajlm-1458	105	43	.	.	PUNCT
ajlm-1458	106	1	discussion	discussion	NOUN
ajlm-1458	106	2	this	this	DET
ajlm-1458	106	3	study	study	NOUN
ajlm-1458	106	4	aimed	aim	VERB
ajlm-1458	106	5	to	to	PART
ajlm-1458	106	6	verify	verify	VERB
ajlm-1458	106	7	the	the	DET
ajlm-1458	106	8	performance	performance	NOUN
ajlm-1458	106	9	of	of	ADP
ajlm-1458	106	10	a	a	DET
ajlm-1458	106	11	new	new	ADJ
ajlm-1458	106	12	commercially	commercially	ADV
ajlm-1458	106	13	available	available	ADJ
ajlm-1458	106	14	,	,	PUNCT
ajlm-1458	106	15	fixed	fix	VERB
ajlm-1458	106	16	pre	pre	ADJ
ajlm-1458	106	17	-	-	ADJ
ajlm-1458	106	18	titrated	titrate	VERB
ajlm-1458	106	19	multicolour	multicolour	PROPN
ajlm-1458	106	20	flow	flow	NOUN
ajlm-1458	106	21	cytometric	cytometric	ADJ
ajlm-1458	106	22	panel	panel	NOUN
ajlm-1458	106	23	system	system	NOUN
ajlm-1458	106	24	,	,	PUNCT
ajlm-1458	106	25	the	the	DET
ajlm-1458	106	26	clearllab	clearllab	NOUN
ajlm-1458	106	27	10c	10c	NOUN
ajlm-1458	106	28	,	,	PUNCT
ajlm-1458	106	29	against	against	ADP
ajlm-1458	106	30	an	an	DET
ajlm-1458	106	31	existing	exist	VERB
ajlm-1458	106	32	ldt	ldt	NOUN
ajlm-1458	106	33	that	that	PRON
ajlm-1458	106	34	required	require	VERB
ajlm-1458	106	35	multiple	multiple	ADJ
ajlm-1458	106	36	manual	manual	ADJ
ajlm-1458	106	37	tube	tube	NOUN
ajlm-1458	106	38	setups	setup	NOUN
ajlm-1458	106	39	(	(	PUNCT
ajlm-1458	106	40	often	often	ADV
ajlm-1458	106	41	exceeding	exceed	VERB
ajlm-1458	106	42	10–12	10–12	ADJ
ajlm-1458	106	43	tubes	tube	NOUN
ajlm-1458	106	44	per	per	ADP
ajlm-1458	106	45	patient	patient	NOUN
ajlm-1458	106	46	)	)	PUNCT
ajlm-1458	106	47	and	and	CCONJ
ajlm-1458	106	48	required	require	VERB
ajlm-1458	106	49	manual	manual	ADJ
ajlm-1458	106	50	titration	titration	NOUN
ajlm-1458	106	51	and	and	CCONJ
ajlm-1458	106	52	separate	separate	ADJ
ajlm-1458	106	53	addition	addition	NOUN
ajlm-1458	106	54	of	of	ADP
ajlm-1458	106	55	reagents	reagent	NOUN
ajlm-1458	106	56	from	from	ADP
ajlm-1458	106	57	a	a	DET
ajlm-1458	106	58	large	large	ADJ
ajlm-1458	106	59	repertoire	repertoire	NOUN
ajlm-1458	106	60	of	of	ADP
ajlm-1458	106	61	liquid	liquid	ADJ
ajlm-1458	106	62	monoclonal	monoclonal	NOUN
ajlm-1458	106	63	antibodies	antibodie	VERB
ajlm-1458	106	64	.	.	PUNCT
ajlm-1458	107	1	this	this	DET
ajlm-1458	107	2	study	study	NOUN
ajlm-1458	107	3	has	have	AUX
ajlm-1458	107	4	revealed	reveal	VERB
ajlm-1458	107	5	that	that	SCONJ
ajlm-1458	107	6	the	the	DET
ajlm-1458	107	7	clearllab	clearllab	NOUN
ajlm-1458	107	8	10c	10c	NOUN
ajlm-1458	107	9	system	system	NOUN
ajlm-1458	107	10	reliably	reliably	ADV
ajlm-1458	107	11	enables	enable	VERB
ajlm-1458	107	12	full	full	ADJ
ajlm-1458	107	13	discovery	discovery	NOUN
ajlm-1458	107	14	of	of	ADP
ajlm-1458	107	15	most	most	ADV
ajlm-1458	107	16	leukaemias	leukaemia	NOUN
ajlm-1458	107	17	and	and	CCONJ
ajlm-1458	107	18	lymphomas	lymphoma	NOUN
ajlm-1458	107	19	,	,	PUNCT
ajlm-1458	107	20	with	with	ADP
ajlm-1458	107	21	full	full	ADJ
ajlm-1458	107	22	concordance	concordance	NOUN
ajlm-1458	107	23	to	to	ADP
ajlm-1458	107	24	our	our	PRON
ajlm-1458	107	25	existing	exist	VERB
ajlm-1458	107	26	in	in	ADP
ajlm-1458	107	27	-	-	PUNCT
ajlm-1458	107	28	house	house	NOUN
ajlm-1458	107	29	ldt	ldt	PROPN
ajlm-1458	107	30	panels	panel	NOUN
ajlm-1458	107	31	.	.	PUNCT
ajlm-1458	108	1	excellent	excellent	ADJ
ajlm-1458	108	2	concordance	concordance	NOUN
ajlm-1458	108	3	was	be	AUX
ajlm-1458	108	4	also	also	ADV
ajlm-1458	108	5	reported	report	VERB
ajlm-1458	108	6	against	against	ADP
ajlm-1458	108	7	corresponding	correspond	VERB
ajlm-1458	108	8	clinical	clinical	ADJ
ajlm-1458	108	9	-	-	PUNCT
ajlm-1458	108	10	pathological	pathological	ADJ
ajlm-1458	108	11	outcomes	outcome	NOUN
ajlm-1458	108	12	in	in	ADP
ajlm-1458	108	13	a	a	DET
ajlm-1458	108	14	subsequent	subsequent	ADJ
ajlm-1458	108	15	analysis	analysis	NOUN
ajlm-1458	108	16	that	that	PRON
ajlm-1458	108	17	looked	look	VERB
ajlm-1458	108	18	at	at	ADP
ajlm-1458	108	19	clearllab	clearllab	NOUN
ajlm-1458	108	20	10c	10c	NUM
ajlm-1458	108	21	outcomes	outcome	NOUN
ajlm-1458	108	22	against	against	ADP
ajlm-1458	108	23	reported	report	VERB
ajlm-1458	108	24	morphological	morphological	ADJ
ajlm-1458	108	25	findings	finding	NOUN
ajlm-1458	108	26	.	.	PUNCT
ajlm-1458	109	1	it	it	PRON
ajlm-1458	109	2	was	be	AUX
ajlm-1458	109	3	expected	expect	VERB
ajlm-1458	109	4	,	,	PUNCT
ajlm-1458	109	5	however	however	ADV
ajlm-1458	109	6	,	,	PUNCT
ajlm-1458	109	7	that	that	SCONJ
ajlm-1458	109	8	the	the	DET
ajlm-1458	109	9	clearllab	clearllab	NOUN
ajlm-1458	109	10	10c	10c	NOUN
ajlm-1458	109	11	system	system	NOUN
ajlm-1458	109	12	would	would	AUX
ajlm-1458	109	13	have	have	VERB
ajlm-1458	109	14	broadly	broadly	ADV
ajlm-1458	109	15	similar	similar	ADJ
ajlm-1458	109	16	clinical	clinical	ADJ
ajlm-1458	109	17	outcomes	outcome	NOUN
ajlm-1458	109	18	to	to	ADP
ajlm-1458	109	19	that	that	PRON
ajlm-1458	109	20	generated	generate	VERB
ajlm-1458	109	21	by	by	ADP
ajlm-1458	109	22	the	the	DET
ajlm-1458	109	23	ldt	ldt	PROPN
ajlm-1458	109	24	,	,	PUNCT
ajlm-1458	109	25	as	as	SCONJ
ajlm-1458	109	26	both	both	DET
ajlm-1458	109	27	systems	system	NOUN
ajlm-1458	109	28	used	use	VERB
ajlm-1458	109	29	flow	flow	NOUN
ajlm-1458	109	30	cytometry	cytometry	NOUN
ajlm-1458	109	31	and	and	CCONJ
ajlm-1458	109	32	the	the	DET
ajlm-1458	109	33	same	same	ADJ
ajlm-1458	109	34	markers	marker	NOUN
ajlm-1458	109	35	to	to	PART
ajlm-1458	109	36	derive	derive	VERB
ajlm-1458	109	37	outcomes	outcome	NOUN
ajlm-1458	109	38	.	.	PUNCT
ajlm-1458	110	1	the	the	DET
ajlm-1458	110	2	multicolour	multicolour	NOUN
ajlm-1458	110	3	capability	capability	NOUN
ajlm-1458	110	4	of	of	ADP
ajlm-1458	110	5	the	the	DET
ajlm-1458	110	6	clearllab	clearllab	NOUN
ajlm-1458	110	7	system	system	NOUN
ajlm-1458	110	8	versus	versus	ADP
ajlm-1458	110	9	2–4	2–4	NOUN
ajlm-1458	110	10	-	-	PUNCT
ajlm-1458	110	11	colour	colour	NOUN
ajlm-1458	110	12	panel	panel	NOUN
ajlm-1458	110	13	ldt	ldt	PROPN
ajlm-1458	110	14	is	be	AUX
ajlm-1458	110	15	what	what	PRON
ajlm-1458	110	16	sets	set	VERB
ajlm-1458	110	17	the	the	DET
ajlm-1458	110	18	two	two	NUM
ajlm-1458	110	19	methods	method	NOUN
ajlm-1458	110	20	apart	apart	ADV
ajlm-1458	110	21	;	;	PUNCT
ajlm-1458	110	22	compact	compact	ADJ
ajlm-1458	110	23	access	access	NOUN
ajlm-1458	110	24	to	to	ADP
ajlm-1458	110	25	27	27	NUM
ajlm-1458	110	26	markers	marker	NOUN
ajlm-1458	110	27	in	in	ADP
ajlm-1458	110	28	just	just	ADV
ajlm-1458	110	29	four	four	NUM
ajlm-1458	110	30	panels	panel	NOUN
ajlm-1458	110	31	,	,	PUNCT
ajlm-1458	110	32	with	with	ADP
ajlm-1458	110	33	trackable	trackable	ADJ
ajlm-1458	110	34	markers	marker	NOUN
ajlm-1458	110	35	between	between	ADP
ajlm-1458	110	36	analyses	analysis	NOUN
ajlm-1458	110	37	,	,	PUNCT
ajlm-1458	110	38	is	be	AUX
ajlm-1458	110	39	a	a	DET
ajlm-1458	110	40	game	game	NOUN
ajlm-1458	110	41	-	-	PUNCT
ajlm-1458	110	42	changer	changer	NOUN
ajlm-1458	110	43	,	,	PUNCT
ajlm-1458	110	44	certainly	certainly	ADV
ajlm-1458	110	45	for	for	ADP
ajlm-1458	110	46	our	our	PRON
ajlm-1458	110	47	site	site	NOUN
ajlm-1458	110	48	,	,	PUNCT
ajlm-1458	110	49	and	and	CCONJ
ajlm-1458	110	50	a	a	DET
ajlm-1458	110	51	notable	notable	ADJ
ajlm-1458	110	52	improvement	improvement	NOUN
ajlm-1458	110	53	over	over	ADP
ajlm-1458	110	54	our	our	PRON
ajlm-1458	110	55	previous	previous	ADJ
ajlm-1458	110	56	approach	approach	NOUN
ajlm-1458	110	57	to	to	ADP
ajlm-1458	110	58	first	first	ADJ
ajlm-1458	110	59	-	-	PUNCT
ajlm-1458	110	60	line	line	NOUN
ajlm-1458	110	61	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	110	62	workup	workup	NOUN
ajlm-1458	110	63	.	.	PUNCT
ajlm-1458	111	1	specifically	specifically	ADV
ajlm-1458	111	2	,	,	PUNCT
ajlm-1458	111	3	the	the	DET
ajlm-1458	111	4	concise	concise	ADJ
ajlm-1458	111	5	multi	multi	ADJ
ajlm-1458	111	6	-	-	ADJ
ajlm-1458	111	7	parameter	parameter	ADJ
ajlm-1458	111	8	format	format	NOUN
ajlm-1458	111	9	of	of	ADP
ajlm-1458	111	10	the	the	DET
ajlm-1458	111	11	m1	m1	NOUN
ajlm-1458	111	12	,	,	PUNCT
ajlm-1458	111	13	m2	m2	PROPN
ajlm-1458	111	14	,	,	PUNCT
ajlm-1458	111	15	b	b	PROPN
ajlm-1458	111	16	and	and	CCONJ
ajlm-1458	111	17	t	t	PROPN
ajlm-1458	111	18	-	-	PUNCT
ajlm-1458	111	19	cell	cell	NOUN
ajlm-1458	111	20	tubes	tube	NOUN
ajlm-1458	111	21	,	,	PUNCT
ajlm-1458	111	22	especially	especially	ADV
ajlm-1458	111	23	with	with	ADP
ajlm-1458	111	24	additional	additional	ADJ
ajlm-1458	111	25	markers	marker	NOUN
ajlm-1458	111	26	that	that	PRON
ajlm-1458	111	27	were	be	AUX
ajlm-1458	111	28	not	not	PART
ajlm-1458	111	29	included	include	VERB
ajlm-1458	111	30	in	in	ADP
ajlm-1458	111	31	a	a	DET
ajlm-1458	111	32	typical	typical	ADJ
ajlm-1458	111	33	first	first	ADJ
ajlm-1458	111	34	-	-	PUNCT
ajlm-1458	111	35	line	line	NOUN
ajlm-1458	111	36	investigation	investigation	NOUN
ajlm-1458	111	37	in	in	ADP
ajlm-1458	111	38	our	our	PRON
ajlm-1458	111	39	laboratory	laboratory	NOUN
ajlm-1458	111	40	ldt	ldt	PROPN
ajlm-1458	111	41	,	,	PUNCT
ajlm-1458	111	42	including	include	VERB
ajlm-1458	111	43	cd16	cd16	PROPN
ajlm-1458	111	44	,	,	PUNCT
ajlm-1458	111	45	cd38	cd38	PROPN
ajlm-1458	111	46	,	,	PUNCT
ajlm-1458	111	47	cd56	cd56	PROPN
ajlm-1458	111	48	,	,	PUNCT
ajlm-1458	111	49	cd64	cd64	PROPN
ajlm-1458	111	50	,	,	PUNCT
ajlm-1458	111	51	cd200	cd200	PROPN
ajlm-1458	111	52	,	,	PUNCT
ajlm-1458	111	53	cd123	cd123	PROPN
ajlm-1458	111	54	and	and	CCONJ
ajlm-1458	111	55	tcrγδ	tcrγδ	INTJ
ajlm-1458	111	56	,	,	PUNCT
ajlm-1458	111	57	has	have	AUX
ajlm-1458	111	58	enabled	enable	VERB
ajlm-1458	111	59	more	more	ADV
ajlm-1458	111	60	precise	precise	ADJ
ajlm-1458	111	61	and	and	CCONJ
ajlm-1458	111	62	detailed	detailed	ADJ
ajlm-1458	111	63	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	111	64	insights	insight	NOUN
ajlm-1458	111	65	.	.	PUNCT
ajlm-1458	112	1	myelomonocytic	myelomonocytic	ADJ
ajlm-1458	112	2	markers	marker	NOUN
ajlm-1458	112	3	in	in	ADP
ajlm-1458	112	4	the	the	DET
ajlm-1458	112	5	m1	m1	PROPN
ajlm-1458	112	6	tube	tube	NOUN
ajlm-1458	112	7	(	(	PUNCT
ajlm-1458	112	8	cd11b	cd11b	PROPN
ajlm-1458	112	9	,	,	PUNCT
ajlm-1458	112	10	cd14	cd14	PROPN
ajlm-1458	112	11	,	,	PUNCT
ajlm-1458	112	12	cd16	cd16	PROPN
ajlm-1458	112	13	,	,	PUNCT
ajlm-1458	112	14	cd64	cd64	PROPN
ajlm-1458	112	15	and	and	CCONJ
ajlm-1458	112	16	hla	hla	PROPN
ajlm-1458	112	17	-	-	PUNCT
ajlm-1458	112	18	dr	dr	PROPN
ajlm-1458	112	19	)	)	PUNCT
ajlm-1458	112	20	or	or	CCONJ
ajlm-1458	112	21	myeloid	myeloid	ADJ
ajlm-1458	112	22	markers	marker	NOUN
ajlm-1458	112	23	(	(	PUNCT
ajlm-1458	112	24	cd13	cd13	PROPN
ajlm-1458	112	25	,	,	PUNCT
ajlm-1458	112	26	cd15	cd15	PROPN
ajlm-1458	112	27	,	,	PUNCT
ajlm-1458	112	28	cd33	cd33	PROPN
ajlm-1458	112	29	,	,	PUNCT
ajlm-1458	112	30	cd117	cd117	PROPN
ajlm-1458	112	31	and	and	CCONJ
ajlm-1458	112	32	hla	hla	PROPN
ajlm-1458	112	33	-	-	PUNCT
ajlm-1458	112	34	dr	dr	PROPN
ajlm-1458	112	35	)	)	PUNCT
ajlm-1458	112	36	in	in	ADP
ajlm-1458	112	37	the	the	DET
ajlm-1458	112	38	m2	m2	PROPN
ajlm-1458	112	39	tube	tube	NOUN
ajlm-1458	112	40	proved	prove	VERB
ajlm-1458	112	41	to	to	PART
ajlm-1458	112	42	be	be	AUX
ajlm-1458	112	43	a	a	DET
ajlm-1458	112	44	distinct	distinct	ADJ
ajlm-1458	112	45	advantage	advantage	NOUN
ajlm-1458	112	46	over	over	ADP
ajlm-1458	112	47	the	the	DET
ajlm-1458	112	48	ldt	ldt	PROPN
ajlm-1458	112	49	to	to	PART
ajlm-1458	112	50	identify	identify	VERB
ajlm-1458	112	51	and	and	CCONJ
ajlm-1458	112	52	distinguish	distinguish	VERB
ajlm-1458	112	53	monocyte	monocyte	NOUN
ajlm-1458	112	54	from	from	ADP
ajlm-1458	112	55	granulocyte	granulocyte	ADJ
ajlm-1458	112	56	lineage	lineage	NOUN
ajlm-1458	112	57	,	,	PUNCT
ajlm-1458	112	58	discern	discern	VERB
ajlm-1458	112	59	all	all	DET
ajlm-1458	112	60	stages	stage	NOUN
ajlm-1458	112	61	of	of	ADP
ajlm-1458	112	62	maturation	maturation	NOUN
ajlm-1458	112	63	,	,	PUNCT
ajlm-1458	112	64	and	and	CCONJ
ajlm-1458	112	65	identify	identify	VERB
ajlm-1458	112	66	asynchronous	asynchronous	ADJ
ajlm-1458	112	67	myelomonocytic	myelomonocytic	ADJ
ajlm-1458	112	68	maturation	maturation	NOUN
ajlm-1458	112	69	,	,	PUNCT
ajlm-1458	112	70	including	include	VERB
ajlm-1458	112	71	characterising	characterise	VERB
ajlm-1458	112	72	immature	immature	ADJ
ajlm-1458	112	73	forms	form	NOUN
ajlm-1458	112	74	and	and	CCONJ
ajlm-1458	112	75	blasts	blast	NOUN
ajlm-1458	112	76	.	.	PUNCT
ajlm-1458	113	1	the	the	DET
ajlm-1458	113	2	combination	combination	NOUN
ajlm-1458	113	3	of	of	ADP
ajlm-1458	113	4	cd11b	cd11b	NOUN
ajlm-1458	113	5	,	,	PUNCT
ajlm-1458	113	6	cd13	cd13	PROPN
ajlm-1458	113	7	,	,	PUNCT
ajlm-1458	113	8	cd14	cd14	PROPN
ajlm-1458	113	9	and	and	CCONJ
ajlm-1458	113	10	cd16	cd16	PROPN
ajlm-1458	113	11	,	,	PUNCT
ajlm-1458	113	12	notably	notably	ADV
ajlm-1458	113	13	with	with	ADP
ajlm-1458	113	14	cd64	cd64	PROPN
ajlm-1458	113	15	,	,	PUNCT
ajlm-1458	113	16	facilitated	facilitate	VERB
ajlm-1458	113	17	a	a	DET
ajlm-1458	113	18	clear	clear	ADJ
ajlm-1458	113	19	distinction	distinction	NOUN
ajlm-1458	113	20	of	of	ADP
ajlm-1458	113	21	monocytic	monocytic	ADJ
ajlm-1458	113	22	maturation	maturation	NOUN
ajlm-1458	113	23	and	and	CCONJ
ajlm-1458	113	24	monocyte	monocyte	NOUN
ajlm-1458	113	25	subsets	subset	NOUN
ajlm-1458	113	26	while	while	SCONJ
ajlm-1458	113	27	also	also	ADV
ajlm-1458	113	28	providing	provide	VERB
ajlm-1458	113	29	insights	insight	NOUN
ajlm-1458	113	30	into	into	ADP
ajlm-1458	113	31	granulocytic	granulocytic	ADJ
ajlm-1458	113	32	differentiation	differentiation	NOUN
ajlm-1458	113	33	.	.	PUNCT
ajlm-1458	114	1	the	the	DET
ajlm-1458	114	2	inclusion	inclusion	NOUN
ajlm-1458	114	3	of	of	ADP
ajlm-1458	114	4	cd16	cd16	PROPN
ajlm-1458	114	5	was	be	AUX
ajlm-1458	114	6	especially	especially	ADV
ajlm-1458	114	7	useful	useful	ADJ
ajlm-1458	114	8	to	to	PART
ajlm-1458	114	9	define	define	VERB
ajlm-1458	114	10	both	both	CCONJ
ajlm-1458	114	11	early	early	ADJ
ajlm-1458	114	12	and	and	CCONJ
ajlm-1458	114	13	late	late	ADJ
ajlm-1458	114	14	maturation	maturation	NOUN
ajlm-1458	114	15	of	of	ADP
ajlm-1458	114	16	granulocytes	granulocyte	NOUN
ajlm-1458	114	17	;	;	PUNCT
ajlm-1458	114	18	clustered	clustered	ADJ
ajlm-1458	114	19	bright	bright	ADJ
ajlm-1458	114	20	cd16	cd16	PROPN
ajlm-1458	114	21	,	,	PUNCT
ajlm-1458	114	22	cd11b	cd11b	NOUN
ajlm-1458	114	23	and	and	CCONJ
ajlm-1458	114	24	cd13	cd13	PROPN
ajlm-1458	114	25	associated	associate	VERB
ajlm-1458	114	26	with	with	ADP
ajlm-1458	114	27	weak	weak	ADJ
ajlm-1458	114	28	cd10	cd10	PROPN
ajlm-1458	114	29	expression	expression	NOUN
ajlm-1458	114	30	allowed	allow	VERB
ajlm-1458	114	31	for	for	ADP
ajlm-1458	114	32	ease	ease	NOUN
ajlm-1458	114	33	of	of	ADP
ajlm-1458	114	34	identification	identification	NOUN
ajlm-1458	114	35	of	of	ADP
ajlm-1458	114	36	neutrophils	neutrophil	NOUN
ajlm-1458	114	37	which	which	PRON
ajlm-1458	114	38	was	be	AUX
ajlm-1458	114	39	helpful	helpful	ADJ
ajlm-1458	114	40	in	in	ADP
ajlm-1458	114	41	discerning	discern	VERB
ajlm-1458	114	42	haemodilution	haemodilution	NOUN
ajlm-1458	114	43	of	of	ADP
ajlm-1458	114	44	a	a	DET
ajlm-1458	114	45	bone	bone	NOUN
ajlm-1458	114	46	marrow	marrow	NOUN
ajlm-1458	114	47	sample	sample	NOUN
ajlm-1458	114	48	.	.	PUNCT
ajlm-1458	115	1	the	the	DET
ajlm-1458	115	2	b	b	PROPN
ajlm-1458	115	3	and	and	CCONJ
ajlm-1458	115	4	t	t	PROPN
ajlm-1458	115	5	-	-	PUNCT
ajlm-1458	115	6	cell	cell	NOUN
ajlm-1458	115	7	tubes	tube	NOUN
ajlm-1458	115	8	also	also	ADV
ajlm-1458	115	9	enabled	enable	VERB
ajlm-1458	115	10	simultaneous	simultaneous	ADJ
ajlm-1458	115	11	distinction	distinction	NOUN
ajlm-1458	115	12	of	of	ADP
ajlm-1458	115	13	lymphoid	lymphoid	ADJ
ajlm-1458	115	14	subsets	subset	NOUN
ajlm-1458	115	15	and	and	CCONJ
ajlm-1458	115	16	provided	provide	VERB
ajlm-1458	115	17	concise	concise	ADJ
ajlm-1458	115	18	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	115	19	information	information	NOUN
ajlm-1458	115	20	about	about	ADP
ajlm-1458	115	21	normal	normal	ADJ
ajlm-1458	115	22	or	or	CCONJ
ajlm-1458	115	23	aberrant	aberrant	ADJ
ajlm-1458	115	24	lymphoid	lymphoid	NOUN
ajlm-1458	115	25	maturation	maturation	NOUN
ajlm-1458	115	26	stages	stage	NOUN
ajlm-1458	115	27	.	.	PUNCT
ajlm-1458	116	1	coincident	coincident	ADJ
ajlm-1458	116	2	aberrant	aberrant	ADJ
ajlm-1458	116	3	loss	loss	NOUN
ajlm-1458	116	4	or	or	CCONJ
ajlm-1458	116	5	asynchronous	asynchronous	ADJ
ajlm-1458	116	6	gain	gain	NOUN
ajlm-1458	116	7	of	of	ADP
ajlm-1458	116	8	specific	specific	ADJ
ajlm-1458	116	9	markers	marker	NOUN
ajlm-1458	116	10	was	be	AUX
ajlm-1458	116	11	easier	easy	ADJ
ajlm-1458	116	12	to	to	PART
ajlm-1458	116	13	discern	discern	VERB
ajlm-1458	116	14	using	use	VERB
ajlm-1458	116	15	the	the	DET
ajlm-1458	116	16	clearllab	clearllab	NOUN
ajlm-1458	116	17	10	10	NUM
ajlm-1458	116	18	-	-	PUNCT
ajlm-1458	116	19	c	c	NOUN
ajlm-1458	116	20	panels	panel	NOUN
ajlm-1458	116	21	;	;	PUNCT
ajlm-1458	116	22	in	in	ADP
ajlm-1458	116	23	contrast	contrast	NOUN
ajlm-1458	116	24	to	to	ADP
ajlm-1458	116	25	our	our	PRON
ajlm-1458	116	26	2–4	2–4	NOUN
ajlm-1458	116	27	-	-	PUNCT
ajlm-1458	116	28	colour	colour	NOUN
ajlm-1458	116	29	ldt	ldt	NOUN
ajlm-1458	116	30	,	,	PUNCT
ajlm-1458	116	31	multiple	multiple	ADJ
ajlm-1458	116	32	markers	marker	NOUN
ajlm-1458	116	33	included	include	VERB
ajlm-1458	116	34	together	together	ADV
ajlm-1458	116	35	in	in	ADP
ajlm-1458	116	36	a	a	DET
ajlm-1458	116	37	single	single	ADJ
ajlm-1458	116	38	clearllab	clearllab	NOUN
ajlm-1458	116	39	panel	panel	NOUN
ajlm-1458	116	40	provided	provide	VERB
ajlm-1458	116	41	clearer	clear	ADJ
ajlm-1458	116	42	evidence	evidence	NOUN
ajlm-1458	116	43	of	of	ADP
ajlm-1458	116	44	simultaneous	simultaneous	ADJ
ajlm-1458	116	45	antigen	antigen	ADJ
ajlm-1458	116	46	losses	loss	NOUN
ajlm-1458	116	47	or	or	CCONJ
ajlm-1458	116	48	gains	gain	NOUN
ajlm-1458	116	49	of	of	ADP
ajlm-1458	116	50	markers	marker	NOUN
ajlm-1458	116	51	.	.	PUNCT
ajlm-1458	117	1	the	the	DET
ajlm-1458	117	2	specific	specific	ADJ
ajlm-1458	117	3	combination	combination	NOUN
ajlm-1458	117	4	of	of	ADP
ajlm-1458	117	5	cd45	cd45	PROPN
ajlm-1458	117	6	,	,	PUNCT
ajlm-1458	117	7	cd19	cd19	PROPN
ajlm-1458	117	8	,	,	PUNCT
ajlm-1458	117	9	cd10	cd10	PROPN
ajlm-1458	117	10	,	,	PUNCT
ajlm-1458	117	11	cd20	cd20	PROPN
ajlm-1458	117	12	,	,	PUNCT
ajlm-1458	117	13	cd34	cd34	PROPN
ajlm-1458	117	14	and	and	CCONJ
ajlm-1458	117	15	cd200	cd200	PROPN
ajlm-1458	117	16	in	in	ADP
ajlm-1458	117	17	the	the	DET
ajlm-1458	117	18	b	b	NOUN
ajlm-1458	117	19	-	-	PUNCT
ajlm-1458	117	20	cell	cell	NOUN
ajlm-1458	117	21	tube	tube	NOUN
ajlm-1458	117	22	,	,	PUNCT
ajlm-1458	117	23	with	with	ADP
ajlm-1458	117	24	hla	hla	PROPN
ajlm-1458	117	25	-	-	PUNCT
ajlm-1458	117	26	dr	dr	PROPN
ajlm-1458	117	27	,	,	PUNCT
ajlm-1458	117	28	cd38	cd38	PROPN
ajlm-1458	117	29	and	and	CCONJ
ajlm-1458	117	30	cd19	cd19	PROPN
ajlm-1458	117	31	in	in	ADP
ajlm-1458	117	32	the	the	DET
ajlm-1458	117	33	m2	m2	PROPN
ajlm-1458	117	34	tube	tube	NOUN
ajlm-1458	117	35	,	,	PUNCT
ajlm-1458	117	36	usually	usually	ADV
ajlm-1458	117	37	reserved	reserve	VERB
ajlm-1458	117	38	for	for	ADP
ajlm-1458	117	39	specific	specific	ADJ
ajlm-1458	117	40	disease	disease	NOUN
ajlm-1458	117	41	-	-	PUNCT
ajlm-1458	117	42	profiled	profile	VERB
ajlm-1458	117	43	ldt	ldt	NOUN
ajlm-1458	117	44	panels	panel	NOUN
ajlm-1458	117	45	in	in	ADP
ajlm-1458	117	46	our	our	PRON
ajlm-1458	117	47	previous	previous	ADJ
ajlm-1458	117	48	practice	practice	NOUN
ajlm-1458	117	49	,	,	PUNCT
ajlm-1458	117	50	has	have	AUX
ajlm-1458	117	51	also	also	ADV
ajlm-1458	117	52	markedly	markedly	ADV
ajlm-1458	117	53	improved	improve	VERB
ajlm-1458	117	54	our	our	PRON
ajlm-1458	117	55	ability	ability	NOUN
ajlm-1458	117	56	to	to	PART
ajlm-1458	117	57	discriminate	discriminate	VERB
ajlm-1458	117	58	early	early	ADJ
ajlm-1458	117	59	normal	normal	ADJ
ajlm-1458	117	60	b	b	NOUN
ajlm-1458	117	61	-	-	PUNCT
ajlm-1458	117	62	cell	cell	NOUN
ajlm-1458	117	63	precursors	precursor	NOUN
ajlm-1458	117	64	from	from	ADP
ajlm-1458	117	65	later	later	ADV
ajlm-1458	117	66	mature	mature	ADJ
ajlm-1458	117	67	polyclonal	polyclonal	ADJ
ajlm-1458	117	68	b	b	NOUN
ajlm-1458	117	69	-	-	PUNCT
ajlm-1458	117	70	cells	cell	NOUN
ajlm-1458	117	71	in	in	ADP
ajlm-1458	117	72	first	first	ADJ
ajlm-1458	117	73	-	-	PUNCT
ajlm-1458	117	74	line	line	NOUN
ajlm-1458	117	75	workup	workup	NOUN
ajlm-1458	117	76	;	;	PUNCT
ajlm-1458	117	77	cd38	cd38	PROPN
ajlm-1458	117	78	-	-	PUNCT
ajlm-1458	117	79	bright	bright	ADJ
ajlm-1458	117	80	expressing	expressing	NOUN
ajlm-1458	117	81	,	,	PUNCT
ajlm-1458	117	82	cd45	cd45	PROPN
ajlm-1458	117	83	negative	negative	ADJ
ajlm-1458	117	84	plasma	plasma	NOUN
ajlm-1458	117	85	cells	cell	NOUN
ajlm-1458	117	86	are	be	AUX
ajlm-1458	117	87	also	also	ADV
ajlm-1458	117	88	easily	easily	ADV
ajlm-1458	117	89	recognised	recognise	VERB
ajlm-1458	117	90	upfront	upfront	NOUN
ajlm-1458	117	91	.	.	PUNCT
ajlm-1458	118	1	further	far	ADV
ajlm-1458	118	2	,	,	PUNCT
ajlm-1458	118	3	we	we	PRON
ajlm-1458	118	4	have	have	AUX
ajlm-1458	118	5	found	find	VERB
ajlm-1458	118	6	that	that	SCONJ
ajlm-1458	118	7	cd123	cd123	PROPN
ajlm-1458	118	8	,	,	PUNCT
ajlm-1458	118	9	along	along	ADP
ajlm-1458	118	10	with	with	ADP
ajlm-1458	118	11	cd19	cd19	PROPN
ajlm-1458	118	12	,	,	PUNCT
ajlm-1458	118	13	cd34	cd34	PROPN
ajlm-1458	118	14	,	,	PUNCT
ajlm-1458	118	15	cd38	cd38	PROPN
ajlm-1458	118	16	and	and	CCONJ
ajlm-1458	118	17	hla	hla	PROPN
ajlm-1458	118	18	-	-	PUNCT
ajlm-1458	118	19	dr	dr	PROPN
ajlm-1458	118	20	,	,	PUNCT
ajlm-1458	118	21	identifies	identify	VERB
ajlm-1458	118	22	b	b	NOUN
ajlm-1458	118	23	-	-	PUNCT
ajlm-1458	118	24	cells	cell	NOUN
ajlm-1458	118	25	in	in	ADP
ajlm-1458	118	26	the	the	DET
ajlm-1458	118	27	m2	m2	PROPN
ajlm-1458	118	28	tube	tube	NOUN
ajlm-1458	118	29	,	,	PUNCT
ajlm-1458	118	30	which	which	PRON
ajlm-1458	118	31	is	be	AUX
ajlm-1458	118	32	especially	especially	ADV
ajlm-1458	118	33	valuable	valuable	ADJ
ajlm-1458	118	34	to	to	PART
ajlm-1458	118	35	discern	discern	VERB
ajlm-1458	118	36	and	and	CCONJ
ajlm-1458	118	37	document	document	VERB
ajlm-1458	118	38	discordant	discordant	ADJ
ajlm-1458	118	39	expression	expression	NOUN
ajlm-1458	118	40	in	in	ADP
ajlm-1458	118	41	normal	normal	ADJ
ajlm-1458	118	42	and	and	CCONJ
ajlm-1458	118	43	abnormal	abnormal	ADJ
ajlm-1458	118	44	precursor	precursor	NOUN
ajlm-1458	118	45	b	b	NOUN
ajlm-1458	118	46	-	-	PUNCT
ajlm-1458	118	47	cells.35,36	cells.35,36	VERB
ajlm-1458	118	48	concurrent	concurrent	ADJ
ajlm-1458	118	49	assessment	assessment	NOUN
ajlm-1458	118	50	of	of	ADP
ajlm-1458	118	51	most	most	ADJ
ajlm-1458	118	52	t	t	NOUN
ajlm-1458	118	53	-	-	PUNCT
ajlm-1458	118	54	cell	cell	NOUN
ajlm-1458	118	55	markers	marker	NOUN
ajlm-1458	118	56	in	in	ADP
ajlm-1458	118	57	the	the	DET
ajlm-1458	118	58	t	t	NOUN
ajlm-1458	118	59	-	-	PUNCT
ajlm-1458	118	60	cell	cell	NOUN
ajlm-1458	118	61	tube	tube	NOUN
ajlm-1458	118	62	was	be	AUX
ajlm-1458	118	63	valuable	valuable	ADJ
ajlm-1458	118	64	for	for	ADP
ajlm-1458	118	65	discerning	discern	VERB
ajlm-1458	118	66	both	both	CCONJ
ajlm-1458	118	67	immature	immature	ADJ
ajlm-1458	118	68	and	and	CCONJ
ajlm-1458	118	69	mature	mature	VERB
ajlm-1458	118	70	t	t	NOUN
ajlm-1458	118	71	-	-	PUNCT
ajlm-1458	118	72	cell	cell	NOUN
ajlm-1458	118	73	lymphoproliferative	lymphoproliferative	ADJ
ajlm-1458	118	74	disorders	disorder	NOUN
ajlm-1458	118	75	.	.	PUNCT
ajlm-1458	119	1	natural	natural	ADJ
ajlm-1458	119	2	killer	killer	NOUN
ajlm-1458	119	3	or	or	CCONJ
ajlm-1458	119	4	cytotoxic	cytotoxic	ADJ
ajlm-1458	119	5	cells	cell	NOUN
ajlm-1458	119	6	were	be	AUX
ajlm-1458	119	7	easily	easily	ADV
ajlm-1458	119	8	identified	identify	VERB
ajlm-1458	119	9	with	with	ADP
ajlm-1458	119	10	cd7	cd7	PROPN
ajlm-1458	119	11	,	,	PUNCT
ajlm-1458	119	12	cd56	cd56	PROPN
ajlm-1458	119	13	or	or	CCONJ
ajlm-1458	119	14	tcrγδ	tcrγδ	NOUN
ajlm-1458	119	15	in	in	ADP
ajlm-1458	119	16	the	the	DET
ajlm-1458	119	17	t	t	NOUN
ajlm-1458	119	18	-	-	PUNCT
ajlm-1458	119	19	cell	cell	NOUN
ajlm-1458	119	20	tube	tube	NOUN
ajlm-1458	119	21	and	and	CCONJ
ajlm-1458	119	22	confirmed	confirm	VERB
ajlm-1458	119	23	with	with	ADP
ajlm-1458	119	24	expression	expression	NOUN
ajlm-1458	119	25	of	of	ADP
ajlm-1458	119	26	cd16	cd16	PROPN
ajlm-1458	119	27	and	and	CCONJ
ajlm-1458	119	28	cd7	cd7	PROPN
ajlm-1458	119	29	in	in	ADP
ajlm-1458	119	30	the	the	DET
ajlm-1458	119	31	m1	m1	PROPN
ajlm-1458	119	32	tube	tube	NOUN
ajlm-1458	119	33	.	.	PUNCT
ajlm-1458	120	1	from	from	ADP
ajlm-1458	120	2	a	a	DET
ajlm-1458	120	3	marker	marker	NOUN
ajlm-1458	120	4	reproducibility	reproducibility	NOUN
ajlm-1458	120	5	perspective	perspective	NOUN
ajlm-1458	120	6	,	,	PUNCT
ajlm-1458	120	7	and	and	CCONJ
ajlm-1458	120	8	in	in	ADP
ajlm-1458	120	9	stark	stark	ADJ
ajlm-1458	120	10	contrast	contrast	NOUN
ajlm-1458	120	11	to	to	ADP
ajlm-1458	120	12	our	our	PRON
ajlm-1458	120	13	ldt	ldt	PROPN
ajlm-1458	120	14	method	method	NOUN
ajlm-1458	120	15	,	,	PUNCT
ajlm-1458	120	16	the	the	DET
ajlm-1458	120	17	primary	primary	ADJ
ajlm-1458	120	18	backbone	backbone	NOUN
ajlm-1458	120	19	markers	marker	NOUN
ajlm-1458	120	20	,	,	PUNCT
ajlm-1458	120	21	cd45	cd45	PROPN
ajlm-1458	120	22	and	and	CCONJ
ajlm-1458	120	23	cd34	cd34	PROPN
ajlm-1458	120	24	,	,	PUNCT
ajlm-1458	120	25	included	include	VERB
ajlm-1458	120	26	as	as	ADP
ajlm-1458	120	27	all	all	DET
ajlm-1458	120	28	four	four	NUM
ajlm-1458	120	29	tubes	tube	NOUN
ajlm-1458	120	30	with	with	ADP
ajlm-1458	120	31	additional	additional	ADJ
ajlm-1458	120	32	secondary	secondary	ADJ
ajlm-1458	120	33	backbone	backbone	NOUN
ajlm-1458	120	34	markers	marker	NOUN
ajlm-1458	120	35	,	,	PUNCT
ajlm-1458	120	36	namely	namely	ADV
ajlm-1458	120	37	cd5	cd5	PROPN
ajlm-1458	120	38	,	,	PUNCT
ajlm-1458	120	39	cd7	cd7	PROPN
ajlm-1458	120	40	,	,	PUNCT
ajlm-1458	120	41	cd10	cd10	PROPN
ajlm-1458	120	42	,	,	PUNCT
ajlm-1458	120	43	cd13	cd13	PROPN
ajlm-1458	120	44	,	,	PUNCT
ajlm-1458	120	45	cd38	cd38	PROPN
ajlm-1458	120	46	and	and	CCONJ
ajlm-1458	120	47	hla	hla	PROPN
ajlm-1458	120	48	-	-	PUNCT
ajlm-1458	120	49	dr	dr	PROPN
ajlm-1458	120	50	,	,	PUNCT
ajlm-1458	120	51	each	each	PRON
ajlm-1458	120	52	repeated	repeat	VERB
ajlm-1458	120	53	across	across	ADP
ajlm-1458	120	54	at	at	ADV
ajlm-1458	120	55	least	least	ADV
ajlm-1458	120	56	two	two	NUM
ajlm-1458	120	57	tubes	tube	NOUN
ajlm-1458	120	58	,	,	PUNCT
ajlm-1458	120	59	proved	prove	VERB
ajlm-1458	120	60	to	to	PART
ajlm-1458	120	61	be	be	AUX
ajlm-1458	120	62	enormously	enormously	ADV
ajlm-1458	120	63	helpful	helpful	ADJ
ajlm-1458	120	64	to	to	PART
ajlm-1458	120	65	track	track	VERB
ajlm-1458	120	66	populations	population	NOUN
ajlm-1458	120	67	between	between	ADP
ajlm-1458	120	68	the	the	DET
ajlm-1458	120	69	four	four	NUM
ajlm-1458	120	70	clearllab	clearllab	NOUN
ajlm-1458	120	71	analyses	analysis	NOUN
ajlm-1458	120	72	.	.	PUNCT
ajlm-1458	121	1	another	another	DET
ajlm-1458	121	2	distinct	distinct	ADJ
ajlm-1458	121	3	advantage	advantage	NOUN
ajlm-1458	121	4	was	be	AUX
ajlm-1458	121	5	that	that	SCONJ
ajlm-1458	121	6	substantively	substantively	ADV
ajlm-1458	121	7	fewer	few	ADJ
ajlm-1458	121	8	cells	cell	NOUN
ajlm-1458	121	9	were	be	AUX
ajlm-1458	121	10	needed	need	VERB
ajlm-1458	121	11	to	to	PART
ajlm-1458	121	12	achieve	achieve	VERB
ajlm-1458	121	13	a	a	DET
ajlm-1458	121	14	relatively	relatively	ADV
ajlm-1458	121	15	extensive	extensive	ADJ
ajlm-1458	121	16	workup	workup	NOUN
ajlm-1458	121	17	in	in	ADP
ajlm-1458	121	18	a	a	DET
ajlm-1458	121	19	paucicellular	paucicellular	ADJ
ajlm-1458	121	20	sample	sample	NOUN
ajlm-1458	121	21	using	use	VERB
ajlm-1458	121	22	clearllab	clearllab	NOUN
ajlm-1458	121	23	.	.	PUNCT
ajlm-1458	122	1	often	often	ADV
ajlm-1458	122	2	during	during	ADP
ajlm-1458	122	3	ldt	ldt	PROPN
ajlm-1458	122	4	use	use	NOUN
ajlm-1458	122	5	,	,	PUNCT
ajlm-1458	122	6	our	our	PRON
ajlm-1458	122	7	site	site	NOUN
ajlm-1458	122	8	would	would	AUX
ajlm-1458	122	9	be	be	AUX
ajlm-1458	122	10	unable	unable	ADJ
ajlm-1458	122	11	to	to	PART
ajlm-1458	122	12	complete	complete	VERB
ajlm-1458	122	13	full	full	ADJ
ajlm-1458	122	14	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	122	15	workup	workup	NOUN
ajlm-1458	122	16	in	in	ADP
ajlm-1458	122	17	paucicellular	paucicellular	ADJ
ajlm-1458	122	18	samples	sample	NOUN
ajlm-1458	122	19	,	,	PUNCT
ajlm-1458	122	20	especially	especially	ADV
ajlm-1458	122	21	in	in	ADP
ajlm-1458	122	22	paediatric	paediatric	ADJ
ajlm-1458	122	23	and	and	CCONJ
ajlm-1458	122	24	bodily	bodily	ADJ
ajlm-1458	122	25	fluid	fluid	ADJ
ajlm-1458	122	26	samples	sample	NOUN
ajlm-1458	122	27	like	like	ADP
ajlm-1458	122	28	cerebrospinal	cerebrospinal	ADJ
ajlm-1458	122	29	fluid	fluid	NOUN
ajlm-1458	122	30	.	.	PUNCT
ajlm-1458	123	1	careful	careful	ADJ
ajlm-1458	123	2	consideration	consideration	NOUN
ajlm-1458	123	3	was	be	AUX
ajlm-1458	123	4	previously	previously	ADV
ajlm-1458	123	5	given	give	VERB
ajlm-1458	123	6	to	to	ADP
ajlm-1458	123	7	implementing	implement	VERB
ajlm-1458	123	8	the	the	DET
ajlm-1458	123	9	established	establish	VERB
ajlm-1458	123	10	state	state	NOUN
ajlm-1458	123	11	-	-	PUNCT
ajlm-1458	123	12	of	of	ADP
ajlm-1458	123	13	-	-	PUNCT
ajlm-1458	123	14	the	the	DET
ajlm-1458	123	15	-	-	PUNCT
ajlm-1458	123	16	art	art	NOUN
ajlm-1458	123	17	euroflow	euroflow	NOUN
ajlm-1458	123	18	system9,20,37	system9,20,37	NOUN
ajlm-1458	123	19	that	that	PRON
ajlm-1458	123	20	is	be	AUX
ajlm-1458	123	21	widely	widely	ADV
ajlm-1458	123	22	used	use	VERB
ajlm-1458	123	23	in	in	ADP
ajlm-1458	123	24	europe	europe	PROPN
ajlm-1458	123	25	.	.	PUNCT
ajlm-1458	124	1	however	however	ADV
ajlm-1458	124	2	,	,	PUNCT
ajlm-1458	124	3	the	the	DET
ajlm-1458	124	4	complex	complex	ADJ
ajlm-1458	124	5	euroflow	euroflow	NOUN
ajlm-1458	124	6	demands	demand	VERB
ajlm-1458	124	7	manual	manual	ADJ
ajlm-1458	124	8	assembly	assembly	NOUN
ajlm-1458	124	9	of	of	ADP
ajlm-1458	124	10	8	8	NUM
ajlm-1458	124	11	-	-	PUNCT
ajlm-1458	124	12	colour	colour	NOUN
ajlm-1458	124	13	marker	marker	NOUN
ajlm-1458	124	14	panels21,38	panels21,38	NOUN
ajlm-1458	124	15	,	,	PUNCT
ajlm-1458	124	16	uses	use	VERB
ajlm-1458	124	17	a	a	DET
ajlm-1458	124	18	repertoire	repertoire	NOUN
ajlm-1458	124	19	of	of	ADP
ajlm-1458	124	20	monoclonal	monoclonal	NOUN
ajlm-1458	124	21	antibodies	antibody	NOUN
ajlm-1458	124	22	and	and	CCONJ
ajlm-1458	124	23	requires	require	VERB
ajlm-1458	124	24	multiple	multiple	ADJ
ajlm-1458	124	25	titrations	titration	NOUN
ajlm-1458	124	26	and	and	CCONJ
ajlm-1458	124	27	pipetting	pipetting	NOUN
ajlm-1458	124	28	protocols	protocol	NOUN
ajlm-1458	124	29	.	.	PUNCT
ajlm-1458	125	1	these	these	PRON
ajlm-1458	125	2	pose	pose	VERB
ajlm-1458	125	3	a	a	DET
ajlm-1458	125	4	significant	significant	ADJ
ajlm-1458	125	5	barrier	barrier	NOUN
ajlm-1458	125	6	to	to	PART
ajlm-1458	125	7	use	use	VERB
ajlm-1458	125	8	in	in	ADP
ajlm-1458	125	9	our	our	PRON
ajlm-1458	125	10	relatively	relatively	ADV
ajlm-1458	125	11	skills	skill	NOUN
ajlm-1458	125	12	-	-	PUNCT
ajlm-1458	125	13	scarce	scarce	ADJ
ajlm-1458	125	14	environment	environment	NOUN
ajlm-1458	125	15	,	,	PUNCT
ajlm-1458	125	16	considering	consider	VERB
ajlm-1458	125	17	the	the	DET
ajlm-1458	125	18	technical	technical	ADJ
ajlm-1458	125	19	effort	effort	NOUN
ajlm-1458	125	20	needed	need	VERB
ajlm-1458	125	21	and	and	CCONJ
ajlm-1458	125	22	potential	potential	ADJ
ajlm-1458	125	23	for	for	ADP
ajlm-1458	125	24	error	error	NOUN
ajlm-1458	125	25	during	during	ADP
ajlm-1458	125	26	the	the	DET
ajlm-1458	125	27	dispensing	dispensing	NOUN
ajlm-1458	125	28	of	of	ADP
ajlm-1458	125	29	monoclonal	monoclonal	NOUN
ajlm-1458	125	30	reagent	reagent	NOUN
ajlm-1458	125	31	encountered	encounter	VERB
ajlm-1458	125	32	in	in	ADP
ajlm-1458	125	33	our	our	PRON
ajlm-1458	125	34	existing	exist	VERB
ajlm-1458	125	35	2–4	2–4	NUM
ajlm-1458	125	36	-	-	PUNCT
ajlm-1458	125	37	colour	colour	NOUN
ajlm-1458	125	38	ldt	ldt	NOUN
ajlm-1458	125	39	.	.	PUNCT
ajlm-1458	126	1	another	another	DET
ajlm-1458	126	2	factor	factor	NOUN
ajlm-1458	126	3	that	that	PRON
ajlm-1458	126	4	hindered	hinder	VERB
ajlm-1458	126	5	the	the	DET
ajlm-1458	126	6	implementation	implementation	NOUN
ajlm-1458	126	7	of	of	ADP
ajlm-1458	126	8	euroflow	euroflow	NOUN
ajlm-1458	126	9	was	be	AUX
ajlm-1458	126	10	the	the	DET
ajlm-1458	126	11	unit	unit	NOUN
ajlm-1458	126	12	’s	’s	PART
ajlm-1458	126	13	heavy	heavy	ADJ
ajlm-1458	126	14	workload	workload	NOUN
ajlm-1458	126	15	.	.	PUNCT
ajlm-1458	127	1	the	the	DET
ajlm-1458	127	2	unit	unit	NOUN
ajlm-1458	127	3	is	be	AUX
ajlm-1458	127	4	a	a	DET
ajlm-1458	127	5	24	24	NUM
ajlm-1458	127	6	-	-	PUNCT
ajlm-1458	127	7	h	h	NOUN
ajlm-1458	127	8	cd4	cd4	PROPN
ajlm-1458	127	9	laboratory	laboratory	NOUN
ajlm-1458	127	10	processing	processing	NOUN
ajlm-1458	127	11	up	up	ADP
ajlm-1458	127	12	to	to	PART
ajlm-1458	127	13	12	12	NUM
ajlm-1458	127	14	000	000	NUM
ajlm-1458	127	15	samples	sample	NOUN
ajlm-1458	127	16	per	per	ADP
ajlm-1458	127	17	month39,40	month39,40	NUM
ajlm-1458	127	18	;	;	PUNCT
ajlm-1458	127	19	the	the	DET
ajlm-1458	127	20	technical	technical	ADJ
ajlm-1458	127	21	staff	staff	NOUN
ajlm-1458	127	22	managing	manage	VERB
ajlm-1458	127	23	the	the	DET
ajlm-1458	127	24	cd4	cd4	PROPN
ajlm-1458	127	25	and	and	CCONJ
ajlm-1458	127	26	hiv	hiv	PROPN
ajlm-1458	127	27	immunology	immunology	NOUN
ajlm-1458	127	28	bench	bench	NOUN
ajlm-1458	127	29	also	also	ADV
ajlm-1458	127	30	support	support	VERB
ajlm-1458	127	31	the	the	DET
ajlm-1458	127	32	leukaemia	leukaemia	NOUN
ajlm-1458	127	33	bench	bench	NOUN
ajlm-1458	127	34	.	.	PUNCT
ajlm-1458	128	1	thus	thus	ADV
ajlm-1458	128	2	,	,	PUNCT
ajlm-1458	128	3	although	although	SCONJ
ajlm-1458	128	4	the	the	DET
ajlm-1458	128	5	staff	staff	NOUN
ajlm-1458	128	6	are	be	AUX
ajlm-1458	128	7	competent	competent	ADJ
ajlm-1458	128	8	to	to	PART
ajlm-1458	128	9	run	run	VERB
ajlm-1458	128	10	the	the	DET
ajlm-1458	128	11	cd4	cd4	PROPN
ajlm-1458	128	12	services	service	NOUN
ajlm-1458	128	13	using	use	VERB
ajlm-1458	128	14	pre	pre	ADJ
ajlm-1458	128	15	-	-	ADJ
ajlm-1458	128	16	titrated	titrated	ADJ
ajlm-1458	128	17	and	and	CCONJ
ajlm-1458	128	18	pipetted	pipette	VERB
ajlm-1458	128	19	reagents	reagent	NOUN
ajlm-1458	128	20	and	and	CCONJ
ajlm-1458	128	21	standardised	standardise	VERB
ajlm-1458	128	22	,	,	PUNCT
ajlm-1458	128	23	automated	automate	VERB
ajlm-1458	128	24	testing	testing	NOUN
ajlm-1458	128	25	procedures,40,41	procedures,40,41	PROPN
ajlm-1458	128	26	they	they	PRON
ajlm-1458	128	27	are	be	AUX
ajlm-1458	128	28	not	not	PART
ajlm-1458	128	29	primarily	primarily	ADV
ajlm-1458	128	30	trained	train	VERB
ajlm-1458	128	31	in	in	ADP
ajlm-1458	128	32	flow	flow	NOUN
ajlm-1458	128	33	cytometry	cytometry	NOUN
ajlm-1458	128	34	.	.	PUNCT
ajlm-1458	129	1	therefore	therefore	ADV
ajlm-1458	129	2	,	,	PUNCT
ajlm-1458	129	3	from	from	ADP
ajlm-1458	129	4	a	a	DET
ajlm-1458	129	5	technical	technical	ADJ
ajlm-1458	129	6	perspective	perspective	NOUN
ajlm-1458	129	7	,	,	PUNCT
ajlm-1458	129	8	the	the	DET
ajlm-1458	129	9	compact	compact	ADJ
ajlm-1458	129	10	,	,	PUNCT
ajlm-1458	129	11	pre	pre	ADJ
ajlm-1458	129	12	-	-	ADJ
ajlm-1458	129	13	titrated	titrate	VERB
ajlm-1458	129	14	clearllab	clearllab	NOUN
ajlm-1458	129	15	10c	10c	NOUN
ajlm-1458	129	16	fixed	fix	VERB
ajlm-1458	129	17	tube	tube	NOUN
ajlm-1458	129	18	reagents27,28	reagents27,28	NOUN
ajlm-1458	129	19	with	with	ADP
ajlm-1458	129	20	automated	automate	VERB
ajlm-1458	129	21	procedures	procedure	NOUN
ajlm-1458	129	22	and	and	CCONJ
ajlm-1458	129	23	standardised	standardised	ADJ
ajlm-1458	129	24	instrument	instrument	NOUN
ajlm-1458	129	25	setup	setup	NOUN
ajlm-1458	129	26	,	,	PUNCT
ajlm-1458	129	27	allows	allow	VERB
ajlm-1458	129	28	our	our	PRON
ajlm-1458	129	29	laboratory	laboratory	NOUN
ajlm-1458	129	30	to	to	PART
ajlm-1458	129	31	undertake	undertake	VERB
ajlm-1458	129	32	sophisticated	sophisticated	ADJ
ajlm-1458	129	33	multicolour	multicolour	ADJ
ajlm-1458	129	34	panel	panel	NOUN
ajlm-1458	129	35	testing	testing	NOUN
ajlm-1458	129	36	confidently	confidently	ADV
ajlm-1458	129	37	while	while	SCONJ
ajlm-1458	129	38	still	still	ADV
ajlm-1458	129	39	addressing	address	VERB
ajlm-1458	129	40	local	local	ADJ
ajlm-1458	129	41	challenges	challenge	NOUN
ajlm-1458	129	42	.	.	PUNCT
ajlm-1458	130	1	implementation	implementation	NOUN
ajlm-1458	130	2	can	can	AUX
ajlm-1458	130	3	significantly	significantly	ADV
ajlm-1458	130	4	reduce	reduce	VERB
ajlm-1458	130	5	leukaemia	leukaemia	NOUN
ajlm-1458	130	6	sample	sample	NOUN
ajlm-1458	130	7	preparation	preparation	NOUN
ajlm-1458	130	8	time	time	NOUN
ajlm-1458	130	9	and	and	CCONJ
ajlm-1458	130	10	improve	improve	VERB
ajlm-1458	130	11	the	the	DET
ajlm-1458	130	12	efficiency	efficiency	NOUN
ajlm-1458	130	13	and	and	CCONJ
ajlm-1458	130	14	quality	quality	NOUN
ajlm-1458	130	15	of	of	ADP
ajlm-1458	130	16	leukaemia	leukaemia	NOUN
ajlm-1458	130	17	testing	testing	NOUN
ajlm-1458	130	18	in	in	ADP
ajlm-1458	130	19	our	our	PRON
ajlm-1458	130	20	site	site	NOUN
ajlm-1458	130	21	.	.	PUNCT
ajlm-1458	131	1	the	the	DET
ajlm-1458	131	2	difficulties	difficulty	NOUN
ajlm-1458	131	3	faced	face	VERB
ajlm-1458	131	4	in	in	ADP
ajlm-1458	131	5	our	our	PRON
ajlm-1458	131	6	centre	centre	NOUN
ajlm-1458	131	7	are	be	AUX
ajlm-1458	131	8	not	not	PART
ajlm-1458	131	9	unique	unique	ADJ
ajlm-1458	131	10	though	though	ADV
ajlm-1458	131	11	.	.	PUNCT
ajlm-1458	132	1	flow	flow	VERB
ajlm-1458	132	2	cytometry	cytometry	NOUN
ajlm-1458	132	3	outcomes	outcome	NOUN
ajlm-1458	132	4	vary	vary	VERB
ajlm-1458	132	5	even	even	ADV
ajlm-1458	132	6	in	in	ADP
ajlm-1458	132	7	far	far	ADV
ajlm-1458	132	8	better	well	ADV
ajlm-1458	132	9	-	-	PUNCT
ajlm-1458	132	10	resourced	resource	VERB
ajlm-1458	132	11	sites.25	sites.25	NOUN
ajlm-1458	132	12	despite	despite	SCONJ
ajlm-1458	132	13	that	that	DET
ajlm-1458	132	14	testing	testing	NOUN
ajlm-1458	132	15	is	be	AUX
ajlm-1458	132	16	undertaken	undertake	VERB
ajlm-1458	132	17	by	by	ADP
ajlm-1458	132	18	dedicated	dedicated	ADJ
ajlm-1458	132	19	and	and	CCONJ
ajlm-1458	132	20	trained	train	VERB
ajlm-1458	132	21	flow	flow	NOUN
ajlm-1458	132	22	cytometry	cytometry	NOUN
ajlm-1458	132	23	laboratory	laboratory	NOUN
ajlm-1458	132	24	personnel	personnel	NOUN
ajlm-1458	132	25	or	or	CCONJ
ajlm-1458	132	26	that	that	SCONJ
ajlm-1458	132	27	there	there	PRON
ajlm-1458	132	28	is	be	VERB
ajlm-1458	132	29	prescribed	prescribed	ADJ
ajlm-1458	132	30	standardisation	standardisation	NOUN
ajlm-1458	132	31	of	of	ADP
ajlm-1458	132	32	multicolour	multicolour	ADJ
ajlm-1458	132	33	methods	method	NOUN
ajlm-1458	132	34	,	,	PUNCT
ajlm-1458	132	35	deviation	deviation	NOUN
ajlm-1458	132	36	from	from	ADP
ajlm-1458	132	37	standardised	standardised	ADJ
ajlm-1458	132	38	protocols	protocol	NOUN
ajlm-1458	132	39	for	for	ADP
ajlm-1458	132	40	instrument	instrument	NOUN
ajlm-1458	132	41	setup	setup	NOUN
ajlm-1458	132	42	and	and	CCONJ
ajlm-1458	132	43	colour	colour	NOUN
ajlm-1458	132	44	compensation,25,42	compensation,25,42	NOUN
ajlm-1458	132	45	as	as	ADV
ajlm-1458	132	46	well	well	ADV
ajlm-1458	132	47	as	as	ADP
ajlm-1458	132	48	differences	difference	NOUN
ajlm-1458	132	49	in	in	ADP
ajlm-1458	132	50	sample	sample	NOUN
ajlm-1458	132	51	preparation	preparation	NOUN
ajlm-1458	132	52	,	,	PUNCT
ajlm-1458	132	53	gating	gate	VERB
ajlm-1458	132	54	strategies	strategy	NOUN
ajlm-1458	132	55	and	and	CCONJ
ajlm-1458	132	56	data	datum	NOUN
ajlm-1458	132	57	interpretation	interpretation	NOUN
ajlm-1458	132	58	,	,	PUNCT
ajlm-1458	132	59	are	be	AUX
ajlm-1458	132	60	reported.25	reported.25	NOUN
ajlm-1458	132	61	the	the	DET
ajlm-1458	132	62	clearllab	clearllab	NOUN
ajlm-1458	132	63	10c	10c	NOUN
ajlm-1458	132	64	system	system	NOUN
ajlm-1458	132	65	can	can	AUX
ajlm-1458	132	66	enable	enable	VERB
ajlm-1458	132	67	our	our	PRON
ajlm-1458	132	68	centre	centre	NOUN
ajlm-1458	132	69	to	to	PART
ajlm-1458	132	70	overcome	overcome	VERB
ajlm-1458	132	71	such	such	ADJ
ajlm-1458	132	72	challenges	challenge	NOUN
ajlm-1458	132	73	as	as	SCONJ
ajlm-1458	132	74	it	it	PRON
ajlm-1458	132	75	is	be	AUX
ajlm-1458	132	76	implemented	implement	VERB
ajlm-1458	132	77	with	with	ADP
ajlm-1458	132	78	standardised	standardised	ADJ
ajlm-1458	132	79	flow	flow	NOUN
ajlm-1458	132	80	cytometer	cytometer	NOUN
ajlm-1458	132	81	multicolour	multicolour	PROPN
ajlm-1458	132	82	instrument	instrument	NOUN
ajlm-1458	132	83	setup	setup	NOUN
ajlm-1458	132	84	and	and	CCONJ
ajlm-1458	132	85	daily	daily	ADJ
ajlm-1458	132	86	prescribed	prescribe	VERB
ajlm-1458	132	87	quality	quality	NOUN
ajlm-1458	132	88	control	control	NOUN
ajlm-1458	132	89	,	,	PUNCT
ajlm-1458	132	90	effectively	effectively	ADV
ajlm-1458	132	91	providing	provide	VERB
ajlm-1458	132	92	predetermined	predetermine	VERB
ajlm-1458	132	93	,	,	PUNCT
ajlm-1458	132	94	user	user	NOUN
ajlm-1458	132	95	-	-	PUNCT
ajlm-1458	132	96	independent	independent	ADJ
ajlm-1458	132	97	operation	operation	NOUN
ajlm-1458	132	98	in	in	ADP
ajlm-1458	132	99	the	the	DET
ajlm-1458	132	100	navios	navio	NOUN
ajlm-1458	132	101	flow	flow	NOUN
ajlm-1458	132	102	cytometers	cytometer	NOUN
ajlm-1458	132	103	.	.	PUNCT
ajlm-1458	133	1	the	the	DET
ajlm-1458	133	2	capability	capability	NOUN
ajlm-1458	133	3	for	for	ADP
ajlm-1458	133	4	standardised	standardised	ADJ
ajlm-1458	133	5	kaluza	kaluza	NOUN
ajlm-1458	133	6	c	c	X
ajlm-1458	133	7	™	™	X
ajlm-1458	133	8	hierarchical	hierarchical	ADJ
ajlm-1458	133	9	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	133	10	analysis	analysis	NOUN
ajlm-1458	133	11	of	of	ADP
ajlm-1458	133	12	four	four	NUM
ajlm-1458	133	13	fixed	fix	VERB
ajlm-1458	133	14	tubes	tube	NOUN
ajlm-1458	133	15	can	can	AUX
ajlm-1458	133	16	also	also	ADV
ajlm-1458	133	17	harmonise	harmonise	VERB
ajlm-1458	133	18	consistent	consistent	ADJ
ajlm-1458	133	19	gating	gating	NOUN
ajlm-1458	133	20	approaches	approach	NOUN
ajlm-1458	133	21	and	and	CCONJ
ajlm-1458	133	22	reporting	reporting	NOUN
ajlm-1458	133	23	strategies	strategy	NOUN
ajlm-1458	133	24	between	between	ADP
ajlm-1458	133	25	reporting	report	VERB
ajlm-1458	133	26	pathologists	pathologist	NOUN
ajlm-1458	133	27	,	,	PUNCT
ajlm-1458	133	28	which	which	PRON
ajlm-1458	133	29	is	be	AUX
ajlm-1458	133	30	especially	especially	ADV
ajlm-1458	133	31	important	important	ADJ
ajlm-1458	133	32	for	for	ADP
ajlm-1458	133	33	standardised	standardised	ADJ
ajlm-1458	133	34	disease	disease	NOUN
ajlm-1458	133	35	interpretation	interpretation	NOUN
ajlm-1458	133	36	.	.	PUNCT
ajlm-1458	134	1	commercial	commercial	ADJ
ajlm-1458	134	2	lyophilised	lyophilise	VERB
ajlm-1458	134	3	panels	panel	NOUN
ajlm-1458	134	4	,	,	PUNCT
ajlm-1458	134	5	like	like	ADP
ajlm-1458	134	6	the	the	DET
ajlm-1458	134	7	clearllab	clearllab	NOUN
ajlm-1458	134	8	10c	10c	NOUN
ajlm-1458	134	9	system	system	NOUN
ajlm-1458	134	10	evaluated	evaluate	VERB
ajlm-1458	134	11	in	in	ADP
ajlm-1458	134	12	this	this	DET
ajlm-1458	134	13	study	study	NOUN
ajlm-1458	134	14	,	,	PUNCT
ajlm-1458	134	15	are	be	AUX
ajlm-1458	134	16	also	also	ADV
ajlm-1458	134	17	expected	expect	VERB
ajlm-1458	134	18	to	to	PART
ajlm-1458	134	19	considerably	considerably	ADV
ajlm-1458	134	20	reduce	reduce	VERB
ajlm-1458	134	21	the	the	DET
ajlm-1458	134	22	technical	technical	ADJ
ajlm-1458	134	23	effort	effort	NOUN
ajlm-1458	134	24	and	and	CCONJ
ajlm-1458	134	25	time	time	NOUN
ajlm-1458	134	26	needed	need	VERB
ajlm-1458	134	27	for	for	ADP
ajlm-1458	134	28	sample	sample	NOUN
ajlm-1458	134	29	preparation	preparation	NOUN
ajlm-1458	134	30	and	and	CCONJ
ajlm-1458	134	31	analysis	analysis	NOUN
ajlm-1458	134	32	.	.	PUNCT
ajlm-1458	135	1	for	for	ADP
ajlm-1458	135	2	example	example	NOUN
ajlm-1458	135	3	,	,	PUNCT
ajlm-1458	135	4	the	the	DET
ajlm-1458	135	5	implementation	implementation	NOUN
ajlm-1458	135	6	of	of	ADP
ajlm-1458	135	7	clearllab	clearllab	NOUN
ajlm-1458	135	8	will	will	AUX
ajlm-1458	135	9	drastically	drastically	ADV
ajlm-1458	135	10	reduce	reduce	VERB
ajlm-1458	135	11	sample	sample	NOUN
ajlm-1458	135	12	preparation	preparation	NOUN
ajlm-1458	135	13	and	and	CCONJ
ajlm-1458	135	14	data	datum	NOUN
ajlm-1458	135	15	acquisition	acquisition	NOUN
ajlm-1458	135	16	time	time	NOUN
ajlm-1458	135	17	for	for	ADP
ajlm-1458	135	18	our	our	PRON
ajlm-1458	135	19	first	first	ADJ
ajlm-1458	135	20	-	-	PUNCT
ajlm-1458	135	21	line	line	NOUN
ajlm-1458	135	22	investigation	investigation	NOUN
ajlm-1458	135	23	of	of	ADP
ajlm-1458	135	24	patient	patient	ADJ
ajlm-1458	135	25	samples	sample	NOUN
ajlm-1458	135	26	and	and	CCONJ
ajlm-1458	135	27	reduce	reduce	VERB
ajlm-1458	135	28	the	the	DET
ajlm-1458	135	29	number	number	NOUN
ajlm-1458	135	30	of	of	ADP
ajlm-1458	135	31	(	(	PUNCT
ajlm-1458	135	32	variable	variable	ADJ
ajlm-1458	135	33	)	)	PUNCT
ajlm-1458	135	34	ldt	ldt	NOUN
ajlm-1458	135	35	monoclonal	monoclonal	NOUN
ajlm-1458	135	36	reagent	reagent	NOUN
ajlm-1458	135	37	panels	panel	NOUN
ajlm-1458	135	38	prepared	prepare	VERB
ajlm-1458	135	39	from	from	ADP
ajlm-1458	135	40	around	around	ADP
ajlm-1458	135	41	20	20	NUM
ajlm-1458	135	42	(	(	PUNCT
ajlm-1458	135	43	table	table	NOUN
ajlm-1458	135	44	1	1	NUM
ajlm-1458	135	45	)	)	PUNCT
ajlm-1458	135	46	to	to	ADP
ajlm-1458	135	47	just	just	ADV
ajlm-1458	135	48	four	four	NUM
ajlm-1458	135	49	standardised	standardised	ADJ
ajlm-1458	135	50	panels	panel	NOUN
ajlm-1458	135	51	(	(	PUNCT
ajlm-1458	135	52	see	see	VERB
ajlm-1458	135	53	table	table	NOUN
ajlm-1458	135	54	2	2	NUM
ajlm-1458	135	55	)	)	PUNCT
ajlm-1458	135	56	with	with	ADP
ajlm-1458	135	57	an	an	DET
ajlm-1458	135	58	estimated	estimate	VERB
ajlm-1458	135	59	reduction	reduction	NOUN
ajlm-1458	135	60	in	in	ADP
ajlm-1458	135	61	sample	sample	NOUN
ajlm-1458	135	62	preparation	preparation	NOUN
ajlm-1458	135	63	from	from	ADP
ajlm-1458	135	64	1.5	1.5	NUM
ajlm-1458	135	65	h	h	NOUN
ajlm-1458	135	66	to	to	ADP
ajlm-1458	135	67	~30	~30	X
ajlm-1458	135	68	min	min	NOUN
ajlm-1458	135	69	.	.	PROPN
ajlm-1458	135	70	a	a	DET
ajlm-1458	135	71	notable	notable	ADJ
ajlm-1458	135	72	advantage	advantage	NOUN
ajlm-1458	135	73	of	of	ADP
ajlm-1458	135	74	the	the	DET
ajlm-1458	135	75	clearllab	clearllab	NOUN
ajlm-1458	135	76	tubes	tube	NOUN
ajlm-1458	135	77	is	be	AUX
ajlm-1458	135	78	that	that	SCONJ
ajlm-1458	135	79	antibodies	antibody	NOUN
ajlm-1458	135	80	are	be	AUX
ajlm-1458	135	81	pre	pre	ADJ
ajlm-1458	135	82	-	-	ADJ
ajlm-1458	135	83	titrated	titrated	ADJ
ajlm-1458	135	84	so	so	SCONJ
ajlm-1458	135	85	that	that	SCONJ
ajlm-1458	135	86	no	no	DET
ajlm-1458	135	87	monoclonal	monoclonal	NOUN
ajlm-1458	135	88	reagents	reagent	NOUN
ajlm-1458	135	89	will	will	AUX
ajlm-1458	135	90	be	be	AUX
ajlm-1458	135	91	added	add	VERB
ajlm-1458	135	92	;	;	PUNCT
ajlm-1458	135	93	this	this	PRON
ajlm-1458	135	94	is	be	AUX
ajlm-1458	135	95	in	in	ADP
ajlm-1458	135	96	striking	strike	VERB
ajlm-1458	135	97	contrast	contrast	NOUN
ajlm-1458	135	98	to	to	ADP
ajlm-1458	135	99	our	our	PRON
ajlm-1458	135	100	previous	previous	ADJ
ajlm-1458	135	101	ldt	ldt	PROPN
ajlm-1458	135	102	practice	practice	NOUN
ajlm-1458	135	103	,	,	PUNCT
ajlm-1458	135	104	where	where	SCONJ
ajlm-1458	135	105	up	up	ADP
ajlm-1458	135	106	to	to	PART
ajlm-1458	135	107	40	40	NUM
ajlm-1458	135	108	or	or	CCONJ
ajlm-1458	135	109	more	more	ADJ
ajlm-1458	135	110	individual	individual	ADJ
ajlm-1458	135	111	monoclonals	monoclonal	NOUN
ajlm-1458	135	112	had	have	VERB
ajlm-1458	135	113	to	to	PART
ajlm-1458	135	114	be	be	AUX
ajlm-1458	135	115	pipetted	pipette	VERB
ajlm-1458	135	116	into	into	ADP
ajlm-1458	135	117	multiple	multiple	ADJ
ajlm-1458	135	118	tubes	tube	NOUN
ajlm-1458	135	119	,	,	PUNCT
ajlm-1458	135	120	in	in	ADP
ajlm-1458	135	121	varying	vary	VERB
ajlm-1458	135	122	combinations	combination	NOUN
ajlm-1458	135	123	with	with	ADP
ajlm-1458	135	124	the	the	DET
ajlm-1458	135	125	potential	potential	NOUN
ajlm-1458	135	126	of	of	ADP
ajlm-1458	135	127	multiple	multiple	ADJ
ajlm-1458	135	128	errors	error	NOUN
ajlm-1458	135	129	(	(	PUNCT
ajlm-1458	135	130	see	see	VERB
ajlm-1458	135	131	table	table	NOUN
ajlm-1458	135	132	1	1	NUM
ajlm-1458	135	133	)	)	PUNCT
ajlm-1458	135	134	.	.	PUNCT
ajlm-1458	136	1	our	our	PRON
ajlm-1458	136	2	previous	previous	ADJ
ajlm-1458	136	3	large	large	ADJ
ajlm-1458	136	4	inventory	inventory	NOUN
ajlm-1458	136	5	of	of	ADP
ajlm-1458	136	6	liquid	liquid	NOUN
ajlm-1458	136	7	-	-	PUNCT
ajlm-1458	136	8	reagent	reagent	NOUN
ajlm-1458	136	9	monoclonal	monoclonal	NOUN
ajlm-1458	136	10	antibodies	antibody	NOUN
ajlm-1458	136	11	also	also	ADV
ajlm-1458	136	12	required	require	VERB
ajlm-1458	136	13	considerable	considerable	ADJ
ajlm-1458	136	14	staff	staff	NOUN
ajlm-1458	136	15	time	time	NOUN
ajlm-1458	136	16	to	to	PART
ajlm-1458	136	17	manage	manage	VERB
ajlm-1458	136	18	procurement	procurement	NOUN
ajlm-1458	136	19	and	and	CCONJ
ajlm-1458	136	20	stock	stock	NOUN
ajlm-1458	136	21	-	-	PUNCT
ajlm-1458	136	22	taking	taking	NOUN
ajlm-1458	136	23	.	.	PUNCT
ajlm-1458	137	1	pre	pre	VERB
ajlm-1458	137	2	-	-	ADJ
ajlm-1458	137	3	dispensed	dispensed	ADJ
ajlm-1458	137	4	reagent	reagent	NOUN
ajlm-1458	137	5	obviates	obviate	VERB
ajlm-1458	137	6	the	the	DET
ajlm-1458	137	7	need	need	NOUN
ajlm-1458	137	8	for	for	ADP
ajlm-1458	137	9	time	time	NOUN
ajlm-1458	137	10	-	-	PUNCT
ajlm-1458	137	11	consuming	consume	VERB
ajlm-1458	137	12	flow	flow	NOUN
ajlm-1458	137	13	cytometric	cytometric	ADJ
ajlm-1458	137	14	titration	titration	NOUN
ajlm-1458	137	15	experiments	experiment	NOUN
ajlm-1458	137	16	as	as	ADV
ajlm-1458	137	17	well	well	ADV
ajlm-1458	137	18	.	.	PUNCT
ajlm-1458	138	1	limitations	limitation	NOUN
ajlm-1458	138	2	firstly	firstly	ADV
ajlm-1458	138	3	,	,	PUNCT
ajlm-1458	138	4	while	while	SCONJ
ajlm-1458	138	5	there	there	PRON
ajlm-1458	138	6	was	be	VERB
ajlm-1458	138	7	100	100	NUM
ajlm-1458	138	8	%	%	NOUN
ajlm-1458	138	9	concordance	concordance	NOUN
ajlm-1458	138	10	between	between	ADP
ajlm-1458	138	11	the	the	DET
ajlm-1458	138	12	ldt	ldt	PROPN
ajlm-1458	138	13	and	and	CCONJ
ajlm-1458	138	14	clearllab	clearllab	NOUN
ajlm-1458	138	15	outcomes	outcome	NOUN
ajlm-1458	138	16	,	,	PUNCT
ajlm-1458	138	17	only	only	ADV
ajlm-1458	138	18	101	101	NUM
ajlm-1458	138	19	case	case	NOUN
ajlm-1458	138	20	reviews	review	NOUN
ajlm-1458	138	21	were	be	AUX
ajlm-1458	138	22	included	include	VERB
ajlm-1458	138	23	.	.	PUNCT
ajlm-1458	139	1	secondly	secondly	ADV
ajlm-1458	139	2	,	,	PUNCT
ajlm-1458	139	3	although	although	SCONJ
ajlm-1458	139	4	the	the	DET
ajlm-1458	139	5	clearllab	clearllab	NOUN
ajlm-1458	139	6	instrument	instrument	NOUN
ajlm-1458	139	7	auto	auto	NOUN
ajlm-1458	139	8	-	-	PUNCT
ajlm-1458	139	9	setup	setup	NOUN
ajlm-1458	139	10	makes	make	VERB
ajlm-1458	139	11	managing	manage	VERB
ajlm-1458	139	12	daily	daily	ADJ
ajlm-1458	139	13	quality	quality	NOUN
ajlm-1458	139	14	control	control	NOUN
ajlm-1458	139	15	and	and	CCONJ
ajlm-1458	139	16	review	review	NOUN
ajlm-1458	139	17	of	of	ADP
ajlm-1458	139	18	complicated	complicated	ADJ
ajlm-1458	139	19	multicolour	multicolour	NOUN
ajlm-1458	139	20	analyses	analysis	NOUN
ajlm-1458	139	21	much	much	ADV
ajlm-1458	139	22	quicker	quick	ADJ
ajlm-1458	139	23	,	,	PUNCT
ajlm-1458	139	24	easier	easy	ADJ
ajlm-1458	139	25	and	and	CCONJ
ajlm-1458	139	26	standardised	standardised	ADJ
ajlm-1458	139	27	,	,	PUNCT
ajlm-1458	139	28	the	the	DET
ajlm-1458	139	29	auto	auto	NOUN
ajlm-1458	139	30	-	-	PUNCT
ajlm-1458	139	31	setup	setup	NOUN
ajlm-1458	139	32	itself	itself	PRON
ajlm-1458	139	33	still	still	ADV
ajlm-1458	139	34	requires	require	VERB
ajlm-1458	139	35	training	training	NOUN
ajlm-1458	139	36	of	of	ADP
ajlm-1458	139	37	operators	operator	NOUN
ajlm-1458	139	38	.	.	PUNCT
ajlm-1458	140	1	attending	attend	VERB
ajlm-1458	140	2	pathologists	pathologist	NOUN
ajlm-1458	140	3	also	also	ADV
ajlm-1458	140	4	need	need	VERB
ajlm-1458	140	5	training	training	NOUN
ajlm-1458	140	6	and	and	CCONJ
ajlm-1458	140	7	are	be	AUX
ajlm-1458	140	8	required	require	VERB
ajlm-1458	140	9	to	to	PART
ajlm-1458	140	10	familiarise	familiarise	VERB
ajlm-1458	140	11	themselves	themselves	PRON
ajlm-1458	140	12	with	with	ADP
ajlm-1458	140	13	kaluza	kaluza	PROPN
ajlm-1458	140	14	software	software	NOUN
ajlm-1458	140	15	and	and	CCONJ
ajlm-1458	140	16	patterns	pattern	NOUN
ajlm-1458	140	17	of	of	ADP
ajlm-1458	140	18	normal	normal	ADJ
ajlm-1458	140	19	and	and	CCONJ
ajlm-1458	140	20	aberrant	aberrant	ADJ
ajlm-1458	140	21	haematological	haematological	ADJ
ajlm-1458	140	22	population	population	NOUN
ajlm-1458	140	23	maturation	maturation	NOUN
ajlm-1458	140	24	.	.	PUNCT
ajlm-1458	141	1	thirdly	thirdly	ADV
ajlm-1458	141	2	,	,	PUNCT
ajlm-1458	141	3	the	the	DET
ajlm-1458	141	4	clearllab	clearllab	NOUN
ajlm-1458	141	5	10c	10c	NOUN
ajlm-1458	141	6	m1	m1	PROPN
ajlm-1458	141	7	,	,	PUNCT
ajlm-1458	141	8	m2	m2	PROPN
ajlm-1458	141	9	,	,	PUNCT
ajlm-1458	141	10	t	t	PROPN
ajlm-1458	141	11	and	and	CCONJ
ajlm-1458	141	12	b	b	X
ajlm-1458	141	13	-	-	PUNCT
ajlm-1458	141	14	cell	cell	NOUN
ajlm-1458	141	15	panels	panel	NOUN
ajlm-1458	141	16	allow	allow	VERB
ajlm-1458	141	17	for	for	ADP
ajlm-1458	141	18	reasonably	reasonably	ADV
ajlm-1458	141	19	extensive	extensive	ADJ
ajlm-1458	141	20	discovery	discovery	NOUN
ajlm-1458	141	21	of	of	ADP
ajlm-1458	141	22	most	most	ADJ
ajlm-1458	141	23	leukaemias	leukaemia	NOUN
ajlm-1458	141	24	,	,	PUNCT
ajlm-1458	141	25	but	but	CCONJ
ajlm-1458	141	26	there	there	PRON
ajlm-1458	141	27	are	be	VERB
ajlm-1458	141	28	currently	currently	ADV
ajlm-1458	141	29	no	no	DET
ajlm-1458	141	30	supplementary	supplementary	ADJ
ajlm-1458	141	31	‘	'	PUNCT
ajlm-1458	141	32	second	second	ADJ
ajlm-1458	141	33	-	-	PUNCT
ajlm-1458	141	34	line	line	NOUN
ajlm-1458	141	35	’	'	PUNCT
ajlm-1458	141	36	clearllab	clearllab	NOUN
ajlm-1458	141	37	investigative	investigative	ADJ
ajlm-1458	141	38	panels	panel	NOUN
ajlm-1458	141	39	available7,8	available7,8	PROPN
ajlm-1458	141	40	to	to	PART
ajlm-1458	141	41	discern	discern	ADJ
ajlm-1458	141	42	markers	marker	NOUN
ajlm-1458	141	43	needed	need	VERB
ajlm-1458	141	44	for	for	ADP
ajlm-1458	141	45	full	full	ADJ
ajlm-1458	141	46	diagnoses	diagnosis	NOUN
ajlm-1458	141	47	;	;	PUNCT
ajlm-1458	141	48	for	for	ADP
ajlm-1458	141	49	example	example	NOUN
ajlm-1458	141	50	,	,	PUNCT
ajlm-1458	141	51	cytoplasmic	cytoplasmic	ADJ
ajlm-1458	141	52	studies	study	NOUN
ajlm-1458	141	53	to	to	PART
ajlm-1458	141	54	discern	discern	VERB
ajlm-1458	141	55	myeloperoxidase	myeloperoxidase	NOUN
ajlm-1458	141	56	or	or	CCONJ
ajlm-1458	141	57	nuclear	nuclear	ADJ
ajlm-1458	141	58	terminal	terminal	NOUN
ajlm-1458	141	59	deoxynucleotidyl	deoxynucleotidyl	NOUN
ajlm-1458	141	60	transferase	transferase	NOUN
ajlm-1458	141	61	(	(	PUNCT
ajlm-1458	141	62	tdt	tdt	PROPN
ajlm-1458	141	63	)	)	PUNCT
ajlm-1458	141	64	expression	expression	NOUN
ajlm-1458	141	65	,	,	PUNCT
ajlm-1458	141	66	cd41	cd41	PROPN
ajlm-1458	141	67	,	,	PUNCT
ajlm-1458	141	68	cd42b	cd42b	NOUN
ajlm-1458	141	69	and	and	CCONJ
ajlm-1458	141	70	cd61	cd61	PROPN
ajlm-1458	141	71	for	for	ADP
ajlm-1458	141	72	platelet	platelet	NOUN
ajlm-1458	141	73	marker	marker	NOUN
ajlm-1458	141	74	investigation	investigation	NOUN
ajlm-1458	141	75	,	,	PUNCT
ajlm-1458	141	76	or	or	CCONJ
ajlm-1458	141	77	extended	extend	VERB
ajlm-1458	141	78	b	b	X
ajlm-1458	141	79	-	-	PUNCT
ajlm-1458	141	80	cell	cell	NOUN
ajlm-1458	141	81	lymphoproliferative	lymphoproliferative	ADJ
ajlm-1458	141	82	workup	workup	PROPN
ajlm-1458	141	83	,	,	PUNCT
ajlm-1458	141	84	including	include	VERB
ajlm-1458	141	85	amongst	amongst	ADP
ajlm-1458	141	86	others	other	NOUN
ajlm-1458	141	87	cd11c	cd11c	NOUN
ajlm-1458	141	88	,	,	PUNCT
ajlm-1458	141	89	cd23	cd23	PROPN
ajlm-1458	141	90	,	,	PUNCT
ajlm-1458	141	91	cd30	cd30	PROPN
ajlm-1458	141	92	,	,	PUNCT
ajlm-1458	141	93	cd43	cd43	PROPN
ajlm-1458	141	94	,	,	PUNCT
ajlm-1458	141	95	cd79b	cd79b	NOUN
ajlm-1458	141	96	and	and	CCONJ
ajlm-1458	141	97	cd123	cd123	PROPN
ajlm-1458	141	98	amongst	amongst	ADP
ajlm-1458	141	99	others	other	NOUN
ajlm-1458	141	100	,	,	PUNCT
ajlm-1458	141	101	is	be	AUX
ajlm-1458	141	102	still	still	ADV
ajlm-1458	141	103	performed	perform	VERB
ajlm-1458	141	104	in	in	ADP
ajlm-1458	141	105	our	our	PRON
ajlm-1458	141	106	laboratory	laboratory	NOUN
ajlm-1458	141	107	to	to	PART
ajlm-1458	141	108	enable	enable	VERB
ajlm-1458	141	109	the	the	DET
ajlm-1458	141	110	world	world	PROPN
ajlm-1458	141	111	health	health	NOUN
ajlm-1458	141	112	organization	organization	NOUN
ajlm-1458	141	113	classification	classification	NOUN
ajlm-1458	141	114	of	of	ADP
ajlm-1458	141	115	haematological	haematological	ADJ
ajlm-1458	141	116	disease	disease	NOUN
ajlm-1458	141	117	.	.	PUNCT
ajlm-1458	142	1	some	some	DET
ajlm-1458	142	2	commercially	commercially	ADV
ajlm-1458	142	3	produced	produce	VERB
ajlm-1458	142	4	,	,	PUNCT
ajlm-1458	142	5	pre	pre	ADJ
ajlm-1458	142	6	-	-	VERB
ajlm-1458	142	7	dispensed	dispensed	ADJ
ajlm-1458	142	8	,	,	PUNCT
ajlm-1458	142	9	fixed	fix	VERB
ajlm-1458	142	10	panels	panel	NOUN
ajlm-1458	142	11	marketed	market	VERB
ajlm-1458	142	12	for	for	ADP
ajlm-1458	142	13	in	in	ADP
ajlm-1458	142	14	vitro	vitro	X
ajlm-1458	142	15	rare	rare	ADJ
ajlm-1458	142	16	event	event	NOUN
ajlm-1458	142	17	use27,38,43,44,45,46,47,48	use27,38,43,44,45,46,47,48	NOUN
ajlm-1458	142	18	could	could	AUX
ajlm-1458	142	19	fill	fill	VERB
ajlm-1458	142	20	the	the	DET
ajlm-1458	142	21	gap	gap	NOUN
ajlm-1458	142	22	.	.	PUNCT
ajlm-1458	143	1	such	such	ADJ
ajlm-1458	143	2	products	product	NOUN
ajlm-1458	143	3	could	could	AUX
ajlm-1458	143	4	potentially	potentially	ADV
ajlm-1458	143	5	be	be	AUX
ajlm-1458	143	6	modified	modify	VERB
ajlm-1458	143	7	to	to	PART
ajlm-1458	143	8	extend	extend	VERB
ajlm-1458	143	9	the	the	DET
ajlm-1458	143	10	diagnostic	diagnostic	ADJ
ajlm-1458	143	11	repertoire	repertoire	NOUN
ajlm-1458	143	12	of	of	ADP
ajlm-1458	143	13	the	the	DET
ajlm-1458	143	14	clearllab	clearllab	NOUN
ajlm-1458	143	15	10c	10c	NOUN
ajlm-1458	143	16	and	and	CCONJ
ajlm-1458	143	17	provide	provide	VERB
ajlm-1458	143	18	for	for	ADP
ajlm-1458	143	19	multicolour	multicolour	ADJ
ajlm-1458	143	20	second	second	ADJ
ajlm-1458	143	21	-	-	PUNCT
ajlm-1458	143	22	line	line	NOUN
ajlm-1458	143	23	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	143	24	investigation	investigation	NOUN
ajlm-1458	143	25	,	,	PUNCT
ajlm-1458	143	26	especially	especially	ADV
ajlm-1458	143	27	for	for	ADP
ajlm-1458	143	28	b	b	NOUN
ajlm-1458	143	29	-	-	PUNCT
ajlm-1458	143	30	cell	cell	NOUN
ajlm-1458	143	31	lymphoproliferative	lymphoproliferative	ADJ
ajlm-1458	143	32	disorders	disorder	NOUN
ajlm-1458	143	33	and	and	CCONJ
ajlm-1458	143	34	plasma	plasma	NOUN
ajlm-1458	143	35	cell	cell	NOUN
ajlm-1458	143	36	dyscrasias	dyscrasia	NOUN
ajlm-1458	143	37	,	,	PUNCT
ajlm-1458	143	38	but	but	CCONJ
ajlm-1458	143	39	this	this	PRON
ajlm-1458	143	40	needs	need	VERB
ajlm-1458	143	41	further	further	ADJ
ajlm-1458	143	42	study	study	NOUN
ajlm-1458	143	43	.	.	PUNCT
ajlm-1458	144	1	conclusion	conclusion	NOUN
ajlm-1458	144	2	in	in	ADP
ajlm-1458	144	3	this	this	DET
ajlm-1458	144	4	study	study	NOUN
ajlm-1458	144	5	,	,	PUNCT
ajlm-1458	144	6	there	there	PRON
ajlm-1458	144	7	was	be	VERB
ajlm-1458	144	8	excellent	excellent	ADJ
ajlm-1458	144	9	concordance	concordance	NOUN
ajlm-1458	144	10	between	between	ADP
ajlm-1458	144	11	our	our	PRON
ajlm-1458	144	12	ldt	ldt	NOUN
ajlm-1458	144	13	and	and	CCONJ
ajlm-1458	144	14	the	the	DET
ajlm-1458	144	15	multicolour	multicolour	ADJ
ajlm-1458	144	16	bc	bc	PROPN
ajlm-1458	144	17	clearllab	clearllab	PROPN
ajlm-1458	144	18	10c	10c	NOUN
ajlm-1458	144	19	panels	panel	NOUN
ajlm-1458	144	20	,	,	PUNCT
ajlm-1458	144	21	with	with	ADP
ajlm-1458	144	22	100	100	NUM
ajlm-1458	144	23	%	%	NOUN
ajlm-1458	144	24	sensitivity	sensitivity	NOUN
ajlm-1458	144	25	and	and	CCONJ
ajlm-1458	144	26	specificity	specificity	NOUN
ajlm-1458	144	27	recorded	record	VERB
ajlm-1458	144	28	against	against	ADP
ajlm-1458	144	29	existing	exist	VERB
ajlm-1458	144	30	ldt	ldt	PROPN
ajlm-1458	144	31	methods	method	NOUN
ajlm-1458	144	32	.	.	PUNCT
ajlm-1458	145	1	there	there	PRON
ajlm-1458	145	2	was	be	VERB
ajlm-1458	145	3	also	also	ADV
ajlm-1458	145	4	excellent	excellent	ADJ
ajlm-1458	145	5	concordance	concordance	NOUN
ajlm-1458	145	6	of	of	ADP
ajlm-1458	145	7	clearllab	clearllab	NOUN
ajlm-1458	145	8	10c	10c	NOUN
ajlm-1458	145	9	reporting	report	VERB
ajlm-1458	145	10	to	to	ADP
ajlm-1458	145	11	documented	document	VERB
ajlm-1458	145	12	clinicopathological	clinicopathological	ADJ
ajlm-1458	145	13	outcomes	outcome	NOUN
ajlm-1458	145	14	.	.	PUNCT
ajlm-1458	146	1	the	the	DET
ajlm-1458	146	2	clearllab	clearllab	NOUN
ajlm-1458	146	3	10c	10c	NUM
ajlm-1458	146	4	panels	panel	NOUN
ajlm-1458	146	5	,	,	PUNCT
ajlm-1458	146	6	with	with	ADP
ajlm-1458	146	7	manufacturer	manufacturer	NOUN
ajlm-1458	146	8	-	-	PUNCT
ajlm-1458	146	9	standardised	standardise	VERB
ajlm-1458	146	10	setup	setup	NOUN
ajlm-1458	146	11	for	for	ADP
ajlm-1458	146	12	colour	colour	NOUN
ajlm-1458	146	13	compensation	compensation	NOUN
ajlm-1458	146	14	,	,	PUNCT
ajlm-1458	146	15	appropriate	appropriate	ADJ
ajlm-1458	146	16	quality	quality	NOUN
ajlm-1458	146	17	control	control	NOUN
ajlm-1458	146	18	and	and	CCONJ
ajlm-1458	146	19	data	datum	NOUN
ajlm-1458	146	20	acquisition	acquisition	NOUN
ajlm-1458	146	21	on	on	ADP
ajlm-1458	146	22	a	a	DET
ajlm-1458	146	23	navios	navio	NOUN
ajlm-1458	146	24	flow	flow	NOUN
ajlm-1458	146	25	cytometer	cytometer	NOUN
ajlm-1458	146	26	,	,	PUNCT
ajlm-1458	146	27	provides	provide	VERB
ajlm-1458	146	28	concise	concise	ADJ
ajlm-1458	146	29	and	and	CCONJ
ajlm-1458	146	30	comprehensive	comprehensive	ADJ
ajlm-1458	146	31	multi	multi	NOUN
ajlm-1458	146	32	-	-	ADJ
ajlm-1458	146	33	immunophenotyping	immunophenotype	VERB
ajlm-1458	146	34	for	for	ADP
ajlm-1458	146	35	typical	typical	ADJ
ajlm-1458	146	36	leukaemias	leukaemia	NOUN
ajlm-1458	146	37	and	and	CCONJ
ajlm-1458	146	38	lymphomas	lymphoma	NOUN
ajlm-1458	146	39	encountered	encounter	VERB
ajlm-1458	146	40	during	during	ADP
ajlm-1458	146	41	routine	routine	ADJ
ajlm-1458	146	42	service	service	NOUN
ajlm-1458	146	43	delivery	delivery	NOUN
ajlm-1458	146	44	while	while	SCONJ
ajlm-1458	146	45	substantially	substantially	ADV
ajlm-1458	146	46	simplifying	simplify	VERB
ajlm-1458	146	47	and	and	CCONJ
ajlm-1458	146	48	standardising	standardise	VERB
ajlm-1458	146	49	sample	sample	NOUN
ajlm-1458	146	50	preparation	preparation	NOUN
ajlm-1458	146	51	and	and	CCONJ
ajlm-1458	146	52	data	datum	NOUN
ajlm-1458	146	53	acquisition	acquisition	NOUN
ajlm-1458	146	54	.	.	PUNCT
ajlm-1458	147	1	acknowledgements	acknowledgement	NOUN
ajlm-1458	147	2	we	we	PRON
ajlm-1458	147	3	would	would	AUX
ajlm-1458	147	4	like	like	VERB
ajlm-1458	147	5	to	to	PART
ajlm-1458	147	6	thank	thank	VERB
ajlm-1458	147	7	the	the	DET
ajlm-1458	147	8	leukaemia	leukaemia	NOUN
ajlm-1458	147	9	immunophenotyping	immunophenotype	VERB
ajlm-1458	147	10	laboratory	laboratory	NOUN
ajlm-1458	147	11	staff	staff	NOUN
ajlm-1458	147	12	,	,	PUNCT
ajlm-1458	147	13	in	in	ADP
ajlm-1458	147	14	particular	particular	ADJ
ajlm-1458	147	15	mrs	mrs	PROPN
ajlm-1458	147	16	merriam	merriam	PROPN
ajlm-1458	147	17	machaba	machaba	PROPN
ajlm-1458	147	18	for	for	ADP
ajlm-1458	147	19	preparation	preparation	NOUN
ajlm-1458	147	20	of	of	ADP
ajlm-1458	147	21	samples	sample	NOUN
ajlm-1458	147	22	used	use	VERB
ajlm-1458	147	23	for	for	ADP
ajlm-1458	147	24	this	this	DET
ajlm-1458	147	25	evaluation	evaluation	NOUN
ajlm-1458	147	26	study	study	NOUN
ajlm-1458	147	27	.	.	PUNCT
ajlm-1458	148	1	competing	compete	VERB
ajlm-1458	148	2	interests	interest	NOUN
ajlm-1458	148	3	the	the	DET
ajlm-1458	148	4	authors	author	NOUN
ajlm-1458	148	5	declare	declare	VERB
ajlm-1458	148	6	they	they	PRON
ajlm-1458	148	7	have	have	VERB
ajlm-1458	148	8	no	no	DET
ajlm-1458	148	9	financial	financial	ADJ
ajlm-1458	148	10	or	or	CCONJ
ajlm-1458	148	11	personal	personal	ADJ
ajlm-1458	148	12	relationships	relationship	NOUN
ajlm-1458	148	13	that	that	PRON
ajlm-1458	148	14	may	may	AUX
ajlm-1458	148	15	have	have	AUX
ajlm-1458	148	16	inappropriately	inappropriately	ADV
ajlm-1458	148	17	influenced	influence	VERB
ajlm-1458	148	18	the	the	DET
ajlm-1458	148	19	writing	writing	NOUN
ajlm-1458	148	20	of	of	ADP
ajlm-1458	148	21	this	this	DET
ajlm-1458	148	22	article	article	NOUN
ajlm-1458	148	23	.	.	PUNCT
ajlm-1458	149	1	authors	author	NOUN
ajlm-1458	149	2	’	’	PART
ajlm-1458	149	3	contributions	contribution	NOUN
ajlm-1458	149	4	d.k.g	d.k.g	ADV
ajlm-1458	149	5	.	.	PUNCT
ajlm-1458	149	6	led	lead	VERB
ajlm-1458	149	7	the	the	DET
ajlm-1458	149	8	study	study	NOUN
ajlm-1458	149	9	and	and	CCONJ
ajlm-1458	149	10	compiled	compile	VERB
ajlm-1458	149	11	the	the	DET
ajlm-1458	149	12	article	article	NOUN
ajlm-1458	149	13	for	for	ADP
ajlm-1458	149	14	publication	publication	NOUN
ajlm-1458	149	15	.	.	PUNCT
ajlm-1458	150	1	l.s	l.s	NOUN
ajlm-1458	150	2	.	.	PROPN
ajlm-1458	151	1	and	and	CCONJ
ajlm-1458	151	2	m.p	m.p	PROPN
ajlm-1458	151	3	.	.	PROPN
ajlm-1458	151	4	analysed	analyse	VERB
ajlm-1458	151	5	the	the	DET
ajlm-1458	151	6	cases	case	NOUN
ajlm-1458	151	7	and	and	CCONJ
ajlm-1458	151	8	recorded	record	VERB
ajlm-1458	151	9	the	the	DET
ajlm-1458	151	10	data	datum	NOUN
ajlm-1458	151	11	for	for	ADP
ajlm-1458	151	12	analysis	analysis	NOUN
ajlm-1458	151	13	comparison	comparison	NOUN
ajlm-1458	151	14	.	.	PUNCT
ajlm-1458	152	1	d.k.g	d.k.g	ADJ
ajlm-1458	152	2	.	.	PUNCT
ajlm-1458	153	1	undertook	undertake	VERB
ajlm-1458	153	2	reporting	reporting	NOUN
ajlm-1458	153	3	of	of	ADP
ajlm-1458	153	4	the	the	DET
ajlm-1458	153	5	validation	validation	NOUN
ajlm-1458	153	6	outcome	outcome	NOUN
ajlm-1458	153	7	.	.	PUNCT
ajlm-1458	154	1	d.l	d.l	PROPN
ajlm-1458	154	2	.	.	PROPN
ajlm-1458	155	1	and	and	CCONJ
ajlm-1458	155	2	d.k.g	d.k.g	PROPN
ajlm-1458	155	3	.	.	PUNCT
ajlm-1458	156	1	oversaw	oversaw	PROPN
ajlm-1458	156	2	technical	technical	ADJ
ajlm-1458	156	3	aspects	aspect	NOUN
ajlm-1458	156	4	and	and	CCONJ
ajlm-1458	156	5	the	the	DET
ajlm-1458	156	6	setup	setup	NOUN
ajlm-1458	156	7	of	of	ADP
ajlm-1458	156	8	new	new	ADJ
ajlm-1458	156	9	protocols	protocol	NOUN
ajlm-1458	156	10	on	on	ADP
ajlm-1458	156	11	the	the	DET
ajlm-1458	156	12	flow	flow	NOUN
ajlm-1458	156	13	cytometer	cytometer	NOUN
ajlm-1458	156	14	.	.	PUNCT
ajlm-1458	157	1	all	all	DET
ajlm-1458	157	2	authors	author	NOUN
ajlm-1458	157	3	discussed	discuss	VERB
ajlm-1458	157	4	the	the	DET
ajlm-1458	157	5	study	study	NOUN
ajlm-1458	157	6	findings	finding	NOUN
ajlm-1458	157	7	.	.	PUNCT
ajlm-1458	158	1	d.k.g	d.k.g	PROPN
ajlm-1458	158	2	.	.	PROPN
ajlm-1458	159	1	wrote	write	VERB
ajlm-1458	159	2	and	and	CCONJ
ajlm-1458	159	3	finalised	finalise	VERB
ajlm-1458	159	4	the	the	DET
ajlm-1458	159	5	final	final	ADJ
ajlm-1458	159	6	draft	draft	NOUN
ajlm-1458	159	7	.	.	PUNCT
ajlm-1458	160	1	all	all	DET
ajlm-1458	160	2	authors	author	NOUN
ajlm-1458	160	3	reviewed	review	VERB
ajlm-1458	160	4	and	and	CCONJ
ajlm-1458	160	5	contributed	contribute	VERB
ajlm-1458	160	6	to	to	ADP
ajlm-1458	160	7	the	the	DET
ajlm-1458	160	8	final	final	ADJ
ajlm-1458	160	9	manuscript	manuscript	NOUN
ajlm-1458	160	10	.	.	PUNCT
ajlm-1458	161	1	sources	source	NOUN
ajlm-1458	161	2	of	of	ADP
ajlm-1458	161	3	support	support	NOUN
ajlm-1458	161	4	funding	funding	NOUN
ajlm-1458	161	5	for	for	ADP
ajlm-1458	161	6	this	this	DET
ajlm-1458	161	7	study	study	NOUN
ajlm-1458	161	8	was	be	AUX
ajlm-1458	161	9	made	make	VERB
ajlm-1458	161	10	possible	possible	ADJ
ajlm-1458	161	11	with	with	ADP
ajlm-1458	161	12	research	research	NOUN
ajlm-1458	161	13	incentive	incentive	NOUN
ajlm-1458	161	14	funds	fund	NOUN
ajlm-1458	161	15	accrued	accrue	VERB
ajlm-1458	161	16	to	to	PART
ajlm-1458	161	17	d.k.g	d.k.g	PROPN
ajlm-1458	161	18	.	.	PUNCT
ajlm-1458	161	19	,	,	PUNCT
ajlm-1458	161	20	awarded	award	VERB
ajlm-1458	161	21	to	to	ADP
ajlm-1458	161	22	her	she	PRON
ajlm-1458	161	23	by	by	ADP
ajlm-1458	161	24	the	the	DET
ajlm-1458	161	25	university	university	NOUN
ajlm-1458	161	26	of	of	ADP
ajlm-1458	161	27	the	the	DET
ajlm-1458	161	28	witwatersrand	witwatersrand	NOUN
ajlm-1458	161	29	.	.	PUNCT
ajlm-1458	162	1	data	datum	NOUN
ajlm-1458	162	2	availability	availability	NOUN
ajlm-1458	162	3	additional	additional	ADJ
ajlm-1458	162	4	data	datum	NOUN
ajlm-1458	162	5	not	not	PART
ajlm-1458	162	6	represented	represent	VERB
ajlm-1458	162	7	in	in	ADP
ajlm-1458	162	8	this	this	DET
ajlm-1458	162	9	article	article	NOUN
ajlm-1458	162	10	are	be	AUX
ajlm-1458	162	11	available	available	ADJ
ajlm-1458	162	12	from	from	ADP
ajlm-1458	162	13	the	the	DET
ajlm-1458	162	14	corresponding	corresponding	ADJ
ajlm-1458	162	15	author	author	NOUN
ajlm-1458	162	16	,	,	PUNCT
ajlm-1458	162	17	d.k.g	d.k.g	ADV
ajlm-1458	162	18	.	.	PUNCT
ajlm-1458	162	19	,	,	PUNCT
ajlm-1458	162	20	upon	upon	SCONJ
ajlm-1458	162	21	reasonable	reasonable	ADJ
ajlm-1458	162	22	request	request	NOUN
ajlm-1458	162	23	.	.	PUNCT
ajlm-1458	163	1	disclaimer	disclaimer	VERB
ajlm-1458	163	2	the	the	DET
ajlm-1458	163	3	views	view	NOUN
ajlm-1458	163	4	and	and	CCONJ
ajlm-1458	163	5	opinions	opinion	NOUN
ajlm-1458	163	6	expressed	express	VERB
ajlm-1458	163	7	in	in	ADP
ajlm-1458	163	8	this	this	DET
ajlm-1458	163	9	article	article	NOUN
ajlm-1458	163	10	are	be	AUX
ajlm-1458	163	11	those	those	PRON
ajlm-1458	163	12	of	of	ADP
ajlm-1458	163	13	the	the	DET
ajlm-1458	163	14	authors	author	NOUN
ajlm-1458	163	15	and	and	CCONJ
ajlm-1458	163	16	do	do	AUX
ajlm-1458	163	17	not	not	PART
ajlm-1458	163	18	necessarily	necessarily	ADV
ajlm-1458	163	19	reflect	reflect	VERB
ajlm-1458	163	20	the	the	DET
ajlm-1458	163	21	official	official	ADJ
ajlm-1458	163	22	policy	policy	NOUN
ajlm-1458	163	23	or	or	CCONJ
ajlm-1458	163	24	position	position	NOUN
ajlm-1458	163	25	of	of	ADP
ajlm-1458	163	26	any	any	DET
ajlm-1458	163	27	affiliated	affiliated	ADJ
ajlm-1458	163	28	agency	agency	NOUN
ajlm-1458	163	29	of	of	ADP
ajlm-1458	163	30	the	the	DET
ajlm-1458	163	31	authors	author	NOUN
ajlm-1458	163	32	.	.	PUNCT
ajlm-1458	164	1	references	reference	NOUN
ajlm-1458	164	2	digiuseppe	digiuseppe	PROPN
ajlm-1458	164	3	ja	ja	PROPN
ajlm-1458	164	4	,	,	PUNCT
ajlm-1458	164	5	wood	wood	PROPN
ajlm-1458	164	6	bl	bl	PROPN
ajlm-1458	164	7	.	.	PUNCT
ajlm-1458	165	1	applications	application	NOUN
ajlm-1458	165	2	of	of	ADP
ajlm-1458	165	3	flow	flow	NOUN
ajlm-1458	165	4	cytometric	cytometric	ADJ
ajlm-1458	165	5	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	165	6	in	in	ADP
ajlm-1458	165	7	the	the	DET
ajlm-1458	165	8	diagnosis	diagnosis	NOUN
ajlm-1458	165	9	and	and	CCONJ
ajlm-1458	165	10	posttreatment	posttreatment	NOUN
ajlm-1458	165	11	monitoring	monitoring	NOUN
ajlm-1458	165	12	of	of	ADP
ajlm-1458	165	13	b	b	PROPN
ajlm-1458	165	14	and	and	CCONJ
ajlm-1458	165	15	t	t	PROPN
ajlm-1458	165	16	lymphoblastic	lymphoblastic	ADJ
ajlm-1458	165	17	leukemia	leukemia	NOUN
ajlm-1458	165	18	/	/	SYM
ajlm-1458	165	19	lymphoma	lymphoma	NOUN
ajlm-1458	165	20	.	.	PUNCT
ajlm-1458	166	1	cytometry	cytometry	PROPN
ajlm-1458	166	2	b	b	PROPN
ajlm-1458	166	3	clin	clin	PROPN
ajlm-1458	166	4	cytom	cytom	NOUN
ajlm-1458	166	5	.	.	PUNCT
ajlm-1458	167	1	2019;96(4):256–265	2019;96(4):256–265	NUM
ajlm-1458	167	2	.	.	PUNCT
ajlm-1458	168	1	https://doi.org/10.1002/cyto.b.21833	https://doi.org/10.1002/cyto.b.21833	VERB
ajlm-1458	168	2	davis	davis	PROPN
ajlm-1458	168	3	bh	bh	PROPN
ajlm-1458	168	4	,	,	PUNCT
ajlm-1458	168	5	holden	holden	PROPN
ajlm-1458	168	6	jt	jt	PROPN
ajlm-1458	168	7	,	,	PUNCT
ajlm-1458	168	8	bene	bene	PROPN
ajlm-1458	168	9	mc	mc	PROPN
ajlm-1458	168	10	,	,	PUNCT
ajlm-1458	168	11	et	et	PROPN
ajlm-1458	168	12	al	al	PROPN
ajlm-1458	168	13	.	.	PROPN
ajlm-1458	168	14	2006	2006	NUM
ajlm-1458	168	15	bethesda	bethesda	PROPN
ajlm-1458	168	16	international	international	ADJ
ajlm-1458	168	17	consensus	consensus	NOUN
ajlm-1458	168	18	recommendations	recommendation	NOUN
ajlm-1458	168	19	on	on	ADP
ajlm-1458	168	20	the	the	DET
ajlm-1458	168	21	flow	flow	NOUN
ajlm-1458	168	22	cytometric	cytometric	ADJ
ajlm-1458	168	23	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	168	24	analysis	analysis	NOUN
ajlm-1458	168	25	of	of	ADP
ajlm-1458	168	26	hematolymphoid	hematolymphoid	ADJ
ajlm-1458	168	27	neoplasia	neoplasia	NOUN
ajlm-1458	168	28	:	:	PUNCT
ajlm-1458	168	29	medical	medical	ADJ
ajlm-1458	168	30	indications	indication	NOUN
ajlm-1458	168	31	.	.	PUNCT
ajlm-1458	169	1	cytometry	cytometry	PROPN
ajlm-1458	169	2	b	b	PROPN
ajlm-1458	169	3	clin	clin	PROPN
ajlm-1458	169	4	cytom	cytom	PROPN
ajlm-1458	169	5	.	.	PUNCT
ajlm-1458	170	1	2007;72	2007;72	NUM
ajlm-1458	170	2	suppl	suppl	ADJ
ajlm-1458	170	3	1	1	NUM
ajlm-1458	170	4	:	:	PUNCT
ajlm-1458	170	5	s5	s5	PROPN
ajlm-1458	170	6	–	–	PUNCT
ajlm-1458	170	7	s13	s13	NOUN
ajlm-1458	170	8	.	.	PUNCT
ajlm-1458	171	1	https://doi.org/10.1002/cyto.b.20365	https://doi.org/10.1002/cyto.b.20365	PRON
ajlm-1458	171	2	kussick	kussick	VERB
ajlm-1458	171	3	sj	sj	PROPN
ajlm-1458	171	4	,	,	PUNCT
ajlm-1458	171	5	fromm	fromm	PROPN
ajlm-1458	171	6	jr	jr	PROPN
ajlm-1458	171	7	,	,	PUNCT
ajlm-1458	171	8	rossini	rossini	PROPN
ajlm-1458	171	9	a	a	PROPN
ajlm-1458	171	10	,	,	PUNCT
ajlm-1458	171	11	et	et	PROPN
ajlm-1458	171	12	al	al	PROPN
ajlm-1458	171	13	.	.	PROPN
ajlm-1458	171	14	four	four	NUM
ajlm-1458	171	15	-	-	PUNCT
ajlm-1458	171	16	color	color	NOUN
ajlm-1458	171	17	flow	flow	NOUN
ajlm-1458	171	18	cytometry	cytometry	NOUN
ajlm-1458	171	19	shows	show	VERB
ajlm-1458	171	20	strong	strong	ADJ
ajlm-1458	171	21	concordance	concordance	NOUN
ajlm-1458	171	22	with	with	ADP
ajlm-1458	171	23	bone	bone	NOUN
ajlm-1458	171	24	marrow	marrow	NOUN
ajlm-1458	171	25	morphology	morphology	NOUN
ajlm-1458	171	26	and	and	CCONJ
ajlm-1458	171	27	cytogenetics	cytogenetic	NOUN
ajlm-1458	171	28	in	in	ADP
ajlm-1458	171	29	the	the	DET
ajlm-1458	171	30	evaluation	evaluation	NOUN
ajlm-1458	171	31	for	for	ADP
ajlm-1458	171	32	myelodysplasia	myelodysplasia	PROPN
ajlm-1458	171	33	.	.	PUNCT
ajlm-1458	172	1	am	be	AUX
ajlm-1458	172	2	j	j	PROPN
ajlm-1458	172	3	clin	clin	PROPN
ajlm-1458	172	4	pathol	pathol	NOUN
ajlm-1458	172	5	.	.	PUNCT
ajlm-1458	173	1	2005;124(2):170–181	2005;124(2):170–181	NUM
ajlm-1458	173	2	.	.	PUNCT
ajlm-1458	174	1	https://doi.org/10.1309/6pbp78g4fba1fdg6	https://doi.org/10.1309/6pbp78g4fba1fdg6	SCONJ
ajlm-1458	174	2	wood	wood	NOUN
ajlm-1458	174	3	bl	bl	PROPN
ajlm-1458	174	4	.	.	PUNCT
ajlm-1458	174	5	flow	flow	VERB
ajlm-1458	174	6	cytometric	cytometric	ADJ
ajlm-1458	174	7	diagnosis	diagnosis	NOUN
ajlm-1458	174	8	of	of	ADP
ajlm-1458	174	9	myelodysplasia	myelodysplasia	NOUN
ajlm-1458	174	10	and	and	CCONJ
ajlm-1458	174	11	myeloproliferative	myeloproliferative	ADJ
ajlm-1458	174	12	disorders	disorder	NOUN
ajlm-1458	174	13	.	.	PUNCT
ajlm-1458	175	1	j	j	PROPN
ajlm-1458	175	2	biol	biol	PROPN
ajlm-1458	175	3	regul	regul	PROPN
ajlm-1458	175	4	homeost	homeost	ADJ
ajlm-1458	175	5	agents	agent	NOUN
ajlm-1458	175	6	.	.	PUNCT
ajlm-1458	176	1	2004;18(2):141–145	2004;18(2):141–145	X
ajlm-1458	176	2	.	.	PUNCT
ajlm-1458	176	3	kussick	kussick	PROPN
ajlm-1458	176	4	sj	sj	PROPN
ajlm-1458	176	5	,	,	PUNCT
ajlm-1458	176	6	wood	wood	PROPN
ajlm-1458	176	7	bl	bl	PROPN
ajlm-1458	176	8	.	.	PUNCT
ajlm-1458	177	1	using	use	VERB
ajlm-1458	177	2	4	4	NUM
ajlm-1458	177	3	-	-	PUNCT
ajlm-1458	177	4	colour	colour	NOUN
ajlm-1458	177	5	flow	flow	NOUN
ajlm-1458	177	6	cytometry	cytometry	NOUN
ajlm-1458	177	7	to	to	PART
ajlm-1458	177	8	identify	identify	VERB
ajlm-1458	177	9	abnormal	abnormal	ADJ
ajlm-1458	177	10	myeloid	myeloid	NOUN
ajlm-1458	177	11	populations	population	NOUN
ajlm-1458	177	12	.	.	PUNCT
ajlm-1458	178	1	arch	arch	ADJ
ajlm-1458	178	2	pathol	pathol	NOUN
ajlm-1458	178	3	lab	lab	NOUN
ajlm-1458	178	4	med	me	VERB
ajlm-1458	178	5	.	.	PUNCT
ajlm-1458	179	1	2003;127(9):1140–1147	2003;127(9):1140–1147	NUM
ajlm-1458	179	2	.	.	PUNCT
ajlm-1458	180	1	https://doi.org/10.5858/2003-127-1140-ucfcti	https://doi.org/10.5858/2003-127-1140-ucfcti	ADJ
ajlm-1458	180	2	davis	davis	PROPN
ajlm-1458	180	3	bh	bh	PROPN
ajlm-1458	180	4	,	,	PUNCT
ajlm-1458	180	5	foucar	foucar	NOUN
ajlm-1458	180	6	k	k	PROPN
ajlm-1458	180	7	,	,	PUNCT
ajlm-1458	180	8	szczarkowski	szczarkowski	NOUN
ajlm-1458	180	9	w	w	PROPN
ajlm-1458	180	10	,	,	PUNCT
ajlm-1458	180	11	et	et	PROPN
ajlm-1458	180	12	al	al	PROPN
ajlm-1458	180	13	.	.	PROPN
ajlm-1458	180	14	u.s.-canadian	u.s.-canadian	PROPN
ajlm-1458	180	15	consensus	consensus	NOUN
ajlm-1458	180	16	recommendations	recommendation	NOUN
ajlm-1458	180	17	on	on	ADP
ajlm-1458	180	18	the	the	DET
ajlm-1458	180	19	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	180	20	analysis	analysis	NOUN
ajlm-1458	180	21	of	of	ADP
ajlm-1458	180	22	hematologic	hematologic	NOUN
ajlm-1458	180	23	neoplasia	neoplasia	NOUN
ajlm-1458	180	24	by	by	ADP
ajlm-1458	180	25	flow	flow	NOUN
ajlm-1458	180	26	cytometry	cytometry	NOUN
ajlm-1458	180	27	:	:	PUNCT
ajlm-1458	180	28	medical	medical	ADJ
ajlm-1458	180	29	indications	indication	NOUN
ajlm-1458	180	30	.	.	PUNCT
ajlm-1458	181	1	cytometry	cytometry	NOUN
ajlm-1458	181	2	.	.	PUNCT
ajlm-1458	182	1	1997;30(5):249–263	1997;30(5):249–263	NUM
ajlm-1458	182	2	.	.	PUNCT
ajlm-1458	183	1	https://doi.org/10.1002/(sici)1097-0320(19971015)30:5<249::aid-cyto6>3.0.co;2-c	https://doi.org/10.1002/(sici)1097-0320(19971015)30:5<249::aid-cyto6>3.0.co;2-c	PROPN
ajlm-1458	183	2	arber	arber	PROPN
ajlm-1458	183	3	da	da	PROPN
ajlm-1458	183	4	,	,	PUNCT
ajlm-1458	183	5	orazi	orazi	X
ajlm-1458	183	6	a	a	PRON
ajlm-1458	183	7	,	,	PUNCT
ajlm-1458	183	8	hasserjian	hasserjian	ADJ
ajlm-1458	183	9	r	r	NOUN
ajlm-1458	183	10	,	,	PUNCT
ajlm-1458	183	11	et	et	PROPN
ajlm-1458	183	12	al	al	PROPN
ajlm-1458	183	13	.	.	PUNCT
ajlm-1458	184	1	the	the	DET
ajlm-1458	184	2	2016	2016	NUM
ajlm-1458	184	3	revision	revision	NOUN
ajlm-1458	184	4	to	to	ADP
ajlm-1458	184	5	the	the	DET
ajlm-1458	184	6	world	world	PROPN
ajlm-1458	184	7	health	health	PROPN
ajlm-1458	184	8	organization	organization	PROPN
ajlm-1458	184	9	classification	classification	NOUN
ajlm-1458	184	10	of	of	ADP
ajlm-1458	184	11	myeloid	myeloid	ADJ
ajlm-1458	184	12	neoplasms	neoplasm	NOUN
ajlm-1458	184	13	and	and	CCONJ
ajlm-1458	184	14	acute	acute	ADJ
ajlm-1458	184	15	leukemia	leukemia	NOUN
ajlm-1458	184	16	.	.	PUNCT
ajlm-1458	185	1	blood	blood	NOUN
ajlm-1458	185	2	.	.	PUNCT
ajlm-1458	186	1	2016;127(20):2391–2405	2016;127(20):2391–2405	NUM
ajlm-1458	186	2	.	.	PUNCT
ajlm-1458	187	1	https://doi.org/10.1182/blood-2016-03-643544	https://doi.org/10.1182/blood-2016-03-643544	PROPN
ajlm-1458	187	2	campo	campo	PROPN
ajlm-1458	187	3	e	e	PROPN
ajlm-1458	187	4	,	,	PUNCT
ajlm-1458	187	5	harris	harris	PROPN
ajlm-1458	187	6	nl	nl	PROPN
ajlm-1458	187	7	,	,	PUNCT
ajlm-1458	187	8	jaffe	jaffe	PROPN
ajlm-1458	187	9	es	es	PROPN
ajlm-1458	187	10	,	,	PUNCT
ajlm-1458	187	11	et	et	PROPN
ajlm-1458	187	12	al	al	PROPN
ajlm-1458	187	13	.	.	PROPN
ajlm-1458	187	14	world	world	PROPN
ajlm-1458	187	15	health	health	PROPN
ajlm-1458	187	16	organization	organization	PROPN
ajlm-1458	187	17	classification	classification	NOUN
ajlm-1458	187	18	of	of	ADP
ajlm-1458	187	19	tumours	tumour	NOUN
ajlm-1458	187	20	of	of	ADP
ajlm-1458	187	21	haematopoietic	haematopoietic	ADJ
ajlm-1458	187	22	and	and	CCONJ
ajlm-1458	187	23	lymphoid	lymphoid	ADJ
ajlm-1458	187	24	tissues	tissue	NOUN
ajlm-1458	187	25	(	(	PUNCT
ajlm-1458	187	26	medicine	medicine	NOUN
ajlm-1458	187	27	)	)	PUNCT
ajlm-1458	187	28	revised	revise	VERB
ajlm-1458	187	29	edition	edition	NOUN
ajlm-1458	187	30	.	.	PUNCT
ajlm-1458	188	1	geneva	geneva	PROPN
ajlm-1458	188	2	:	:	PUNCT
ajlm-1458	188	3	who	who	PRON
ajlm-1458	188	4	;	;	PUNCT
ajlm-1458	188	5	2017	2017	NUM
ajlm-1458	188	6	.	.	PUNCT
ajlm-1458	189	1	van	van	PROPN
ajlm-1458	189	2	dongen	dongen	PROPN
ajlm-1458	189	3	jj	jj	PROPN
ajlm-1458	189	4	,	,	PUNCT
ajlm-1458	189	5	lhermitte	lhermitte	PROPN
ajlm-1458	189	6	l	l	PROPN
ajlm-1458	189	7	,	,	PUNCT
ajlm-1458	189	8	bottcher	bottcher	PROPN
ajlm-1458	189	9	s	s	PROPN
ajlm-1458	189	10	,	,	PUNCT
ajlm-1458	189	11	et	et	PROPN
ajlm-1458	189	12	al	al	PROPN
ajlm-1458	189	13	.	.	PROPN
ajlm-1458	189	14	euroflow	euroflow	ADJ
ajlm-1458	189	15	antibody	antibody	NOUN
ajlm-1458	189	16	panels	panel	NOUN
ajlm-1458	189	17	for	for	ADP
ajlm-1458	189	18	standardised	standardised	ADJ
ajlm-1458	189	19	n	n	CCONJ
ajlm-1458	189	20	-	-	PUNCT
ajlm-1458	189	21	dimensional	dimensional	ADJ
ajlm-1458	189	22	flow	flow	NOUN
ajlm-1458	189	23	cytometric	cytometric	ADJ
ajlm-1458	189	24	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	189	25	of	of	ADP
ajlm-1458	189	26	normal	normal	ADJ
ajlm-1458	189	27	,	,	PUNCT
ajlm-1458	189	28	reactive	reactive	ADJ
ajlm-1458	189	29	and	and	CCONJ
ajlm-1458	189	30	malignant	malignant	ADJ
ajlm-1458	189	31	leukocytes	leukocyte	NOUN
ajlm-1458	189	32	.	.	PUNCT
ajlm-1458	190	1	leukemia	leukemia	NOUN
ajlm-1458	190	2	.	.	PUNCT
ajlm-1458	191	1	2012;26(9):1908–1975	2012;26(9):1908–1975	NUM
ajlm-1458	191	2	.	.	PUNCT
ajlm-1458	192	1	https://doi.org/10.1038/leu.2012.120	https://doi.org/10.1038/leu.2012.120	PROPN
ajlm-1458	192	2	lucio	lucio	PROPN
ajlm-1458	192	3	p	p	PROPN
ajlm-1458	192	4	,	,	PUNCT
ajlm-1458	192	5	gaipa	gaipa	PROPN
ajlm-1458	192	6	g	g	PROPN
ajlm-1458	192	7	,	,	PUNCT
ajlm-1458	192	8	van	van	PROPN
ajlm-1458	192	9	lochem	lochem	PROPN
ajlm-1458	192	10	eg	eg	PROPN
ajlm-1458	192	11	,	,	PUNCT
ajlm-1458	192	12	et	et	PROPN
ajlm-1458	192	13	al	al	PROPN
ajlm-1458	192	14	.	.	PROPN
ajlm-1458	192	15	biomed	biomed	PROPN
ajlm-1458	192	16	-	-	PUNCT
ajlm-1458	192	17	i	i	PRON
ajlm-1458	192	18	concerted	concert	VERB
ajlm-1458	192	19	action	action	NOUN
ajlm-1458	192	20	report	report	NOUN
ajlm-1458	192	21	:	:	PUNCT
ajlm-1458	192	22	flow	flow	VERB
ajlm-1458	192	23	cytometric	cytometric	ADJ
ajlm-1458	192	24	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	192	25	of	of	ADP
ajlm-1458	192	26	precursor	precursor	NOUN
ajlm-1458	192	27	b	b	NOUN
ajlm-1458	192	28	-	-	PUNCT
ajlm-1458	192	29	all	all	ADV
ajlm-1458	192	30	with	with	ADP
ajlm-1458	192	31	standardised	standardised	ADJ
ajlm-1458	192	32	triple	triple	ADJ
ajlm-1458	192	33	-	-	PUNCT
ajlm-1458	192	34	stainings	staining	NOUN
ajlm-1458	192	35	.	.	PUNCT
ajlm-1458	193	1	biomed-1	biomed-1	ADP
ajlm-1458	193	2	concerted	concerted	ADJ
ajlm-1458	193	3	action	action	NOUN
ajlm-1458	193	4	investigation	investigation	NOUN
ajlm-1458	193	5	of	of	ADP
ajlm-1458	193	6	minimal	minimal	ADJ
ajlm-1458	193	7	residual	residual	ADJ
ajlm-1458	193	8	disease	disease	NOUN
ajlm-1458	193	9	in	in	ADP
ajlm-1458	193	10	acute	acute	ADJ
ajlm-1458	193	11	leukemia	leukemia	NOUN
ajlm-1458	193	12	:	:	PUNCT
ajlm-1458	193	13	international	international	ADJ
ajlm-1458	193	14	standardization	standardization	NOUN
ajlm-1458	193	15	and	and	CCONJ
ajlm-1458	193	16	clinical	clinical	ADJ
ajlm-1458	193	17	evaluation	evaluation	NOUN
ajlm-1458	193	18	.	.	PUNCT
ajlm-1458	194	1	leukemia	leukemia	NOUN
ajlm-1458	194	2	.	.	PUNCT
ajlm-1458	195	1	2001;15(8):1185–1192	2001;15(8):1185–1192	NUM
ajlm-1458	195	2	.	.	PUNCT
ajlm-1458	196	1	https://doi.org/10.1038/sj.leu.2402150	https://doi.org/10.1038/sj.leu.2402150	PROPN
ajlm-1458	196	2	porwit	porwit	PROPN
ajlm-1458	196	3	-	-	PUNCT
ajlm-1458	196	4	macdonald	macdonald	PROPN
ajlm-1458	196	5	a	a	X
ajlm-1458	196	6	,	,	PUNCT
ajlm-1458	196	7	bjorklund	bjorklund	NOUN
ajlm-1458	196	8	e	e	NOUN
ajlm-1458	196	9	,	,	PUNCT
ajlm-1458	196	10	lucio	lucio	PROPN
ajlm-1458	196	11	p	p	PROPN
ajlm-1458	196	12	,	,	PUNCT
ajlm-1458	196	13	et	et	PROPN
ajlm-1458	196	14	al	al	PROPN
ajlm-1458	196	15	.	.	PUNCT
ajlm-1458	197	1	biomed-1	biomed-1	ADP
ajlm-1458	197	2	concerted	concerted	ADJ
ajlm-1458	197	3	action	action	NOUN
ajlm-1458	197	4	report	report	NOUN
ajlm-1458	197	5	:	:	PUNCT
ajlm-1458	197	6	flow	flow	VERB
ajlm-1458	197	7	cytometric	cytometric	ADJ
ajlm-1458	197	8	characterisation	characterisation	NOUN
ajlm-1458	197	9	of	of	ADP
ajlm-1458	197	10	cd7	cd7	PROPN
ajlm-1458	197	11	+	+	PROPN
ajlm-1458	197	12	cell	cell	NOUN
ajlm-1458	197	13	subsets	subset	NOUN
ajlm-1458	197	14	in	in	ADP
ajlm-1458	197	15	normal	normal	ADJ
ajlm-1458	197	16	bone	bone	NOUN
ajlm-1458	197	17	marrow	marrow	NOUN
ajlm-1458	197	18	as	as	ADP
ajlm-1458	197	19	a	a	DET
ajlm-1458	197	20	basis	basis	NOUN
ajlm-1458	197	21	for	for	ADP
ajlm-1458	197	22	the	the	DET
ajlm-1458	197	23	diagnosis	diagnosis	NOUN
ajlm-1458	197	24	and	and	CCONJ
ajlm-1458	197	25	follow	follow	VERB
ajlm-1458	197	26	-	-	PUNCT
ajlm-1458	197	27	up	up	NOUN
ajlm-1458	197	28	of	of	ADP
ajlm-1458	197	29	t	t	PROPN
ajlm-1458	197	30	cell	cell	NOUN
ajlm-1458	197	31	acute	acute	NOUN
ajlm-1458	197	32	lymphoblastic	lymphoblastic	ADJ
ajlm-1458	197	33	leukemia	leukemia	NOUN
ajlm-1458	197	34	(	(	PUNCT
ajlm-1458	197	35	t	t	NOUN
ajlm-1458	197	36	-	-	PUNCT
ajlm-1458	197	37	all	all	PRON
ajlm-1458	197	38	)	)	PUNCT
ajlm-1458	197	39	.	.	PUNCT
ajlm-1458	198	1	leukemia	leukemia	NOUN
ajlm-1458	198	2	.	.	PUNCT
ajlm-1458	199	1	2000;14(5):816–825	2000;14(5):816–825	X
ajlm-1458	199	2	.	.	PROPN
ajlm-1458	199	3	https://doi.org/10.1038/sj.leu.2401741	https://doi.org/10.1038/sj.leu.2401741	PROPN
ajlm-1458	199	4	borowitz	borowitz	PROPN
ajlm-1458	199	5	mj	mj	PROPN
ajlm-1458	199	6	,	,	PUNCT
ajlm-1458	199	7	wood	wood	PROPN
ajlm-1458	199	8	bl	bl	PROPN
ajlm-1458	199	9	,	,	PUNCT
ajlm-1458	199	10	devidas	devidas	PROPN
ajlm-1458	199	11	m	m	PRON
ajlm-1458	199	12	,	,	PUNCT
ajlm-1458	199	13	et	et	PROPN
ajlm-1458	199	14	al	al	PROPN
ajlm-1458	199	15	.	.	PUNCT
ajlm-1458	200	1	prognostic	prognostic	ADJ
ajlm-1458	200	2	significance	significance	NOUN
ajlm-1458	200	3	of	of	ADP
ajlm-1458	200	4	minimal	minimal	ADJ
ajlm-1458	200	5	residual	residual	ADJ
ajlm-1458	200	6	disease	disease	NOUN
ajlm-1458	200	7	in	in	ADP
ajlm-1458	200	8	high	high	ADJ
ajlm-1458	200	9	-	-	PUNCT
ajlm-1458	200	10	risk	risk	NOUN
ajlm-1458	200	11	b	b	NOUN
ajlm-1458	200	12	-	-	PUNCT
ajlm-1458	200	13	all	all	PRON
ajlm-1458	200	14	:	:	PUNCT
ajlm-1458	200	15	a	a	DET
ajlm-1458	200	16	report	report	NOUN
ajlm-1458	200	17	from	from	ADP
ajlm-1458	200	18	children	child	NOUN
ajlm-1458	200	19	’s	’s	PART
ajlm-1458	200	20	oncology	oncology	NOUN
ajlm-1458	200	21	group	group	PROPN
ajlm-1458	200	22	study	study	PROPN
ajlm-1458	200	23	aall0232	aall0232	PROPN
ajlm-1458	200	24	.	.	PUNCT
ajlm-1458	201	1	blood	blood	NOUN
ajlm-1458	201	2	.	.	PUNCT
ajlm-1458	202	1	2015;126(8):964–971	2015;126(8):964–971	NUM
ajlm-1458	202	2	.	.	PUNCT
ajlm-1458	202	3	https://doi.org/10.1182/blood-2015-03-633685	https://doi.org/10.1182/blood-2015-03-633685	PROPN
ajlm-1458	202	4	godwin	godwin	PROPN
ajlm-1458	202	5	cd	cd	PROPN
ajlm-1458	202	6	,	,	PUNCT
ajlm-1458	202	7	zhou	zhou	PROPN
ajlm-1458	202	8	y	y	PROPN
ajlm-1458	202	9	,	,	PUNCT
ajlm-1458	202	10	othus	othus	PROPN
ajlm-1458	202	11	m	m	PROPN
ajlm-1458	202	12	,	,	PUNCT
ajlm-1458	202	13	et	et	PROPN
ajlm-1458	202	14	al	al	PROPN
ajlm-1458	202	15	.	.	PROPN
ajlm-1458	202	16	acute	acute	PROPN
ajlm-1458	202	17	myeloid	myeloid	PROPN
ajlm-1458	202	18	leukemia	leukemia	PROPN
ajlm-1458	202	19	measurable	measurable	ADJ
ajlm-1458	202	20	residual	residual	ADJ
ajlm-1458	202	21	disease	disease	NOUN
ajlm-1458	202	22	detection	detection	NOUN
ajlm-1458	202	23	by	by	ADP
ajlm-1458	202	24	flow	flow	NOUN
ajlm-1458	202	25	cytometry	cytometry	NOUN
ajlm-1458	202	26	in	in	ADP
ajlm-1458	202	27	peripheral	peripheral	ADJ
ajlm-1458	202	28	blood	blood	NOUN
ajlm-1458	202	29	versus	versus	ADP
ajlm-1458	202	30	bone	bone	NOUN
ajlm-1458	202	31	marrow	marrow	NOUN
ajlm-1458	202	32	.	.	PUNCT
ajlm-1458	203	1	blood	blood	NOUN
ajlm-1458	203	2	.	.	PUNCT
ajlm-1458	204	1	2021;137(4):569–572	2021;137(4):569–572	X
ajlm-1458	204	2	.	.	PROPN
ajlm-1458	204	3	https://doi.org/10.1182/blood.2020006219	https://doi.org/10.1182/blood.2020006219	NOUN
ajlm-1458	204	4	theunissen	theunissen	VERB
ajlm-1458	204	5	p	p	X
ajlm-1458	204	6	,	,	PUNCT
ajlm-1458	204	7	mejstrikova	mejstrikova	PROPN
ajlm-1458	204	8	e	e	PROPN
ajlm-1458	204	9	,	,	PUNCT
ajlm-1458	204	10	sedek	sedek	NOUN
ajlm-1458	204	11	l	l	PROPN
ajlm-1458	204	12	,	,	PUNCT
ajlm-1458	205	1	et	et	PROPN
ajlm-1458	205	2	al	al	PROPN
ajlm-1458	205	3	.	.	PROPN
ajlm-1458	205	4	standardised	standardise	VERB
ajlm-1458	205	5	flow	flow	NOUN
ajlm-1458	205	6	cytometry	cytometry	NOUN
ajlm-1458	205	7	for	for	ADP
ajlm-1458	205	8	highly	highly	ADV
ajlm-1458	205	9	sensitive	sensitive	ADJ
ajlm-1458	205	10	mrd	mrd	ADJ
ajlm-1458	205	11	measurements	measurement	NOUN
ajlm-1458	205	12	in	in	ADP
ajlm-1458	205	13	b	b	NOUN
ajlm-1458	205	14	-	-	PUNCT
ajlm-1458	205	15	cell	cell	NOUN
ajlm-1458	205	16	acute	acute	ADJ
ajlm-1458	205	17	lymphoblastic	lymphoblastic	ADJ
ajlm-1458	205	18	leukemia	leukemia	NOUN
ajlm-1458	205	19	.	.	PUNCT
ajlm-1458	206	1	blood	blood	NOUN
ajlm-1458	206	2	.	.	PUNCT
ajlm-1458	207	1	2017;129(3):347–357	2017;129(3):347–357	X
ajlm-1458	207	2	.	.	PUNCT
ajlm-1458	207	3	https://doi.org/10.1182/blood-2016-07-726307	https://doi.org/10.1182/blood-2016-07-726307	NUM
ajlm-1458	207	4	wood	wood	PROPN
ajlm-1458	207	5	bl	bl	PROPN
ajlm-1458	207	6	.	.	PROPN
ajlm-1458	207	7	acute	acute	PROPN
ajlm-1458	207	8	myeloid	myeloid	PROPN
ajlm-1458	207	9	leukemia	leukemia	PROPN
ajlm-1458	207	10	minimal	minimal	ADJ
ajlm-1458	207	11	residual	residual	ADJ
ajlm-1458	207	12	disease	disease	NOUN
ajlm-1458	207	13	detection	detection	NOUN
ajlm-1458	207	14	:	:	PUNCT
ajlm-1458	207	15	the	the	DET
ajlm-1458	207	16	difference	difference	NOUN
ajlm-1458	207	17	from	from	ADP
ajlm-1458	207	18	normal	normal	ADJ
ajlm-1458	207	19	approach	approach	NOUN
ajlm-1458	207	20	.	.	PUNCT
ajlm-1458	208	1	curr	curr	PROPN
ajlm-1458	208	2	protoc	protoc	PROPN
ajlm-1458	208	3	cytom	cytom	PROPN
ajlm-1458	208	4	.	.	PUNCT
ajlm-1458	209	1	2020;93(1):e73	2020;93(1):e73	NUM
ajlm-1458	209	2	.	.	PUNCT
ajlm-1458	209	3	https://doi.org/10.1002/cpcy.73	https://doi.org/10.1002/cpcy.73	PROPN
ajlm-1458	209	4	brooimans	brooimans	PROPN
ajlm-1458	209	5	ra	ra	PROPN
ajlm-1458	209	6	,	,	PUNCT
ajlm-1458	209	7	van	van	PROPN
ajlm-1458	209	8	der	der	PROPN
ajlm-1458	209	9	velden	velden	PROPN
ajlm-1458	209	10	vhj	vhj	PROPN
ajlm-1458	209	11	,	,	PUNCT
ajlm-1458	209	12	boeckx	boeckx	NOUN
ajlm-1458	209	13	n	n	CCONJ
ajlm-1458	209	14	,	,	PUNCT
ajlm-1458	209	15	et	et	PROPN
ajlm-1458	209	16	al	al	PROPN
ajlm-1458	209	17	.	.	PUNCT
ajlm-1458	210	1	immunophenotypic	immunophenotypic	ADJ
ajlm-1458	210	2	measurable	measurable	ADJ
ajlm-1458	210	3	residual	residual	ADJ
ajlm-1458	210	4	disease	disease	NOUN
ajlm-1458	210	5	(	(	PUNCT
ajlm-1458	210	6	mrd	mrd	PROPN
ajlm-1458	210	7	)	)	PUNCT
ajlm-1458	210	8	in	in	ADP
ajlm-1458	210	9	acute	acute	ADJ
ajlm-1458	210	10	myeloid	myeloid	ADJ
ajlm-1458	210	11	leukemia	leukemia	NOUN
ajlm-1458	210	12	:	:	PUNCT
ajlm-1458	210	13	is	be	AUX
ajlm-1458	210	14	multicentric	multicentric	ADJ
ajlm-1458	210	15	mrd	mrd	ADJ
ajlm-1458	210	16	assessment	assessment	NOUN
ajlm-1458	210	17	feasible	feasible	ADJ
ajlm-1458	210	18	?	?	PUNCT
ajlm-1458	211	1	leuk	leuk	PROPN
ajlm-1458	211	2	res	re	NOUN
ajlm-1458	211	3	.	.	PUNCT
ajlm-1458	211	4	2019;76:39–47	2019;76:39–47	NUM
ajlm-1458	211	5	.	.	PUNCT
ajlm-1458	212	1	https://doi.org/10.1016/j.leukres.2018.11.014	https://doi.org/10.1016/j.leukres.2018.11.014	PROPN
ajlm-1458	212	2	keeney	keeney	PROPN
ajlm-1458	212	3	m	m	PROPN
ajlm-1458	212	4	,	,	PUNCT
ajlm-1458	212	5	barnett	barnett	PROPN
ajlm-1458	212	6	d	d	PROPN
ajlm-1458	212	7	,	,	PUNCT
ajlm-1458	212	8	gratama	gratama	PROPN
ajlm-1458	212	9	jw	jw	PROPN
ajlm-1458	212	10	.	.	PROPN
ajlm-1458	212	11	impact	impact	NOUN
ajlm-1458	212	12	of	of	ADP
ajlm-1458	212	13	standardisation	standardisation	NOUN
ajlm-1458	212	14	on	on	ADP
ajlm-1458	212	15	clinical	clinical	ADJ
ajlm-1458	212	16	cell	cell	NOUN
ajlm-1458	212	17	analysis	analysis	NOUN
ajlm-1458	212	18	by	by	ADP
ajlm-1458	212	19	flow	flow	NOUN
ajlm-1458	212	20	cytometry	cytometry	NOUN
ajlm-1458	212	21	.	.	PUNCT
ajlm-1458	213	1	j	j	PROPN
ajlm-1458	213	2	biol	biol	PROPN
ajlm-1458	213	3	regul	regul	PROPN
ajlm-1458	213	4	homeost	homeost	ADJ
ajlm-1458	213	5	agents	agent	NOUN
ajlm-1458	213	6	.	.	PUNCT
ajlm-1458	214	1	2004;18(3–4):305–312	2004;18(3–4):305–312	NUM
ajlm-1458	214	2	.	.	PUNCT
ajlm-1458	214	3	finak	finak	PROPN
ajlm-1458	214	4	g	g	NOUN
ajlm-1458	214	5	,	,	PUNCT
ajlm-1458	214	6	langweiler	langweiler	NOUN
ajlm-1458	214	7	m	m	PROPN
ajlm-1458	214	8	,	,	PUNCT
ajlm-1458	214	9	jaimes	jaimes	PROPN
ajlm-1458	214	10	m	m	PROPN
ajlm-1458	214	11	,	,	PUNCT
ajlm-1458	214	12	et	et	PROPN
ajlm-1458	214	13	al	al	PROPN
ajlm-1458	214	14	.	.	PUNCT
ajlm-1458	215	1	standardising	standardise	VERB
ajlm-1458	215	2	flow	flow	NOUN
ajlm-1458	215	3	cytometry	cytometry	NOUN
ajlm-1458	215	4	immunophenotyping	immunophenotype	VERB
ajlm-1458	215	5	analysis	analysis	NOUN
ajlm-1458	215	6	from	from	ADP
ajlm-1458	215	7	the	the	DET
ajlm-1458	215	8	human	human	ADJ
ajlm-1458	215	9	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	215	10	consortium	consortium	NOUN
ajlm-1458	215	11	.	.	PUNCT
ajlm-1458	216	1	sci	sci	PROPN
ajlm-1458	216	2	rep	rep	PROPN
ajlm-1458	216	3	.	.	PROPN
ajlm-1458	216	4	2016;6:20686	2016;6:20686	NUM
ajlm-1458	216	5	.	.	PUNCT
ajlm-1458	217	1	https://doi.org/10.1038/srep20686	https://doi.org/10.1038/srep20686	PROPN
ajlm-1458	217	2	novakova	novakova	PROPN
ajlm-1458	217	3	m	m	PROPN
ajlm-1458	217	4	,	,	PUNCT
ajlm-1458	217	5	glier	glier	ADJ
ajlm-1458	217	6	h	h	NOUN
ajlm-1458	217	7	,	,	PUNCT
ajlm-1458	217	8	brdickova	brdickova	PROPN
ajlm-1458	217	9	n	n	CCONJ
ajlm-1458	217	10	,	,	PUNCT
ajlm-1458	217	11	et	et	PROPN
ajlm-1458	217	12	al	al	PROPN
ajlm-1458	217	13	.	.	PUNCT
ajlm-1458	218	1	how	how	SCONJ
ajlm-1458	218	2	to	to	PART
ajlm-1458	218	3	make	make	VERB
ajlm-1458	218	4	usage	usage	NOUN
ajlm-1458	218	5	of	of	ADP
ajlm-1458	218	6	the	the	DET
ajlm-1458	218	7	standardised	standardised	ADJ
ajlm-1458	218	8	euroflow	euroflow	NOUN
ajlm-1458	218	9	8	8	NUM
ajlm-1458	218	10	-	-	PUNCT
ajlm-1458	218	11	colour	colour	NOUN
ajlm-1458	218	12	protocols	protocol	NOUN
ajlm-1458	218	13	possible	possible	ADJ
ajlm-1458	218	14	for	for	ADP
ajlm-1458	218	15	instruments	instrument	NOUN
ajlm-1458	218	16	of	of	ADP
ajlm-1458	218	17	different	different	ADJ
ajlm-1458	218	18	manufacturers	manufacturer	NOUN
ajlm-1458	218	19	.	.	PUNCT
ajlm-1458	219	1	j	j	PROPN
ajlm-1458	219	2	immunol	immunol	NOUN
ajlm-1458	219	3	methods	method	NOUN
ajlm-1458	219	4	.	.	PUNCT
ajlm-1458	220	1	2019;475:112388	2019;475:112388	X
ajlm-1458	220	2	.	.	PUNCT
ajlm-1458	221	1	https://doi.org/10.1016/j.jim.2017.11.007	https://doi.org/10.1016/j.jim.2017.11.007	PROPN
ajlm-1458	221	2	kalina	kalina	PROPN
ajlm-1458	221	3	t	t	PROPN
ajlm-1458	221	4	,	,	PUNCT
ajlm-1458	221	5	flores	flores	PROPN
ajlm-1458	221	6	-	-	PUNCT
ajlm-1458	221	7	montero	montero	PROPN
ajlm-1458	221	8	j	j	PROPN
ajlm-1458	221	9	,	,	PUNCT
ajlm-1458	221	10	van	van	PROPN
ajlm-1458	221	11	der	der	PROPN
ajlm-1458	221	12	velden	velden	PROPN
ajlm-1458	221	13	vh	vh	PROPN
ajlm-1458	221	14	,	,	PUNCT
ajlm-1458	221	15	et	et	PROPN
ajlm-1458	221	16	al	al	PROPN
ajlm-1458	221	17	.	.	PROPN
ajlm-1458	221	18	euroflow	euroflow	ADJ
ajlm-1458	221	19	standardisation	standardisation	NOUN
ajlm-1458	221	20	of	of	ADP
ajlm-1458	221	21	flow	flow	NOUN
ajlm-1458	221	22	cytometer	cytometer	NOUN
ajlm-1458	221	23	instrument	instrument	NOUN
ajlm-1458	221	24	settings	setting	NOUN
ajlm-1458	221	25	and	and	CCONJ
ajlm-1458	221	26	immunophenotyping	immunophenotype	VERB
ajlm-1458	221	27	protocols	protocol	NOUN
ajlm-1458	221	28	.	.	PUNCT
ajlm-1458	222	1	leukemia	leukemia	NOUN
ajlm-1458	222	2	.	.	PUNCT
ajlm-1458	223	1	2012;26(9):1986–2010	2012;26(9):1986–2010	NUM
ajlm-1458	223	2	.	.	PUNCT
ajlm-1458	224	1	https://doi.org/10.1038/leu.2012.122	https://doi.org/10.1038/leu.2012.122	PROPN
ajlm-1458	224	2	kalina	kalina	PROPN
ajlm-1458	224	3	t	t	PROPN
ajlm-1458	224	4	,	,	PUNCT
ajlm-1458	224	5	brdickova	brdickova	PROPN
ajlm-1458	224	6	n	n	CCONJ
ajlm-1458	224	7	,	,	PUNCT
ajlm-1458	224	8	glier	glier	ADJ
ajlm-1458	224	9	h	h	NOUN
ajlm-1458	224	10	,	,	PUNCT
ajlm-1458	224	11	et	et	PROPN
ajlm-1458	224	12	al	al	PROPN
ajlm-1458	224	13	.	.	PUNCT
ajlm-1458	224	14	frequent	frequent	ADJ
ajlm-1458	224	15	issues	issue	NOUN
ajlm-1458	224	16	and	and	CCONJ
ajlm-1458	224	17	lessons	lesson	NOUN
ajlm-1458	224	18	learned	learn	VERB
ajlm-1458	224	19	from	from	ADP
ajlm-1458	224	20	euroflow	euroflow	PROPN
ajlm-1458	224	21	qa	qa	PROPN
ajlm-1458	224	22	.	.	PUNCT
ajlm-1458	225	1	j	j	PROPN
ajlm-1458	225	2	immunol	immunol	NOUN
ajlm-1458	225	3	methods	method	NOUN
ajlm-1458	225	4	.	.	PUNCT
ajlm-1458	226	1	2019;475:112520	2019;475:112520	X
ajlm-1458	226	2	.	.	PUNCT
ajlm-1458	227	1	https://doi.org/10.1016/j.jim.2018.09.008	https://doi.org/10.1016/j.jim.2018.09.008	PROPN
ajlm-1458	227	2	wood	wood	PROPN
ajlm-1458	227	3	bl	bl	PROPN
ajlm-1458	227	4	.	.	PUNCT
ajlm-1458	228	1	principles	principle	NOUN
ajlm-1458	228	2	of	of	ADP
ajlm-1458	228	3	minimal	minimal	ADJ
ajlm-1458	228	4	residual	residual	ADJ
ajlm-1458	228	5	disease	disease	NOUN
ajlm-1458	228	6	detection	detection	NOUN
ajlm-1458	228	7	for	for	ADP
ajlm-1458	228	8	hematopoietic	hematopoietic	ADJ
ajlm-1458	228	9	neoplasms	neoplasm	NOUN
ajlm-1458	228	10	by	by	ADP
ajlm-1458	228	11	flow	flow	NOUN
ajlm-1458	228	12	cytometry	cytometry	NOUN
ajlm-1458	228	13	.	.	PUNCT
ajlm-1458	229	1	cytometry	cytometry	PROPN
ajlm-1458	229	2	b	b	PROPN
ajlm-1458	229	3	clin	clin	PROPN
ajlm-1458	229	4	cytom	cytom	PROPN
ajlm-1458	229	5	.	.	PUNCT
ajlm-1458	230	1	2016;90(1):47–53	2016;90(1):47–53	X
ajlm-1458	230	2	.	.	PUNCT
ajlm-1458	231	1	https://doi.org/10.1002/cyto.b.21239	https://doi.org/10.1002/cyto.b.21239	X
ajlm-1458	231	2	johansson	johansson	PROPN
ajlm-1458	231	3	u	u	PROPN
ajlm-1458	231	4	,	,	PUNCT
ajlm-1458	231	5	bloxham	bloxham	PROPN
ajlm-1458	231	6	d	d	PROPN
ajlm-1458	231	7	,	,	PUNCT
ajlm-1458	231	8	couzens	couzen	VERB
ajlm-1458	231	9	s	s	PART
ajlm-1458	231	10	,	,	PUNCT
ajlm-1458	231	11	et	et	PROPN
ajlm-1458	231	12	al	al	PROPN
ajlm-1458	231	13	.	.	PUNCT
ajlm-1458	232	1	guidelines	guideline	NOUN
ajlm-1458	232	2	on	on	ADP
ajlm-1458	232	3	the	the	DET
ajlm-1458	232	4	use	use	NOUN
ajlm-1458	232	5	of	of	ADP
ajlm-1458	232	6	multicolour	multicolour	ADJ
ajlm-1458	232	7	flow	flow	NOUN
ajlm-1458	232	8	cytometry	cytometry	NOUN
ajlm-1458	232	9	in	in	ADP
ajlm-1458	232	10	the	the	DET
ajlm-1458	232	11	diagnosis	diagnosis	NOUN
ajlm-1458	232	12	of	of	ADP
ajlm-1458	232	13	haematological	haematological	ADJ
ajlm-1458	232	14	neoplasms	neoplasm	NOUN
ajlm-1458	232	15	.	.	PUNCT
ajlm-1458	233	1	br	br	PROPN
ajlm-1458	233	2	j	j	PROPN
ajlm-1458	233	3	haematol	haematol	NOUN
ajlm-1458	233	4	.	.	PUNCT
ajlm-1458	234	1	2014;165(4):455–488	2014;165(4):455–488	NUM
ajlm-1458	234	2	.	.	PUNCT
ajlm-1458	234	3	https://doi.org/10.1111/bjh.12789	https://doi.org/10.1111/bjh.12789	NOUN
ajlm-1458	234	4	hedley	hedley	PROPN
ajlm-1458	234	5	bd	bd	PROPN
ajlm-1458	234	6	,	,	PUNCT
ajlm-1458	234	7	keeney	keeney	PROPN
ajlm-1458	234	8	m.	m.	PROPN
ajlm-1458	234	9	technical	technical	PROPN
ajlm-1458	234	10	issues	issue	NOUN
ajlm-1458	234	11	:	:	PUNCT
ajlm-1458	234	12	flow	flow	NOUN
ajlm-1458	234	13	cytometry	cytometry	NOUN
ajlm-1458	234	14	and	and	CCONJ
ajlm-1458	234	15	rare	rare	ADJ
ajlm-1458	234	16	event	event	NOUN
ajlm-1458	234	17	analysis	analysis	NOUN
ajlm-1458	234	18	.	.	PUNCT
ajlm-1458	235	1	int	int	NOUN
ajlm-1458	235	2	j	j	PROPN
ajlm-1458	235	3	lab	lab	NOUN
ajlm-1458	235	4	hematol	hematol	NOUN
ajlm-1458	235	5	.	.	PUNCT
ajlm-1458	236	1	2013;35(3):344–350	2013;35(3):344–350	NUM
ajlm-1458	236	2	.	.	PUNCT
ajlm-1458	237	1	https://doi.org/10.1111/ijlh.12068	https://doi.org/10.1111/ijlh.12068	PROPN
ajlm-1458	237	2	glier	glier	PROPN
ajlm-1458	237	3	h	h	NOUN
ajlm-1458	237	4	,	,	PUNCT
ajlm-1458	237	5	heijnen	heijnen	PROPN
ajlm-1458	237	6	i	i	PRON
ajlm-1458	237	7	,	,	PUNCT
ajlm-1458	237	8	hauwel	hauwel	PROPN
ajlm-1458	237	9	m	m	PROPN
ajlm-1458	237	10	,	,	PUNCT
ajlm-1458	237	11	et	et	PROPN
ajlm-1458	237	12	al	al	PROPN
ajlm-1458	237	13	.	.	PUNCT
ajlm-1458	237	14	standardisation	standardisation	NOUN
ajlm-1458	237	15	of	of	ADP
ajlm-1458	237	16	8	8	NUM
ajlm-1458	237	17	-	-	PUNCT
ajlm-1458	237	18	colour	colour	NOUN
ajlm-1458	237	19	flow	flow	NOUN
ajlm-1458	237	20	cytometry	cytometry	NOUN
ajlm-1458	237	21	across	across	ADP
ajlm-1458	237	22	different	different	ADJ
ajlm-1458	237	23	flow	flow	NOUN
ajlm-1458	237	24	cytometer	cytometer	NOUN
ajlm-1458	237	25	instruments	instrument	NOUN
ajlm-1458	237	26	:	:	PUNCT
ajlm-1458	237	27	a	a	DET
ajlm-1458	237	28	feasibility	feasibility	NOUN
ajlm-1458	237	29	study	study	NOUN
ajlm-1458	237	30	in	in	ADP
ajlm-1458	237	31	clinical	clinical	ADJ
ajlm-1458	237	32	laboratories	laboratory	NOUN
ajlm-1458	237	33	in	in	ADP
ajlm-1458	237	34	switzerland	switzerland	PROPN
ajlm-1458	237	35	.	.	PUNCT
ajlm-1458	238	1	j	j	PROPN
ajlm-1458	238	2	immunol	immunol	NOUN
ajlm-1458	238	3	methods	method	NOUN
ajlm-1458	238	4	.	.	PUNCT
ajlm-1458	239	1	2019;475:112348	2019;475:112348	NUM
ajlm-1458	239	2	.	.	PUNCT
ajlm-1458	240	1	https://doi.org/10.1016/j.jim.2017.07.013	https://doi.org/10.1016/j.jim.2017.07.013	PROPN
ajlm-1458	240	2	smallwood	smallwood	PROPN
ajlm-1458	240	3	c	c	PROPN
ajlm-1458	240	4	,	,	PUNCT
ajlm-1458	240	5	galama	galama	PROPN
ajlm-1458	240	6	l	l	NOUN
ajlm-1458	240	7	,	,	PUNCT
ajlm-1458	240	8	apoll	apoll	PROPN
ajlm-1458	240	9	l	l	PROPN
ajlm-1458	240	10	,	,	PUNCT
ajlm-1458	240	11	heinrich	heinrich	PROPN
ajlm-1458	240	12	k	k	PROPN
ajlm-1458	240	13	,	,	PUNCT
ajlm-1458	240	14	buchanan	buchanan	PROPN
ajlm-1458	240	15	s	s	PROPN
ajlm-1458	240	16	,	,	PUNCT
ajlm-1458	240	17	demers	demers	PROPN
ajlm-1458	240	18	j.	j.	PROPN
ajlm-1458	240	19	examining	examine	VERB
ajlm-1458	240	20	the	the	DET
ajlm-1458	240	21	economic	economic	ADJ
ajlm-1458	240	22	impact	impact	NOUN
ajlm-1458	240	23	of	of	ADP
ajlm-1458	240	24	laboratory	laboratory	NOUN
ajlm-1458	240	25	developed	develop	VERB
ajlm-1458	240	26	testing	testing	NOUN
ajlm-1458	240	27	in	in	ADP
ajlm-1458	240	28	flow	flow	NOUN
ajlm-1458	240	29	cytometry	cytometry	NOUN
ajlm-1458	240	30	immunophenotyping	immunophenotype	VERB
ajlm-1458	240	31	for	for	ADP
ajlm-1458	240	32	hematologic	hematologic	ADJ
ajlm-1458	240	33	malignancies	malignancy	NOUN
ajlm-1458	240	34	:	:	PUNCT
ajlm-1458	240	35	an	an	DET
ajlm-1458	240	36	analysis	analysis	NOUN
ajlm-1458	240	37	of	of	ADP
ajlm-1458	240	38	health	health	NOUN
ajlm-1458	240	39	resource	resource	NOUN
ajlm-1458	240	40	utilization	utilization	NOUN
ajlm-1458	240	41	.	.	PUNCT
ajlm-1458	241	1	value	value	NOUN
ajlm-1458	241	2	health	health	NOUN
ajlm-1458	241	3	.	.	PUNCT
ajlm-1458	242	1	2015;18(7):a335	2015;18(7):a335	NOUN
ajlm-1458	242	2	–	–	PUNCT
ajlm-1458	242	3	a766	a766	PROPN
ajlm-1458	242	4	.	.	PUNCT
ajlm-1458	243	1	https://doi.org/10.1016/j.jval.2015.09.700	https://doi.org/10.1016/j.jval.2015.09.700	NUM
ajlm-1458	243	2	hedley	hedley	PROPN
ajlm-1458	243	3	bd	bd	PROPN
ajlm-1458	243	4	,	,	PUNCT
ajlm-1458	243	5	cheng	cheng	PROPN
ajlm-1458	243	6	g	g	PROPN
ajlm-1458	243	7	,	,	PUNCT
ajlm-1458	243	8	luider	luider	PROPN
ajlm-1458	243	9	j	j	PROPN
ajlm-1458	243	10	,	,	PUNCT
ajlm-1458	243	11	et	et	PROPN
ajlm-1458	243	12	al	al	PROPN
ajlm-1458	243	13	.	.	PROPN
ajlm-1458	243	14	initial	initial	ADJ
ajlm-1458	243	15	flow	flow	NOUN
ajlm-1458	243	16	cytometric	cytometric	ADJ
ajlm-1458	243	17	evaluation	evaluation	NOUN
ajlm-1458	243	18	of	of	ADP
ajlm-1458	243	19	the	the	DET
ajlm-1458	243	20	clearllab	clearllab	NOUN
ajlm-1458	243	21	lymphoid	lymphoid	NOUN
ajlm-1458	243	22	screen	screen	NOUN
ajlm-1458	243	23	.	.	PUNCT
ajlm-1458	244	1	cytometry	cytometry	PROPN
ajlm-1458	244	2	b	b	PROPN
ajlm-1458	244	3	clin	clin	PROPN
ajlm-1458	244	4	cytom	cytom	PROPN
ajlm-1458	244	5	.	.	PUNCT
ajlm-1458	245	1	2018;94(5):707–713	2018;94(5):707–713	NUM
ajlm-1458	245	2	.	.	PUNCT
ajlm-1458	245	3	https://doi.org/10.1002/cyto.b.21603	https://doi.org/10.1002/cyto.b.21603	VERB
ajlm-1458	245	4	hedley	hedley	PROPN
ajlm-1458	245	5	bd	bd	PROPN
ajlm-1458	245	6	,	,	PUNCT
ajlm-1458	245	7	cheng	cheng	PROPN
ajlm-1458	245	8	g	g	PROPN
ajlm-1458	245	9	,	,	PUNCT
ajlm-1458	245	10	keeney	keeney	PROPN
ajlm-1458	245	11	m	m	PROPN
ajlm-1458	245	12	,	,	PUNCT
ajlm-1458	245	13	et	et	PROPN
ajlm-1458	245	14	al	al	PROPN
ajlm-1458	245	15	.	.	PUNCT
ajlm-1458	246	1	a	a	DET
ajlm-1458	246	2	multicenter	multicenter	ADJ
ajlm-1458	246	3	study	study	NOUN
ajlm-1458	246	4	evaluation	evaluation	NOUN
ajlm-1458	246	5	of	of	ADP
ajlm-1458	246	6	the	the	DET
ajlm-1458	246	7	clearllab	clearllab	NOUN
ajlm-1458	246	8	10c	10c	NUM
ajlm-1458	246	9	panels	panel	NOUN
ajlm-1458	246	10	.	.	PUNCT
ajlm-1458	247	1	cytometry	cytometry	PROPN
ajlm-1458	247	2	b	b	PROPN
ajlm-1458	247	3	clin	clin	PROPN
ajlm-1458	247	4	cytom	cytom	PROPN
ajlm-1458	247	5	.	.	PUNCT
ajlm-1458	248	1	2020	2020	NUM
ajlm-1458	248	2	.	.	PUNCT
ajlm-1458	249	1	bossuyt	bossuyt	NOUN
ajlm-1458	249	2	pm	pm	PROPN
ajlm-1458	249	3	,	,	PUNCT
ajlm-1458	249	4	reitsma	reitsma	VERB
ajlm-1458	249	5	jb	jb	PROPN
ajlm-1458	249	6	,	,	PUNCT
ajlm-1458	249	7	bruns	bruns	PROPN
ajlm-1458	249	8	de	de	PROPN
ajlm-1458	249	9	,	,	PUNCT
ajlm-1458	249	10	et	et	PROPN
ajlm-1458	249	11	al	al	PROPN
ajlm-1458	249	12	.	.	PROPN
ajlm-1458	250	1	towards	towards	ADP
ajlm-1458	250	2	complete	complete	ADJ
ajlm-1458	250	3	and	and	CCONJ
ajlm-1458	250	4	accurate	accurate	ADJ
ajlm-1458	250	5	reporting	reporting	NOUN
ajlm-1458	250	6	of	of	ADP
ajlm-1458	250	7	studies	study	NOUN
ajlm-1458	250	8	of	of	ADP
ajlm-1458	250	9	diagnostic	diagnostic	ADJ
ajlm-1458	250	10	accuracy	accuracy	NOUN
ajlm-1458	250	11	:	:	PUNCT
ajlm-1458	250	12	the	the	DET
ajlm-1458	250	13	stard	stard	PROPN
ajlm-1458	250	14	initiative	initiative	NOUN
ajlm-1458	250	15	.	.	PUNCT
ajlm-1458	251	1	clin	clin	PROPN
ajlm-1458	251	2	chem	chem	NOUN
ajlm-1458	251	3	lab	lab	NOUN
ajlm-1458	251	4	med	me	VERB
ajlm-1458	251	5	.	.	PUNCT
ajlm-1458	252	1	2003;41(1):68–73	2003;41(1):68–73	X
ajlm-1458	252	2	.	.	PUNCT
ajlm-1458	253	1	https://doi.org/10.1515/cclm.2003.012	https://doi.org/10.1515/cclm.2003.012	PROPN
ajlm-1458	253	2	uk	uk	PROPN
ajlm-1458	253	3	neqas	neqas	NOUN
ajlm-1458	253	4	.	.	PUNCT
ajlm-1458	254	1	leukaemia	leukaemia	NOUN
ajlm-1458	254	2	immunophenotyping	immunophenotype	VERB
ajlm-1458	254	3	part	part	NOUN
ajlm-1458	254	4	1	1	NUM
ajlm-1458	254	5	and	and	CCONJ
ajlm-1458	254	6	part	part	NOUN
ajlm-1458	254	7	2	2	NUM
ajlm-1458	254	8	2021	2021	NUM
ajlm-1458	254	9	[	[	X
ajlm-1458	254	10	homepage	homepage	NOUN
ajlm-1458	254	11	on	on	ADP
ajlm-1458	254	12	the	the	DET
ajlm-1458	254	13	internet	internet	NOUN
ajlm-1458	254	14	]	]	PUNCT
ajlm-1458	254	15	.	.	PUNCT
ajlm-1458	255	1	2021	2021	NUM
ajlm-1458	256	1	[	[	X
ajlm-1458	256	2	cited	cite	VERB
ajlm-1458	256	3	2022	2022	NUM
ajlm-1458	256	4	may	may	AUX
ajlm-1458	256	5	]	]	PUNCT
ajlm-1458	256	6	.	.	PUNCT
ajlm-1458	257	1	available	available	ADJ
ajlm-1458	257	2	from	from	ADP
ajlm-1458	257	3	:	:	PUNCT
ajlm-1458	258	1	http://www.ukneqasli.co.uk/eqa-pt-programmes/flow-cytometry-programmes/leukaemia-immunophenotyping-part-1-accredited/	http://www.ukneqasli.co.uk/eqa-pt-programmes/flow-cytometry-programmes/leukaemia-immunophenotyping-part-1-accredited/	PROPN
ajlm-1458	258	2	lawrie	lawrie	PROPN
ajlm-1458	258	3	d	d	PROPN
ajlm-1458	258	4	,	,	PUNCT
ajlm-1458	258	5	coetzee	coetzee	PROPN
ajlm-1458	258	6	lm	lm	PROPN
ajlm-1458	258	7	,	,	PUNCT
ajlm-1458	258	8	glencross	glencross	ADJ
ajlm-1458	258	9	dk	dk	PROPN
ajlm-1458	258	10	.	.	PUNCT
ajlm-1458	259	1	a	a	DET
ajlm-1458	259	2	model	model	NOUN
ajlm-1458	259	3	for	for	ADP
ajlm-1458	259	4	continuous	continuous	ADJ
ajlm-1458	259	5	quality	quality	NOUN
ajlm-1458	259	6	control	control	NOUN
ajlm-1458	259	7	incorporating	incorporate	VERB
ajlm-1458	259	8	sample	sample	NOUN
ajlm-1458	259	9	-	-	PUNCT
ajlm-1458	259	10	to	to	ADP
ajlm-1458	259	11	-	-	PUNCT
ajlm-1458	259	12	sample	sample	NOUN
ajlm-1458	259	13	assessment	assessment	NOUN
ajlm-1458	259	14	of	of	ADP
ajlm-1458	259	15	optical	optical	ADJ
ajlm-1458	259	16	alignment	alignment	NOUN
ajlm-1458	259	17	,	,	PUNCT
ajlm-1458	259	18	fluorescence	fluorescence	NOUN
ajlm-1458	259	19	sensitivity	sensitivity	NOUN
ajlm-1458	259	20	,	,	PUNCT
ajlm-1458	259	21	and	and	CCONJ
ajlm-1458	259	22	volumetric	volumetric	ADJ
ajlm-1458	259	23	operation	operation	NOUN
ajlm-1458	259	24	of	of	ADP
ajlm-1458	259	25	flow	flow	NOUN
ajlm-1458	259	26	cytometers	cytometer	NOUN
ajlm-1458	259	27	.	.	PUNCT
ajlm-1458	260	1	cytometry	cytometry	PROPN
ajlm-1458	260	2	b	b	PROPN
ajlm-1458	260	3	clin	clin	PROPN
ajlm-1458	260	4	cytom	cytom	PROPN
ajlm-1458	260	5	.	.	PUNCT
ajlm-1458	261	1	2010;78(3):201–210	2010;78(3):201–210	X
ajlm-1458	261	2	.	.	PUNCT
ajlm-1458	262	1	https://doi.org/10.1002/cyto.b.20520	https://doi.org/10.1002/cyto.b.20520	PRON
ajlm-1458	262	2	scott	scott	PROPN
ajlm-1458	262	3	le	le	PROPN
ajlm-1458	262	4	,	,	PUNCT
ajlm-1458	262	5	glencross	glencross	PROPN
ajlm-1458	262	6	dk	dk	PROPN
ajlm-1458	262	7	.	.	PROPN
ajlm-1458	262	8	monitoring	monitoring	NOUN
ajlm-1458	262	9	reproducibility	reproducibility	NOUN
ajlm-1458	262	10	of	of	ADP
ajlm-1458	262	11	single	single	ADJ
ajlm-1458	262	12	analysis	analysis	NOUN
ajlm-1458	262	13	,	,	PUNCT
ajlm-1458	262	14	single	single	ADJ
ajlm-1458	262	15	platform	platform	NOUN
ajlm-1458	262	16	cd4	cd4	PROPN
ajlm-1458	262	17	cell	cell	NOUN
ajlm-1458	262	18	counts	count	NOUN
ajlm-1458	262	19	in	in	ADP
ajlm-1458	262	20	a	a	DET
ajlm-1458	262	21	high	high	ADJ
ajlm-1458	262	22	volume	volume	NOUN
ajlm-1458	262	23	,	,	PUNCT
ajlm-1458	262	24	low	low	ADJ
ajlm-1458	262	25	resource	resource	NOUN
ajlm-1458	262	26	laboratory	laboratory	NOUN
ajlm-1458	262	27	setting	set	VERB
ajlm-1458	262	28	using	use	VERB
ajlm-1458	262	29	sequential	sequential	ADJ
ajlm-1458	262	30	bead	bead	NOUN
ajlm-1458	262	31	count	count	NOUN
ajlm-1458	262	32	rates	rate	NOUN
ajlm-1458	262	33	.	.	PUNCT
ajlm-1458	263	1	cytometry	cytometry	PROPN
ajlm-1458	263	2	b	b	PROPN
ajlm-1458	263	3	clin	clin	PROPN
ajlm-1458	263	4	cytom	cytom	NOUN
ajlm-1458	263	5	.	.	PUNCT
ajlm-1458	264	1	2005;67(1):31–32	2005;67(1):31–32	NUM
ajlm-1458	264	2	.	.	PUNCT
ajlm-1458	265	1	https://doi.org/10.1002/cyto.b.20066	https://doi.org/10.1002/cyto.b.20066	X
ajlm-1458	265	2	coulter	coulter	PROPN
ajlm-1458	265	3	b.	b.	PROPN
ajlm-1458	265	4	clearlab	clearlab	PROPN
ajlm-1458	265	5	10c	10c	PROPN
ajlm-1458	265	6	application	application	NOUN
ajlm-1458	265	7	system	system	NOUN
ajlm-1458	265	8	guide	guide	NOUN
ajlm-1458	265	9	.	.	PUNCT
ajlm-1458	266	1	1st	1st	ADJ
ajlm-1458	266	2	ed	ed	NOUN
ajlm-1458	266	3	.	.	PUNCT
ajlm-1458	266	4	clare	clare	PROPN
ajlm-1458	266	5	:	:	PUNCT
ajlm-1458	267	1	beckman	beckman	PROPN
ajlm-1458	267	2	coulter	coulter	PROPN
ajlm-1458	267	3	ireland	ireland	PROPN
ajlm-1458	267	4	inc	inc	PROPN
ajlm-1458	267	5	;	;	PUNCT
ajlm-1458	267	6	2019	2019	NUM
ajlm-1458	267	7	.	.	PUNCT
ajlm-1458	268	1	clinical	clinical	PROPN
ajlm-1458	268	2	&	&	CCONJ
ajlm-1458	268	3	laboratory	laboratory	PROPN
ajlm-1458	268	4	standards	standards	PROPN
ajlm-1458	268	5	institute	institute	PROPN
ajlm-1458	268	6	.	.	PUNCT
ajlm-1458	269	1	ep12	ep12	PROPN
ajlm-1458	269	2	-	-	PUNCT
ajlm-1458	269	3	a	a	DET
ajlm-1458	269	4	user	user	NOUN
ajlm-1458	269	5	protocol	protocol	NOUN
ajlm-1458	269	6	for	for	ADP
ajlm-1458	269	7	validation	validation	NOUN
ajlm-1458	269	8	of	of	ADP
ajlm-1458	269	9	quantitative	quantitative	ADJ
ajlm-1458	269	10	test	test	NOUN
ajlm-1458	269	11	performance	performance	NOUN
ajlm-1458	269	12	;	;	PUNCT
ajlm-1458	269	13	approved	approve	VERB
ajlm-1458	269	14	guideline	guideline	NOUN
ajlm-1458	269	15	.	.	PUNCT
ajlm-1458	270	1	wayne	wayne	PROPN
ajlm-1458	270	2	,	,	PUNCT
ajlm-1458	270	3	pa	pa	PROPN
ajlm-1458	270	4	:	:	PUNCT
ajlm-1458	270	5	clsi	clsi	ADJ
ajlm-1458	270	6	;	;	PUNCT
ajlm-1458	270	7	2002	2002	NUM
ajlm-1458	270	8	.	.	PUNCT
ajlm-1458	271	1	zeidan	zeidan	PROPN
ajlm-1458	271	2	ma	ma	PROPN
ajlm-1458	271	3	,	,	PUNCT
ajlm-1458	271	4	kamal	kamal	PROPN
ajlm-1458	271	5	hm	hm	PROPN
ajlm-1458	271	6	,	,	PUNCT
ajlm-1458	271	7	el	el	PROPN
ajlm-1458	271	8	shabrawy	shabrawy	PROPN
ajlm-1458	271	9	da	da	PROPN
ajlm-1458	271	10	,	,	PUNCT
ajlm-1458	271	11	esh	esh	PROPN
ajlm-1458	271	12	am	be	AUX
ajlm-1458	271	13	,	,	PUNCT
ajlm-1458	271	14	sattar	sattar	PROPN
ajlm-1458	271	15	rh	rh	PROPN
ajlm-1458	271	16	.	.	PROPN
ajlm-1458	271	17	significance	significance	NOUN
ajlm-1458	271	18	of	of	ADP
ajlm-1458	271	19	cd34	cd34	PROPN
ajlm-1458	271	20	/	/	SYM
ajlm-1458	271	21	cd123	cd123	PROPN
ajlm-1458	271	22	expression	expression	NOUN
ajlm-1458	271	23	in	in	ADP
ajlm-1458	271	24	detection	detection	NOUN
ajlm-1458	271	25	of	of	ADP
ajlm-1458	271	26	minimal	minimal	ADJ
ajlm-1458	271	27	residual	residual	ADJ
ajlm-1458	271	28	disease	disease	NOUN
ajlm-1458	271	29	in	in	ADP
ajlm-1458	271	30	b	b	ADJ
ajlm-1458	271	31	-	-	PUNCT
ajlm-1458	271	32	acute	acute	ADJ
ajlm-1458	271	33	lymphoblastic	lymphoblastic	ADJ
ajlm-1458	271	34	leukemia	leukemia	NOUN
ajlm-1458	271	35	in	in	ADP
ajlm-1458	271	36	children	child	NOUN
ajlm-1458	271	37	.	.	PUNCT
ajlm-1458	272	1	blood	blood	NOUN
ajlm-1458	272	2	cells	cell	NOUN
ajlm-1458	272	3	mol	mol	ADP
ajlm-1458	272	4	dis	dis	PROPN
ajlm-1458	272	5	.	.	PUNCT
ajlm-1458	273	1	2016;59:113–118	2016;59:113–118	NUM
ajlm-1458	273	2	.	.	PUNCT
ajlm-1458	274	1	https://doi.org/10.1016/j.bcmd.2016.05.005	https://doi.org/10.1016/j.bcmd.2016.05.005	PROPN
ajlm-1458	274	2	bras	bras	PROPN
ajlm-1458	274	3	ae	ae	PROPN
ajlm-1458	274	4	,	,	PUNCT
ajlm-1458	274	5	de	de	PROPN
ajlm-1458	274	6	haas	haas	PROPN
ajlm-1458	274	7	v	v	PROPN
ajlm-1458	274	8	,	,	PUNCT
ajlm-1458	274	9	van	van	PROPN
ajlm-1458	274	10	stigt	stigt	NOUN
ajlm-1458	274	11	a	a	PRON
ajlm-1458	274	12	,	,	PUNCT
ajlm-1458	274	13	et	et	PROPN
ajlm-1458	274	14	al	al	PROPN
ajlm-1458	274	15	.	.	PUNCT
ajlm-1458	274	16	cd123	cd123	PROPN
ajlm-1458	274	17	expression	expression	NOUN
ajlm-1458	274	18	levels	level	NOUN
ajlm-1458	274	19	in	in	ADP
ajlm-1458	274	20	846	846	NUM
ajlm-1458	274	21	acute	acute	ADJ
ajlm-1458	274	22	leukemia	leukemia	NOUN
ajlm-1458	274	23	patients	patient	NOUN
ajlm-1458	274	24	based	base	VERB
ajlm-1458	274	25	on	on	ADP
ajlm-1458	274	26	standardised	standardised	ADJ
ajlm-1458	274	27	immunophenotyping	immunophenotyping	NOUN
ajlm-1458	274	28	.	.	PUNCT
ajlm-1458	275	1	cytometry	cytometry	PROPN
ajlm-1458	275	2	b	b	PROPN
ajlm-1458	275	3	clin	clin	PROPN
ajlm-1458	275	4	cytom	cytom	NOUN
ajlm-1458	275	5	.	.	PUNCT
ajlm-1458	276	1	2019;96(2):134–142	2019;96(2):134–142	NUM
ajlm-1458	276	2	.	.	PUNCT
ajlm-1458	277	1	https://doi.org/10.1002/cyto.b.21745	https://doi.org/10.1002/cyto.b.21745	PROPN
ajlm-1458	277	2	van	van	PROPN
ajlm-1458	277	3	dongen	dongen	PROPN
ajlm-1458	277	4	jj	jj	PROPN
ajlm-1458	277	5	,	,	PUNCT
ajlm-1458	277	6	orfao	orfao	NOUN
ajlm-1458	277	7	a	a	PRON
ajlm-1458	277	8	,	,	PUNCT
ajlm-1458	277	9	euroflow	euroflow	ADJ
ajlm-1458	277	10	c.	c.	PROPN
ajlm-1458	277	11	euroflow	euroflow	PROPN
ajlm-1458	277	12	:	:	PUNCT
ajlm-1458	277	13	resetting	reset	VERB
ajlm-1458	277	14	leukemia	leukemia	NOUN
ajlm-1458	277	15	and	and	CCONJ
ajlm-1458	277	16	lymphoma	lymphoma	NOUN
ajlm-1458	277	17	immunophenotyping	immunophenotype	VERB
ajlm-1458	277	18	.	.	PUNCT
ajlm-1458	278	1	basis	basis	NOUN
ajlm-1458	278	2	for	for	ADP
ajlm-1458	278	3	companion	companion	NOUN
ajlm-1458	278	4	diagnostics	diagnostic	NOUN
ajlm-1458	278	5	and	and	CCONJ
ajlm-1458	278	6	personalised	personalised	ADJ
ajlm-1458	278	7	medicine	medicine	NOUN
ajlm-1458	278	8	.	.	PUNCT
ajlm-1458	279	1	leukemia	leukemia	NOUN
ajlm-1458	279	2	.	.	PUNCT
ajlm-1458	280	1	2012;26(9):1899–1907	2012;26(9):1899–1907	NUM
ajlm-1458	280	2	.	.	PUNCT
ajlm-1458	281	1	https://doi.org/10.1038/leu.2012.121	https://doi.org/10.1038/leu.2012.121	PROPN
ajlm-1458	281	2	van	van	PROPN
ajlm-1458	281	3	der	der	PROPN
ajlm-1458	281	4	velden	velden	PROPN
ajlm-1458	281	5	vhj	vhj	PROPN
ajlm-1458	281	6	,	,	PUNCT
ajlm-1458	281	7	flores	flores	PROPN
ajlm-1458	281	8	-	-	PUNCT
ajlm-1458	281	9	montero	montero	PROPN
ajlm-1458	281	10	j	j	PROPN
ajlm-1458	281	11	,	,	PUNCT
ajlm-1458	281	12	perez	perez	PROPN
ajlm-1458	281	13	-	-	PUNCT
ajlm-1458	281	14	andres	andres	PROPN
ajlm-1458	281	15	m	m	PROPN
ajlm-1458	281	16	,	,	PUNCT
ajlm-1458	281	17	et	et	PROPN
ajlm-1458	281	18	al	al	PROPN
ajlm-1458	281	19	.	.	PROPN
ajlm-1458	281	20	optimisation	optimisation	NOUN
ajlm-1458	281	21	and	and	CCONJ
ajlm-1458	281	22	testing	testing	NOUN
ajlm-1458	281	23	of	of	ADP
ajlm-1458	281	24	dried	dry	VERB
ajlm-1458	281	25	antibody	antibody	NOUN
ajlm-1458	281	26	tube	tube	NOUN
ajlm-1458	281	27	:	:	PUNCT
ajlm-1458	281	28	the	the	DET
ajlm-1458	281	29	euroflow	euroflow	ADJ
ajlm-1458	281	30	lst	lst	NOUN
ajlm-1458	281	31	and	and	CCONJ
ajlm-1458	281	32	pidot	pidot	NOUN
ajlm-1458	281	33	tubes	tube	NOUN
ajlm-1458	281	34	as	as	ADP
ajlm-1458	281	35	examples	example	NOUN
ajlm-1458	281	36	.	.	PUNCT
ajlm-1458	282	1	j	j	PROPN
ajlm-1458	282	2	immunol	immunol	NOUN
ajlm-1458	282	3	methods	method	NOUN
ajlm-1458	282	4	.	.	PUNCT
ajlm-1458	283	1	2019;475:112287	2019;475:112287	NUM
ajlm-1458	283	2	.	.	PUNCT
ajlm-1458	284	1	https://doi.org/10.1016/j.jim.2017.03.011	https://doi.org/10.1016/j.jim.2017.03.011	AUX
ajlm-1458	284	2	glencross	glencross	ADJ
ajlm-1458	284	3	dk	dk	PROPN
ajlm-1458	284	4	,	,	PUNCT
ajlm-1458	284	5	coetzee	coetzee	PROPN
ajlm-1458	284	6	lm	lm	PROPN
ajlm-1458	284	7	,	,	PUNCT
ajlm-1458	284	8	cassim	cassim	PROPN
ajlm-1458	284	9	n.	n.	PROPN
ajlm-1458	284	10	an	an	DET
ajlm-1458	284	11	integrated	integrate	VERB
ajlm-1458	284	12	tiered	tiere	VERB
ajlm-1458	284	13	service	service	NOUN
ajlm-1458	284	14	delivery	delivery	NOUN
ajlm-1458	284	15	model	model	NOUN
ajlm-1458	284	16	(	(	PUNCT
ajlm-1458	284	17	itsdm	itsdm	PROPN
ajlm-1458	284	18	)	)	PUNCT
ajlm-1458	284	19	based	base	VERB
ajlm-1458	284	20	on	on	ADP
ajlm-1458	284	21	local	local	ADJ
ajlm-1458	284	22	cd4	cd4	PROPN
ajlm-1458	284	23	testing	testing	NOUN
ajlm-1458	284	24	demands	demand	NOUN
ajlm-1458	284	25	can	can	AUX
ajlm-1458	284	26	improve	improve	VERB
ajlm-1458	284	27	turn	turn	NOUN
ajlm-1458	284	28	-	-	PUNCT
ajlm-1458	284	29	around	around	ADP
ajlm-1458	284	30	times	time	NOUN
ajlm-1458	284	31	and	and	CCONJ
ajlm-1458	284	32	save	save	VERB
ajlm-1458	284	33	costs	cost	NOUN
ajlm-1458	284	34	whilst	whilst	SCONJ
ajlm-1458	284	35	ensuring	ensure	VERB
ajlm-1458	284	36	accessible	accessible	ADJ
ajlm-1458	284	37	and	and	CCONJ
ajlm-1458	284	38	scalable	scalable	ADJ
ajlm-1458	284	39	cd4	cd4	PROPN
ajlm-1458	284	40	services	service	NOUN
ajlm-1458	284	41	across	across	ADP
ajlm-1458	284	42	a	a	DET
ajlm-1458	284	43	national	national	ADJ
ajlm-1458	284	44	programme	programme	NOUN
ajlm-1458	284	45	.	.	PUNCT
ajlm-1458	285	1	plos	plos	PROPN
ajlm-1458	285	2	one	one	NUM
ajlm-1458	285	3	.	.	PUNCT
ajlm-1458	286	1	2014;9(12):e114727	2014;9(12):e114727	NOUN
ajlm-1458	286	2	.	.	PUNCT
ajlm-1458	287	1	https://doi.org/10.1371/journal.pone.0114727	https://doi.org/10.1371/journal.pone.0114727	PROPN
ajlm-1458	287	2	glencross	glencross	PROPN
ajlm-1458	287	3	dk	dk	PROPN
ajlm-1458	287	4	,	,	PUNCT
ajlm-1458	287	5	janossy	janossy	NOUN
ajlm-1458	287	6	g	g	PROPN
ajlm-1458	287	7	,	,	PUNCT
ajlm-1458	287	8	coetzee	coetzee	PROPN
ajlm-1458	287	9	lm	lm	PROPN
ajlm-1458	287	10	,	,	PUNCT
ajlm-1458	287	11	et	et	PROPN
ajlm-1458	287	12	al	al	PROPN
ajlm-1458	287	13	.	.	PUNCT
ajlm-1458	288	1	large	large	ADJ
ajlm-1458	288	2	-	-	PUNCT
ajlm-1458	288	3	scale	scale	NOUN
ajlm-1458	288	4	affordable	affordable	ADJ
ajlm-1458	288	5	panleucogated	panleucogate	VERB
ajlm-1458	288	6	cd4	cd4	PROPN
ajlm-1458	288	7	+	+	PROPN
ajlm-1458	288	8	testing	testing	NOUN
ajlm-1458	288	9	with	with	ADP
ajlm-1458	288	10	proactive	proactive	ADJ
ajlm-1458	288	11	internal	internal	ADJ
ajlm-1458	288	12	and	and	CCONJ
ajlm-1458	288	13	external	external	ADJ
ajlm-1458	288	14	quality	quality	NOUN
ajlm-1458	288	15	assessment	assessment	NOUN
ajlm-1458	288	16	:	:	PUNCT
ajlm-1458	288	17	in	in	ADP
ajlm-1458	288	18	support	support	NOUN
ajlm-1458	288	19	of	of	ADP
ajlm-1458	288	20	the	the	DET
ajlm-1458	288	21	south	south	ADJ
ajlm-1458	288	22	african	african	ADJ
ajlm-1458	288	23	national	national	PROPN
ajlm-1458	288	24	comprehensive	comprehensive	PROPN
ajlm-1458	288	25	care	care	NOUN
ajlm-1458	288	26	,	,	PUNCT
ajlm-1458	288	27	treatment	treatment	NOUN
ajlm-1458	288	28	and	and	CCONJ
ajlm-1458	288	29	management	management	NOUN
ajlm-1458	288	30	programme	programme	NOUN
ajlm-1458	288	31	for	for	ADP
ajlm-1458	288	32	hiv	hiv	PROPN
ajlm-1458	288	33	and	and	CCONJ
ajlm-1458	288	34	aids	aids	PROPN
ajlm-1458	288	35	.	.	PUNCT
ajlm-1458	289	1	cytometry	cytometry	PROPN
ajlm-1458	289	2	b	b	PROPN
ajlm-1458	289	3	clin	clin	PROPN
ajlm-1458	289	4	cytom	cytom	PROPN
ajlm-1458	289	5	.	.	PUNCT
ajlm-1458	290	1	2008;74	2008;74	NUM
ajlm-1458	290	2	suppl	suppl	ADJ
ajlm-1458	290	3	1	1	NUM
ajlm-1458	290	4	:	:	PUNCT
ajlm-1458	290	5	s40	s40	NOUN
ajlm-1458	290	6	–	–	PUNCT
ajlm-1458	290	7	s51	s51	X
ajlm-1458	290	8	.	.	PUNCT
ajlm-1458	291	1	https://doi.org/10.1002/cyto.b.20384	https://doi.org/10.1002/cyto.b.20384	X
ajlm-1458	291	2	coetzee	coetzee	PROPN
ajlm-1458	291	3	lm	lm	PROPN
ajlm-1458	291	4	,	,	PUNCT
ajlm-1458	291	5	glencross	glencross	ADJ
ajlm-1458	291	6	dk	dk	PROPN
ajlm-1458	291	7	.	.	PROPN
ajlm-1458	291	8	performance	performance	NOUN
ajlm-1458	291	9	verification	verification	NOUN
ajlm-1458	291	10	of	of	ADP
ajlm-1458	291	11	the	the	DET
ajlm-1458	291	12	new	new	ADJ
ajlm-1458	291	13	fully	fully	ADV
ajlm-1458	291	14	automated	automate	VERB
ajlm-1458	291	15	aquios	aquio	NOUN
ajlm-1458	291	16	flow	flow	NOUN
ajlm-1458	291	17	cytometer	cytometer	NOUN
ajlm-1458	291	18	panleucogate	panleucogate	NOUN
ajlm-1458	291	19	(	(	PUNCT
ajlm-1458	291	20	plg	plg	NOUN
ajlm-1458	291	21	)	)	PUNCT
ajlm-1458	291	22	platform	platform	NOUN
ajlm-1458	291	23	for	for	ADP
ajlm-1458	291	24	cd4	cd4	PROPN
ajlm-1458	291	25	-	-	PUNCT
ajlm-1458	291	26	t	t	PROPN
ajlm-1458	291	27	-	-	PUNCT
ajlm-1458	291	28	lymphocyte	lymphocyte	NOUN
ajlm-1458	291	29	enumeration	enumeration	NOUN
ajlm-1458	291	30	in	in	ADP
ajlm-1458	291	31	south	south	PROPN
ajlm-1458	291	32	africa	africa	PROPN
ajlm-1458	291	33	.	.	PUNCT
ajlm-1458	292	1	plos	plos	PROPN
ajlm-1458	292	2	one	one	NUM
ajlm-1458	292	3	.	.	PUNCT
ajlm-1458	293	1	2017;12(11):e0187456	2017;12(11):e0187456	NOUN
ajlm-1458	293	2	.	.	PUNCT
ajlm-1458	294	1	https://doi.org/10.1371/journal.pone.0187456	https://doi.org/10.1371/journal.pone.0187456	PROPN
ajlm-1458	294	2	glier	glier	PROPN
ajlm-1458	294	3	h	h	NOUN
ajlm-1458	294	4	,	,	PUNCT
ajlm-1458	294	5	novakova	novakova	PROPN
ajlm-1458	294	6	m	m	PROPN
ajlm-1458	294	7	,	,	PUNCT
ajlm-1458	294	8	te	te	PROPN
ajlm-1458	294	9	marvelde	marvelde	PROPN
ajlm-1458	294	10	j	j	PROPN
ajlm-1458	294	11	,	,	PUNCT
ajlm-1458	294	12	et	et	PROPN
ajlm-1458	294	13	al	al	PROPN
ajlm-1458	294	14	.	.	PROPN
ajlm-1458	294	15	comments	comment	NOUN
ajlm-1458	294	16	on	on	ADP
ajlm-1458	294	17	euroflow	euroflow	ADJ
ajlm-1458	294	18	standard	standard	ADJ
ajlm-1458	294	19	operating	operating	NOUN
ajlm-1458	294	20	procedures	procedure	NOUN
ajlm-1458	294	21	for	for	ADP
ajlm-1458	294	22	instrument	instrument	NOUN
ajlm-1458	294	23	set	set	NOUN
ajlm-1458	294	24	-	-	PUNCT
ajlm-1458	294	25	up	up	NOUN
ajlm-1458	294	26	and	and	CCONJ
ajlm-1458	294	27	compensation	compensation	NOUN
ajlm-1458	294	28	for	for	ADP
ajlm-1458	294	29	bd	bd	PROPN
ajlm-1458	294	30	facs	facs	PROPN
ajlm-1458	294	31	canto	canto	PROPN
ajlm-1458	294	32	ii	ii	PROPN
ajlm-1458	294	33	,	,	PUNCT
ajlm-1458	294	34	navios	navio	NOUN
ajlm-1458	294	35	and	and	CCONJ
ajlm-1458	294	36	bd	bd	PROPN
ajlm-1458	294	37	facs	facs	PROPN
ajlm-1458	294	38	lyric	lyric	NOUN
ajlm-1458	294	39	instruments	instrument	NOUN
ajlm-1458	294	40	.	.	PUNCT
ajlm-1458	295	1	j	j	PROPN
ajlm-1458	295	2	immunol	immunol	NOUN
ajlm-1458	295	3	methods	method	NOUN
ajlm-1458	295	4	.	.	PUNCT
ajlm-1458	296	1	2019;475:112680	2019;475:112680	X
ajlm-1458	296	2	.	.	PUNCT
ajlm-1458	297	1	https://doi.org/10.1016/j.jim.2019.112680	https://doi.org/10.1016/j.jim.2019.112680	PROPN
ajlm-1458	297	2	hedley	hedley	PROPN
ajlm-1458	297	3	bd	bd	PROPN
ajlm-1458	297	4	,	,	PUNCT
ajlm-1458	297	5	keeney	keeney	PROPN
ajlm-1458	297	6	m	m	PROPN
ajlm-1458	297	7	,	,	PUNCT
ajlm-1458	297	8	popma	popma	PROPN
ajlm-1458	297	9	j	j	PROPN
ajlm-1458	297	10	,	,	PUNCT
ajlm-1458	297	11	chin	chin	PROPN
ajlm-1458	297	12	-	-	PUNCT
ajlm-1458	297	13	yee	yee	PROPN
ajlm-1458	297	14	i.	i.	PROPN
ajlm-1458	297	15	novel	novel	PROPN
ajlm-1458	297	16	lymphocyte	lymphocyte	NOUN
ajlm-1458	297	17	screening	screen	VERB
ajlm-1458	297	18	tube	tube	NOUN
ajlm-1458	297	19	using	use	VERB
ajlm-1458	297	20	dried	dry	VERB
ajlm-1458	297	21	monoclonal	monoclonal	NOUN
ajlm-1458	297	22	antibody	antibody	NOUN
ajlm-1458	297	23	reagents	reagent	NOUN
ajlm-1458	297	24	.	.	PUNCT
ajlm-1458	298	1	cytometry	cytometry	PROPN
ajlm-1458	298	2	b	b	PROPN
ajlm-1458	298	3	clin	clin	PROPN
ajlm-1458	298	4	cytom	cytom	PROPN
ajlm-1458	298	5	.	.	PUNCT
ajlm-1458	299	1	2015;88(6):361–370	2015;88(6):361–370	NUM
ajlm-1458	299	2	.	.	PUNCT
ajlm-1458	299	3	https://doi.org/10.1002/cyto.b.21251	https://doi.org/10.1002/cyto.b.21251	X
ajlm-1458	299	4	flores	flores	PROPN
ajlm-1458	299	5	-	-	PUNCT
ajlm-1458	299	6	montero	montero	PROPN
ajlm-1458	299	7	j	j	PROPN
ajlm-1458	299	8	,	,	PUNCT
ajlm-1458	299	9	grigore	grigore	VERB
ajlm-1458	299	10	g	g	NOUN
ajlm-1458	299	11	,	,	PUNCT
ajlm-1458	299	12	fluxa	fluxa	NOUN
ajlm-1458	299	13	r	r	NOUN
ajlm-1458	299	14	,	,	PUNCT
ajlm-1458	299	15	et	et	PROPN
ajlm-1458	299	16	al	al	PROPN
ajlm-1458	299	17	.	.	PROPN
ajlm-1458	299	18	euroflow	euroflow	PROPN
ajlm-1458	299	19	lymphoid	lymphoid	NOUN
ajlm-1458	299	20	screening	screen	VERB
ajlm-1458	299	21	tube	tube	NOUN
ajlm-1458	299	22	(	(	PUNCT
ajlm-1458	299	23	lst	lst	NOUN
ajlm-1458	299	24	)	)	PUNCT
ajlm-1458	299	25	database	database	NOUN
ajlm-1458	299	26	for	for	ADP
ajlm-1458	299	27	automated	automate	VERB
ajlm-1458	299	28	identification	identification	NOUN
ajlm-1458	299	29	of	of	ADP
ajlm-1458	299	30	blood	blood	NOUN
ajlm-1458	299	31	lymphocyte	lymphocyte	ADJ
ajlm-1458	299	32	subsets	subset	NOUN
ajlm-1458	299	33	.	.	PUNCT
ajlm-1458	300	1	j	j	PROPN
ajlm-1458	300	2	immunol	immunol	NOUN
ajlm-1458	300	3	methods	method	NOUN
ajlm-1458	300	4	.	.	PUNCT
ajlm-1458	301	1	2019;475:112662	2019;475:112662	NUM
ajlm-1458	301	2	.	.	PUNCT
ajlm-1458	302	1	https://doi.org/10.1016/j.jim.2019.112662	https://doi.org/10.1016/j.jim.2019.112662	PUNCT
ajlm-1458	302	2	bento	bento	NOUN
ajlm-1458	302	3	l	l	NOUN
ajlm-1458	302	4	,	,	PUNCT
ajlm-1458	302	5	correia	correia	PROPN
ajlm-1458	302	6	r	r	PROPN
ajlm-1458	302	7	,	,	PUNCT
ajlm-1458	302	8	de	de	PROPN
ajlm-1458	302	9	sousa	sousa	PROPN
ajlm-1458	302	10	f	f	PROPN
ajlm-1458	302	11	,	,	PUNCT
ajlm-1458	302	12	et	et	PROPN
ajlm-1458	302	13	al	al	PROPN
ajlm-1458	302	14	.	.	PUNCT
ajlm-1458	302	15	performance	performance	NOUN
ajlm-1458	302	16	of	of	ADP
ajlm-1458	302	17	eight	eight	NUM
ajlm-1458	302	18	-	-	PUNCT
ajlm-1458	302	19	colour	colour	NOUN
ajlm-1458	302	20	dry	dry	ADJ
ajlm-1458	302	21	antibody	antibody	NOUN
ajlm-1458	302	22	reagent	reagent	NOUN
ajlm-1458	302	23	in	in	ADP
ajlm-1458	302	24	the	the	DET
ajlm-1458	302	25	detection	detection	NOUN
ajlm-1458	302	26	of	of	ADP
ajlm-1458	302	27	minimal	minimal	ADJ
ajlm-1458	302	28	residual	residual	ADJ
ajlm-1458	302	29	disease	disease	NOUN
ajlm-1458	302	30	in	in	ADP
ajlm-1458	302	31	chronic	chronic	ADJ
ajlm-1458	302	32	lymphocytic	lymphocytic	ADJ
ajlm-1458	302	33	leukemia	leukemia	NOUN
ajlm-1458	302	34	samples	sample	NOUN
ajlm-1458	302	35	.	.	PUNCT
ajlm-1458	303	1	cytometry	cytometry	PROPN
ajlm-1458	303	2	b	b	PROPN
ajlm-1458	303	3	clin	clin	PROPN
ajlm-1458	303	4	cytom	cytom	PROPN
ajlm-1458	303	5	.	.	PUNCT
ajlm-1458	304	1	2020	2020	NUM
ajlm-1458	304	2	.	.	PUNCT
ajlm-1458	305	1	https://doi.org/10.1002/cyto.b.21875	https://doi.org/10.1002/cyto.b.21875	X
ajlm-1458	305	2	rajab	rajab	VERB
ajlm-1458	305	3	a	a	NOUN
ajlm-1458	305	4	,	,	PUNCT
ajlm-1458	305	5	axler	axler	NOUN
ajlm-1458	305	6	o	o	NOUN
ajlm-1458	305	7	,	,	PUNCT
ajlm-1458	305	8	leung	leung	PROPN
ajlm-1458	305	9	j	j	PROPN
ajlm-1458	305	10	,	,	PUNCT
ajlm-1458	305	11	wozniak	wozniak	PROPN
ajlm-1458	305	12	m	m	PROPN
ajlm-1458	305	13	,	,	PUNCT
ajlm-1458	305	14	porwit	porwit	NOUN
ajlm-1458	305	15	a.	a.	NOUN
ajlm-1458	305	16	ten	ten	NUM
ajlm-1458	305	17	-	-	PUNCT
ajlm-1458	305	18	color	color	NOUN
ajlm-1458	305	19	15	15	NUM
ajlm-1458	305	20	-	-	PUNCT
ajlm-1458	305	21	antibody	antibody	NOUN
ajlm-1458	305	22	flow	flow	NOUN
ajlm-1458	305	23	cytometry	cytometry	NOUN
ajlm-1458	305	24	panel	panel	NOUN
ajlm-1458	305	25	for	for	ADP
ajlm-1458	305	26	immunophenotyping	immunophenotype	VERB
ajlm-1458	305	27	of	of	ADP
ajlm-1458	305	28	lymphocyte	lymphocyte	ADJ
ajlm-1458	305	29	population	population	NOUN
ajlm-1458	305	30	.	.	PUNCT
ajlm-1458	306	1	int	int	NOUN
ajlm-1458	306	2	j	j	PROPN
ajlm-1458	306	3	lab	lab	NOUN
ajlm-1458	306	4	hematol	hematol	NOUN
ajlm-1458	306	5	.	.	PUNCT
ajlm-1458	307	1	2017;39	2017;39	NUM
ajlm-1458	307	2	suppl	suppl	ADJ
ajlm-1458	307	3	1:76–85	1:76–85	NUM
ajlm-1458	307	4	.	.	PUNCT
ajlm-1458	308	1	https://doi.org/10.1111/ijlh.12678	https://doi.org/10.1111/ijlh.12678	PROPN
ajlm-1458	308	2	correia	correia	PROPN
ajlm-1458	308	3	rp	rp	PROPN
ajlm-1458	308	4	,	,	PUNCT
ajlm-1458	308	5	rajab	rajab	VERB
ajlm-1458	308	6	a	a	PRON
ajlm-1458	308	7	,	,	PUNCT
ajlm-1458	308	8	bento	bento	NOUN
ajlm-1458	308	9	lc	lc	PROPN
ajlm-1458	308	10	,	,	PUNCT
ajlm-1458	308	11	et	et	PROPN
ajlm-1458	308	12	al	al	PROPN
ajlm-1458	308	13	.	.	PUNCT
ajlm-1458	309	1	a	a	DET
ajlm-1458	309	2	ten	ten	NUM
ajlm-1458	309	3	-	-	PUNCT
ajlm-1458	309	4	colour	colour	NOUN
ajlm-1458	309	5	tube	tube	NOUN
ajlm-1458	309	6	with	with	ADP
ajlm-1458	309	7	dried	dry	VERB
ajlm-1458	309	8	antibody	antibody	NOUN
ajlm-1458	309	9	reagents	reagent	NOUN
ajlm-1458	309	10	for	for	ADP
ajlm-1458	309	11	the	the	DET
ajlm-1458	309	12	screening	screening	NOUN
ajlm-1458	309	13	of	of	ADP
ajlm-1458	309	14	hematological	hematological	ADJ
ajlm-1458	309	15	malignancies	malignancy	NOUN
ajlm-1458	309	16	.	.	PUNCT
ajlm-1458	310	1	int	int	PROPN
ajlm-1458	310	2	j	j	PROPN
ajlm-1458	310	3	lab	lab	NOUN
ajlm-1458	310	4	hematol	hematol	NOUN
ajlm-1458	310	5	.	.	PUNCT
ajlm-1458	311	1	2018;40(2):136–143	2018;40(2):136–143	X
ajlm-1458	311	2	.	.	PUNCT
ajlm-1458	311	3	https://doi.org/10.1111/ijlh.12753	https://doi.org/10.1111/ijlh.12753	PROPN
ajlm-1458	311	4	bouriche	bouriche	PROPN
ajlm-1458	311	5	l	l	NOUN
ajlm-1458	311	6	,	,	PUNCT
ajlm-1458	311	7	bernot	bernot	VERB
ajlm-1458	311	8	d	d	NOUN
ajlm-1458	311	9	,	,	PUNCT
ajlm-1458	311	10	nivaggioni	nivaggioni	ADJ
ajlm-1458	311	11	v	v	NOUN
ajlm-1458	311	12	,	,	PUNCT
ajlm-1458	311	13	arnoux	arnoux	NOUN
ajlm-1458	311	14	i	i	PRON
ajlm-1458	311	15	,	,	PUNCT
ajlm-1458	311	16	loosveld	loosveld	PROPN
ajlm-1458	311	17	m.	m.	NOUN
ajlm-1458	311	18	detection	detection	NOUN
ajlm-1458	311	19	of	of	ADP
ajlm-1458	311	20	minimal	minimal	ADJ
ajlm-1458	311	21	residual	residual	ADJ
ajlm-1458	311	22	disease	disease	NOUN
ajlm-1458	311	23	in	in	ADP
ajlm-1458	311	24	b	b	PROPN
ajlm-1458	311	25	cell	cell	NOUN
ajlm-1458	311	26	acute	acute	NOUN
ajlm-1458	311	27	lymphoblastic	lymphoblastic	ADJ
ajlm-1458	311	28	leukemia	leukemia	NOUN
ajlm-1458	311	29	using	use	VERB
ajlm-1458	311	30	an	an	DET
ajlm-1458	311	31	eight	eight	NUM
ajlm-1458	311	32	-	-	PUNCT
ajlm-1458	311	33	color	color	NOUN
ajlm-1458	311	34	tube	tube	NOUN
ajlm-1458	311	35	with	with	ADP
ajlm-1458	311	36	dried	dry	VERB
ajlm-1458	311	37	antibody	antibody	NOUN
ajlm-1458	311	38	reagents	reagent	NOUN
ajlm-1458	311	39	.	.	PUNCT
ajlm-1458	312	1	cytometry	cytometry	PROPN
ajlm-1458	312	2	b	b	PROPN
ajlm-1458	312	3	clin	clin	PROPN
ajlm-1458	312	4	cytom	cytom	PROPN
ajlm-1458	312	5	.	.	PUNCT
ajlm-1458	313	1	2019;96(2):158–163	2019;96(2):158–163	NUM
ajlm-1458	313	2	.	.	PUNCT
ajlm-1458	313	3	https://doi.org/10.1002/cyto.b.21766	https://doi.org/10.1002/cyto.b.21766	PUNCT